Data Requirements for Antimicrobial Pesticides, 59382-59446 [E8-23127]
Download as PDF
59382
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Parts 158 and 161
RIN 2070–AD30
Data Requirements for Antimicrobial
Pesticides
Environmental Protection
Agency (EPA).
ACTION: Proposed rule.
AGENCY:
SUMMARY: EPA proposes to revise and
update the existing data requirements
for antimicrobial pesticides. The
proposed revisions are needed to reflect
current scientific knowledge and
current Agency regulatory practices, and
to improve protection of the general
population as well as sensitive
subpopulations. The proposed
requirements are intended to further
enhance the Agency’s ability to make
regulatory decisions about the human
health and environmental fate and
effects of antimicrobial pesticide
products.
Comments must be received on
or before January 6, 2009.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPP–2008–0110, by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Office of Pesticide Programs
(OPP) Regulatory Public Docket (7502P),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA 22202.
Deliveries are only accepted during the
Docket’s normal hours of operation
(8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays).
Special arrangements should be made
for deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
Instructions: Direct your comments to
docket ID number EPA–HQ–OPP–2008–
0110. EPA’s policy is that all comments
received will be included in the docket
without change and may be made
available on-line at https://
www.regulations.gov, including any
personal information provided, unless
the comment includes information
claimed to be Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
Do not submit information that you
sroberts on PROD1PC70 with PROPOSALS
DATES:
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
consider to be CBI or otherwise
protected through regulations.gov or email. The regulations.gov website is an
‘‘anonymous access’’ system, which
means EPA will not know your identity
or contact information unless you
provide it in the body of your comment.
If you send an e-mail comment directly
to EPA without going through
regulations.gov, your e-mail address
will be automatically captured and
included as part of the comment that is
placed in the docket and made available
on the Internet. If you submit an
electronic comment, EPA recommends
that you include your name and other
contact information in the body of your
comment and with any disk or CD-ROM
you submit. If EPA cannot read your
comment due to technical difficulties
and cannot contact you for clarification,
EPA may not be able to consider your
comment. Electronic files should avoid
the use of special characters, any form
of encryption, and be free of any defects
or viruses.
Docket: All documents in the docket
are listed in the docket index available
in regulations.gov. To access the
electronic docket, go to https://
www.regulations.gov, select ‘‘Advanced
Search,’’ then ‘‘Docket Search.’’ Insert
the docket ID number where indicated
and select the ‘‘Submit’’ button. Follow
the instructions on the regulations.gov
website to view the docket index or
access available documents. Although
listed in the index, some information is
not publicly available, e.g., CBI or other
information whose disclosure is
restricted by statute. Certain other
material, such as copyrighted material,
is not placed on the Internet and will be
publicly available only in hard copy
form. Publicly available docket
materials are available either in the
electronic docket at https://
www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA
22202. The hours of operation of this
Docket Facility are from 8:30 a.m. to 4
p.m., Monday through Friday, excluding
legal holidays. The Docket Facility
telephone number is (703) 305–5805.
FOR FURTHER INFORMATION CONTACT:
Kathryn Boyle, Field and External
Affairs Division, Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460–0001; mail code
7506P; telephone number: 703–305–
6304; fax number: 703–305–5884; e-mail
address: boyle.kathryn@epa.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00002
Fmt 4701
Sfmt 4702
I. General Information
A. Does this Action Apply to Me?
You may be affected by this action if
you are a producer of pesticide products
(NAICS 32532), antifoulants (NAICS
32551), antimicrobial pesticides (NAICS
32561) or wood preservatives (NAICS
32519), importers of such products, or
any person or company who seeks to
register an antimicrobial, antifoulant
coating, ballast water treatment, or
wood preservative pesticide or to obtain
a tolerance for such a pesticide. This
listing is not intended to be exhaustive,
but rather provides a guide for readers
regarding entities likely to be affected by
this action. Other types of entities not
listed above could also be affected. The
North American Industrial
Classification System (NAICS) codes
have been provided to assist you and
others in determining whether this
action might apply to certain entities. If
you have any questions regarding the
applicability of this action to a
particular entity, please contact Norm
Cook, Chief of the Risk Assessment and
Science Support Branch in the
Antimicrobials Division of the Office of
Pesticide Programs at 703–308–8253 or
via email, cook.norm@epa.gov.
B. What Should I Consider as I Prepare
My Comments for EPA?
1. Docket. EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2008–0110. Publicly available
docket materials are available either in
the electronic docket at https://
www.regulations.gov, or, if only
available in hard copy, at the Office of
Pesticide Programs (OPP) Regulatory
Public Docket in Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA 22202. The
hours of operation of this Docket
Facility are from 8:30 a.m. to 4 p.m.,
Monday through Friday, excluding legal
holidays. The Docket Facility telephone
number is (703) 305–5805.
2. Tips for preparing your comments.
When submitting comments, remember
to:
i. Identify the document by docket ID
number and other identifying
information (subject heading, Federal
Register date and page number).
ii. Follow directions. The Agency may
ask you to respond to specific questions
or organize comments by referencing a
Code of Federal Regulations (CFR) part
or section number.
iii. Explain why you agree or disagree;
suggest alternatives and substitute
language for your requested changes.
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
iv. Describe any assumptions and
provide any technical information and/
or data that you used.
v. If you estimate potential costs or
burdens, explain how you arrived at
your estimate in sufficient detail to
allow for it to be reproduced.
vi. Provide specific examples to
illustrate your concerns and suggest
alternatives.
vii. Explain your views as clearly as
possible, avoiding the use of profanity
or personal threats.
viii. Make sure to submit your
comments by the comment period
deadline identified.
II. Background
sroberts on PROD1PC70 with PROPOSALS
A. What Action is the Agency Taking?
The Environmental Protection Agency
(EPA or the Agency) is proposing to
establish a separate listing of the data
requirements for antimicrobial
pesticides in Title 40 of the Code of
Federal Regulations (CFR) in subpart W
of part 158. This proposal sets out use
patterns that are designed to make it
easier to determine which requirements
apply to antimicrobial products. In
addition to retaining most current data
requirements for antimicrobials, this
proposal incorporates nine new data
requirements and revises other existing
data requirements. This rule, once final,
is intended to further enhance the
Agency’s ability to make regulatory
decisions about the human health, and
environmental fate and effects of
antimicrobial pesticide products.
The Agency has previously issued
updated data requirements for
conventional pesticides, and
biochemical and microbial pesticides in
part 158. This proposal is part of a larger
effort to update and improve all of the
data requirements for pesticide
regulatory purposes. Data requirements
for antimicrobial pesticides, currently
contained in part 161, are proposed to
be revised and included in part 158
upon promulgation.
Generally, antimicrobials are
considered to be those chemicals that
disinfect and sanitize. However, within
this proposal EPA is using the term
antimicrobials to collectively refer to
antimicrobial pesticides, antifoulant
coatings and paints, and wood
preservatives.
As discussed in Unit XVIII.A., EPA
has prepared a white paper entitled
‘‘Use of Structure-Activity Relationship
(SAR) Information and Quantitative
SAR (QSAR) Modeling For Fulfilling
Data Requirements for Antimicrobial
Pesticide Chemicals and Informing
EPA’s Risk Management Process,’’ a
copy of which is contained in the
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
docket for this proposed rule (Ref. 43).
The white paper discusses the current
level of information and usage of
structure-activity-relationship (SAR)
assessments and Quantitative SAR
(QSAR) modeling to fulfill data
requirements in the Pesticide Program.
The Agency specifically seeks comment
on this support document.
Since many antimicrobial pesticides
are typically rinsed down the drain,
EPA has considered the potential
impacts of pesticides that are discharged
into wastewater treatment plants
(WWTPs). This proposed rule addresses
the issue of down-the-drain
antimicrobials by proposing four new
data requirements for use in a screeninglevel assessment on the fate of
antimicrobials that reach a WWTP. To
assess the impacts of this screening
assessment and utility of the new data
requirements for decision-making, EPA
prepared four case studies (Ref. 42). The
case studies, copies of which are
contained in the docket for this
proposed rule, are discussed in more
detail in Unit XII.D. The Agency
specifically seeks comment on the
proposed approach for evaluating the
potential impact of antimicrobial
pesticide chemicals on WWTPs and
nontarget organisms in receiving water
bodies, and on the case studies,
including the assumptions used in those
studies, that were used to develop the
proposed approach. EPA will consider
comments specific to the case studies
along with comments on the proposed
approach, as the Agency evaluates the
use of the proposed approach for downthe-drain antimicrobials in the final rule
for antimicrobial data requirements.
On October 26, 2007, EPA
promulgated final rules establishing
data requirements for conventional
pesticides (72 FR 60934), and
biochemical pesticides and microbial
pesticides (72 FR 60988). These final
rules were effective on December 24,
2007, and are therefore the current part
158. As part of those actions, on October
24, 2007, (72 FR 60251) EPA preserved
the original part 158 data requirements
to provide continued regulatory
coverage for antimicrobial pesticides
until the Agency could promulgate a
final regulation. To accomplish this,
EPA transferred intact the original 1984
data requirements of part 158 into a new
part 161, entitled ‘‘Data Requirements
for Antimicrobial Pesticides.’’ Part 161,
which applies only to antimicrobial
pesticides, contains the current data
requirements for antimicrobial pesticide
chemicals.
As explained in the preamble to the
conventional pesticide final rule, EPA
intended to preserve the existing data
PO 00000
Frm 00003
Fmt 4701
Sfmt 4702
59383
requirements for antimicrobial
pesticides until a new rule tailored
specifically to antimicrobial pesticides
could be promulgated. Part 161 is
intended to be transitional. Once
subpart W of part 158 is promulgated,
there will be no need for part 161.
Accordingly, EPA proposes to revoke
part 161 upon the effective date of a
final rule arising from today’s proposal.
B. Reasons for Today’s Action
Since the promulgation of part 158 in
1984, the Agency has recognized that
the tables and test notes promulgated in
1984 failed to adequately address the
unique applications, use patterns, and
other factors germane to antimicrobial
pesticides. Part 158 specifies the types
of data and information generally
required for making sound regulatory
judgments under the Federal
Insecticide, Fungicide, and Rodenticide
Act (FIFRA). The types of actions for
which these data are needed include
experimental use, registration, amended
registration, reregistration, or
registration review (collectively referred
to in this proposal as ‘‘registration’’).
The information required under FIFRA
for registration of food-use pesticides is
also information the Agency needs in
order to grant tolerances or exemptions
from the requirement of tolerances
under section 408 of the Federal Food,
Drug, and Cosmetic Act (FFDCA).
Required data are intended to provide
information about the potential adverse
effects of uses of pesticides, and to
define what is generally expected from
applicants for registration in support of
their products. However, it must be
emphasized that each applicant has the
continuing obligation under FIFRA to
demonstrate that an individual product
meets the standard for registration
under section 3 of FIFRA or section 408
of FFDCA. Accordingly, as indicated in
current § 158.75 and § 161.75,
additional data may be needed to reflect
the characteristics and use of specific
pesticide products under review.
Since the data requirements now set
out in part 161 (formerly part 158) were
first published in 1984, every
disciplinary area and requirement has
been reconsidered and many have been
revised in practice. These changes have
been needed because the state of the
science underlying the data
requirements has advanced, and
because the Agency has learned in
specific registration actions that
additional or different data are
necessary to make sound regulatory
decisions. These case-by-case decisions
have been made in accordance with
§ 158.75, which allows the Agency to
impose additional data requirements
E:\FR\FM\08OCP2.SGM
08OCP2
59384
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
beyond those specified in part 158 and
now part 161.
Use patterns specific to antimicrobial
pesticides are not specified in part 161,
as they were not set out separately when
originally promulgated in 1984. As a
result, applicants have needed to
interpret the data requirements often via
extensive consultation with and
interpretation from the Agency to
determine the antimicrobial data
requirements for a particular product.
Today, EPA is proposing that the
antimicrobial pesticide requirements be
codified in a separate subpart W to part
158 with use patterns (see Unit IV.I. of
this preamble) and groups of use
patterns specific to antimicrobials.
Today’s proposed rule is part of a
series of rules to update all of the data
requirements for pesticide products. On
October 26, 2007, EPA published in the
Federal Register two final rules to
promulgate the data requirements for
conventional (72 FR 60934), and
biochemical and microbial (72 FR
60988) pesticide chemicals. These rules
and their proposals (conventional
(March 11, 2005) (70 FR 12276) and
biochemical and microbial (March 8,
2006) (71 FR12072)) state the rationales
for requiring and/or revising particular
data requirements. With few exceptions,
these rationales are also applicable to
antimicrobial pesticide chemicals, and
as such have not been repeated in
today’s proposed rule. Today’s proposal
discusses in detail only those revisions
that are singularly applicable to
antimicrobial pesticides, including
antifoulants and wood preservatives.
C. Benefits of this Proposal
Greater detail on the benefits of this
proposal is provided in the document
entitled ‘‘Economic Analysis of the
Proposed Change in Data Requirements
for Antimicrobial Pesticides’’ which is
available in the docket for this
rulemaking (Ref. 44). The following
briefly highlights the anticipated
benefits:
1. More refined assessments mean less
uncertainty and clearer understanding
of actual risks. EPA’s current applicator/
user exposure data base is not
comprehensive, especially regarding
exposures to antimicrobials in industrial
and residential settings. The new data
that would be collected once this
proposal becomes final would allow the
Agency to conduct improved pre- and
post-application exposure assessments
for applicators/users, and the general
public. This will benefit not only
workers (including applicators) and
consumers by helping EPA to make
better informed regulatory decisions
that are neither too stringent nor too
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
lenient, but also benefit the regulated
industry by reducing the uncertainty in
Agency risk assessments. Thus, today’s
proposal will reduce, but not eliminate,
uncertainty related to the risks posed by
antimicrobial pesticides.
2. Clarity and transparency to
regulated community means savings.
The enhanced clarity and transparency
of the information presented in part 158,
subpart W should enhance the ability of
industry to efficiently manage their
antimicrobial registration submissions.
Applicants may save time and money by
understanding when studies are needed.
Having all required studies available to
EPA at the time of application should
halt potential delays in the registration
process, thereby enabling registration of
antimicrobial pesticides sooner.
Products would enter the market faster.
3. EPA information assists other
communities in assessing pesticide
risks. Scientific, environmental, and
health communities find antimicrobial
pesticide toxicity information useful to
respond to a variety of needs. For
example, medical professionals are
concerned about the health of patients
exposed to antimicrobials; poison
control centers use and distribute
information on toxicity and treatment
associated with poisoning; and
scientists use toxicity information to
characterize the effects of antimicrobial
pesticides and to assess risks of
pesticide exposure. Similarly, those
responsible for protection of nontarget
wildlife need reliable information about
antimicrobial pesticides and assurance
that pesticides do not pose an
unreasonable threat. The proposed
changes will help the scientific,
environmental, and health communities
by increasing the breadth, quality, and
reliability of Agency regulatory
decisions by improving their scientific
underpinnings.
4. Better informed users mean
informed risk-reduction choices. Better
regulatory decisions resulting from the
proposed changes should also mean that
the label will provide better information
on the use of the antimicrobial
pesticide. A pesticide label is the user’s
direction for using pesticides safely and
effectively. It contains important
information about where to use (or not
use) the product, health and safety
information to be read and understood
before using a pesticide product, and
how to dispose of that product. This
benefits users by enhancing their ability
to obtain antimicrobial pesticide
products appropriate to their needs, and
to use and dispose of products in a
manner that is safe and environmentally
sound. Applicators/users may benefit
from label information based on the data
PO 00000
Frm 00004
Fmt 4701
Sfmt 4702
submitted to the extent it helps inform
their decisions about whether or how to
use particular pesticides to avoid
potential exposure.
D. What is the Agency’s Authority for
Taking this Action?
This action is issued under the
authority of sections 3, 4, 5, 10, 12, and
25 of FIFRA as amended and section
408 of FFDCA. The data required for a
registration, reregistration, experimental
use permit, or tolerance are listed in 40
CFR part 158.
III. Statutory and Historical
Framework
A. FIFRA
Under FIFRA section 3, every
pesticide product must be registered
with EPA or specifically exempted
under FIFRA section 25(b) before being
sold or distributed in the United States.
Under FIFRA, an applicant for a new
registration or an existing registrant
(collectively referred to as applicant in
this proposal) must demonstrate to the
Agency’s satisfaction that, among other
things, the pesticide product, when
used in accordance with widespread
and commonly recognized practice, will
not cause ‘‘unreasonable adverse
effects’’ to humans or the environment.
This safety determination requires the
Agency to weigh the risks of the use of
the pesticide against any benefits. EPA
must determine that the standard for
registration contained in FIFRA is met
before granting a registration.
1. Registration. Section 3 of FIFRA
contains the requirements for
registration. Specifically, FIFRA section
3(c)(2) provides EPA broad authority,
before and after registration, to require
scientific testing and submission of the
resulting data to the Agency by
applicants for registration of pesticide
products. An applicant must furnish
EPA with substantial amounts of data
on the pesticide, its composition,
toxicity, potential human exposure,
environmental properties, and
ecological effects, as well as information
on its product performance (efficacy) in
certain cases. Although the data
requirements are imposed primarily as a
part of initial registration, EPA is
authorized under FIFRA section
3(c)(2)(B) to require a registrant to
develop and submit additional data to
maintain a registration.
2. Reregistration. FIFRA section 4
requires that EPA reregister each
pesticide product first registered before
November 1984. This date was chosen
because pesticides registered after 1984
were subject to the part 158
requirements of the 1984 regulation.
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
EPA has completed the reregistration/
tolerance reassessment process for fooduse pesticides and expects to complete
all reregistration activities by the
statutory deadline of August 2008.
3. Registration review. FIFRA section
3(g) mandates that the registrations of
all pesticides are to be periodically
reviewed. Changes in science, public
policy, and pesticide use practices occur
over time. Through the new registration
review program implemented via a
regulation promulgated on August 9,
2006 (71 FR 45719) (40 CFR part 155,
subpart C), the Agency is periodically
reevaluating all registered pesticides to
assure that they continue to meet the
statutory standard of no unreasonable
adverse effects. Starting in 2006,
registration review began to replace
EPA’s reregistration program as the
mechanism for systematic review of
existing pesticides. The registration
review process begins by reviewing the
available information in the possession
of the Agency and then determining the
specific data needed for assessing a
particular pesticide. Thus, the data
needed, and the scope and depth of the
Agency’s review will be tailored to the
specific circumstances of a particular
pesticide. This means that reviews will
be commensurate with the complexity
of the issues associated with each
pesticide.
4. Experimental Use Permits (EUPs).
Subject to some exceptions, FIFRA
section 5 requires persons seeking
permission for experimental use of a
pesticide under controlled condition to
obtain an experimental use permit. A
EUP allows limited use of a pesticide for
specified experimental and data
collection purposes intended to support
future registration of the pesticide.
Because a EUP is for limited use under
controlled conditions, the data needed
to support issuance of the permit are
correspondingly less than those
required for full registration. The
regulations governing the issuance of
EUPs are found in 40 CFR part 172. In
its final rule ‘‘Data Requirements for
Conventional Pesticides’’ EPA
promulgated subpart C of part 158 to
contain the data requirements for EUPs,
which will be applied on a case-by-case
basis to any EUP applications for an
antimicrobial pesticide.
5. Registration requirements for
antimicrobials. FIFRA section 3(h)
requires that EPA evaluate its
registration process to identify
improvements and reforms that will
reduce historical review times for
antimicrobial applications. This
includes defining the classes of
antimicrobial use patterns and the types
of application review, conforming
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
reviews to risks and benefits, ensuring
efficacy, and meeting review time goals.
EPA believes that this rule assists in
meeting the section 3(h) mandate. By
defining the 12 use patterns for
antimicrobials in relation to the data
required for a registration under FIFRA,
EPA is providing clearer and more
transparent information to applicants.
This should result in submissions to
EPA that contain the required data and
therefore can be reviewed and evaluated
more expeditiously.
B. FFDCA
FFDCA requires EPA to determine
that the level of pesticide chemical
residues in food and feed will be safe for
human consumption. The safety
standard set under FFDCA section
408(b) and (c) defines safe as ‘‘a
reasonable certainty that no harm’’ will
result from exposures to pesticide
chemical residues. The combination of
aggregate and cumulative exposure
assessments required by FFDCA section
408 increases the nature and scope of
EPA’s risk assessment, and potentially
increases the types and amounts of data
needed to determine that the FFDCA
safety standard is met.
Under FFDCA section 408, EPA is
authorized to establish tolerances for
pesticide residues in food and feed, or
to exempt a pesticide from the
requirement of a tolerance, if warranted.
In this preamble, references to
tolerances include exemptions from
tolerance since the standards and
procedures for both are the same. The
safety standard applies to tolerances in
a number of regulatory situations,
including:
• Tolerances that support registration
under FIFRA;
• Tolerances for imported products
which are established to allow
importation of pesticide-treated
commodities, but for which no U.S.
registration is sought;
• Time-limited tolerances which are
established for FIFRA section 18
emergency exemptions; and
• Temporary tolerances established for
experimental use permits under FIFRA
section 5.
C. Linking FIFRA and FFDCA Safety
Standards
Under FIFRA section 2(bb), a
pesticide that is inconsistent with, or
does not meet, the FFDCA section 408
safety standard poses an unreasonable
adverse effect that precludes new or
continued registration. Given this
linkage between registration and
tolerances, it makes sense for EPA to
define data requirements for both
purposes: The data required to support
PO 00000
Frm 00005
Fmt 4701
Sfmt 4702
59385
a determination of ‘‘reasonable certainty
of no harm’’ under FFDCA are an
integral part of the data needed for an
‘‘unreasonable adverse effects’’
determination under FIFRA.
Consequently, when promulgated, these
proposed data requirements would
encompass the basic data requirements
for both registration and tolerancesetting determinations. EPA has
authority to require additional data on
a case-by-case basis.
D. Scope of Proposed Subpart W
FIFRA contains a number of
provisions specific to ‘‘antimicrobial
pesticides’’ as defined in FIFRA section
2(mm). The statutory definition contains
a complex construction of functionality,
types of organisms, and intended use to
describe what is encompassed by the
term ‘‘antimicrobial pesticide.’’ EPA
believes that the definition was
primarily intended to be used in
conjunction with the provisions of
section 3(h), which contains
requirements for process improvements,
timeframes for review purposes, and
other regulatory matters, but,
significantly, does not include
provisions pertaining to data
requirements. The definition in section
2(mm) as it relates to section 3(h) was
discussed fully in a proposed rule
issued in the Federal Register of
September 17, 1999 (64 FR 50672).
The statutory definition, however,
does not mesh with the Agency’s needs
in developing this proposed rule
concerning data requirements. Data
requirements depend upon the use
pattern, taking into account the
pesticide’s hazard and exposure
profiles. How well the pesticide kills or
repels particular pests are relevant
factors in the determination of product
performance data requirements.
Neither FIFRA section 3(c)(2) nor
section 3(h) requires the Agency to
develop data requirements for an
‘‘antimicrobial pesticide’’ as defined
specifically in section 2(mm). Therefore,
the scope of this proposal has been
expanded beyond ‘‘antimicrobial
pesticide’’ as defined by FIFRA section
2(mm) to include related pesticides that
are excluded from the 2(mm) definition.
The broader applicability of this 40 CFR
part 158, subpart W is intended to
ensure that all pesticides currently
considered as antimicrobial products for
purposes of FIFRA section 33 fees and
review periods are covered.
Accordingly, this proposal applies to:
• Antimicrobial pesticides, as defined
in FIFRA section 2(mm).
• Pesticide products for antimicrobial
uses in/on food or feed.
• Antifoulant paints and coatings.
E:\FR\FM\08OCP2.SGM
08OCP2
59386
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
• Wood preservatives.
• Pesticide products intended to be
manufactured into any of the above.
devoted to biochemical (subpart U) and
microbial (subpart V) pesticides. The
revised data requirements for
antimicrobial pesticides would be
incorporated into part 158 as subpart W.
IV. Introduction to Subpart W
A. Data Requirements for Registration
First promulgated in 1984, EPA’s
pesticide data requirements outline the
kinds of data and related information
typically needed to register a pesticide.
In this proposal, the data requirements
are organized by scientific discipline
(e.g., toxicology), just as the existing
data requirements in part 158 for
conventional, and biochemical and
microbial pesticides and those in part
161 for antimicrobials. A significant
change in this proposal from the
existing data requirements in part 161 is
the introduction of 12 use patterns
specific to antimicrobials. Since there is
much variety in pesticide chemistry,
exposure, and hazard, the requirements
are designed to be flexible. Test notes to
the data requirements tables explain the
conditions under which data are
typically needed. Essentially, the data
requirements identify the questions that
the applicant will need to answer
regarding a pesticide product before the
Agency can register it. Data
requirements address both components
of a risk assessment, i.e., the hazards
that the pesticide presents, and the
estimated level of exposure to humans
or nontarget species. Having the
appropriate information enables the
Agency to understand when those
hazards pose risks. The answer to one
question may inform the kind of
information needed to answer other
questions. For example, a pesticide that
is persistent and toxicologically potent
may require more extensive exposure
data to help establish a safe level of
exposure. In addition, because a number
of antimicrobials are used for public
health purposes (for example,
disinfectants, sterilants, or sanitizers),
there are product performance data
requirements to assure that the
antimicrobial product works as
intended.
sroberts on PROD1PC70 with PROPOSALS
B. Structure of Part 158
At this time data requirements for
conventional, biochemical, and
microbial pesticides are established in
40 CFR part 158. Data requirements for
antimicrobial pesticides are established
in 40 CFR part 161.
Part 158 contains general provisions
concerning all pesticide data (subpart
A), instructions on how to use the data
tables that follow (subpart B), and a
series of disciplinary data tables that are
focused on conventional pesticides
(subparts C – O). Individual subparts are
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
C. Subpart W of Part 158
Subpart W is proposed to be a
freestanding series of tables and
regulatory text establishing specific data
requirements for each scientific
discipline for antimicrobial pesticides.
EPA recognizes that antimicrobial uses
are generally different from the uses
more typically associated with
conventional pesticides (e.g.,
agricultural outdoor uses) and therefore
can have different combinations of
exposure considerations. The use
patterns and expected exposures
typically determine the data
requirements for any pesticide.
Antimicrobial pesticides are no different
in this regard from conventional,
biochemical, and microbial pesticides.
The order of proposed subpart W
mirrors that of the larger part 158: from
product chemistry, to efficacy, to
hazard/toxicity requirements (both
human health and ecological toxicity),
to exposure data requirements
(application and post-application
human exposures, and exposure to
residues in food), and environmental
fate requirements, which overlap human
exposure through drinking water. Units
V–XIV of this preamble describe the
revisions to the current requirements.
The proposed data requirement tables
are comprehensive. Generally, the data
requirements for each discipline are
discussed separately, but the applicator
and post-application exposure
disciplines are discussed together in a
single unit.
D. Clarifying How to Use the Data
Tables
Part 158 subpart B contains a stepwise process to assist the applicant in
determining the data needed to support
its particular product. At this time
subpart B is specific to the needs of
conventional, and biochemical and
microbial pesticides. The process
needed for antimicrobials is no
different. EPA is proposing certain
clarifying changes to subpart B to
specify the needs of antimicrobial
pesticides. Specifically, EPA proposes
to include antimicrobial use patterns in
§ 158.100 and a reference to the
antimicrobial use site index that will be
available on the EPA website.
While EPA is attempting to assist the
applicant in subpart B, it is important to
emphasize that it is the applicant’s
obligation under FIFRA to demonstrate
that an individual product meets the
PO 00000
Frm 00006
Fmt 4701
Sfmt 4702
standard under FIFRA and that of
FFDCA. Accordingly, applicants are
encouraged to consult with the Agency
on the appropriate data requirements, as
proposed here, as related to their
specific product prior to and during the
registration process.
EPA is continuing its current system
of identifying the applicability of data
requirements in the data tables. In
essence, the data requirements illustrate
the questions the registrant will need to
answer about the safety of the pesticide
product before the Agency can register
it. Because of the variety of chemicals
and use patterns, and because EPA must
retain flexibility to tailor data
requirements as appropriate, only
qualitative descriptors are in the tables.
Test notes provide more specific
information on the applicability of
specific data requirements.
The table descriptors NR (not
required), R (required), and CR
(conditionally required) should be
viewed as a general presentation,
indicating the likelihood that the data
requirement applies. The use of R does
not necessarily indicate that a study is
always required, but that it is more
likely to be required than not. For
example, if the applicant wanted to
apply his pesticide to apples, then crop
field trials would be required almost
always on apples. However, if the
physical/chemical properties of the
chemical did not lend themselves to the
test, such as performing an inhalation
test with a chemical that is a solid and
has an extremely low vapor pressure,
then a waiver might be granted.
Generally test notes for R studies
discuss any particular circumstances
when the testing might not be required.
The use of CR means a study is less
likely to be required. Triggers in the test
notes indicate the circumstances under
which the Agency has learned through
experience that the information is
needed. Although only an
approximation, if percentages were to be
assigned to indicate the need for a
particular study, then R could be
viewed as representing the submission
of a study 50% to 100% of the time and
CR would be up to 50%.
Thus, NR, R, and CR are used for
convenience to make the table format
feasible, but serve only as a general
indication of the applicability of a data
requirement. In all cases, the test notes
referred to in the table must be
consulted to determine the actual need
for the data. Applicants are also
encouraged to visit the Agency’s
website, entitled ‘‘Data Requirements for
Pesticide Registration’’ (see https://
www.epa.gov/pesticides/regulating/
data_requirements.htm). Since it is not
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
possible to sufficiently delineate all
circumstances in test notes, consultation
with EPA is encouraged.
The table format includes a column
heading entitled ‘‘Guideline,’’ which
refers to the OPPTS (Office of Pollution
Prevention and Toxic Substances)
Harmonized Test Guidelines. Guideline
numbers are provided as information/
guidance to applicants. These
Guidelines set forth recommended
instructions and test methods for
performing a study to generate the
required data. Since these are guidance
documents, the applicant is not required
to use these Guidelines, but may instead
seek to fulfill the data requirement by
other appropriate means such as
alternative test methods, submission of
an article from open literature, or use of
modeling. The applicant may submit a
protocol of his own devising for the
Agency to review. However, the OPPTS
Harmonized Guidelines have been
developed through a rigorous scientific
process, including extensive peer
review by the FIFRA Scientific Advisory
Panel. Additionally, many of the
Guidelines have been harmonized
internationally. As such, they represent
the recommended approach to
developing high-quality data that
should satisfy EPA’s data needs for risk
assessment.
sroberts on PROD1PC70 with PROPOSALS
E. The Nature of Changes to
Requirements
Proposed subpart W does not differ
greatly from the data requirements for
conventional pesticides promulgated in
October 2007. Where this proposal
differs is in the explicit adaptation of
those data requirements to
antimicrobials. As previously discussed,
antimicrobial uses were covered in the
original (1984) part 158. However part
158 (now transitioned for antimicrobials
as part 161) was developed primarily for
agricultural pesticides. Since the use
patterns which now appear in tables in
part 161 are not specific to
antimicrobials, often it has been
difficult to discern directly from such
tables the data requirements for certain
antimicrobials. Without extensive
consultation with and interpretation
from the Agency, frequently it has been
difficult for applicants to effectively use
the tables to determine which data
requirements apply to antimicrobials.
Today’s proposal reflects the Agency’s
current needs for risk assessment of
antimicrobials. Describing the
antimicrobial data requirements in
terms of use patterns specific to
antimicrobial uses provides a clarity
that should reduce the need for
extensive consultations.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
There are nine new data requirements
for antimicrobials set out in this
proposal. Two (developmental
neurotoxicity and immunotoxicity) are
the same new data requirements as
promulgated in the final rule for
conventional chemicals (72 FR 60934)
(see Unit VIII). While photodegradation
in soil studies have been routinely
required for conventional chemicals,
this study would be a new data
requirement for wood preservatives (see
Unit XII). Similarly, two new exposure
data requirements (soil residue
dissipation and non-dietary ingestion
exposure) are today proposed for
antimicrobials (see Unit IX.D).
Four new data requirements
(activated sludge sorption isotherm
study; ready biodegradability study;
porous pot study; and modified
activated sludge, respiration inhibition
test) are proposed today for
antimicrobials that are not included in
the final rule for conventional
pesticides. This is due to the nature of
antimicrobial pesticides, which
includes many down-the-drain uses, i.e.
those discharged to public treatment
systems, and is discussed in Units XII.B.
and C.
Most screening-level environmental
fate assessments would be performed
using the hydrolysis, photodegradation
in water, activated sludge sorption
isotherm, ready biodegradability, and
modified activated sludge, respiration
inhibition tests. For wood preservatives,
the results of the photodegradation in
soil study may also be considered in the
screening-level assessment. If the
porous pot study is triggered based on
the results of the ready biodegradability
study, then those results would also be
considered.
EPA notes that its proposed approach
for performing a screening-level fate
assessment could potentially result in
the submission of higher-tiered studies.
There are seven higher-tiered
environmental fate studies, that could
be triggered based on a weight-ofevidence evaluation of the results of the
screening-level studies. For example, if
the screening-level assessment were to
indicate that a down-the-drain chemical
would partition to sludge, soil, or
sediment, then higher-tiered
environmental fate studies such as the
aerobic and anaerobic soil metabolism
studies may be required. If the chemical
would partition to water then highertiered ecotoxicity studies such as the
fish early life stage may be required.
Thus, the higher-tiered studies that
could be triggered include both the
environmental fate and ecotoxicity
scientific disciplines.
PO 00000
Frm 00007
Fmt 4701
Sfmt 4702
59387
While not a new data requirement,
subchronic dermal testing of end-use
products has not been routinely
required and therefore would be
considered a new testing requirement.
The circumstances for requiring the
testing is the same as for conventional
chemicals. (See Unit VIII).
Each data requirement proposed in
Units, VIII, IX, X, XII, XIII, and XIV is
described as ‘‘new,’’ ‘‘current practices,’’
or ‘‘existing.’’ ‘‘New’’ means that the
data requirement has never been
required or has rarely been required on
a case-by-case basis, and has not been
routinely considered during the
Agency’s evaluation of the data needed
for the purpose of risk assessment.
‘‘Current practices’’ encompasses the
data that is typically required to register
an antimicrobial pesticide product. This
would include existing data
requirements that are codified in part
161 as well as those that are not codified
in part 161 and are now being proposed
for codification in part 158, subpart W.
It would also include any study that has
been routinely required on a case-bycase basis, or any study that is routinely
considered during the Agency’s
evaluation of the data needed for the
purpose of risk assessment but is
infrequently required because the
triggers for that study are infrequently
met.
‘‘Existing’’ requirements are a subset
of ‘‘current practices.’’ This particular
subset means that the data requirement
is codified in part 161 and being
transferred to part 158, subpart W either
‘‘as is’’ or with specified changes to the
test notes, to the Rs, CRs, and NRs, or
to the use patterns for which required.
If there are proposed revisions to an
existing data requirement, then
clarifications on these proposed
revisions are included in the preamble.
Such revisions include proposing
changes such as a change from
conditionally-required to required, a
change in the number of test species, or
expanding the number of use patterns
for which the test is required.
As previously discussed, there are
frequently consultations to discern data
requirements for certain of the
antimicrobial use patterns. These
consultations have led to general
understandings as to the data required
for a particular use pattern. For certain
use patterns, all of the studies are
considered to be the Agency’s current
practices. As an example, for the wood
preservative use patterns, there is not a
good fit to any of the part 161 use
patterns in the tables and therefore the
data needed to register a wood
preservative is difficult to interpret from
those tables. Given these circumstances,
E:\FR\FM\08OCP2.SGM
08OCP2
59388
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
EPA developed a series of requirements
developed specifically for wood
preservatives. These requirements are
not codified in CFR, but the applicants
understand that these are the data
needed for wood preservatives and they
routinely provide these studies to EPA.
F. Tiered Data Requirements
The Agency has organized the
proposed requirements for antimicrobial
pesticide products to support a tiered
testing approach. Under such an
approach the Agency prescribes a
specific subset of ‘‘lower tier’’ studies
that are conducted first. The results of
this first- or lower-tiered testing are then
used in conjunction with exposure data
or other information to determine the
need for more complex ‘‘higher tier’’
studies. The risk assessment must
provide sufficient information to make
the risk management decisions needed
to register the product or establish a
tolerance. This is a significant factor in
the tiering process.
Data requirements have been tiered
when EPA believes it can adequately
conduct a risk assessment using a tiered
approach. The conditions for
‘‘triggering’’ these higher tiered studies
are specified in the test notes to the
tables in proposed subpart W. A tiered
data submission process is intended to
allow the Agency to assess a pesticide’s
risk without requiring the applicant to
conduct and submit studies that may
not be needed for the regulatory
decision. For certain chemicals, data
from lower tiered requirements may be
sufficient in and of themselves or in
combination with other data to address
the Agency’s risk concerns without
submission of higher tiered data
requirements. In other cases, data from
lower tiered requirements may indicate
that higher tiered data need to be
provided. The Agency expects
applicants to consult with the Agency,
as needed, to determine when
submission of higher tiered data may be
required.
The Agency has tiered the data
requirements based on an
understanding of the potential exposure
for a specific use pattern. As an
example, for toxicology studies used to
support human health risk assessments,
the high human exposure grouping
specifies 19 toxicology studies as
required at the lower tier. The low
human exposure grouping specifies 13
toxicology studies as required. The
Agency considered the frequency,
duration, and/or magnitude of the
exposure to determine the lower tier of
toxicology testing requirements for both
the high and low human exposure
groupings.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
For ecotoxicity data requirements, the
Agency requires a first tier of required
data for all antimicrobials regardless of
the use pattern. The need for higher
tiered data depends not only on the
frequency, duration, or magnitude of the
exposure, but also on the results of the
first tier of the data.
Such a flexible approach allows EPA
to require enough data, but not more
than enough, to make the required
safety finding. Such an approach is the
same as that used for other pesticides;
however, for antimicrobials the
progression from lower to higher tier
requirements may differ from that of
conventional pesticides because the
uses and expected exposures are
different.
G. Impact of this Proposal on Future
and Existing Registrations
This proposal concerns prospective
data requirements for future
registrations of antimicrobial pesticides.
That is, these proposed data
requirements, once final, would apply
to all new applications for registration
of antimicrobial pesticides submitted
after the effective date of the rule. The
new data requirements would also
apply to applications of antimicrobial
pesticides that are undergoing Agency
review when the new regulation goes
into effect. EPA believes that there may
be a need for some type of a limited
transition ‘‘window’’ for certain
antimicrobial registration applications.
EPA anticipates applicants of
applications that were submitted, but
not yet approved when the new
regulations go into effect, may need to
discuss with EPA the specifics of their
application and whether additional time
may be needed to complete generation
of certain studies that may then be
required to fulfill new data
requirements. The Agency specifically
requests comment on implementing the
effective date of the final rule for
antimicrobials with regards to future
registrations of antimicrobials.
The Agency does not intend to apply
these requirements automatically or
routinely to all existing pesticide
registrations. While EPA intends a
flexible approach to imposing the new
requirements upon existing products,
the Agency may find it necessary to callin data on certain existing registrations,
for example, as warranted by emerging
risks of concern for particular pesticides
or as a result of possible future
programmatic changes and priorities on
existing pesticides, or during
registration review.
However, EPA notes that issuance of
this proposed rule provides notice to
applicants of potential new data
PO 00000
Frm 00008
Fmt 4701
Sfmt 4702
requirements and of potential expansion
of existing data requirements to
additional antimicrobial use patterns.
Applicants and potential applicants for
new registrations as well as registrants
of existing products may wish to
evaluate their products in light of the
proposed requirements. As always, the
Agency encourages applicants to
consult with EPA, if they have any
questions regarding data requirements.
H. Weight-of-Evidence Approach
The weight-of-evidence (WOE)
approach is referenced in several
subpart W test notes. Such an approach
requires a critical analysis of the entire
body of available data for consistency
and biological plausibility. Some
considerations in this approach are
listed below:
• Sufficiency of data. Studies that
completely characterize both the effects
and exposure of the agent have more
credibility and support than studies that
contain data gaps.
• Quality of the data. Potentially
relevant studies are judged for quality
and studies of higher quality are given
more weight than those of lower quality.
• Evidence of causality. The degree of
correlation between the presence of an
agent and some adverse effect is an
important consideration.
• Corroborative information.
Supplementary information relevant to
the conclusions reached in the
assessment is incorporated, e.g., studies
demonstrating agreement between
model predictions and observed effects.
WOE considers the kinds of evidence
available, how that evidence fits
together in drawing conclusions, and
significant issues/strengths/limitations
of the data and conclusions. WOE is not
simply tallying the number of positive
or negative studies.
I. Use Patterns in Subpart W
The general use pattern groups
described in subpart B of part 158 are
not used as the bases for describing
antimicrobial data requirements. Those
general use patterns were developed for
and are appropriate to conventional
pesticide chemicals.
Some years ago, 12 use categories
were developed specifically for
antimicrobials. At that time the
Agency’s data requirements for all
pesticide chemicals were specified by
use patterns developed for and
appropriate to conventional pesticide
chemicals. To fit antimicrobial uses into
this agricultural scheme, the
antimicrobial use categories referred
back to the then-existing use patterns.
With the Agency’s intention to establish
specific data requirements for
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
antimicrobials in subpart W, this
referral is no longer needed.
Therefore, the Agency is proposing
that the use categories employed in
recent years to generalize the range of
uses for individual antimicrobial
pesticide chemicals, now constitute the
use patterns for specifying the
antimicrobials data requirements in the
tables in proposed subpart W.
Additionally, EPA is proposing to
codify in § 158.2201 the specific use
patterns for antimicrobials.
FIFRA section 3(h)(3)(A)(ii)(I) requires
that EPA ‘‘define the various classes of
antimicrobial use patterns.’’ For
antimicrobial pesticides, the Agency
proposes to structure its requirements
by using a system of 12 use patterns
based on similarity of use, purpose,
pesticidal function, the nature of the
exposure, and, in some cases,
application methods. Today’s proposal
meshes with the statutory mandate to
identify classes of antimicrobial use
patterns by defining for each use pattern
the data requirements that apply. EPA
requests comment not only on the 12
antimicrobial use patterns described in
this Unit, but also on the usefulness of
these use patterns. EPA also requests
comment on whether or not any
different/additional use patterns should
be codified by splitting or recombining
the existing use patterns to make
separate and distinct use patterns.
Antimicrobial use patterns also reflect
environmental concerns for indoor
versus outdoor use, as well as food
versus nonfood-use, and high versus
low human exposure. The 12 general
use patterns for antimicrobial pesticides
are described below. Examples within
each use pattern are provided:
1. Agricultural premises and
equipment. This use pattern includes
many indirect food uses with mostly
indoor use sites.
• Farm and farm animal premises such
as animal houses and pens (including
milk houses), parlors, stalls, and barns.
• Transportation vehicles used to
transport animals.
• Equipment such as forks, shovels,
scrapers; halters, ropes, other restraining
equipment; racks, mangers, feeders,
waterers, troughs, and fountains.
• Food-handling equipment such as
milking equipment.
2. Food-handling/storage
establishments, premises, and
equipment. This use pattern also
includes many indirect food uses due to
the treatment of food contact surfaces
and the resultant human exposures. All
use sites are indoor.
• Food or feed processing plants.
• Eating establishments such as
restaurants and cafeterias.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
• Food storage or distribution
facilities.
• Commercial transportation vehicles,
shipping, and storage containers.
• Food or feed stores and markets.
• Vending machines.
3. Commercial, institutional and
industrial premises and equipment.
This use pattern includes nonfood
contact areas of commercial sites.
Typically, antimicrobial pesticides
would be applied to ceilings, doors,
doorknobs, fixtures, floors, light
switches, stairs, walls, windows, and
woodwork as part of routine cleaning
practices. Included within this use
pattern are residential school and
daycare institutions.
This use pattern includes both indoor
and outdoor uses. Some of the uses have
the potential for significant exposure
due to the repetitive nature of certain
exposures and therefore may be
considered as high human exposure.
4. Residential and public access
premises. This use pattern includes
mostly nonfood areas, although it
includes food-handling areas in homes.
Some of the uses have the potential for
significant exposure due to the
repetitive nature of certain exposures
and therefore may be considered as high
human exposure. Most uses are indoor.
• Premises, contents, and equipment
of homes, apartments, mobile homes
and shelters, including home-based
daycare.
• Public areas, public buildings, and
public rooms.
• Commercial kennels, or living
quarters of pets, zoo animals, race
horses, or laboratory animals.
5. Medical premises and equipment.
Medical waste is defined as any solid
waste that is generated in the diagnosis,
treatment, or immunization of human
beings or animals, in research pertaining
thereto, or in the production of
biologicals including, but not limited to,
culture and stocks, pathological wastes,
human blood and blood products, and
sharps. This use pattern is considered to
be indoor nonfood. Some of the uses
have the potential for repeated exposure
and therefore may be considered as high
human exposure.
• Hospital or medical environments
such as clinics, dental offices, nursing
homes, sick rooms, morgues, and
veterinary clinics.
• Non-critical medical equipment
such as bedpans, basins, and furniture.
6. Human drinking water systems.
Human drinking water systems include
any methods used to provide potable
water from raw water supplies. This use
pattern is considered to be high human
exposure due to the potential for human
PO 00000
Frm 00009
Fmt 4701
Sfmt 4702
59389
exposures via drinking water, as well as
dermal exposures to the treated water.
• Public water systems.
• Individual water systems.
• Emergency water systems.
• Water purifier units.
• Private water systems of individual
homes, farms, institutions, camps,
resorts, and industrial plants.
• Emergency water systems for the
public, campers, travelers, military, and
fishermen.
7. Materials preservatives. Materials
preservatives are antimicrobial
chemicals added during industrial
processes to prevent the growth of
microorganisms. Examples of such uses
include paints, coatings, adhesives,
textiles, and paper. This use pattern
includes food and nonfood, and mostly
indoor uses.
8. Industrial processes and water
systems. Certain antimicrobial
chemicals, known as microbiocides, are
used to control the growth of bacteria,
fungi, and algae in circulating water
systems. There are two types of systems:
‘‘once-through’’ and ‘‘recirculating.’’
For ‘‘once-through’’ systems, the
water is not re-used and is therefore
released into the aquatic environment or
a wastewater treatment plant after a
single cycle through the system. Oncethrough uses have the potential for
significant environmental exposure
when the treated water is released to the
environment. Large volumes of water (as
much as millions of gallons per minute)
may be released directly to a river,
estuary, or marine environment within
minutes or hours of adding the
antimicrobial to the system. In addition
to the potential for environmental
exposure after release, there is the
potential for high human exposure via
drinking water if the intake pipe for a
drinking water treatment plant is
downstream. Also, the water could be
used in crop and/or livestock
production thus providing for
additional human exposure.
However, for many uses of water in
industrial plants the treated water is reused repeatedly within the system,
‘‘recirculating’’ in the system multiple
times until released into the aquatic
environment or a wastewater treatment
plant. EPA has assumed that the
releases are scheduled as the
antimicrobial has been ‘‘used-up.’’
Given the lower frequency of release,
resulting in lower volumes released to
the environment, recirculating uses are
likely to have less environmental
exposure than that of once-through
systems.
As will be explained later in Unit XI,
for the purposes of determining data
requirements for environmental fate and
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59390
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
ecological effects, the industrial
processes and water systems use pattern
will be subdivided. Because of the
distinct differences between the oncethrough and recirculating water
systems, the once-through water system
will be grouped with those use patterns
with potential for higher environmental
exposures and the recirculating water
system with those use patterns with the
potential for lower environmental
exposures.
9. Antifoulant paints and coatings.
Antifoulants are coatings and paints
applied to boat hulls and bottoms, crab
and lobster pots, and underwater
structures or equipment to control the
growth of freshwater or marine fouling
organisms. Antifoulant coatings have
the potential for high environmental
exposure most particularly for marine
(both freshwater and saltwater)
environments.
Also included within this use pattern
is ballast water, that is, the water that is
pumped in and out of ballast tanks as
a ship’s weight changes due to loading
and unloading of cargo. Ballast water
provides needed stability for safe
operation of marine vessels. In recent
years there have been significant
concerns about transport of marine
species from one marine environment to
another in ballast water. When
discharged into a new environment, the
new species may become invasive and
disrupt the native ecology. Ballast water
treatments (such as adding an
antimicrobial to the ballast water before
discharge) are intended to prevent this.
The Agency has reviewed few
applications for ballast water
treatments, presumably because
treatment of ballast water to prevent the
transfer of microorganisms from one
marine environment to another is
relatively new. Since ballast water
treatments also have the potential for
high exposure to the aquatic (both
freshwater and seawater) environment,
EPA has grouped the ballast water
treatment pesticide chemicals with the
antifoulant coating pesticide chemicals.
10. Wood preservatives. Wood
preservative products are those which
claim to control wood degradation
problems due to fungal rot or decay,
sapstain, molds, or wood-destroying
insects. This use pattern has the
potential for high exposure for both
humans and the environment with
mostly outdoor use sites. Certain uses
can be food-uses. The types of wood and
the products that can be manufactured
with this treated wood are:
• Freshly cut logs or lumber.
• Seasoned building materials.
• Utility poles, fence posts and rails.
• Structural members.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
• Structures and dwellings.
• Transportation vehicles (truck beds
and support structures).
• Crop containers.
• Lawn furniture and decks.
• Playground equipment.
• Garden/landscape timbers.
• Log homes.
11. Swimming pools. Products in this
use pattern are used to prevent/control
the growth of bacteria or algae in the
water systems of swimming pools,
Jacuzzis, and hot tubs. This use pattern
is considered to be high human
exposure. Under routine use little or no
environmental exposure is expected, as
the water in swimming pools, Jacuzzis,
or hot tubs is considered to be separated
from the natural environment. However,
when draining is needed, depending on
the volume of water and the location of
the pool or hot tub, it is most likely that
discharge would be down-the-drain to a
wastewater treatment plant, to a storm
drain that discharges to a stream, or
directly to soil.
12. Aquatic areas. Products in this use
pattern are designed to control or kill
slime-forming bacteria, fungi, or algae in
lakes, ponds, streams, drainage ditches,
and other bodies of water. In addition to
the potential for environmental
exposure, there is the potential for high
human exposure via drinking water if
the intake pipe for a drinking water
treatment plant is in a lake or
downstream, or through recreational
activities such as swimming. Also, the
water could be used in crop and/or
livestock production thus providing for
additional human exposure.
J. Use Site Index
As part of this action, the Agency is
proposing to place on its website an
Antimicrobial Use Site Index similar to
the existing Pesticide Use Site Index at
https://www.epa.gov/pesticides/
regulating/usesite/index.htm.
Information similar to that which would
be included on the Antimicrobial Use
Site Index is included in the docket for
this action (Ref. 41). The existing
Pesticide Use Site Index will be retitled, the Pesticide Use Site Index for
Conventional, Biochemical, and
Microbial Pesticides to distinguish it
from the Antimicrobial Use Site Index.
K. Request for Comments
The Agency invites the public to
provide its views and suggestions for
changes on all of the various proposals
in this document. Specifically included
within the Agency’s request for
comments are the following proposals:
• SAR white paper.
• Four case studies.
PO 00000
Frm 00010
Fmt 4701
Sfmt 4702
• 12 general use patterns, suggestions
for different/additional use patterns,
and their utility.
• Proposed new down-the-drain
requirements.
Additionally, in other parts of this
proposed rule, EPA is specifically
requesting comments on certain issues.
As appropriate during the
development of this proposal, EPA has
occasionally shared information with
the regulated community on the data
requirements that were under
consideration. Commenters are
encouraged to comment on such sharing
of information as part of the
administrative process of developing
this proposed rule.
The Agency welcomes comments on
the following topics of particular
interest to the Agency:
• All aspects of the administrative
process used to develop this proposed
rule including outreach activities.
• The need for, value of, and any
alternatives to, the data requirements
described in this document.
• The scientific basis of this proposed
rule.
• The clarity of the proposed data
requirements for antimicrobial
pesticides and the relationship between
the proposed data requirements and
EPA’s statutory determinations.
• The economic analysis of the
proposed rule, as well as on its
underlying assumptions, economic data,
and high- and low-cost options and
alternatives.
Commenters are encouraged to
present any data or information that
should be considered by EPA during the
development of the final rule. Describe
any assumptions and provide any
technical information and data used in
preparing your comments. Explain
estimates in sufficient detail to allow for
them to be reproduced for validation.
EPA’s underlying principle in
developing the proposed revisions has
been to strike an appropriate balance
between the need for adequate data to
make the statutorily mandated
determinations and informed risk
management decisions, while
minimizing data collection burdens on
applicants.
V. Product Chemistry
The Agency proposes to apply the
product chemistry data requirements for
conventional pesticide chemicals, in
subpart D, to antimicrobial products.
These requirements were promulgated
in the final rule on October 26, 2007, (72
FR 60934). Product chemistry
requirements identify the basic identity,
and chemical and physical
characteristics of a pesticide chemical.
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
These data, to a limited extent, are used
to determine if a pesticide contains
contaminants which are of toxicological
or environmental concern and are
necessary to determine proper label
precautions. Product chemistry
requirements are generally not
dependent on a pesticide’s intended use
pattern, and therefore it is appropriate
to apply the same requirements to
antimicrobial pesticides as required for
conventional pesticides. If
circumstances particular to
antimicrobial pesticides should arise,
then the Agency has the authority to
require the appropriate product
chemistry data on a case-by-case basis.
VI. Product Performance Data
Requirements
EPA is not proposing to revise
product performance data requirements
(§ 158.2220) at this time. At this time
there are nearly identical product
performance data requirements for
antimicrobial chemicals in both
§ 158.400 and part 161. EPA proposes to
transfer the contents of the existing
product performance data requirements
for antimicrobial pesticides into subpart
W, specifically § 158.2220. The table is
transferred essentially unchanged. EPA
is also proposing to delete the
duplicative data requirements for
antimicrobials from the table in
§ 158.400. After the publication of the
final rule, all product performance data
requirements for antimicrobials will be
contained in § 158.2220.
In the Federal Register of September
17, 1999, (64 FR 50726), EPA published
a proposed rule entitled, ‘‘Registration
Requirements for Antimicrobial
Pesticide Products and Other Pesticide
Regulatory Changes.’’ In that proposed
rule, EPA proposed various definitions
for public health pesticides. Today, the
Agency is re-proposing definitions for
the following terms: disinfectant,
fungicide, microbiological water
purifier, sanitizer, sterilant,
tuberculocide, and virucide. These
proposed definitions are identical to
those in the 1999 proposal. The Agency
is also re-proposing the 1999 criteria
that EPA would use to consider whether
a product makes a public health claim.
The comments that were received on the
1999 proposed rule were considered for
today’s proposed rule.
The current regulations in part 161
require that each applicant must ensure
through testing that its products are
efficacious when used in accordance
with label directions and commonly
accepted practices. The requirement to
submit product performance data is
directly linked to making a public
health claim. Today’s proposal makes
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
explicit what antimicrobial claims
would be considered public health
claims for purposes of product
performance data submission.
At the time of application, EPA
requires the submission of product
performance data for products making a
public health claim. An application will
not be approved in the absence of
acceptable data substantiating a public
health claim. EPA requires the
development of product performance
data for all other (non-public–health)
products, but does not review or
approve such data as part of a new or
amended registration. If, after the
product has been registered, EPA has
reason to review such data (for example,
there are indications that the product
does not perform as claimed), then EPA
will require the registrant to submit
such data within a reasonable time. A
request for submission of product
performance data after product
registration is not required to be done
under the Data Call-In provisions of
FIFRA section 3(c)(2)(B), but is instead
authorized by regulation.
Accordingly, if an antimicrobial
product makes a claim to control
microorganisms that pose a threat to
human health, the applicant is then
required to submit product performance
data to support its registration. The
types of product performance data
required by the Agency to support
registration of an antimicrobial are
determined by the types of claims made
on the product’s label (e.g., sanitizer,
disinfectant) and the intended use site
for the product (e.g., hard surface,
fabric).
VII. Human Health Risk Assessment
The data needed to conduct a human
health risk assessment include both
toxicology and exposure data.
Toxicology studies are used to assess
hazards of pesticides to humans and
domestic animals, and include a variety
of acute, subchronic, and chronic
toxicity studies; developmental/
reproductive tests; and tests to assess
mutagenicity and pesticide metabolism.
To assess human health risk, there must
be sufficient information to select the
appropriate doses and end-points, i.e.,
the Agency must know the level of
exposure at which an adverse effect is
observed. This requires a toxicological
database that is not only complete in the
endpoints it covers, but is also of
acceptable quality. The duration of the
toxicity study approximates the
estimated duration of the human
exposure, while considering species
differences in maturational milestones
and overall life span. The toxicology
PO 00000
Frm 00011
Fmt 4701
Sfmt 4702
59391
data requirements are discussed in Unit
VIII of this preamble.
For EPA to assess the potential risks
that antimicrobial products pose to
humans, it is necessary not only to
assess the hazard of the antimicrobial
active ingredient based on toxicology
information, but also to estimate human
exposures to the antimicrobial based on
the product use patterns. For
antimicrobials, three types of exposure
data are required: applicator, postapplication, and residue chemistry
(which includes exposure via food and
water).
Applicator and post-application
exposure data are used to evaluate
exposures to persons in occupational
and non-occupational settings,
including residential, commercial,
institutional, and recreational sites.
Exposure data include: dermal and
inhalation exposure data for applicators,
post-application residue data, postapplication monitoring data, use
information, and human activity
information. Applicator and postapplication data requirements are
discussed in Unit IX of this preamble.
Residue chemistry information is
used to establish tolerances for residues
of pesticide chemicals (and any
metabolites of concern) in/on food
crops, processed foods, and animal
products consumed by humans when
the animal consumes a feed item
derived from these crops. The Agency
estimates the dietary exposure of the
general population and various
population subgroups to pesticide
residues in food by using the residue
data as inputs to the dietary modeling.
The dietary exposure is then used in
conjunction with toxicity data to
determine risk. Residue chemistry data
requirements are discussed in Unit X.
VIII. Toxicology Data Requirements
A. Toxicology Data Requirements for
Antimicrobials
EPA proposes to adapt the basic
toxicology data types as listed in
subpart F of current part 158 to support
applications for antimicrobial products.
However, EPA also proposes to modify
the applicability of those requirements
to reflect the differing risks of and levels
of exposure to antimicrobials.
As with conventional pesticides, the
types of toxicology studies required for
antimicrobials can include acute,
subchronic, and chronic toxicity
studies, as well as carcinogenicity,
prenatal developmental toxicity,
reproductive toxicity, mutagenicity,
neurotoxicity, immunotoxicity, and
other studies.
E:\FR\FM\08OCP2.SGM
08OCP2
59392
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
1. Acute toxicity studies provide
information that serves as a basis for
classification and precautionary labeling
and the need for child resistant
packaging.
2. Subchronic toxicity studies provide
information that can be used to assess
human health hazards that may result
from repeated exposures to a pesticide
over a limited period of time. These data
also provide information for selecting
proper dose levels for chronic/
carcinogenicity studies.
3. Chronic toxicity studies are used to
assess potential hazards resulting from
prolonged and repeated exposures to a
pesticide over a significant portion of
the life span.
4. Prenatal developmental toxicity
studies are designed to assess the
potential of a pesticide to induce effects
in offspring as the result of exposure of
the mother during pregnancy.
5. Multigeneration reproduction
studies are designed to provide
information concerning the general
effects of a pesticide on overall
reproductive capability.
6. Mutagenicity studies assess the
ability of the pesticide to interact
directly or indirectly with cellular DNA,
RNA, proteins, or chromosomes and the
potential for adverse effects on cellular
genetic material.
7. Neurotoxicity studies evaluate the
potential of the pesticide to adversely
affect the structure and functions of the
nervous system.
8. Immunotoxicity studies evaluate
the potential of the pesticide to
adversely impact the immune system.
9. Metabolism studies evaluate the
absorption, distribution,
biotransformation, and excretion of the
pesticide.
B. The History of Toxicology
Requirements for Antimicrobials
By 1984, the Agency had reconsidered
its toxicology data requirements for all
pesticides, including antimicrobials. For
instance, it had become clear that
exposure to antimicrobial pesticides
might well be long-term and frequent
since many antimicrobials were used
indoors in close proximity to humans.
Occupational users often were exposed
to concentrated antimicrobial products
while mixing and diluting the product
for use, and might be exposed to an
antimicrobial pesticide for large
portions of their working lifetimes. In
response to the reregistration program
initiated under the 1988 amendments to
FIFRA, EPA concluded that additional
data were needed to properly evaluate
the potential hazards associated with
antimicrobial pesticides. Consequently,
the Agency began to require more
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
toxicity data for antimicrobials. In 1987,
based on its evolving understanding of
antimicrobial uses, the Agency issued
an Antimicrobial Toxicology Data CallIn (DCI) Notice (52 FR 595, January 7,
1987) (Ref. 24), which specified a tiered
approach for submission of toxicology
and human exposure data.
The 1987 Antimicrobial Toxicology
DCI divided antimicrobial pesticides
into three exposure categories: low,
medium, and high. The toxicology data
required was tiered according the
amount of exposure. The first tier
toxicology data requirements (low
exposure) were the standard acute
studies, a 90–day dermal or inhalation
study, a prenatal developmental toxicity
study in one species, and a battery of
mutagenicity studies. The second tier
(medium exposure) included the firsttier toxicology studies and a subchronic
feeding study, a prenatal developmental
study in a second species, and a dermal
absorption study. The third tier (high
exposure) included the first- and
second-tier studies and the chronic
feeding, carcinogenicity, reproduction,
and metabolism studies. All food-use
antimicrobials were considered high
exposure.
Applicants could fulfill the toxicology
data requirements by submitting the
appropriate toxicity studies or by
submitting a combination of toxicity
studies and exposure data. The Agency
used the exposure data and submitted
toxicology data to determine whether
and which additional toxicology studies
were needed to assess the hazard of the
antimicrobial.
In proposing part 158, subpart W, the
Agency is specifying the toxicology data
requirements it believes are appropriate
for specific antimicrobial use categories,
drawing upon EPA’s experience since
1987. EPA is now proposing two
groupings: Low- and high-exposure. In
practice, the submission, review, and
evaluation of toxicity data merged the
low- and medium-exposure categories.
Therefore, the low- and mediumexposure categories from the 1987 DCI
were combined to create what is today
the low exposure category.
Today’s proposed approach
conceptually follows the tiering
approach used in 1987. Generally, data
requirements proceed in a tiered
manner from simpler to more complex
studies considering the frequency,
duration, and magnitude of exposure as
well as the dermal absorption of the
pesticide. Knowledge gained from
results of assessments performed using
these lower tiered studies is used to
indicate if any higher tiered studies are
required. The Agency does not prescribe
a required sequence of toxicological
PO 00000
Frm 00012
Fmt 4701
Sfmt 4702
testing. There are many factors that
could affect the testing progression.
Rather, decisions regarding the
sequence in which the tests are
conducted are left up to the applicant.
Thus, the applicant has flexibility to
determine the sequence of testing, as
best suited for their particular chemical.
Early consultation with the Agency is
recommended to attain a common
understanding of the sequencing that
should be used.
C. Groupings for Antimicrobial
Toxicology Data Requirements
1. Overview. This proposal divides the
antimicrobial uses into two groups, high
human exposure and low human
exposure uses. Because high human
exposure uses may pose higher risks,
more toxicology studies are required
than for uses with less exposure. For the
purpose of determining toxicology data
requirements, high human exposure is
defined as that resulting in human
exposures over a considerable portion of
the human lifespan. Exposure to food
and water, which occurs throughout the
human life span, is therefore a high
human exposure. For other exposures
such as occupational and residential,
the Agency has considered the
frequency, duration, or magnitude of the
exposure to determine in its best
professional judgment if the exposure is
high. One or a combination of these
parameters led the Agency to make the
determination that the exposure is high.
As an example, swimmers may swim
daily or weekly, from several minutes to
several hours with almost their entire
body in the water. There are workers
who manually pour concentrates into
vessels for mixing (with water or other
chemicals) in order to prepare dilute
solutions for use. Such exposures can
occur daily, weekly, monthly, or
episodically as dictated by the
circumstances of the job. Particularly in
the absence of personal protective
equipment, these workers have the
potential for high dermal and inhalation
exposures. Accordingly, for the
purposes of defining data requirements,
EPA proposes to categorize food and
feed uses and certain nonfood-uses as
high human exposure.
As discussed, the Agency considers
high human exposure uses to be those
that could result in pesticide residues
occurring in food or feed, or in drinking
water. These would include, but are not
limited to:
• Human or animal drinking water.
• Fruit and vegetable rinses.
• Egg washes.
• Outdoor aquatic uses in lakes, rivers,
or streams which have the potential to
contaminate potable water.
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
• Indirect food uses with residues
equal to or greater than 200 parts per
billion (ppb).
• Any use that requires a tolerance or
tolerance exemption (except for indirect
food uses requiring a tolerance or
tolerance exemption in which residues
are less than 200 ppb).
EPA also considers high human
exposure uses to be those uses that
could result in high exposure to
applicators, and any other antimicrobial
uses which could result in high
exposure to humans. These would
include but are not limited to:
• Wood preservatives.
• Metal cutting (metalworking) fluids.
• Swimming pools.
This list is not exhaustive. There may
be other uses that the Agency would
consider high human exposure uses
based on their potential for human
exposure. Low human exposure uses are
defined as those that are not high
human exposure uses.
The Agency is proposing an approach
that might allow an applicant for
registration of a pesticide with low
human exposure uses to generate fewer
studies in total than would be required
for high human exposure uses. Under
this proposal, applicants with low
human exposure antimicrobials may
perform tests in a tiered fashion. As
previously explained, for toxicology
studies the high human exposure
grouping specifies 19 toxicology studies
as required, and for the low human
exposure grouping, 13 toxicology
studies as required. After the 13
required studies for low human
exposure are reviewed by the Agency,
additional testing may be required for
low-exposure uses based on the result(s)
of the lower-tiered studies. These 13
studies could indicate a low risk
potential or could trigger the need for
additional data.
The table in proposed § 158.2230
presents the toxicology data
requirements. The proposed toxicology
data requirements for the two groupings
(high human exposure and low human
exposure) are separated into two
columns showing test by test whether it
is typically required (shown as R) or
conditionally required (shown as CR).
The Agency recognizes that
toxicology testing can represent a large
burden on applicants and can involve
significant animal testing.
Consequently, the Agency works with
applicants, the scientific community,
and other stakeholders to ensure that
data requirements produce the
information needed to enable the
Agency to make the safety findings
required under FIFRA and FFDCA. The
tiering process proposed within the
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
toxicology data requirements requires
fewer studies for lower exposures. The
Agency also works to design study
protocols that minimize the
development burden and limit uses of
test animals. Toxicity testing
requirements may be satisfied in a
combined study, such as combining the
prenatal developmental and
reproductive toxicity testing
requirements in a single study.
However, if this option is chosen, the
protocol must be approved by the
Agency prior to the initiation of the
study. Details for developing protocols
are available from the Agency.
2. Data requirements for high human
exposure uses. For high human
exposure uses, EPA is proposing to
require the following studies: Acute
oral, dermal, and inhalation toxicity;
primary eye and dermal irritation;
dermal sensitization; subchronic studies
in two species; mutagenicity studies;
acute and subchronic neurotoxicity
testing; prenatal developmental toxicity
studies in two species; a two-generation
reproduction study; a chronic feeding
study in one species; carcinogenicity
studies in two species; a mammalian
metabolism study; and an
immunotoxicity study. Based on a
weight-of-evidence evaluation, a
developmental neurotoxicity study may
be required. If the Agency determines,
based on use information that dermal
exposure is the major route of exposure,
then EPA may require dermal
absorption testing or toxicological
studies conducted by the dermal route.
i. Wood preservatives. For wood
preservatives, the Agency may require
toxicity data on both the active
ingredient which is incorporated into
the wood and on transformation/
degradation products which occur in
wood post-treatment. Such
transformation/degradation products
would include dislodgeable residues
(i.e., residues that occur from hand
contact with treated wood) or leachate
residues (i.e., residues that occur in soil
or water in contact with treated wood).
ii. Metal working fluids (MWFs).
While both ‘‘open’’ and ‘‘closed’’ MWF
systems are high human exposure uses,
under the appropriate circumstances,
the Agency distinguishes between
‘‘open’’ and ‘‘closed’’ systems. Fewer
toxicity data may be required for a
‘‘closed’’ system. If the use of the MWF
is limited to ‘‘closed’’ systems only, the
applicant clearly identifies the use as
such, and the Agency agrees, then fewer
toxicity studies would be required for
that ‘‘closed’’ system. Based upon
review and evaluation of the submitted
toxicity studies and exposure data, EPA
may determine that fewer additional
PO 00000
Frm 00013
Fmt 4701
Sfmt 4702
59393
toxicity studies than would generally be
submitted are required. Upon request
the Agency will provide written
guidance concerning exposure, toxicity,
and other data requirements for ‘‘open’’
and ‘‘closed’’ MWF systems.
3. Data requirements for low human
exposure uses. As previously discussed,
the Agency proposes to apply a tiered
system to toxicology testing
requirements for low human exposure
antimicrobials. The required data are:
Acute oral, dermal, and inhalation
toxicity; primary eye and dermal
irritation; dermal sensitization; a
subchronic toxicity study in the rodent;
prenatal developmental toxicity studies
in two species; a two-generation
reproduction study; mutagenicity
studies; and immunotoxicity testing.
Based on the review of these studies,
additional studies may be required if
there is evidence of significant toxicity
in the submitted studies. Evidence that
could trigger concerns may include data
indicating neurotoxicity,
immunotoxicity, developmental,
reproductive, or other systemic toxicity
such as the presence of neoplastic
growth or significant target organ
toxicity. In such cases, appropriate
studies to address the Agency’s hazard
or risk concern would be required. The
table in proposed § 158.2230 contains
test notes that explain how these
toxicology requirements are proposed to
be applied to low human exposure
antimicrobials.
4. Data requirements for indirect food
uses. For the purpose of determining
toxicology data requirements, an
antimicrobial use is considered an
indirect food use when the
antimicrobial pesticide is applied to a
surface or incorporated into a material
that may contact food, but is not applied
directly to food. Residues of the
pesticide or its degradates can be
transferred to the food when it comes
into contact with these treated surfaces
and articles. Examples of antimicrobial
uses which may result in residues in
food, through normal use, are sanitizers
and disinfectants, which may be used in
food-handling areas, but not directly
applied to the food.
With the passage of the Food Quality
Protection Act of 1996 (FQPA), as later
modified by the Antimicrobial
Regulation Technical Corrections Act of
1998 (ARTCA), EPA currently has the
responsibility for establishing tolerances
or tolerance exemptions for all pesticide
uses that result in residues in or on
food, except for:
• Residues that result from the use of
antimicrobial substances on food or in
water that comes into contact with food,
if such substances are used where food
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59394
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
is prepared, packed, or held for
commercial purposes. (For raw food
commodities, this exclusion does not
apply if the antimicrobial is applied in
a facility where only such foods are
treated and the treatment of the foods
does not constitute food processing.)
• Antimicrobial substances used as
food contact substances in or on food,
such as those used in the manufacture
of food contact packaging. This
exclusion does not apply to objects
impregnated with a food contact
substance (other than food packaging
material) if the inclusion of the
substance is intended to have an
antimicrobial effect on the food contact
surface of the object.
FDA has the responsibility for
regulating these antimicrobial
substances as food additives under
section 409 of the FFDCA. However,
under the provisions of FIFRA section
2(bb) prior to registration of a pesticide
that may result in residues of that
pesticide in or on food (including
sanitizers, disinfectants, and
slimicides), EPA must make a safety
finding that the pesticide residue meets
the standard set forth in section 408 of
FFDCA. This applies even if FDA will
establish a food additive regulation for
the use of the antimicrobial substance
under section 409 of the FFDCA.
Since publication in 2002 of its final
guidance for toxicology
recommendations for food contact
substances, FDA has used an approach
with several tiers: residues less than 0.5
ppb, between 0.5 and 50 ppb, between
50 ppb and 1,000 ppb, and greater than
1,000 ppb. EPA recognizes the historic
usefulness of the FDA’s tiered approach
and proposes to adopt it conceptually,
but with a modification appropriate to
antimicrobials (biocides). FDA’s
guidance (Ref. 8) specifically
recommends that a factor of 5 be used
to account for the toxicity of biocides.
Further modifications to this approach
are needed for EPA to perform an
assessment of risk that conforms to the
FFDCA section 408 safety finding which
now requires consideration of the ‘‘...
special susceptibility of infants and
children to the pesticide chemical
residues....’’. Thus, additional studies
are needed even for the lower exposures
for which FDA historically would not
have required data.
Accordingly, EPA proposes to classify
indirect food uses of antimicrobials
which result in residues in or on food
of less than 200 ppb as low human
exposure uses for purposes of subpart
W. Given FDA’s historical experience
with biocides, EPA believes that the 200
ppb (1,000 ppb divided by 5)
benchmark is a reasonable delineation
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
between high and low human
exposures. Antimicrobials used in a
manner which results in residues in
food from an indirect use that are equal
to or greater than 200 ppb would be
considered high exposure uses. The
Agency specifically requests comment
on the use of 200 ppb residues in food
as the differentiation between the high
and low human exposure for the
purposes of subpart W.
For indirect food uses, the applicant
should begin the process by collecting
all available information. Since many
indirect food uses were previously
evaluated by FDA, there may be a
petition that was submitted to FDA. For
some chemicals, toxicity testing may
have been conducted and reviewed in
the open literature. After identifying the
available reliable information, the
applicant should compare this
information to the data requirements in
the appropriate column in the table in
§ 158.2230. If the applicant believes that
an existing study satisfies the data
requirement, then this should be
discussed with EPA.
The applicant is also encouraged to
review the approach discussed in Unit
XVIII.A. of this preamble on the use of
Structure-Activity-Relationship (SAR)
assessments to ascertain if such
techniques could provide useful
information in preparing a submission
to EPA.
D. Acute Toxicity Studies for End-Use
Products
EPA proposes to add a test note to
clarify that the currently required six
acute toxicity studies are to be
conducted on the product as formulated
for sale and distribution. These six acute
studies may also be needed for the
product as diluted for use. Many
antimicrobial products are diluted at the
point of use, but can still lead to
significant exposure. The applicant has
the option of also conducting certain
studies using the highest diluted
concentration (i.e., the least diluted
product) permitted by the labeling. This
test note codifies EPA’s current
practices. Consultation with the Agency
is highly suggested to assure that the
appropriate product and any
appropriate dilutions are tested.
E. Neurotoxicity
EPA promulgated toxicity
requirements for conventional pesticide
chemicals, in which the data
requirements for neurotoxicity were
revised. The former test battery of three
studies was revised to include only two
studies. The rationale for those revisions
was discussed in Unit XI of that
proposed rule (March 11, 2005) (70 FR
PO 00000
Frm 00014
Fmt 4701
Sfmt 4702
12276), and in the final rule preamble
(October 26, 2007) (72 FR 60934). That
rationale is also applicable to
antimicrobial pesticide chemicals.
EPA proposes to adopt the current
conventional pesticide data
requirements for neurotoxicity testing to
antimicrobials. Adopting the battery of
two neurotoxicity studies would codify
the Agency’s current practices.
The current adult neurotoxicity test
battery for antimicrobials in part 161
consists of three studies: Acute delayed
neurotoxicity (hen), 90–day
neurotoxicity (hen), and 90–day
neurotoxicity (mammal). The mammal
subchronic neurotoxicity study is
required if the acute oral, dermal, or
inhalation toxicity studies show
neurotoxicity or neuropathy. The
existing required data are inadequate for
evaluating neurotoxic effects of some
chemicals.
The proposed battery of two studies
in the rat is more sensitive than the
neurotoxicity tests currently required in
part 161. The objective of the proposed
acute and subchronic neurotoxicity
battery is to evaluate the incidence and
severity of the functional and behavioral
effects, the level of motor activity, and
the histopathology of the nervous
system following exposure to a pesticide
chemical.
Under this proposal, an adult
neurotoxicity test battery of two studies
would replace the current battery of
three studies. The two studies are an
acute and a subchronic 90–day
neurotoxicity study in rats. The acute
study would detect possible neurotoxic
effects resulting from a single exposure.
The subchronic study would detect
possible effects resulting from repeated
exposures. These studies were
presented to the FIFRA SAP in 1994,
which endorsed them, and the Agency
has generally required them on a caseby-case basis since 1992 for all
pesticides, including antimicrobial
pesticides.
The required parameters for a
subchronic neurotoxicity study may be
incorporated into the standard 90–day
subchronic feeding study in rats. The
acute and subchronic neurotoxicity
studies in adult rats, in addition to
providing data on the potential for
adverse neurotoxic effects, may also
provide a basis for comparing the
potential for age-related differences in
impacts on the nervous system if a
developmental neurotoxicity study is
triggered for the same chemical.
For high human exposure uses, EPA
proposes to require both the acute
neurotoxicity and subchronic
neurotoxicity studies in the rat. For low
human exposure uses, both
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
neurotoxicity studies are proposed to be
conditionally required (CR) and would
be triggered if there is evidence of
neurotoxic effects in the 90–day oral
study in rodents or if other data show
evidence of neurotoxicity.
sroberts on PROD1PC70 with PROPOSALS
F. 90–Day Oral Studies
EPA proposes to adopt the current
conventional pesticide data
requirements for subchronic (90–day)
studies to antimicrobials. Oral 90–day
toxicity studies in two species are
currently required in part 161 for high
human exposure uses and conditionally
required in part 161 for low human
exposure uses. The Agency is proposing
to continue this existing requirement for
high human exposure uses in part 158,
subpart W. The Agency is proposing to
require an oral 90–day study in one
species (rodent) for low human
exposure uses and to conditionally
require testing in a second species (nonrodent). For low human exposure uses,
this change from two conditionally
required studies to one required and one
conditionally required study would
codify current practices.
Often, range-finding studies of at least
90 days are needed to select the
appropriate dose levels for the mouse
carcinogenicity study. Thus, 90–day
studies are often performed routinely by
most investigators prior to the initiation
of the carcinogenicity study. Often the
range-finding studies have been
submitted to the Agency for review.
Because of their utility in determining
the dose levels in the mouse
carcinogenicity study, in the test notes,
the Agency encourages the use of rangefinding studies in the mouse.
Additionally, all 90–day subchronic
studies in the rodent can be designed to
simultaneously fulfill the requirements
of the 90–day neurotoxicity study by
adding separate groups of animals for
testing. Although the subchronic
guidelines include the measurement of
certain neurological endpoints, they do
not meet the requirement for a 90–day
neurotoxicity study.
G. 21/28–day Dermal and 90–day
Dermal Testing with End-Use Product
Currently in part 161 there is a
conditional requirement for 21–day
and/or 90–day dermal toxicity studies
for all use patterns. The Agency is
proposing to continue to conditionally
require 21/28–day and/or 90–day
dermal toxicity studies for all
antimicrobials. As determined by the
Agency, based on the use pattern,
frequency of exposure, and magnitude
of exposure, the 21/28 day study may
provide the appropriate information for
risk assessment purposes.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
59395
Just as with conventional pesticides,
the Agency is proposing to require
subchronic dermal testing of the enduse product if the product or any
component of the product may increase
dermal absorption of the active
ingredient(s) or could potentiate toxic or
pharmacologic effects. Testing of an
end-use (formulated) product in either
of these studies has not been routinely
required and therefore would be a new
testing requirement for antimicrobials.
A test note has been added to both of
these existing data requirements to
describe the triggers for end-use product
testing.
Currently, end-use products are
required to be tested for acute dermal
toxicity and dermal irritation. Without
additional subchronic testing of the enduse product, risk from dermal exposure
to an end-use product may be
underestimated for those products that
contain an inert ingredient that
increases the dermal absorption of the
active ingredient. An example of such
an inert ingredient would be dimethyl
sulfoxide.
sanitizer application to a hard surface
such as a desktop. Thus, there is a
greater potential for the applicator to be
exposed to large amounts of pesticide.
In addition, many of the components of
HVAC&R systems are typically
inaccessible and could create unique
exposure scenarios for applicators. Postapplication exposure to building
occupants is also a concern. When the
treated system resumes operation, the
potential exists for the pesticide to be
readily spread throughout the building.
For these reasons, the Agency is
proposing to modify the requirement for
90–day subchronic studies to address
HVAC&R uses. Specifically, the Agency
is proposing to replace the 90–day oral
toxicity test with two 90–day toxicity
tests, one by the dermal route, and one
by the inhalation route. These are the
primary routes of exposure from
HVAC&R uses, and such route-specific
studies are intended to provide the
Agency with the information needed to
characterize the hazard for the risk
assessment for HVAC&R uses of
antimicrobial pesticides.
H. 90–day Dermal and 90–day
Inhalation Testing for HVAC&R Uses
Heating, ventilation, air conditioning,
and refrigeration systems (collectively
referred to as HVAC&R) refer to systems
which refrigerate, exclusively air
condition, or exclusively heat, as well as
those in which one system provides
both heating and cooling. HVAC&R
systems are present in industrial,
institutional, commercial, and
residential establishments, and include,
but are not limited to: air ducts, duct
fittings, duct liners, fans, supply ducts,
return ducts, exhaust ducts, intakes,
outlets, louvers, diffusers, dampers,
plenums, outdoor air intakes, air
handling units, and any other ductwork
and similar components. The Agency is
concerned with potential exposures and
risks from application of antimicrobial
pesticide products used to treat the
surfaces of HVAC&’s system
components. An example of such
treatment would be use of an
antimicrobial as part of air duct
cleaning.
HVAC&R is a unique use site which
must be specifically identified on the
label of the antimicrobial product. The
application of an antimicrobial product
to an HVAC&R system represents a use
pattern substantially different from
other hard surface disinfection or
sanitizer treatments. Application to
HVAC&R systems may require that
larger volumes of the antimicrobial be
applied to both internal and external
system components than would
typically be used as a disinfection/
I. Chronic Studies
PO 00000
Frm 00015
Fmt 4701
Sfmt 4702
Currently in part 161 a chronic
toxicity study in two species is required
for all food-uses and conditionally
required for all other use patterns.
Today the Agency is proposing to
continue this existing requirement by
requiring a chronic study in the rodent
for high human exposures and
conditionally requiring the study for
low human exposures.
In its final rule for conventional
pesticide chemicals, the Agency
eliminated the requirement for an oral
chronic study in a second, non-rodent
species, usually the dog. Similarly, EPA
is proposing to eliminate the 1–year dog
study as a data requirement for
antimicrobial pesticides. EPA’s
reasoning is fully explained in the final
rule (Unit X) for conventional pesticides
(Refs. 36, 37, and 38). For antimicrobials
EPA would adopt the same criteria (as
set out in the applicable test note to the
table in proposed § 158.2230) for the
rare circumstances when a 1–year dog
study might be required.
J. Carcinogenicity Studies
Currently in part 161 two
carcinogenicity studies are required for
all food-uses and conditionally required
for all other use patterns. Today the
Agency is proposing to continue this
existing requirement by requiring
carcinogenicity studies in two species
for high human exposures and
conditionally requiring the studies for
low human exposures.
E:\FR\FM\08OCP2.SGM
08OCP2
59396
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
K. Prenatal Developmental Toxicity
The Agency proposes to require two
oral prenatal developmental toxicity
studies (one in rodents and one in a
non-rodent species) to support the
registration of every antimicrobial
pesticide product. This not only codifies
the Agency’s current practices, but also
harmonizes the requirements for
antimicrobials with those of
conventional pesticides.
The Agency encourages applicants for
registration to consider the use of
combined study protocols in satisfying
this requirement. A prenatal
developmental toxicity study segment
could be added to a two-generation
reproduction study in rodents. By
combining protocols, a single study
could satisfy the requirement for both
prenatal developmental and
reproductive toxicity in the rodent.
While it is recognized that the cost of
the reproduction study would increase
somewhat due to the additional work
scope, the total cost of the combined
study would be substantially less than
that incurred by conducting the two
studies separately. Moreover, a
combined reproduction/developmental
protocol should not require the use of
additional animals and would increase
the efficient utilization of the animals
being studied. The second required
prenatal developmental toxicity study
in the non-rodent would then be
performed separately.
The Agency may require an additional
prenatal developmental study by
another route of exposure (usually
dermal) if there is evidence of
developmental toxicity in any of the
available studies and the other route of
exposure is, in the Agency’s judgment,
a significant route of exposure (Refs. 3,
18, and 35). Submission of such a study
is an infrequent occurrence: only one
dermal prenatal developmental toxicity
study has been submitted for an
antimicrobial.
sroberts on PROD1PC70 with PROPOSALS
L. Reproduction
The Agency proposes to require a
reproductive toxicity study to support
the registration of every antimicrobial
pesticide product. This codifies the
Agency’s current practices.
For many years, for nonfood-uses, the
Agency did not require a reproductive
toxicity study for low human exposure
antimicrobials. However, in 1997, it was
suggested that, without a reproductive
toxicity study, the Agency could be
missing reproductive risks of concern.
For example, the Pest Management
Regulatory Agency (PMRA) of Canada,
presented the results of a retrospective
analysis during the public comment
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
portion of the FIFRA SAP in June 1997
(Ref. 13). Although the SAP did not
comment on this analysis, the Agency
determined that a reproductive toxicity
study would ensure that it did not miss
potential reproductive risks of concern.
In making the safety finding under
FFDCA, the Agency is required to
consider the special susceptibility/
sensitivity of infants and children to
pesticide chemical residues. EPA cannot
adequately characterize the
susceptibility of infants and children
without a reproduction and fertility
effects study that assesses the
occurrence of biologically adverse
effects on the male and female
reproductive system, as well as on the
developing organisms from exposure
prior to conception (either parent),
during prenatal development, or postnatally in the offspring up to the time
of sexual maturation. Thus, to make the
safety finding requires reproduction
testing, since reproductive toxicity
testing endpoints are not adequately
assessed in the other required toxicity
studies. Therefore, these other studies
do not provide adequate ‘‘triggers’’
which would indicate the potential for
reproductive toxicity.
Today’s proposal harmonizes the
requirements for antimicrobials with
those of conventional pesticides. EPA
has been requiring a reproductive
toxicity study for all antimicrobials for
the last several years.
As noted in Unit VIII.K. of this
preamble, the prenatal developmental
and reproductive toxicity testing
requirements may be combined in a
single study. If the applicant does not
choose this option, then separate
developmental and reproductive
toxicity studies must be conducted.
M. Developmental Neurotoxicity (DNT)
In practice, EPA evaluates each
pesticide using all available
toxicological information that might
indicate a need for a developmental
neurotoxicity study. The DNT study has
been required on a case-by-case basis for
certain conventional chemicals for fooduse and nonfood-use registrations since
1991.
Just as with conventional pesticide
chemicals, the Agency is now proposing
that DNT testing be conditionally
required for all antimicrobial pesticides.
This would be a new requirement for
antimicrobial pesticides. The study is
triggered based upon a weight-ofevidence evaluation of the toxicological
database. The criteria involved in this
weight-of-evidence evaluation are the
same as those for conventional pesticide
chemicals and are presented below:
PO 00000
Frm 00016
Fmt 4701
Sfmt 4702
1. The antimicrobial pesticide causes
treatment-related neurological effects in
adult animal studies, such as:
• Clinical signs of neurotoxicity.
• Neuropathology.
• Functional or behavioral effects.
2. The antimicrobial pesticide causes
treatment-related neurological effects in
developing animals, following pre- or
post-natal exposure such as:
• Nervous system malformations or
neuropathy.
• Brain weight changes in offspring.
• Functional or behavioral changes in
the offspring.
3. The antimicrobial pesticide elicits
a causative association between
exposures and adverse neurological
effects in human epidemiological
studies.
4. The antimicrobial pesticide evokes
a mechanism that is associated with
adverse effects on the development of
the nervous system, such as:
• SAR relationship to known
neurotoxicants.
• Altered neuroreceptor or
neurotransmitter responses.
EPA proposes the addition of the
developmental neurotoxicity study to
the toxicology testing requirements as a
conditional requirement. The two
required developmental toxicity studies
do not include an in-depth assessment
of the development of the nervous
system and therefore do not provide the
same information as the DNT. In
implementing this conditional
requirement, applicants are encouraged
to apply what is known about the
chemical and its toxicity to develop a
rational, science-based approach to this
testing.
N. Mutagenicity
Mutagenicity testing is required in
part 161; however, just as with
conventional pesticide chemicals, the
Agency is proposing to change the
specific types of tests to be performed to
satisfy the mutagenicity testing
requirement (Refs. 4 and 26). A battery
of mutagenicity tests is currently
required in part 161 to assess the
potential of the test chemical to
adversely affect the genetic material in
the cell and subsequently serve as part
of the Agency’s weight-of-evidence
approach for classifying potential
human carcinogens. Mutagenicity data
are also used to evaluate potential
heritable effects in humans.
Mutagenicity testing would no longer be
subdivided into the categories of gene
mutation, structural chromosomal
aberrations, and other genotoxic effects,
with selection from a wide range of
mutagenicity tests satisfying these
categories.
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
For conventional pesticides, the
Agency requires in § 158.500 an initial
battery for mutagenicity testing that
consists of a bacterial reverse mutation
assay with Salmonella typhimurium
and Escherichia coli, an assay with
mammalian cells in culture, and an in
vivo cytogenetics assay. The Agency has
selected the bacterial assay because it is
a primary test for detecting intrinsic
mutagenicity of many classes of
biologically active chemicals. The
genetics of each test strain of
Salmonella and select strains of E. coli
have been well-validated, and the assay
is easy to perform, is used routinely
throughout the world, and has an
extensive data base of tested chemicals.
The mammalian cells in culture assay
will detect a wider spectrum of possible
genetic endpoints not assayed in the
bacterial test. The in vivo cytogenetics
assay provides an important
examination of the potential effect a test
compound may have on an intact
mammalian system. Data from this
study provide information on in vivo
metabolism, repair capabilities,
pharmacokinetic factors (e.g., biological
half-life, absorption, distribution,
excretion) and target organ/tissue
effects.
EPA is proposing to modify the
requirement for a bacterial reverse
mutation assay conducted with
Salmonella typhimurium and
Escherichia coli. For antimicrobials, it is
not always practical to test
antimicrobials for mutagenicity in
bacterial test systems such as the
bacterial reverse mutation assay. Most
antimicrobial pesticides are toxic to
bacteria, and therefore can only be
tested at very low doses in bacterial
assays. This means that, for
antimicrobials, negative results in
studies done in bacterial test systems do
not necessarily demonstrate nonmutagenicity. Given this limitation of
bacterial reverse mutation assays such
as the Ames test, EPA must carefully
review Ames studies conducted using
antimicrobials. Cytotoxicity and the test
levels used in the study are critical
factors to consider when determining if
the results of an Ames test is acceptable
or not, that is, whether the test fulfills
the data requirement. However, the
Agency has previously accepted Ames
tests for antimicrobials after review and
evaluation indicates the validity of the
results. If the results of the Ames tests
are not valid, then the applicant would
need to discuss other mutagenicity
testing with the Agency, such as a
forward mutation assay conducted using
mouse lymphoma L5178Y cells. The test
notes to the proposed mutagenicity
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
requirements have been modified
accordingly.
Since there are many different
mutagenicity tests available besides
those in the initial battery, other types
of testing may have been performed in
the course of product research and
development. In addition to the initial
battery, data from such mutagenicity
tests must be submitted to the Agency,
along with a reference list of all studies
and papers known to the applicant
concerning the mutagenicity of the test
chemical. Having this information at the
beginning of a mutagenicity assessment
will greatly facilitate EPA’s effort to
provide a more accurate assessment of
the mutagenicity of the antimicrobial
pesticide in question.
O. Immunotoxicity
Just as with conventional pesticide
chemicals, the Agency proposes to
require immunotoxicity testing for all
antimicrobial pesticides. This would be
a new data requirement.
Immunotoxicity testing is necessary to
evaluate the potential of a chemical to
produce adverse effects on the immune
system. Immune system suppression has
been associated with increased
incidences of infections and neoplasia
(abnormal and uncontrolled cell
growth). In 1993, the National Research
Council reviewed the technical
literature and found that some
pesticides are immunosuppressive (Ref.
19).
Because the immune system is highly
complex, studies not specifically
conducted to assess immunotoxic
function are inadequate to characterize
a pesticide’s potential immunotoxicity,
even if some tissues subject to
immunotoxic insult are examined.
While data from hematology, lymphoid
organ weights, and histopathology of
routine chronic or subchronic toxicity
studies may offer useful information on
potential immunotoxic effects, these
endpoints alone are insufficient to
predict effects on immunotoxic function
(Refs. 15 and 16). Therefore, the Agency
is proposing to require functional
immunotoxicity testing along with the
data from immunotoxicity endpoints in
other studies to predict the potential
risk of pesticides on the immune system
more accurately.
P. Metabolism and Pharmacokinetics
Currently in part 161 a metabolism
study is required for all food-uses and
conditionally required for all other use
patterns. Today the Agency is proposing
to continue this existing requirement by
requiring a metabolism and
pharmacokinetics study for high human
PO 00000
Frm 00017
Fmt 4701
Sfmt 4702
59397
exposures and conditionally requiring
the study for low human exposures.
Q. Companion Animal Safety
Currently in part 161 a domestic
animal safety study is conditionally
required. According to the test note in
§ 161.340 this study would be required
on a case-by-case basis. Today the
Agency is proposing to continue this
existing requirement by conditionally
requiring the study for all antimicrobial
use patterns. The test note specifies that
the study would be triggered if the
product’s use would result in exposure
to domestic animals.
R. Dermal Penetration
Currently in part 161 a dermal
penetration study is conditionally
required for all antimicrobial use
patterns. Today the Agency is proposing
to continue this existing requirement by
conditionally requiring a dermal
penetration study for all antimicrobial
use patterns.
IX. Handler and Post-Application
Exposure Data Requirements
A. General
Exposure data are used in the
evaluation of the exposures to persons
in occupational and non-occupational
settings (§ 158.2260 and § 158.2270). For
antimicrobials this includes residential,
commercial and industrial, institutional,
agricultural premises, and recreational
sites. Data include dermal, inhalation,
and non-dietary oral exposures.
Most past exposure research with
antimicrobial products has studied
either handler exposure (i.e., exposure
of people who mix, load, or apply
antimicrobial pesticides in the course of
the application process or through other
work-related tasks) or post-application
exposure of people to residues of
antimicrobial pesticides after
application, in treated areas or on
treated surfaces.
Handler exposure research may
measure exposure to undiluted
antimicrobial products as the products
are mixed for application, or it may
measure exposure to antimicrobial
products diluted for use. Antimicrobial
pesticide applicators may be industrial
or other workers, professional
applicators, or consumers using the
product in or around their homes.
EPA considers handler exposure data
essential for fulfilling its mandate to
protect human health from pesticide
risk, including aggregate and cumulative
risk, and is therefore proposing to
require handler exposure studies for all
antimicrobial products, when the
toxicity and exposure criteria are
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59398
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
triggered. Codifying this requirement
would assist applicants for registration
of antimicrobial pesticides to determine
which studies are required and then to
design and conduct acceptable studies
measuring handler exposure.
Post-application exposure research
measures exposures of people to
residues of antimicrobial pesticides after
their use or application, and thus does
not involve the direct exposure that
occurs during use. Of particular concern
to EPA is the potential exposure of
infants and children to post-application
residues of products used in and around
homes, daycare centers, or schools.
The data requirements proposed here
are based on the Agency’s current
practice of requiring exposure data
when certain toxicity and exposure
criteria are met. These criteria are
described in proposed § 158.2260 and
§ 158.2270. Today’s proposal seeks to
harmonize the exposure requirements
for antimicrobials with those of
conventional pesticides. The applicator
(handler) exposure data requirements
are the same as those codified for
conventional pesticides. The postapplication data requirements are the
same as conventionals, with the
exception of one study (Dislodgeable
Foliar Residue and Turf Transferable
Residues) that is not needed for
antimicrobials.
The proposed requirement of such
data for antimicrobial products when
the toxicity and exposure criteria are
triggered would allow the Agency to
conduct more thorough exposure
assessments for residential as well as
occupational sites, and to cover all use
and exposure scenarios for such sites.
EPA presented the need for additional
handler exposure data to the SAP in
January 2007 (Ref. 39) and to the Human
Studies Review Board (HSRB) in April
2007 (Ref. 40). Both groups agreed that
additional data are warranted.
Research undertaken to address the
proposed handler and post-application
data requirements may involve
intentional exposure of human subjects
as those terms are defined in EPA’s
rules at 40 CFR 26.1102, and if they do,
protocols and supporting
documentation as specified in that rule
must be submitted for review by EPA
and the HSRB before any subjects are
enrolled in the research. If research
involving intentional exposure of
human subjects is initiated without
EPA’s prior review, the resulting data
will not be accepted in support of
registration. Parties who are unsure
whether proposed research involves
intentional exposure are encouraged to
consult with EPA before proceeding
with the research.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
B. Use of Surrogate Data
To support registration of an
antimicrobial pesticide product,
according to the proposed tables in
§ 158.2260 and § 158.2270, applicants
would generate needed exposure data
with a typical end-use product.
However, the Agency recognizes the
need to minimize the economic burden
of generating data to meet human
exposure data requirements while
obtaining sufficient data and
information for exposure and risk
assessments. Whenever appropriate,
surrogate data may be used for the
assessment of antimicrobial pesticides.
The Agency is currently working with
several industry Task Forces that are
generating exposure monitoring data
that may be able to be used as surrogate
data sources. The Antimicrobial
Exposure Assessment Task Force
(AEATF-II) is developing handler
exposure data for antimicrobial
applications (such as mopping, wiping,
aerosol sprays, painting, etc.). Task
Force members can consider using this
surrogate data, if determined by the
Agency to be suitable, to assess
antimicrobial handler risk instead of
generating their own data. If surrogate
data are inadequate for the Agency to
adequately predict likely exposures and
the resultant risks, then applicants
would need to submit chemical-specific
and/or product-specific data.
C. Handler Exposure
The Agency proposes to require data
addressing handler exposure for
antimicrobials when the toxicity and
exposure criteria are triggered. As
discussed in Unit IX.A., this not only
codifies the Agency’s current practices,
but also harmonizes the requirements
for antimicrobials with those of
conventional pesticides. EPA now
proposes to codify these requirements in
proposed § 158.2260 and set out
explicitly in § 158.2260(b) the triggers
describing the circumstances under
which such data must be submitted.
For handler exposure, the proposed
data requirements are as follows:
1. Dermal exposure studies. EPA
proposes to require data for both
outdoor and indoor dermal exposures to
estimate the dermal exposure to persons
directly handling pesticides. The
number of exposure studies that may be
required depends on the variety of use
sites, their similarities, and whether the
uses are indoor or outdoor. In the
absence of surrogate data, generally, the
selection of the appropriate testing
site(s) is based on the exposure sites
with the highest potential for exposure.
Generally, this is determined based on
PO 00000
Frm 00018
Fmt 4701
Sfmt 4702
the label uses and use rates.
Consultation with the Agency is
recommended for determining the
appropriate use site(s) for testing.
Studies of dermal exposure are often
designed to concurrently measure
inhalation exposure.
2. Inhalation exposure studies. Just as
with the dermal exposure studies, EPA
proposes to require data for both
outdoor and indoor inhalation exposure
studies. In the absence of surrogate data,
generally, the selection of the
appropriate testing site(s) is based on
the exposure sites with the highest
potential for exposure. For inhalation
exposure studies, the use sites with the
potential for the highest exposure are
almost always indoors. Based on its
experience, the Agency believes
potential exposure is highest indoors
because the pesticide is confined in a
closed area and therefore is less likely
to be rapidly diffused or dispersed. This
means that if the application rates are
the same for an indoor scenario and an
outdoor scenario, then the Agency may
require only the indoor inhalation
study, as that would have the highest
potential exposure. Consultation with
the Agency is recommended for
determining the appropriate use site(s)
for testing. Studies of inhalation
exposure are often designed to
concurrently measure dermal exposure.
3. Biological monitoring. Biological
monitoring is the only type of applicator
exposure study proposed as a
conditional requirement. Data from
biological monitoring studies provide
the Agency with estimates of the
internal dose or amount of a pesticide
in the body. EPA proposes to allow the
submission of biological monitoring
data in addition to, or in lieu of, dermal
or inhalation exposure data, provided
the human pharmacokinetics of the
pesticide residue is sufficiently
understood to permit the back
calculation to determine the total
internal dose, and providing further that
there are adequate analytical methods
available. Biological monitoring offers
the advantage of assessing the internal
dose, as opposed to the exposure or
amount of chemical coming in contact
with the surface of the skin or available
for inhalation in the lungs as measured
using passive dosimetry techniques.
Because biological monitoring is
necessarily specific to the material
tested, generally it cannot be conducted
using a surrogate chemical.
4. Data reporting and calculations.
EPA proposes to require applicants to
submit data reporting and calculation
information whenever applicator
exposure data are submitted. These data
are needed by Agency scientists for an
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
appropriate level of review and
evaluation, and offer a submission
format that the Agency has found
useful. This information is important
because it allows EPA to assess the
quality and validity of the exposure
study and thus the accuracy of the
estimates and resultant exposure
calculations derived from that study.
The types of information that would be
included under this data requirement
include:
• The chemical formulas used in the
calculations.
• The data used in the calculations,
including the raw data manipulation/
correction used in order to calculate
limits of detection/limits of
quantification.
• The statistical analyses required.
• The quality control data for lab/field
recovery and storage stability.
• The actual calculations.
Included within the data reporting
and calculations requirement would be
information on the ethical conduct of
the research. EPA regulations at 40 CFR
26.1303 require that the ethical conduct
of all research involving human subjects
be fully documented at the time of
submission of the data resulting from
the research. This requirement will
apply to all exposure studies involving
human subjects submitted to EPA under
the pesticide laws, without regard to
whether the research involves
intentional exposure. Data from
exposure studies not accompanied by
the required documentation of ethical
conduct will not be accepted for review.
5. Product use information. EPA is
proposing to require product use
information for both occupational and
residential use patterns. Product use
information assists EPA to more
accurately assess pesticide exposure to
applicators by describing how the
pesticide is actually used and applied.
EPA requires this information because
differences in use can translate to
significant differences in exposure, and
thus in risk. For applicator exposure,
use information may include, but is not
limited to, who applies the
antimicrobial pesticide, the use sites,
site locations, use directions,
application rates and frequencies,
application equipment and methods,
protective equipment used, protective
clothing worn, and other information
that will determine exposure to
antimicrobial pesticide handlers.
The Agency acknowledges that the
guideline for applicator product use
information has not yet been finalized.
However, the guideline for applicator
product use information should be
substantially similar to the one for postapplication. The guideline for post-
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
application product use information
was presented to the FIFRA Science
Advisory Panel (SAP) in March 1998.
(The draft guideline is available at
https://www.epa.gov/scipoly/sap/
meetings/1998/march/contents.htm.)
The Agency will finalize both
guidelines before publishing a final rule
establishing antimicrobial data
requirements.
D. Post-Application Exposure
The current data requirements for
post-application exposure in § 161.390
are focused on reentry to treated areas
by agricultural workers. Since the
promulgation of these requirements in
1984, the Agency has become
increasingly concerned about postapplication risks to persons in
occupational settings other than
conventional food, feed, and fiber crop
agriculture. The Agency is now
proposing to require post-application
exposure data for other settings where
people may be exposed, regardless of
whether they are on-the-job or
bystanders. Under current practice,
post-application exposure data are
generally required for occupational and
residential settings on a case-by-case
basis when specific toxicity and
exposure criteria have been met.
Moreover, FFDCA mandates that EPA
perform additional scientific analyses
which before 1996 had not been a
routine part of the Agency’s risk
assessment process, including the
assessment of aggregate exposures from
multiple pathways including dietary
and non-dietary routes of exposure.
The Agency proposes to require data
addressing post-application exposure
for antimicrobials when the toxicity and
exposure criteria are triggered. Two new
exposure data requirements (soil residue
dissipation and non-dietary ingestion
exposure) are today proposed for
antimicrobials. As discussed in Unit
IX.A., this not only codifies the
Agency’s current practices, but also
harmonizes the requirements for
antimicrobials with those of
conventional pesticides. EPA now
proposes to codify these requirements in
proposed § 158.2270 and set out
explicitly in § 158.2270(b) the triggers
describing the circumstances under
which such data must be submitted.
For post-application exposure, the
proposed data requirements are as
follows:
1. Soil residue dissipation. These data
are needed to characterize exposures to
residues of antimicrobials, and most
particularly wood preservatives, that
occur through contact with outdoor
soils. This information is critical for
assessing risks to children who play
PO 00000
Frm 00019
Fmt 4701
Sfmt 4702
59399
around and are in contact with treated
wood structures such as decks, play
sets, and gazebos, and the surrounding
soils. This would be a new data
requirement for antimicrobials.
Protocols must be approved by the
Agency prior to the initiation of the
study. Details for developing protocols
are available from the Agency.
2. Indoor surface residue dissipation.
The Agency proposes to require the
indoor surface residue dissipation study
(sometimes known as a surface wipe
sampling study). This study supplies
information on residue dissipation from
treated areas and articles such as
carpets, hardwood floors, and counter
tops, after antimicrobial pesticides have
been used. It is also used to determine
residue dissipation from decks and
other structures manufactured from
treated wood.
These data would quantify residue
loads and characterize the dissipation
rate (i.e., how fast pesticide residues
disperse over time following
application) of antimicrobial pesticides
on indoor surfaces. The Agency could
then assess the magnitude and duration
of human exposure to antimicrobials
present as surface residues. Without
such data, the Agency has no precise
means of calculating human exposures
to such substances from contacting
surfaces over time. This requirement
would not apply to uses that are not
surface treatments, e.g., aquatic areas,
swimming pools, antifoulant coatings
and paints.
The draft guideline for indoor surface
residue dissipation is available at https://
www.epa.gov/scipoly/sap/meetings/
1998/march/contents.htm. This draft
guideline was externally peer-reviewed
before presentation to the SAP in 1998.
An examination of the FIFRA SAP
website since 1998 to the present will
show many presentations to the SAP on
assessing occupational and residential
exposures. Science has evolved in this
area.
EPA notes that it has reviewed and
accepted many studies, on a case-bycase basis, that were not conducted in
accordance with current guidelines, but
which serve its needs and provide
suitable information for risk assessment
purposes. The guidelines themselves do
not impose mandatory requirements.
Instead, they present recognized
standards for conducting acceptable
tests, guidance on evaluating and
reporting data, definition of terms, and
suggested study protocols. The draft
guideline, therefore, serves as a starting
point for pre-protocol submission
meetings where the Agency’s scientists
can provide guidance to registrants or
task forces on aspects of study design.
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59400
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
The Agency’s scientists are always
willing to work with individual
registrants to develop study designs to
fulfill data requirements. The Agency
will finalize this guideline before
publishing a final rule establishing
antimicrobial data requirements.
For wood preservatives, EPA has
worked with the Consumer Product
Safety Commission (CPSC) to develop
methodologies for conducting surface
wipe sampling studies on wood.
Protocols for wood preservative treated
surface wipe sampling studies must be
approved by the Agency prior to the
initiation of the study. Details for
developing protocols are available from
the Agency.
3. Dermal exposure. EPA proposes to
require dermal exposure data for both
outdoor and indoor dermal exposures to
estimate the dermal exposure to persons
exposed after the pesticide application
has been completed. The discussion in
Unit IX.C. of this preamble for handler
dermal studies is also applicable to
post-application exposures.
4. Inhalation exposure. EPA proposes
to require inhalation exposure data for
both outdoor and indoor inhalation
exposures to estimate the inhalation
exposure to persons exposed after the
pesticide application has been
completed. The discussion in Unit IX.C.
of this preamble for handler inhalation
studies is also applicable to postapplication exposures.
5. Biological monitoring. A
conditional requirement for biological
monitoring data was discussed in Unit
IX.C. That discussion is also applicable
to the proposed conditional requirement
for biological monitoring for postapplication exposure which codifies the
Agency’s current practices.
6. Product use information. EPA
proposes to require product use
information for all antimicrobials. Such
information has been routinely
submitted to EPA by applicants and is
now being codified as a separate and
distinct requirement. For postapplication exposure, required product
use information includes information on
reapplication rates and frequencies,
post-application entry restrictions, reentry intervals, rinsing and other
residue removal practices, and other use
data relevant to exposure after
application. The draft guideline for
post-application product use
information is available at https://
www.epa.gov/scipoly/sap/meetings/
1998/march/contents.htm. The Agency
will finalize this guideline before
promulgating a final rule establishing
antimicrobial data requirements.
7. Description of human activity. For
post-application exposure the Agency is
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
proposing to require a description of
human activities. Information on those
persons who may enter treated areas
after the application is complete has
been routinely submitted to EPA by
applicants and is now being codified as
a separate and distinct requirement
These data will allow for a more
accurate evaluation of the exposure
potential associated with use of an
antimicrobial pesticide. The description
of human activity data would define the
activity patterns that affect exposures
(e.g., defining the exposed populations
in commercial/institutional and
residential settings, the application
sites, site-specific information on
exposure time per activity, type of
protective clothing worn, and any other
relevant use activity data). The
description of human activity
information would be used with the use
information (both application and postapplication), to help the Agency
determine whether the exposure
potential for humans is likely to be
significant, and if additional data will
be needed.
8. Data reporting and calculations.
EPA proposes to require applicants to
submit data reporting and calculation
information whenever post-application
exposure data are submitted. Such
information has been routinely
submitted to EPA by applicants as part
of any submission of exposure data and
is now being codified as a separate and
distinct requirement. The discussion in
Unit IX.C. of this preamble for handler
data reporting and calculations is also
applicable to post-application
exposures. Note in particular the
discussion of the requirement at 40 CFR
26.1303 for full documentation of the
ethical conduct of all submitted
research involving human subjects,
whether or not they were intentionally
exposed.
9. Non-dietary ingestion exposure.
The Agency proposes to require a nondietary ingestion exposure study for
residential types of exposures only. This
study is not required for occupational
exposures since the primary concern for
adult workers is exposure via the
dermal and inhalation routes. This
would be a new data requirement that
evaluates the potential oral exposures to
humans, particularly children, from
antimicrobial pesticide residues from
sources other than food.
Note that EPA regulations at 40 CFR
26.1203 prohibits, without exception,
conduct of any research intended for
submission to EPA under the pesticide
laws which involves intentional
exposure of children under 18. Thus,
any study of potential exposure of
children, oral or by any other pathway,
PO 00000
Frm 00020
Fmt 4701
Sfmt 4702
to antimicrobial pesticide residues must
only be an observational study,
involving no intentional exposure of
children.
Incidental oral exposure via hand-tomouth, object-to-mouth and direct
mouthing/ingestion is an important
exposure pathway for infants and
toddlers. The results from these studies
will be used to assess the risks
associated with the incidental ingestion
of antimicrobial pesticides by children
following antimicrobial pesticide
applications in residential or public
settings, or exposure to treated surfaces
(e.g., carpets, toys, wood structures).
This study would be required for uses
in and around the home, daycare
centers and schools.
The Agency is primarily concerned
with non-dietary exposures immediately
following application of the
antimicrobial pesticide; therefore,
dissipation studies alone would not
provide the information needed to
assess risks from non-dietary ingestion.
Information such as frequency/duration
of hand-to-mouth activities and surface
area mouthed are often needed as input
values for the calculations that are
performed to assess non-dietary
ingestion exposure. When appropriate,
EPA’s Exposure Factors Handbooks (see
https://cfpub.epa.gov/ncea/cfm/
recordisplay.cfm?deid=20563) can be
used as the source of this frequency/
duration information. However, the data
in these Handbooks cannot replace
chemical-specific information from
studies of treated articles/surfaces that
quantifies the amount of pesticide
residue on such surfaces.
Non-dietary ingestion may also occur
through hand-to-mouth or object-tomouth transfer of antimicrobial
pesticide residues during activities
performed by children (e.g., crawling)
that put them in close proximity with
treated surfaces. Non-dietary ingestion
exposure would be expected in
residential or public (e.g., schools,
daycare) settings following exposures to:
• Soils in contact with, or adjacent to,
preservative-treated wood structures
such as play structures.
• Outdoor surfaces such as decks.
• Indoor surfaces such as
antimicrobial pesticide-treated paint
chips, or antimicrobial-sprayed floors or
walls.
• Antimicrobial-treated textiles,
polymers, or other items (e.g., clothing,
bedding, carpets, or toys).
Non-dietary ingestion studies would,
for example, monitor the amounts of
pesticide residues in the rinsate from
hand washing, and thus allow the
Agency to develop science-based
models or formulas to estimate
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
inadvertent exposure. The draft
guideline for non-dietary ingestion is
available at https://www.epa.gov/scipoly/
sap/meetings/1998/march/
contents.htm. This draft guideline was
externally peer-reviewed before
presentation to the SAP in 1998. An
examination of the FIFRA SAP website
since 1998 to the present will show
many presentations to the SAP on
assessing occupational and residential
exposures. Science has evolved in this
area.
EPA notes that it has reviewed and
accepted many studies, on a case-bycase basis, that were not conducted in
accordance with current guidelines, but
which serve its needs and provide
suitable information for risk assessment
purposes. The guidelines themselves do
not impose mandatory requirements.
Instead, they present recognized
standards for conducting acceptable
tests, guidance on evaluating and
reporting data, definition of terms, and
suggested study protocols. The draft
guideline, therefore, serves as a starting
point for pre-protocol submission
meetings where the Agency’s scientists
can provide guidance to registrants or
task forces on aspects of study design.
The Agency’s scientists are always
willing to work with individual
registrants to develop study designs to
fulfill data requirements. The Agency
will finalize this guideline before
publishing a final rule establishing
antimicrobial data requirements.
sroberts on PROD1PC70 with PROPOSALS
X. Residue Chemistry Data
Requirements
A. General
EPA proposes to adapt the basic
residue chemistry data requirements
(§ 158.2290) as listed in subpart O of
current part 158 to support applications
for antimicrobial products. However,
EPA also proposes to modify the
applicability of those requirements to
reflect the differing risks and levels of
exposure of antimicrobials. Residue
chemistry data are used by the Agency
to estimate dietary exposure to pesticide
residues from food. If there are no direct
or indirect food uses for the
antimicrobial, then no residue
chemistry data are required.
The proposed changes will allow EPA
to better estimate human dietary
exposure to antimicrobial residues in or
on food or feed, to more accurately
assess tolerances and tolerance
exemptions, and to provide additional
tools for the enforcement of pesticide
residue tolerances to ensure that food
entering the commercial market meets
the ‘‘reasonable certainty of no harm’’
standard under FFDCA.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
The residue chemistry database is
designed to determine the composition
of the pesticide residue and how much
of that residue is present in food or
animal feed. Residue chemistry studies
include those which define:
• The nature of the residue, i.e.,
metabolism studies.
• The magnitude of the residue, i.e.,
those studies which measure how much
of the residue of concern is present in
food, feed, and water.
Food-use pesticides require both
types of studies. Both plant and
livestock metabolism studies are needed
to determine the breakdown of the
pesticide chemical in a living system,
that is, whether the chemical stays
intact or is converted into metabolites.
Occasionally, the metabolites are toxic
and are included in the analyses as a
residue of concern. Magnitude of the
residue (MOR) studies are performed to
determine the level of residues of
concern in food. Data collection residue
analytical methods are reviewed by EPA
as part of the validation of the
metabolism and MOR studies which are
used to establish tolerances.
In addition to dietary risk
assessments, residue chemistry data are
used to establish pesticide tolerances,
the maximum level of pesticide residue
that may remain on food. Because these
are legal limits enforced by FDA,
enforcement methods for detecting the
presence and amount of the residue are
needed, and are used by FDA, USDA,
and the States for food inspection
purposes.
There are distinct differences between
the residue chemistry requirements of
conventional pesticides that are applied
to crops in a field setting and those of
antimicrobials that are more likely to be
applied in a confined setting such as a
food processing plant. Those differences
are reflected in the data requirements.
For example, no migration studies are
required for terrestrial food and feed
uses in part 158, subpart O, and no
rotational crop studies are required for
any antimicrobial uses. Certain test
notes in part 158, subpart O and in
subpart W are also different. As
expected, the differences result from the
different use patterns.
Units X.B. and C. of this preamble
discuss the two main categories of fooduses for the purpose of antimicrobial
residue chemistry data requirements,
direct and indirect. Units X.D. through
Q. of this preamble explain changes to
specific residue chemistry data
requirements appropriate to
antimicrobials. For the purpose of
determining antimicrobial residue
chemistry data requirements, most
antimicrobial pesticides will be
PO 00000
Frm 00021
Fmt 4701
Sfmt 4702
59401
classified as either direct or indirect
food uses, which are generally
delineated in Units X.B. and C. of this
preamble. For the purposes of defining
the residue chemistry data requirements
for antimicrobials, the table in proposed
§ 158.2290 further delineates direct and
indirect uses into four categories: direct
and indirect food uses, agricultural
premises, and aquatic uses. Applicants
should consult with the Agency on the
appropriate category(ies) for their
product.
B. Direct Food Uses
If the antimicrobial is applied directly
to food or water, it is a direct food use.
Such uses would include, but are not
limited to:
• Livestock.
• Livestock feed.
• Drinking water for humans, livestock
and/or poultry.
• Egg washes.
• Fruit and vegetable rinses.
• Aquatic areas that have the potential
to contaminate potable water.
• Post-harvest applications that occur
in the field, at a treatment facility (such
as a packing shed), during transport,
and while in storage, until the
processing of the raw agricultural
commodity begins.
No currently registered antimicrobial
products are applied to agricultural field
crops. Should an application for such an
antimicrobial product be submitted to
EPA, then the Agency would likely
require the same data as specified in
part 158, subpart O for other field-use
pesticides applied to crops, as the test
notes more accurately reflect the
conditionalities of a terrestrial use
pattern.
C. Indirect Food Uses
For the purpose of determining
residue chemistry data requirements, an
antimicrobial use is considered an
indirect food use when the
antimicrobial pesticide is applied to a
surface or incorporated into a material
that will subsequently contact food, that
is, the pesticide is not applied directly
to the food. Residues of the pesticide or
its degradates can be transferred to the
food when it comes into contact with
these treated surfaces and articles.
Antimicrobial products labeled for
treatment of hard non-porous surfaces
which may come into contact with food
(e.g., food area premises and equipment)
are classified as indirect food contact
uses. Sanitizers and disinfectants which
remain on the surface of food-handling
or processing equipment are indirect
food uses. Sanitizers incorporated into
articles (e.g., plastic products such as
coffee cups or cutting boards) intended
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59402
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
for food contact are also indirect food
uses.
Hard surfaces are considered to be
food surfaces when food is prepared for
consumption, either commercially or
residentially on such surfaces. Examples
of hard surfaces are eating utensils,
dinnerware, pots and pans, cutting
boards, food preparation surfaces,
countertops, refrigerator shelves,
refrigerator bins, ice trays, dining table
tops, and cabinet shelves. Wood treated
with an antimicrobial pesticide product
could be used to construct or maintain
a bee hive, a cattle trough or feeding
station. These and other indirect
contacts with food or feed are assessed
to evaluate the need for a tolerance or
tolerance exemption.
For the purpose of conducting a risk
assessment for a sanitizer (an
antimicrobial not rinsed from foodcontact surfaces), the Agency uses the
directions on the antimicrobial product
label in combination with modeled data
to determine the amount of the sanitizer
remaining. Under this approach, EPA
will initially assume that all of the
sanitizer residues remain on the surface
and thus have the potential to enter the
food. This is a worst-case or screeninglevel assumption. EPA will then use this
modeled estimate in combination with
toxicity data to determine if there is a
risk of concern and/or whether to
establish a tolerance or tolerance
exemption. If there are risk concerns
and if scientifically appropriate, EPA
may refine the estimate of residues
remaining on the surface using more
realistic model assumptions. If no risks
of concern are identified using these
refined assumptions, then most likely
EPA would not require higher-tiered,
measured surface residue data. Of
course, as an alternative to the Agency’s
use of these screening-level or refined,
modeled estimates, the applicant may
provide data that measures the actual
amount of sanitizer remaining on the
treated surface or transferring to food.
For disinfectants (antimicrobials with
potable water rinses) EPA proposes to
generally follow the risk assessment
approach outlined for sanitizer
solutions. EPA would disregard the
potable water rinsing and assume that
worst-case residues (estimated using the
sanitizer model) are available for
entering food items. Alternatively, the
applicant can provide data measuring
the actual amount of disinfectant
remaining on the surface or transferring
to food after rinsing the treated surface.
If the antimicrobial is to be
incorporated into products with food
contact uses and bears a claim of surface
sanitizing activity, the Agency will
generally, in the absence of data,
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
evaluate the need for a tolerance or
tolerance exemption by assuming
complete transference of the chemical
into food over the lifetime of the treated
product. Alternatively, the applicant
may submit migration studies to
demonstrate the rate or amount of
transference of the antimicrobial into
food items.
D. Chemical Identity
Currently in part 161, information on
chemical identity is required for all use
patterns. Today the Agency is proposing
to continue this existing requirement by
requiring information on chemical
identity for all antimicrobial use
patterns.
E. Directions for Use
Currently in part 161, directions for
use are required for all use patterns.
Today the Agency is proposing to
continue this existing requirement by
requiring this information for all
antimicrobial use patterns.
F. Proposed Tolerance
Currently in part 161, a proposed
tolerance is required for all food-use
patterns. Today the Agency is proposing
to continue this existing requirement by
requiring a proposed tolerance for all
antimicrobial food-use patterns.
G. Reasonable Grounds in Support of
Petition
Currently in part 161, reasonable
grounds in support of petition is
required for all food-use patterns. Today
the Agency is proposing to continue this
existing requirement by requiring this
information for all antimicrobial fooduse patterns.
H. Submittal of Analytical Reference
Standards
Currently in part 161, submittal of
analytical reference standards is
required for all food-use patterns. Today
the Agency is proposing to continue this
existing requirement by requiring
submittal of these standards for all
antimicrobial food-use patterns.
I. Nature of the Residue in Plants
The Agency proposes to continue to
require a nature of the residue study in
plants for aquatic uses and direct food
contact uses. The Agency proposes to
continue to conditionally require this
study to support agricultural premise
uses.
J. Nature of the Residue in Livestock
The Agency proposes to continue to
require a nature of the residue in
livestock study to support agricultural
premise uses. The Agency is also
PO 00000
Frm 00022
Fmt 4701
Sfmt 4702
proposing to continue to conditionally
require a nature of the residue in
livestock study to support direct food
contact uses and aquatic areas. As with
the data requirements for conventional
pesticide chemicals EPA is proposing to
change the chemical substance with
which the test is performed. This would
codify existing practices.
For antimicrobials used to treat
animal drinking water, or to treat wood
in contact with animals or animal feed,
or in aquatic areas, the Agency proposes
to change the test substance for the
nature of the residue in livestock study
from ‘‘pure active ingredient,
radiolabeled (PAIRA) and plant
metabolites’’ to ‘‘PAIRA or radiolabeled
plant metabolite.’’ The test substance
‘‘metabolites’’ will be changed to
‘‘metabolite’’ to clarify that dosing with
more than one compound in any one
study is not acceptable. This is needed
because in studies involving
simultaneous dosing with both the
active ingredient and plant metabolites,
it is impossible to determine the amount
of metabolite due to active metabolism
from that introduced through
intentional dosing. Simultaneous dosing
with the active ingredient and any
metabolites may not produce useful
results, because the active ingredient
and metabolites may have different
metabolic pathways that cannot be
differentiated. In most cases dosing with
only the parent compound is necessary.
However, in cases where plant and
animal metabolites are found to differ,
separate studies in which livestock are
dosed separately with each unique plant
metabolite may also be required.
The Agency proposes to specify in the
test note that the livestock metabolism
study would be required when an
antimicrobial is applied directly to
livestock, to livestock premises, to
livestock drinking water, to livestock
feed, or to crops used for livestock feed.
This would also include antimicrobial
uses to treat wood in contact with
animals or animal feed, or in aquatic
areas given the potential use for crop
and livestock production. Such
applications may result in both oral and
dermal exposure of animals to the
pesticide and, depending on the results,
may necessitate magnitude of the
residue studies to quantify the residues
in meat, milk, poultry, and eggs.
K. Residue Analytical Methods
EPA proposes to require development
and submission of analytical methods
whenever a numerical tolerance is
established. Residue analytical methods
have two primary purposes:
• To collect residue data for
establishing tolerance levels and
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
conducting dietary exposure
assessments.
• To enforce the tolerances established
by EPA in 40 CFR part 180.
Residue analytical methods are
currently required in part 161, and EPA
proposes to continue this requirement.
These methods are required only if a
numerical tolerance is established and
since numerical tolerances are rarely
established for antimicrobials,
submission of this data should be a rare
occurrence.
In part 158, subpart W, EPA is
proposing to create separate entries in
the proposed table in § 158.2290 for
these two types of residue analytical
methods to clearly indicate the need for
both types of methods, or a method that
can be used for both data collection and
enforcement purposes. EPA believes
that the separation of the combined
requirement into separate and distinct
requirements will provide clarity to
applicants.
The enforcement method has the
following characteristics:
• Analyzes for the residues of
regulatory concern, i.e., those named in
the established tolerance.
• Is reasonably rapid (typically one
day or less).
• Uses readily available equipment
and reagents.
• Must be clearly and completely
described in a stepwise manner such
that laboratory personnel competent
using similar procedures can
successfully perform the procedure on
the first trial.
• Is subject to an independent
laboratory validation.
• Has a mechanism to confirm the
results.
The data collection method has the
following characteristics:
• Analyzes for all residues of
toxicological concern.
• No limitation on duration of
procedure.
• May use specially-developed and
very expensive equipment.
• Validation is subject only to internal
laboratory controls.
If the applicant can develop one
method and the Agency finds that this
one method satisfies the criteria for both
the enforcement and the data collection
method, then only one method needs to
be submitted. Otherwise, two methods
must be submitted. For the proposed
table in § 158.2290 the ‘‘Rs’’ and ‘‘CRs’’
specified in the residue analytical
method data requirements reflect the
Agency’s best professional estimate of
the likelihood of a numerical tolerance
being established for an antimicrobial
pesticide chemical and thus resulting in
the requirement to submit the data.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
As with the data requirements for
conventional pesticide chemicals, the
Agency proposes to change the chemical
substance for residue analytical
methods from ‘‘TGAI and metabolites’’
to ‘‘residue of concern.’’ This would
codify existing test practices.
As with conventional pesticide
chemicals (subpart O of part 158), the
Agency is proposing to require an
independent laboratory validation (ILV)
of residue analytical methods to ensure
the accuracy and reproducibility of data
used for tolerance enforcement
purposes. Codifying this current (since
1988) practice (Ref. 28) would promote
development of clearly written,
complete descriptions of analytical
methods that can be used by Federal
and State enforcement agencies.
L. Multiresidue Method Testing
The current requirement in 40 CFR
part 161 for residue analytical methods
actually encompasses several
submissions to the Agency. The first is
the chemical-specific method(s)
discussed in Unit X.K. of this preamble
and the second is the multiresidue
testing. In promulgating its part 158
conventional pesticide data
requirements, the Agency separated this
combined requirement into separate and
distinct requirements. EPA is proposing
to do the same for antimicrobial
pesticides.
Today, the Agency is proposing to
codify the requirement for testing the
residue of concern of the antimicrobial
pesticide using the FDA’s and the
USDA’s multiresidue methods (MRM)
as a separate data requirement. As
above, the Rs and CRs in the proposed
table in § 158.2290 reflect the Agency’s
best professional estimate of the
likelihood of a numerical tolerance
being established. This testing is
required only if a numerical tolerance is
established and since numerical
tolerances are rarely established for
antimicrobials, submission of this data
should be a rare occurrence.
MRMs are important components of
pesticide monitoring and enforcement
programs. In food monitoring programs,
such as those of FDA and USDA, it is
not practical or feasible to test for each
individual pesticide in a separate test.
The MRMs are used to detect the
presence of many pesticides, and then if
needed, re-testing is done with the
chemical-specific tolerance enforcement
method. Since the residue analytical
method requirement is intended to refer
to a method that is specific for one
pesticide (sometimes called a ‘‘single
residue method’’) and the multiresidue
methods currently in use are designed
to measure as many pesticides as
PO 00000
Frm 00023
Fmt 4701
Sfmt 4702
59403
possible, it is clearer to list these as two
separate data requirements.
M. Storage Stability
As with conventional pesticides, the
Agency proposes to add a storage
stability study as an explicit
requirement to validate the results of the
various magnitude of the residue
studies. Such data have been required
previously as a part of the magnitude of
the residue study, but will now, as with
conventional pesticides, be codified as a
separate requirement. As discussed in a
test note to the proposed table in
§ 158.2290 storage stability data are
required for any food or feed use
requiring magnitude of the residue
studies unless analytical samples are
stored frozen for 30 days or less, and the
active ingredient is not know to be
volatile or labile. This test note would
clarify when storage stability data are
needed and also harmonizes the
requirements for antimicrobials with
those of conventional pesticides.
Magnitude of the residue studies
address how levels of pesticide residues
in samples of human foods and
livestock feeds are determined. These
samples are often stored for extended
periods of time prior to analysis. Since
tolerances are based on residues at the
time of harvest (or sample collection)
and the residues may be lost by
processes such as degradation and
volatilization during storage prior to
analysis, storage stability data
predicting the pattern of degradation, if
any, of residues during this period are
critical to understanding the results of
the field trial studies.
N. Magnitude of Residue (MOR) Studies
As with conventional pesticides, the
Agency proposes to change the test
substance from EP (end-use product) to
TEP (typical end-use product) for the
following types of MOR studies: Crop
field trials, processed food or feed,
potable water, fish, irrigated crops, and
food handling studies.
Residue data are needed for only one
TEP of each formulation type used on a
given commodity or site. When newer
or other types of formulations are
proposed for use, either additional
residue data can be submitted to show
that the use of these new or different
formulations result in residues
comparable to those arising from the
original formulation for which residue
chemistry data already exist, or side-byside bridging studies can be conducted
for the different types of formulations. If
the new formulation results in residues
higher than those from use of the
original formulation, then the same
number of trials would generally be
E:\FR\FM\08OCP2.SGM
08OCP2
59404
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
required for the new formulation as was
required for the original formulation.
This would codify a longstanding
practice at EPA for various MOR
studies. The Rs and CRs reflect the
likelihood of the need for MOR studies
in the Agency’s best professional
judgment. Test notes to the table in the
proposed § 158.2290 describe the
specific circumstances in which MOR
studies may be required for an
antimicrobial.
sroberts on PROD1PC70 with PROPOSALS
O. Magnitude of Residue in Meat, Milk,
Poultry, and Eggs
Similar to the livestock metabolism
study, the Agency proposes to change
the test substance for the meat/milk/
poultry/egg (M/M/P/E) MOR studies.
Due to the difficulties in interpreting
results of studies in which a mixture is
fed, the Agency is currently
discouraging the feeding of mixtures
and is instead requesting the feeding of
isolated compounds in livestock
studies. Hence, to codify current
practice, the test substance will be
changed to read a single plant
metabolite instead of metabolites in the
plural. Provided that plant and animal
metabolites are the same, the parent
compound must be the test substance in
livestock feeding studies. If any plant
metabolite exists that is not also an
animal metabolite, a separate feeding
study may be required involving dosing
with that unique plant metabolite. The
Agency will inform the applicant when
this additional testing is required. It is
expected that this study will be rarely
requested.
The Agency proposes to continue the
conditional requirement for M/M/P/E
MOR studies for agricultural premises,
indirect food uses, direct food uses and
aquatic uses. There are three types of M/
M/P/E MOR studies: livestock feeding
studies, direct livestock treatments, and
agricultural premise treatments. The
Agency proposes to clarify that livestock
feeding studies generally are not
required when (1) residues are not
found in/on feed items or (2) livestock
metabolism studies indicate minimal
transfer of the pesticide residue to
tissues, milk or eggs. For those
pesticides which leave non-detectable
or low residues in feed items and for
which the livestock metabolism study
shows little transfer of radioactivity to
tissues, the Agency may be able to
conclude that data on the level of
residues in livestock and their
byproducts are not necessary. Livestock
premise treatment studies are required
for those antimicrobials used to clean or
otherwise treat livestock premises such
as feedlots. These are expected to be the
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
most common studies applicable to
antimicrobials.
P. Anticipated Residues
The term ‘‘anticipated residue’’ (AR)
refers to exposure data that would
permit significant refinement of dietary
exposure estimates. Refinement means
that the Agency would estimate very
realistic dietary exposure estimates after
first using the screening-level estimates
that allow EPA to perform a very quick,
but conservative dietary risk
assessment.
As previously discussed, no currently
registered antimicrobial products are
applied to agricultural field crops.
Generally, for antimicrobial direct fooduses, when performing the initial,
screening-level dietary risk assessment,
EPA uses the antimicrobial tolerances as
the input values for dietary modeling. If
there are risk concerns and if
scientifically appropriate, EPA may
refine (that is to be more realistic) the
input values by using data showing the
pesticide residues in food closer to the
point of consumption. Market basket
surveys are an example of one source of
residue data that could be used to
generate more realistic dietary exposure
estimates for direct food-uses.
Anticipated residue data would be
required when estimates of risk using
residues at the tolerance level result in
a risk of concern, and a more realistic
estimate is needed.
However, antimicrobials also include
indirect food uses such as sanitizers and
disinfectants which remain on the
surface of food-handling or processing
equipment. For these indirect food-uses,
generally when performing the initial,
screening-level dietary risk assessment,
EPA uses several high-end (overestimated) assumptions as the input
values for dietary modeling. In such an
assessment, the same assumptions are
used for every dietary assessment. Such
an assessment can be performed
quickly, and if there are no risk
concerns, then the dietary assessment is
considered to be complete. However, if
there are risk concerns and as
scientifically appropriate, EPA would
begin a process of using the available
information and data to refine, that is to
be more realistic, in estimating input
values.
Since the screening-level risk
assessment did not consider the
particular use pattern of the
antimicrobial chemical, as a first
refinement, EPA would modify the
assumptions to account for the
particular use pattern of the chemical.
Refinements to the assumptions can also
be made if measured data such as a
migration study were available.
PO 00000
Frm 00024
Fmt 4701
Sfmt 4702
AR data would be required when
estimates of risk have been refined using
information and any measured data
initially available to EPA, and these
refined risks result in a risk of concern.
Taking samples from treated hard
surfaces is an example of one source of
residue data that could be used to
generate more realistic dietary exposure
estimates for an indirect food-use.
If there is no food-use, then AR data
would not be submitted to EPA. AR data
would be a conditional requirement that
is triggered only when estimates of risk
conducted using residues at the
tolerance level may result in a risk of
concern. This means that AR data
would be required only for a food-use,
and only if a numerical tolerance is
established, and then only if the risk
assessment conducted at tolerance level
results in a risk of concern. This would
be an infrequent occurrence for
antimicrobials. Establishing this data
requirement for antimicrobials not only
codifies the Agency’s current practices,
but also harmonizes the requirements
for antimicrobials with those of
conventional pesticides.
Q. Food Migration Studies
This study is unique to antimicrobials
and this proposal codifies current
practices. EPA is proposing to
conditionally require a migration study
for indirect food uses when modeled
estimates of the amount of antimicrobial
residues transferred to the food or feed
may result in a risk of concern. This
study would not be required for any
other uses.
A migration study is performed to
determine the amount of a chemical
substance that can enter a food
commodity through contact with a
treated surface. There are two basic
types of migration studies. The first type
includes sanitizing and disinfecting
solutions that are applied to equipment
in a food-processing facility. The second
type includes matrices such as wood,
plastic, paper, cloth, or rubber which
may be impregnated with antimicrobial
pesticides. The migration of the
antimicrobial into the food occurs when
the food commodity comes into contact
with the treated surface or the
impregnated matrix.
As previously discussed, the Agency
believes that it is possible to model a
worst-case estimate of the amount of the
antimicrobial chemical that migrates
into the food commodity. If the worstcase estimates do not result in a risk of
concern, then the applicant would not
need to submit a migration study. As an
alternative to these worst-case estimates,
the applicant may provide data for the
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
amount of sanitizer/disinfectant
remaining on the surface.
There is no Agency guideline for
conducting a migration study. EPA
routinely accepts studies performed
according to FDA’s food migration
protocol/guidance. Applicants are
encouraged to use existing FDA
methodologies. Information that could
be of value to applicants developing
protocols is on the FDA website (Refs.
7, 9, 10, and 11). Protocols must be
approved by the Agency prior to the
initiation of the study. However, if a
migration study has been reviewed and
accepted by FDA, then this fact should
be included in the submission to EPA,
along with the migration study.
XI. Environmental Risk Assessment
sroberts on PROD1PC70 with PROPOSALS
A. General
Environmental fate studies evaluate
the mobility, distribution and
dissipation of a pesticide in various
compartments of the environment, such
as water, soil, air, and sediment. These
studies are designed to identify which
dissipation processes are likely to occur
when the pesticide is released into the
environment and characterize the
significant degradates likely to result
from these processes. Data from these
studies are used as inputs in exposure
models, and, in conjunction with
ecological effects studies, are used to
assess whether a pesticide has the
potential to cause adverse effects to
wildlife, fish, plants, and humans.
Environmental fate studies are
discussed in Unit XII. of this preamble.
Ecological effects data are used by the
Agency to determine the toxicological
hazards of pesticides to various
nontarget organisms, such as birds,
mammals, fish, bees, terrestrial and
aquatic invertebrates, and plants. These
tests include short-term acute, subacute,
reproduction, simulated field, and full
field studies arranged in a tiered system
that progresses from the basic laboratory
tests to the applied field tests.
Ecological effects testing for nontarget
organisms are discussed in Unit XIII,
and nontarget plants in Unit XIV of this
preamble.
These data provide a foundation for
an environmental risk assessment. The
results of the environmental fate
assessment are evaluated in conjunction
with the results of the ecological effects
data to determine the potential of the
pesticide to cause harmful effects to
nontarget organisms and plants.
The Agency has divided the
antimicrobial pesticides into two groups
for determining environmental fate and
ecotoxicity data requirements: the low
environmental exposure grouping and
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
high environmental exposure grouping
as discussed in Unit XI.B.
B. Determination of the Two Groupings:
Low and High Environmental Exposure
1. Factors considered in determining
the groupings. As previously discussed,
EPA is proposing to establish its 12
antimicrobial use patterns in § 158.2201.
EPA examined these use patterns and
identified those that occur outdoors,
discharge effluent directly to the
outdoors, or result in materials treated
with antimicrobials (i.e., wood
preservatives and antifoulants) being
placed in the environment. Given this
direct link to the environment, and
correspondingly higher exposure
potential, there is a greater potential for
concern. In fact, EPA has been requiring
more data for such use patterns than for
other antimicrobial use patterns.
2. The high environmental exposure
grouping. The Agency believes that the
potential for environmental exposure is
high for three of the use patterns and
part of a fourth use pattern. For the
purposes of requiring data, the
following use patterns represent the
high environmental exposure grouping
for environmental fate (§ 158.2280) and
ecotoxicity (§ 158.2240 and § 158.2250)
data requirements:
• Once-through industrial processes
and water systems (part of the industrial
processes and water systems use
pattern).
• Antifoulant paints and coatings.
• Wood preservatives.
• Aquatic areas.
The data that have been typically
required for the use patterns now
included in the high environmental
exposure grouping are used to calculate
estimated environmental concentrations
(EECs) of the pesticide in different
environmental media. These EECs are
needed to conduct quantitative
environmental and ecological risk
assessments. These data would also
have applicability to drinking water
exposure assessments that are used in
human health risk assessments.
3. The low environmental exposure
grouping. The low environmental
exposure grouping is defined as those
use patterns that are not included in the
high environmental exposure grouping.
For the purposes of requiring data, the
following use patterns represent the low
environmental exposure grouping for
environmental fate (§ 158.2280) and
ecotoxicity (§ 158.2240 and § 158.2250)
data requirements:
• Agricultural premises and
equipment.
• Food-handling and storage
establishments, premises and
equipment.
PO 00000
Frm 00025
Fmt 4701
Sfmt 4702
59405
• Commercial, institutional and
industrial premises and equipment.
• Residential and public access
premises.
• Medical premises and equipment.
• Human drinking water systems.
• Materials preservatives.
• Swimming pools.
• Recirculating industrial processes
and water systems (part of the industrial
processes and water systems use
pattern).
C. Data Requirements for Wood
Preservatives
As discussed previously in this
proposal, wood preservatives are
considered to be an antimicrobial use
pattern with high expectation of
environmental exposure. Wood that has
been treated with a wood preservative
product is placed directly into the
outdoor environment, thus leading to
the potential for significant release of
the wood preservative into the
environment. The data required to
register a wood preservative product
depend on the use site of the treated
wood, which can be land-only, aquaticonly or both. For instance, a wood
preservative product which would be
used in or near water will usually have
more data requirements concerning the
effects of the pesticide on aquatic
organisms than a product that is not
used in or near water.
Therefore, if a product specifies that
wood that has been treated with that
product cannot be used in areas with
the potential for that wood coming into
contact with water, then EPA believes
that the potential for exposure is
decreased. Accordingly, it is current
EPA practice to require fewer
environmental fate and ecological
effects studies for such products. In
practice it is difficult to assure that
wood treated with a wood preservative
that is for land-use only will not come
in contact with water. Treated wood
intended for a use with little potential
aquatic exposure could be inadvertently
diverted to other uses, such as marine
docks or pilings, which would have
considerable aquatic exposure. The
Agency does not know if or how often
this kind of diversion occurs. However,
the Agency notes that in the United
States, wood preservatives are
categorized using the American Wood
Preservers’ Association Use Category
system. These categories describe the
exposure conditions which treated
wood products can be subjected to
when in service. The categories,
although general, provide some measure
of control over how treated wood
products are used.
E:\FR\FM\08OCP2.SGM
08OCP2
59406
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
A concern that has been raised to EPA
is the difference in how different
countries regulate wood preservative
products. This could present a challenge
for joint reviews of wood preservatives
since different data requirements and
differing programmatic objectives could
result in different regulatory decisions.
Today’s proposed data requirements
are based on EPA’s current practice of
determining the data required for a
wood preservative product dependent
on the usage (land-only versus land and
aquatic). The Agency requests
comments on the regulation of wood
preservative products, and based on the
comments received could continue with
the split usage or determine to no longer
have such a split usage.
XII. Environmental Fate Data
Requirements
sroberts on PROD1PC70 with PROPOSALS
A. Environmental Fate Data
Requirements for Antimicrobials
The Agency proposes to adapt the
basic environmental fate data types
(§ 158.2280) as listed in subpart N of
current part 158 to support applications
for antimicrobial products. EPA also
proposes to modify the applicability of
those requirements to antimicrobials to
reflect differing risks and levels of
exposure. Moreover, new types of data
are needed to evaluate the risks
associated with use patterns more
typically associated with antimicrobials,
such as discharge through sewer
systems and wastewater treatment
plants to the environment. As discussed
in this Unit, such studies could include:
Activated sludge sorption isotherm,
ready biodegradability, and modified
activated sludge, respiration inhibition
test.
Fate studies characterize how a
pesticide chemical dissipates once it is
released into the environment, and
identify the significant transformation
products likely to result from these
processes. Fate studies include both
laboratory and field studies. Such
studies can provide input parameters
needed in simulation modeling. Under
a tiered testing scheme, a specified set
of laboratory studies determined by the
use patterns is performed first, and then
a preliminary, qualitative environmental
fate and transport assessment is
developed from the results of those
lower-tiered studies and the modeling.
This assessment could determine that
no additional studies are needed. Or,
this assessment could trigger highertiered laboratory-based studies, and/or
to design or trigger appropriate field
studies. Fate studies can also be used as
triggers for determining which
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
ecological effects data will be needed to
support registration.
Once the higher-tiered studies have
been reviewed and evaluated, then the
Agency would use all these data to
develop quantitative environmental fate
and drinking water exposure
assessments, and to calculate estimated
environmental concentrations of the
pesticide in different media (such as
water, sediment, or soils) under various
pesticide application and site scenarios.
The Agency uses these estimates of
exposure in conjunction with toxicity
data to assess whether a pesticide has
the potential to cause adverse effects on
human health via exposure through
drinking water and the environment via
exposures through both water and soil.
B. History of Environmental Fate Data
Requirements for Antimicrobials
In 1984, at the time of promulgation
of the original part 158 data
requirements, there were no
environmental fate data requirements
for the indoor use pattern. At that time,
EPA assumed that many of the indoor
uses went down-the-drain to a
wastewater treatment plant (WWTP), at
which point dilution and degradation,
or removal by WWTP processes would
mitigate environmental concerns. Thus,
currently, in part 161, there are no
environmental fate data requirements
for the indoor use pattern.
In 1997, the Agency presented a draft
of the antimicrobial data requirements
to the FIFRA Science Advisory Panel
(SAP) (Ref. 29). As part of its
presentation EPA explained its intent to
divide antimicrobial uses into two
groupings based on the potential for
environmental exposure (high
environmental exposure and low
environmental exposure). In 1997, the
Agency defined the low environmental
exposure grouping as the following
eight use scenarios: Agricultural
premises and equipment; foodhandling/storage establishments
premises and equipment; commercial,
institutional and industrial premises
and equipment; residential and public
access premises; medical premises and
equipment; human drinking water
systems; materials preservatives; and
swimming pools. For these eight use
scenarios for environmental fate data
the Agency intended to require a very
reduced data set (hydrolysis data).
In its report, the SAP expressed its
concerns about ‘‘the lack of chemical
fate data,’’ indicated that hydrolysis
would be an important pathway of
concern for only a subset of
antimicrobial chemicals, and stated that
both biodegradation data, and microbial
data should also be required. According
PO 00000
Frm 00026
Fmt 4701
Sfmt 4702
to the SAP, this was ‘‘to ensure the
safety of environmental discharge but
also for protection of publicly owned
treatment works (POTWs) and other
treatment systems which often rely on
microbial treatment processes.’’ In
response to the SAP’s concerns, the
Agency reexamined the need for
environmental fate data other than
hydrolysis. As a result of this 1997
reexamination, the Agency determined
to conditionally require data on
photodegradation in water for low
environmental exposures. At that time,
the Agency determined not to require
biodegradation or microbial data.
More recently, as part of its
development of this proposed rule, EPA
re-evaluated the 1997 SAP
recommendations concerning the data
requirements for environmental fate,
and nontarget plant and organisms. The
reason for this re-evaluation was, in
part, due to certain comments that were
received in response to the 2005
proposed rule for conventional pesticide
chemicals (70 FR 12276, March 11,
2005). Additionally, the Agency was
also becoming increasingly aware of
detections of antimicrobial chemicals in
various environmental compartments.
The Agency received comments from
four California water treatment
authorities and from environmental
agencies from two cities in California.
The comments centered on their strong
recommendations that FIFRA data
requirements should be equivalent to
the data required to develop water
quality criteria (WQC) under the Clean
Water Act (CWA) and should consider
water quality issues related to urban
pesticide use. California water-treatment
authorities questioned the adequacy of
the Agency’s assessment of risks with
regard to water quality considerations
including: Use of aquatic toxicity data,
surface water quality studies, and urban
uses of pesticides, particularly when
these uses result in pesticide residues in
receiving waters from storm sewers or
sewage treatment plants.
EPA believes that even though these
comments were received in response to
the conventional pesticide chemicals
proposed rule, the submitted
information on receiving waters for
wastewater treatment plants is
particularly applicable to
antimicrobials, many of which are used
indoors. This means that the
antimicrobial goes down-the-drain and
eventually reaches a wastewater
treatment plant. Therefore, in its
response to comments document for the
final rule for conventional pesticide
chemicals, EPA agreed that pesticide
discharge into municipal sewage
systems is an important issue
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
particularly for those antimicrobial
pesticides which are typically rinsed
down the drain. EPA stated it would
consider the issue of down-the-drain
chemicals in the proposed rule for
antimicrobials.
As a first step toward re-evaluating its
processes and procedures for
conducting a risk assessment for an
antimicrobial chemical that goes downthe-drain, the Pesticide Program
discussed these issues with EPA’s Office
of Water (OW). The Agency is becoming
increasingly aware of detections of
antimicrobial pesticide chemicals in
various environmental compartments,
including surface water. An example of
a chemical with such detections is
triclosan (Refs. 12, 17, 22, and 23). The
detection of such chemicals in surface
water indicates that the antimicrobial
(or its degradate) is moving from the
area of application, down-the-drain to a
WWTP, and then into the environment
via the treated effluent. Certain
chemicals can pose a risk even at low
levels. Based on the Agency’s concerns
about the potential effects of
antimicrobials on the biological
treatment processes used in WWTPs,
concerns about potential
bioconcentration of antimicrobials after
release, and possible effects on
nontarget species, the Agency now
believes that new environmental fate
data requirements are needed for downthe-drain antimicrobial uses.
Therefore, EPA is proposing to require
data to address environmental fate
(degradation), biodegradation data, and
microbial data, for the low
environmental exposure grouping (as
defined in Unit XI.B. and once-through
industrial processes and water systems.
These data reflect the Agency’s concern
about the potential movement of
antimicrobials and their degradates from
the indoor environment to the outdoor
environment. Additionally, these lowertiered data will allow EPA to conduct
screening-level environmental fate
assessments which can then indicate the
need for higher-tiered fate and
ecotoxicity studies and higher-tiered
environmental assessments.
EPA specifically requests comments
on the Agency’s rationale for requiring
data to perform a screening assessment
on down-the-drain antimicrobial uses,
the potential for performing highertiered studies based on the results of the
screening assessment, and the cost and
burden of performing the studies.
EPA also notes that three use patterns,
wood preservatives, antifoulants, and
aquatic uses are not considered downthe-drain use patterns. As previously
discussed, these uses either occur
outdoors and thus discharge directly to
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
the environment, or result in materials
treated with antimicrobials being placed
in the environment. Since these use
patterns are unlikely to go down-thedrain, a screening-level environmental
fate assessment is not needed.
C. Today’s Proposal for Low
Environmental Exposure Antimicrobials
The Agency believes that
environmental exposures from the use
patterns discussed in Unit XI.B.3. of this
preamble are likely to be small, because
(1) the sites where these uses occur are
not rapidly or directly connected to
aquatic environments, (2) some of the
applications occur on a very infrequent
basis and other applications involve
very small amounts of the antimicrobial,
and (3) in many cases wastewaters
containing these antimicrobials are
processed in WWTPs. The indirect
movement of antimicrobials from the
use sites into the outdoor environment
occurs mostly through water. In many
cases, leachates, rinsates, and flushes
are released down-the-drain, and
eventually reach a WWTP. WWTPs
degrade chemicals in their influent,
although the degree of degradation
varies widely depending on the
chemical, the treatment process and
other factors (e.g., ambient temperature).
After treatment, the effluent (the treated
water and any chemicals remaining in
that water) is released into the aquatic
environment, or to the terrestrial
environment via land application of
sewage sludge.
Given the expectation of low
exposures to the environment, EPA
proposes to use a tiered system of data
requirements to determine the type of
environmental fate assessment needed
for the low environmental exposure
grouping. A screening-level assessment
would be used to determine the
potential of the antimicrobial chemical
to directly harm the microbial treatment
processes present in wastewater
treatment systems, the environmental
compartment(s) that the antimicrobial is
likely to partition to, and the amount of
antimicrobial that could be present in
the effluent that the treatment plant
releases to the environment. The
presence of antimicrobials in an effluent
release means that an ecological
assessment could be required to
evaluate risks to endangered species. It
is also possible that estimation of
concentrations to use in a drinking
water assessment could be required.
The lower-tiered environmental fate
studies being proposed for the
screening-level assessment for the low
environmental exposure grouping are
discussed in detail in Units XII.E. – K.
of this preamble. The higher-tiered
PO 00000
Frm 00027
Fmt 4701
Sfmt 4702
59407
studies that would be triggered are
based on a weight-of-evidence
evaluation of the results of the lowertiered studies are discussed in Units
XII.L. – Q. EPA’s proposal to
conditionally require these data for the
low environmental exposure grouping
would for these studies expand the
number of use patterns for which the
test is conditionally required.
It may be possible to model some of
the needed parameters. The applicant is
encouraged to review the approach
discussed in Unit XVIII.A. of this
preamble on the use of StructureActivity-Relationship (SAR)
assessments to ascertain if such
techniques could provide useful
information in preparing their
submission to EPA.
EPA is proposing to conduct the
screening-level of its fate assessment for
these low environmental exposure
antimicrobials with non-direct, delayed
environmental connections in a threepronged approach. The three prongs are
designed to (1) estimate the number of
days per year of exceedance of the
antimicrobial surface water
concentration of concern to aquatic
organisms in a surface water body
downstream of a treatment plant, (2)
determine any negative effect of the
antimicrobials in the influent on the
activated sludge biomass in biological
wastewater treatment systems, and (3)
determine the potential for the
antimicrobial to accumulate in sediment
or in organisms downstream from the
WWTP release, or for there to be
negative impacts on nontarget
organisms in the receiving water body.
For the first prong, modeling would
be used to estimate a screening-level
exposure concentration of the
antimicrobial in a surface water body
that receives effluent from a WWTP.
EPA anticipates using the Down-theDrain model with the Probabilistic
Dilution Model (PDM) option in the
Exposure and Fate Assessment
Screening Tool (E-FAST) (Version 2.0)
available from the Agency’s website (see
https://www.epa.gov/oppt/exposure/
pubs/efast.htm). This model option uses
readily available data as inputs to
estimate conservative (i.e., high-end)
exposure concentrations. E-FAST has
been independently peer-reviewed by
EPA’s Science Advisory Board.
Comments from that peer review have
been incorporated into Version 2.0 of EFAST.
The PDM option of E-FAST can
predict downstream chemical
concentrations from an industrial
discharge and from disposal of
consumer products into household
wastewater. The module uses a simple
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59408
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
mass balance approach that uses
probability distributions as inputs. The
concentration of the chemical in the
receiving surface water body is also
calculated as a probability distribution
of the ratio of WWTP effluent flow and
stream flow immediately downstream of
the WWTP. The Down-the-Drain Model
can be run with or without the PDM
option.
The Down-the-Drain Model requires
as an input value the production
volume of the chemical. If this
information cannot be supplied by the
applicant, then the Agency would need
to estimate the volume. The production
volume would be used as if the entire
volume of the chemical were expected
to go down the drain. However, the
Agency would be able to modify the
production volume to account for the
percentage of the chemical that is
expected to actually go down the drain.
As an example, almost all of a toilet
bowl cleaner can be reasonably
expected to go down the drain, but a
hard surface cleaner could also vaporize
into the air, dry on the surface, or be
disposed of on paper towels into the
trash. Therefore it may be reasonable to
adjust the production volume used as an
input to the Down-the-Drain model. The
model estimates human exposure from
ingestion of drinking water and fish,
and concentrations of chemicals in
surface waters downstream of WWTPs.
The PDM option estimates the number
of days of exceedance of a concentration
of concern for aquatic organisms.
Concentrations of concern are based on
measurements of acute and/or chronic
effects to aquatic organisms.
For the second prong of the
assessment, EPA intends to require five
environmental fate studies to determine
the potential of the antimicrobial to
harm the microbial treatment processes
in wastewater treatment systems, and to
determine the potential amount of
antimicrobial present in the effluent that
the treatment plant releases to the
environment. Higher-tiered studies
would be triggered based on a weightof-evidence evaluation of the results of
the following lower tiered studies:
Hydrolysis; photodegradation in water;
modified activated sludge, respiration
inhibition test; activated sludge sorption
isotherm; and ready biodegradability.
These tests are discussed in Units XII.E.,
F., H., I., and K. of this preamble.
• The data from the hydrolysis study
would allow EPA to determine if the
antimicrobial hydrolyzes in water
during transport to the WWTP, and also
after release to the environment. These
data are routinely used to understand
the persistence of a chemical in the
environment, and when the hydrolysis
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
breakdown products should also be
considered in the environmental fate
assessment.
• The data from the photodegradation
in water study would allow EPA to
determine if the antimicrobial degrades
in shallow water due to exposure to
sunlight. These data are used to
understand the persistence of a
chemical in surface water.
• The modified activated sludge,
respiration inhibition test would allow
EPA to identify antimicrobials which
could harm the microorganisms found
in biological wastewater treatment
systems and would also indicate
suitable antimicrobial concentrations for
use in the ready biodegradability test.
• The activated sludge sorption
isotherm study would allow EPA to
assess the distribution of the
antimicrobial between the sludge and
aqueous phases.
• The ready biodegradability study
would allow the Agency to determine
whether the chemical tested achieves
‘‘pass levels’’ for ready biodegradability.
These screening tests are so stringent
that it is assumed that the chemicals
that meet the pass levels will rapidly
and completely biodegrade in aquatic
environments under aerobic conditions.
Modeling could also be used to
predict the removal of a chemical in a
sewage treatment plant. STPWINTM is
part of the EPI SUITE modeling
available via the Agency’s website (see
https://www.epa.gov/oppt/exposure/
pubs/episuite.htm). STPWINTM can
predict values not only for the total
removal but also three contributing
processes: Biodegradation, sorption to
sludge, and stripping to air.
The third prong of the fate assessment
would use the available product
chemistry data (for example octanol/
water partition coefficient, vapor
pressure, or solubility in water) or
predicted/modeled data to determine
the potential for the antimicrobial to
bioconcentrate. This is consistent with
the approach used in the Agency’s PBT
profiler, an assessment tool that
estimates environmental persistence (P),
bioconcentration potential (B), and
aquatic toxicity (T) of a chemical based
on its molecular structure. (see https://
www.epa.gov/oppt/pbtprofiler.)
The Agency would then use the
results of all three prongs to conduct a
screening-level environmental fate
assessment. It is also possible that
information from open literature could
be useful to the Agency for its
assessment. By combining the modeled
exposure estimates with information on
the persistence of the antimicrobial, its
distribution in the environment, and its
ability to harm the microorganisms
PO 00000
Frm 00028
Fmt 4701
Sfmt 4702
found in a biological WWTP, the
Agency could determine if there are risk
concerns. Based on the concerns, EPA
would be able to determine if a more indepth risk assessment would be
required for certain environmental
media. Higher-tiered data could be
required to support such a risk
assessment. The specific data would
depend on the environmental medium
in which the antimicrobial and its
transformation products reside, and on
the concentrations in the environment.
• If the antimicrobial is completely
degraded to non-toxic degradates, then
it is likely that no higher-tiered
environmental fate data would be
required.
• If the antimicrobial is not completely
degraded by the WWTP and is in the
effluent released to surface water, then
depending on the concentrations that
then occur in the environment, an
assessment similar to that of an
antimicrobial with high environmental
exposure could be needed.
• If the antimicrobial partitions to
water, then the possible higher-tiered
environmental fate studies would
include: Leaching and adsorption/
desorption, and aerobic and anaerobic
aquatic metabolism.
• If the antimicrobial is likely to
partition to sludge, soil, or sediment,
then possible higher-tiered
environmental fate studies would
include aerobic and anaerobic soil
metabolism studies, and sediment
studies. EPA has considered that
antimicrobials may be present in
biosolids (sewage sludge) that are land
applied. While soil and sediment data
would be required for an antimicrobial
risk assessment, these data may also be
useful to EPA’s Biosolids Program
conducted under 40 CFR part 503.
The Agency specifically seeks
comment on this proposed approach for
performing a screening-level
environment fate assessment and the
potential for triggering higher-tiered
studies.
D. Case Studies
To assess whether the proposed
approach provides the data needed to
assess exposure and risk of
antimicrobial pesticides released to the
environment via down-the-drain use
patterns, the Agency has conducted four
case studies. All of the models used for
the case studies are peer-reviewed, and
publicly available. These case studies,
entitled ‘‘Four Case Studies of
Antimicrobial Pesticides in the Downthe-Drain Screening Model, Using the
Proposed Approach for a ScreeningLevel Environmental fate Assessment’’
(Ref. 42) reflect a particular integration
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
of the modeling results specific to the
needs of antimicrobials.
Four antimicrobial pesticides that
have completed scientific review in the
reregistration process were selected to
represent a range of influent volumes to
WWTPs, and general environmental fate
and transport properties. Antimicrobials
undergoing reregistration were chosen
because they have fairly complete
supporting data bases, and are well
understood; that is, they allow a
comparison of the proposed approach
with real-world information.
In selecting these four chemicals, the
Agency attempted to select at least one
chemical that should trigger higher tier
data requirements and one that should
trigger no higher tier data requirements.
The environmental fate and transport
characteristics considered during the
case studies were environmental
persistence, biodegradability, hydrolytic
stability, and sorption potential.
Although not intended to represent all
possible combinations of chemical
characteristics, use scenarios, and usage
volumes, the four antimicrobials
selected for the case studies were
intended to include a sufficiently broad
range of possible outcomes to credibly
assess the proposed approach.
• Chemical A was intended to
represent a chemical with a high
loading (mass) within the WWTP’s
influent, high toxicity to fish and
aquatic invertebrates, high hydrolytic
stability, relatively high potential to
biodegrade during wastewater
treatment, and low to moderate
potential to adsorb to activated sludge.
This chemical was picked as a ‘‘worstcase’’ example.
• Chemical B was intended to
represent a chemical with a relatively
low to moderate loading (mass) within
the WWTP’s influent, high toxicity to
fish and aquatic invertebrates, high
hydrolytic stability, and no available
data on biodegradability during
wastewater treatment or the potential to
adsorb to activated sludge.
• Chemical C represents a ‘‘best-case’’
example. It is an organic acid that has
a high loading (mass) within the
WWTP’s influent, potential to
bioaccumulate, high water solubility, no
environmental fate data, and no
ecotoxicity data. This chemical was
selected as a case study because it
degrades quickly and would be
expected to have little potential for
ecotoxicity.
• Chemical D represents a mixture of
two organic chemicals with relatively
low loading (mass) within the WWTP’s
influent volume, high resistance to
biodegradation during wastewater
treatment, low potential to sorb to
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
activated sludge, and fairly low toxicity
to fish and aquatic invertebrates.
The specific identities of the
antimicrobials have been ‘‘blinded’’ to
focus those who may wish to comment
on the proposed approach, and not what
the result ‘‘should’’ be for a particular
chemical.
Many, but not all, of the values
selected for input data for the case
studies were based on measured or
estimated values for existing
antimicrobial pesticides. In some
instances, values for input data needed
to run models to assess exposure and
risk from down-the-drain releases were
not available. In those instances,
hypothetical values were used.
Hypothetical values were also
sometimes selected to enable the cases
to have sufficiently different key
environmental fate and transport
properties to be able to more rigorously
test the proposed tiered approach for
assessing exposure and risk to
chemicals that are released down-thedrain.
TABLE 1.—CASE STUDIES—Continued
Study
Results
Chemical C: An Organic Acid that is
Highly Soluble in
Water
There are no data to
show that Chemical C would harm
microorganisms
found in biological
wastewater treatment systems.
Chemical D: A Mixture of Chemicals
Chemical D does
not appear to
pose ecological
risks at the assumed production
levels. However,
the potential for
biodegradation
and any potential
impacts on waste
water treatment
plant organisms
could not be
ascertained with
the available information. Therefore,
the proposed new
lower tiered environmental fate
studies are required.
TABLE 1.—CASE STUDIES
Study
Results
Chemical A: A
Chemical that
Does Not Hydrolyze and Only Partially Biodegrades
The proposed approach indicated
Chemical A has
considerable potential to pose ecological concerns.
Aerobic and anaerobic soil metabolism studies
are needed to refine environmental
fate and dissipation, and highertier ecotoxicity
studies are needed to determine
risk to nontarget
species.
Chemical B: A
Chemical Which Is
Stable to Hydrolysis, But There Is
No Data on the
Potential to Biodegrade During
Wastewater Treatment or Adsorb to
Activated Sludge
The proposed approach indicated
that the lower
tiered environmental fate studies are needed to
determine Chemical B’s dissipation
rate in wastewater
treatment plants.
Several higher
tiered ecotoxicity
studies are needed to determine
risk to nontarget
species.
PO 00000
Frm 00029
Fmt 4701
Sfmt 4702
59409
From these case studies the Agency
concludes that the proposed approach
produces the results desired by the
Agency. The proposed approach
effectively distinguishes between
chemicals that will require more indepth review and therefore higher-tiered
studies versus chemicals that require
only the lower tiered environmental fate
and ecotoxicity studies to determine
that no or few additional higher tiered
studies are needed.
The Agency specifically seeks
comment on the case studies (Ref. 42)
performed, including the assumptions
used as model inputs. EPA will consider
comments specific to the case studies
along with comments on the proposed
approach, as the Agency evaluates the
use of the proposed approach for downthe-drain antimicrobials in the final rule
for antimicrobial data requirements.
E. Hydrolysis Study
EPA proposes to require a hydrolysis
study for all antimicrobial pesticides. In
40 CFR part 161, hydrolysis studies are
currently required for all use patterns
except indoor. (The indoor part 161 use
pattern is being considered by EPA to be
similar to the low environmental
exposure grouping.) Accordingly, EPA
proposes to continue to require
hydrolysis studies for all of the high
environmental exposure use patterns
(once-through industrial processes and
water systems, antifoulant paints and
coatings, wood preservatives, and
E:\FR\FM\08OCP2.SGM
08OCP2
59410
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
aquatic areas) and to codify the
requirement for all other antimicrobial
use patterns. In practice, hydrolysis
studies have been required for all
antimicrobial chemicals for over 10
years.
As previously discussed, EPA intends
to require the hydrolysis study as part
of the lower tier of environmental fate
data requirements for down-the-drain
chemicals. Chemicals that hydrolyze
rapidly to less toxic chemicals may need
few higher tiered studies. This study
will allow EPA to determine how fast
the antimicrobial breaks down in the
presence of water and what degradates
are formed.
sroberts on PROD1PC70 with PROPOSALS
F. Photodegradation in Water
In 40 CFR part 161, the
photodegradation in water study is
required for aquatic use patterns. The
Agency proposes to continue its existing
requirement for a photodegradation in
water study for the antimicrobial
aquatic areas use pattern. The Agency
also proposes to require the study for all
other antimicrobial uses. This would
expand the number of use patterns for
which this study is required.
This study will allow EPA to
determine the degradation of the
pesticide in shallow water bodies as a
result of exposure to sunlight.
Chemicals that degrade quickly in the
environment may need few higher tier
studies. As with the data requirements
for conventional pesticide chemicals,
EPA intends to clarify in a test note
certain conditions when
photodegradation testing would not be
required. Data on photodegradation in
water would not be required when the
electronic absorption spectra, measured
at pHs 5, 7, and 9 of the chemical and
its hydrolytic products, if any, do not
show absorption or tailing between 290
and 800 nanometers. If no absorption or
tailing occurs in this range, it is unlikely
that photodegradation occurs (Refs. 25
and 27).
G. Photodegradation in Soil
The Agency is proposing to require
the photodegradation in soil study for
wood preservatives only. Leaching of
wood preservatives (both the parent or
transformation products) from
preservative-treated wood could
contaminate the surrounding soils. This
would be a new data requirement which
would provide data on the dissipation,
nature and persistence of wood
preservative degradation products
formed by soil surface catalyzed
photolysis. Using these data the Agency
can assess the extent and duration of
human (e.g., children playing below
decks) and/or nontarget organism
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
exposures to soils adjacent to
preservative-treated wood structures.
Such soils may contain the parent
compound and/or transformation
products, which could include those
formed via photodegradation processes.
H. Activated Sludge Sorption Isotherm
The activated sludge sorption
isotherm study would be a new data
requirement. EPA is proposing to
require this study only for the low
environmental exposure grouping and
the once-through industrial processes
and water systems. This study is not
required for wood preservatives,
antifoulants, or aquatic areas.
For antimicrobial chemicals that go
down-the-drain and reach a WWTP, as
part of its screening-level environmental
fate assessment, EPA will analyze the
potential impact of the antimicrobial
chemical on the microorganisms in the
typical biological treatment processes of
a WWTP. The activated sludge sorption
isotherm study would allow EPA to
assess the distribution of the
antimicrobial between the sludge and
aqueous phases. This information is
important in determining the method
used in the ready biodegradability test
and the higher-tiered studies that may
be required. Antimicrobials that are
predominantly in the water column and
do not sorb to sludge may not need
testing that focuses on sediment and
soils, such as the aerobic and anaerobic
soil metabolism studies. Antimicrobials
that predominantly sorb to the sludge,
soil, and sediment may not need testing
that focuses on water, such as the
aerobic and anaerobic aquatic
metabolism studies.
I. Ready Biodegradability
The ready biodegradability study
would be a new data requirement. EPA
is proposing to require this study only
for the low environmental exposure
grouping and the once-through
industrial processes and water systems.
This study is not required for wood
preservatives, antifoulants, or aquatic
areas.
For antimicrobial chemicals that go
down-the-drain and reach a WWTP, as
part of its screening-level environmental
fate assessment, EPA will analyze the
potential impact of the antimicrobial
chemical on the microorganisms in the
biological treatment processes of a
WWTP. Biodegradation is an important
environmental pathway in which the
antimicrobial is broken down into
‘‘smaller’’ chemicals by bacteria. This
study supplies information on the rate
of breakdown and the completeness of
the degradation to carbon dioxide and
water. A ready biodegradability study
PO 00000
Frm 00030
Fmt 4701
Sfmt 4702
would allow the Agency to determine
whether the chemical achieves ‘‘pass
levels’’ for ready biodegradability (e.g.,
70% removal of dissolved organic
carbon). These screening tests are so
stringent that it is assumed that
antimicrobials that ‘‘pass’’ will rapidly
and completely biodegrade in aquatic
environments under aerobic conditions.
Chemicals that degrade quickly and
completely may need few higher tiered
studies.
J. Porous Pot Test
The Agency is proposing to
conditionally require the porous pot
study for antimicrobials based on the
results of the ready biodegradability
test. This would be a new data
requirement. EPA is proposing to
require this study only for the low
environmental exposure grouping and
the once-through industrial processes
and water systems. This study is not
required for wood preservatives,
antifoulants, or aquatic areas.
The porous pot study simulates the
processes in the aeration basin of the
activated sludge sewage treatment
process. It is therefore a more realistic
test than the biodegradability test. A
chemical that did not ‘‘pass’’ the
biodegradability test could degrade
(partially or completely) under different
conditions. The porous pot study would
provide a measure of the extent of
biodegradation or removal likely to
occur during sewage treatment. An
antimicrobial that degrades quickly and
completely in a typical wastewater
treatment plant may need few higher
tiered studies.
K. Modified Activated Sludge,
Respiration Inhibition Test
The modified activated sludge,
respiration inhibition test would be a
new data requirement. EPA is proposing
to require this study only for the low
environmental exposure grouping and
the once-through industrial processes
and water systems. This study is not
required for wood preservatives,
antifoulants, or aquatic areas.
For antimicrobial chemicals that go
down-the-drain and reach a WWTP, as
part of its screening-level environmental
fate assessment, EPA will analyze the
potential impact of the antimicrobial
chemical on the microorganisms in the
biological treatment processes of a
WWTP. The modified activated sludge,
respiration inhibition test would allow
EPA to identify antimicrobials which
could harm the microorganisms found
in WWTPs and thus impair the ability
of these bacteria to carry out their
intended function. Additionally, this
study would also indicate suitable
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
concentrations for use in the ready
biodegradability test.
sroberts on PROD1PC70 with PROPOSALS
L. Leaching and Adsorption/Desorption
In 40 CFR part 161, leaching and
adsorption/desorption studies are
required for all use patterns except the
indoor. Accordingly, EPA proposes to
continue to require the leaching and
adsorption/desorption studies for all of
the high environmental exposure use
patterns: Once-through industrial
processes and water systems,
antifoulant paints and coatings, wood
preservatives, and aquatic areas.
EPA is also proposing to conditionally
require these data for the low
environmental exposure grouping. This
would expand the number of use
patterns for which the test is
conditionally required. For the low
environmental exposure grouping, the
leaching and adsorption/desorption
study is considered to be a higher-tiered
study that would be triggered based on
a weight-of-evidence evaluation of the
results of the hydrolysis,
photodegradation in water, activated
sludge sorption isotherm, ready
biodegradability, and modified activated
sludge, respiration inhibition tests.
The leaching and adsorption/
desorption study would provide
information on the mobility of the
antimicrobial pesticide in soils. The
antimicrobial pesticide may or may not
be transported to surface water and/or
ground water bodies used for drinking
water. The presence of an antimicrobial
pesticide in drinking water sources
could contribute to exposure via
drinking water.
M. Aerobic Soil Metabolism
The Agency proposes to adapt its
current requirement in 40 CFR part 161
for an aerobic soil metabolism study to
the specific needs of antimicrobial
chemicals. Currently, 40 CFR part 161
requires this study for terrestrial and
outdoor types of uses.
The aerobic soil metabolism study
would be conditionally required for the
low environmental exposure grouping,
and once-through industrial processes
and water systems. This would expand
the number of use patterns for which
the test is conditionally required. The
aerobic soil metabolism study is
considered to be a higher-tiered study
that would be triggered based on a
weight-of-evidence evaluation of the
results of the hydrolysis,
photodegradation in water, activated
sludge sorption isotherm, ready
biodegradability, and modified activated
sludge, respiration inhibition tests.
For aquatic areas, data would be
required only for use sites that are
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
intermittently dry. This would codify
current practices for aquatic areas.
For wood preservatives, the Agency
proposes to require an aerobic soil
metabolism study. This would codify
current practices for wood
preservatives.
The aerobic soil metabolism study
would allow EPA to better understand
the antimicrobial pesticide’s
degradation under aerobic (oxygen-rich)
conditions in the laboratory. The results
of the study would help to determine
how fast the antimicrobial degrades in
the presence of microorganisms in
different natural soils, and what
metabolites are formed. Chemicals that
degrade quickly in soil are likely to have
lower exposure estimates.
N. Anaerobic Soil Metabolism
Due to a printing error, the data
requirement for an anaerobic soil
metabolism study was inadvertently
omitted from the data tables (now in 40
CFR part 161) in 1991, and subsequent
publications of the CFR. EPA asserts
that this requirement is still in
existence: This data requirement was
never intentionally removed from the
CFR by notice and comment
rulemaking, and is not considered a new
requirement. Therefore, EPA proposes
to adapt its current requirement for an
anaerobic soil metabolism study to the
specific needs of antimicrobial
chemicals by conditionally requiring the
study for the low environmental
exposure grouping, and wood
preservatives.
EPA is expanding the number of use
patterns for which the test is
conditionally required. For the low
environmental exposure grouping, the
anaerobic soil metabolism study is
considered to be a higher-tiered study
that would be triggered based on a
weight-of-evidence evaluation of the
results of the hydrolysis,
photodegradation in water, activated
sludge sorption isotherm, ready
biodegradability, and modified activated
sludge, respiration inhibition tests.
For wood preservatives, the anaerobic
soil metabolism study would be
required if treated wood is used in
aquatic environments or in soils which
may become flooded or waterlogged.
This would codify current practices for
wood preservatives.
The anaerobic soil metabolism study
would facilitate a better understanding
of the antimicrobial pesticide’s
degradation under anaerobic (oxygenpoor) conditions in the laboratory. The
results of the study would help to
determine how fast the antimicrobial
degrades in the presence of
microorganisms in different natural
PO 00000
Frm 00031
Fmt 4701
Sfmt 4702
59411
soils, and what metabolites are formed.
Chemicals that degrade quickly in soil
are likely to have lower exposure
estimates.
O. Aerobic and Anaerobic Aquatic
Metabolism
In 40 CFR part 161 both the aerobic
and anaerobic aquatic metabolism
studies are required for aquatic uses. For
antimicrobial chemicals, the Agency
considers this to include the following
uses: Once-through industrial processes
and water systems, antifoulant paints
and coatings, and aquatic areas.
Therefore, the Agency proposes to
continue its current requirement for
aerobic and anaerobic aquatic
metabolism studies for these uses. For
wood preservatives these studies have
been required on a case-by-case basis;
therefore, this proposal would codify
current practices.
EPA is also proposing to conditionally
require these two studies for the low
environmental exposure grouping. This
would expand the number of use
patterns for which the test is
conditionally required..
Anaerobic aquatic metabolism studies
describe and measure the formation of
pesticide residues in the water column
or sediment under low-oxygen
conditions. Aerobic aquatic metabolism
studies determine the effects that
exposure to aerobic, or oxygen-rich
conditions in the water column or
sediment can have on a pesticide when
it is dispersed through the aquatic
environment. Since the degradation or
dissipation pathways of pesticides in
aquatic environments are almost always
different from those of terrestrial
systems, soil metabolism studies may
not clearly define the paths of
degradation found in aquatic
environments. For the low
environmental exposure grouping, the
aerobic and anaerobic aquatic
metabolism studies are considered to be
higher-tiered studies that would be
triggered based on a weight-of-evidence
evaluation of the results of the
hydrolysis, photodegradation in water,
activated sludge sorption isotherm,
ready biodegradability, and modified
activated sludge, respiration inhibition
tests. Chemicals that degrade quickly in
water or sediment are likely to have
lower exposure estimates.
P. Aquatic Sediment Studies
Aquatic sediment studies are required
for aquatic use patterns in 40 CFR part
161. Accordingly, the Agency proposes
to continue its current requirement for
aquatic sediment studies for the
antimicrobial aquatic areas use pattern.
EPA is also proposing to conditionally
E:\FR\FM\08OCP2.SGM
08OCP2
59412
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
require an aquatic sediment study for all
other antimicrobial use patterns based
on the antimicrobial’s potential for
aquatic exposure.
For the low environmental exposure
grouping, the aquatic sediment study is
considered to be a higher-tiered study
that would be triggered based on a
weight-of-evidence evaluation of the
results of the hydrolysis,
photodegradation in water, activated
sludge sorption isotherm, ready
biodegradability, and modified activated
sludge, respiration inhibition tests. This
would expand the number of use
patterns for which the test is
conditionally required.
For the once-through industrial
processes and water systems,
antifoulant paints and coatings, and
wood preservatives, data would be
required based on the potential for
aquatic exposure and if the weight-ofevidence indicates that the active
ingredient or principal transformation
products are likely to have the potential
for persistence, mobility, nontarget
aquatic toxicity or bioaccumulation.
This would codify current practices.
The aquatic field dissipation study is
used to determine the nontarget fate of
a terrestrially applied pesticide that has
a high potential to enter aquatic
environments and to substantiate
laboratory findings. The laboratory
studies address one environmental fate
process at a time. The aquatic field
dissipation study examines pesticide
loss or movement in water and
sediment. Under field conditions
degradation/dissipation processes can
proceed differently from how they
occurred under laboratory conditions.
Data from this study can reduce the
potential overestimation to both
exposure and risk that can result from
having only laboratory generated data.
Protocols must be approved by the
Agency prior to the initiation of the
study. Details for developing protocols
are available from the Agency.
Q. Monitoring of Representative U.S.
Waters
The Agency is proposing to
conditionally require monitoring of
representative U.S. waters for all
antimicrobial use patterns. This would
include freshwater, saltwater,
surfacewater, and groundwater. This
would codify current practices.
The Agency would use a weight-ofevidence approach taking into account
factors such as available monitoring
data; the vulnerability of the freshwater,
estuarine, or marine water resources;
and the persistence and fate of the
pesticide active ingredient (or
degradate). Protocols must be approved
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
by the Agency prior to the initiation of
the study. Details for developing
protocols are available from the Agency.
Based on past experience, the Agency
believes that these monitoring data
would be required only for a very small
number of antimicrobial pesticide
registrations. Monitoring for tributyltin
antifoulants of the near coastal waters of
the United States including the Great
Lakes was required under the Organotin
Anti-fouling Paint Control Act of 1988.
In 1989, pesticide registrants were
required to provide these monitoring
data under FIFRA section 3(c)(2)(B).
These tributyltin antifoulants data are
the only monitoring of representative U.
S. waters that has been required for an
antimicrobial to date.
R. Special Leaching Study
The Agency is proposing to require
special leaching studies for antifoulant
paints and coatings, and wood
preservatives. Part 161 is not explicit in
the data that are currently required
because those use patterns are not
delineated sufficiently for antimicrobial
pesticide chemicals. This proposal
would codify the Agency’s current
practices. These studies are needed
because leaching from treated materials
is the primary source of environmental
exposure to antifoulants and wood
preservatives. These studies would
provide basic information about the
availability of the pesticide to the
environment, and would be used to
perform exposure and risk assessments.
There is no OPPTS Harmonized
guideline for these studies. The
applicant may perform the study with a
protocol of their choice, or may use the
American Wood Preservers’
Association’s (AWPA) Standard Method
of Determining the Leachability of
Wood Preservatives (AWPA E11–97),
AWPA’s Standard Method for
Determining the Leachability of Wood
Preservatives in Soil Contact (AWPA
E20–04), and the American Society for
Testing and Materials (ASTM) Standard
Test Method for Organotin Release Rates
of Antifouling Coating Systems in Sea
Water (ASTM D5108–90), or their
equivalents. As stated in the test notes
to the table in proposed § 158.2280,
prior approval by the Agency of studies
conducted according to AWPA E11–97
or ASTM D5108–90 is not required.
However, all studies that would be
conducted according to other protocols
must be approved by the Agency prior
to the initiation of the study. Details for
developing protocols are available from
the Agency.
PO 00000
Frm 00032
Fmt 4701
Sfmt 4702
XIII. Nontarget Organisms Data
Requirements
A. Nontarget Organisms Data
Requirements for Antimicrobials
EPA proposes to adapt the basic
nontarget organism data types
(§ 158.2240) as listed in subpart G of
current part 158 to support applications
for antimicrobial products. EPA
proposes to modify the applicability of
those requirements to antimicrobials to
reflect differing risks and levels of
exposure. Part 161 is not explicit in the
data that are currently required because
those use patterns are not delineated
sufficiently for antimicrobial pesticide
chemicals. The proposed table, in
§ 158.2240, will provide greater
transparency and clarity.
Ecological effects testing includes
short-term, acute, subacute, chronic,
and reproduction studies, which
progress from laboratory tests to applied
field tests. These data allow the Agency
to determine if the standard for
registration is met and whether
precautionary label statements
concerning toxicity or potential adverse
effects to nontarget organisms are
necessary.
The Agency is proposing to use a
tiered system of ecological effects
testing to assess the potential risks of
pesticide uses to nontarget animals
(aquatic and terrestrial vertebrates and
invertebrates) for antimicrobial
pesticide chemicals. For the first tier of
testing EPA proposes to require for all
antimicrobial pesticides three types of
acute ecological effects studies.
• Avian acute oral LD50.
• Acute freshwater fish LC50.
• Acute freshwater invertebrates EC50.
These acute studies measure toxicity
in representative species of the
nontarget species most likely to be
adversely affected and allow EPA to
develop precautionary labeling. Such
labeling includes statements such as
‘‘This product is extremely toxic to
birds’’ or ‘‘This product is toxic to fish.’’
These statements provide needed
information in case of unintended or coincident exposure to antimicrobials,
such as a transportation accident. And,
in fact, these studies are currently
required for an application for
registration.
These first tier data would be required
for all antimicrobial use patterns and
performed with the technical grade
active ingredient (TGAI). Higher-tiered
data would be required when the
appropriate trigger in § 158.2240 is met.
For instance, results from these first tier
studies may indicate the need for acute
toxicity testing in an additional species,
or higher-tiered studies to assess hazard
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
to other species or in other parts of the
environment. Other factors, such as,
toxicity, persistence, and/or potential
for bioaccumulation, may indicate the
need for higher-tiered ecological effects
and environmental fate data. All typical
end-use product (TEP) testing is
considered to be higher tier. An
applicant must carefully consider
whether studies listed in the higher tier
data requirements are required for
registration of his product and should
consult with the Agency, as needed.
The Agency has divided the
antimicrobial pesticides into two groups
for determining ecological effect data
requirements, based on their expected
environmental exposure. The two
groupings are the same groupings used
for environmental fate data
requirements: Low and high
environmental exposure groupings. (see
Unit XI.B of this preamble.)
sroberts on PROD1PC70 with PROPOSALS
B. The Low Environmental Exposure
Grouping
The use patterns within this grouping
are the same as those described in Unit
XI.B. of this preamble for environmental
fate data requirements. As previously
discussed in this Unit, EPA proposes to
require a first tier of three ecological
effects studies for all antimicrobials.
These three acute ecotoxicity studies in
combination with the screening-level
environmental fate assessment proposed
to be required for assessing the impacts
of antimicrobial pesticides on WWTPs,
are the initial studies for environmental
modeling for risk assessment purposes.
For the low environmental exposure
grouping, higher-tiered ecotoxicity
studies are conditioned on a weight-ofevidence evaluation of the results of the
tier one ecotoxicity studies and/or the
results of the screening-level
environmental fate assessment. Thus,
the studies described in Unit XIII.F., G.,
I., J., K., L., and M. could be triggered.
C. The High Environmental Exposure
Grouping
As with the environmental fate data
requirements, the high exposure
environmental group consists of the
once-through industrial processes and
water systems, antifoulant paints and
coatings, aquatic areas, and wood
preservatives. These uses either occur
outdoors, discharge effluent directly to
the outdoors, or result in materials
treated with antimicrobials (e.g., wood
preservatives and antifoulants) being
placed in the environment, thereby
leading to potentially significant
environmental exposure. For the high
environmental exposure grouping, EPA
proposes to require three first tier
ecological effects studies and depending
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
on the use pattern, other ecotoxicity
studies such as avian studies and TEP
testing. The Agency may require
additional ecotoxicity studies based on
the results of these studies or on other
information.
D. Acute Avian Oral Toxicity
In 40 CFR part 161 acute avian studies
are conditionally required for ‘‘indoor’’
uses of antimicrobials, and are required
for aquatic uses of antimicrobials. (The
indoor part 161 use pattern is being
considered by EPA to be similar to the
low environmental exposure grouping.)
The Agency is proposing to require
submission of acute avian LD50 toxicity
studies for all antimicrobial use
patterns. These studies are needed as
part of the tier one ecotoxicity testing,
and as previously explained are used to
develop precautionary labeling.
Testing in one avian species is
required for the low environmental
exposure grouping. The shift from CR to
R for the low environmental exposure
grouping would expand the number of
use patterns for which this study is
required.
For antimicrobial chemicals, the
Agency considers the aquatic use
pattern in part 161 to include the
following antimicrobial use patterns:
Once-through industrial processes and
water systems, antifoulant paints and
coatings, and aquatic areas. Therefore,
the Agency proposes to continue its
current requirement for acute avian oral
acute toxicity studies for these uses. For
wood preservatives these studies have
been required on a case-by-case basis;
therefore, this proposal would codify
current practices.
As with the data requirements for
conventional pesticide chemicals, the
Agency is proposing to change the
testing requirement from one species to
two species for all antimicrobial use
patterns except the low environmental
exposure grouping. The change to two
species is consistent with the Agency’s
current practices.
The species proposed in this proposal
differ from those in the requirements for
conventional pesticides. Many
conventional chemicals are applied
outdoors and are considered to be
terrestrial uses. For antimicrobials the
Agency is proposing that the testing be
conducted with a waterfowl species and
an upland game bird species. The
selection of waterfowl and upland game
species is consistent with the current
submissions by registrants of
antimicrobial products and reflects the
data needed for the many indoor and
aquatic uses of antimicrobials.
PO 00000
Frm 00033
Fmt 4701
Sfmt 4702
59413
E. Acute Aquatic Toxicity Studies
The Agency is proposing to require
acute aquatic toxicity studies (LC50 fish
and EC50 invertebrate) for all
antimicrobial uses. These studies are
needed as part of the tier one ecotoxicity
testing, and as previously explained are
used to develop precautionary labeling.
1. Tier 1 testing. In part 161, acute
aquatic toxicity studies are
conditionally required for ‘‘indoor’’ uses
of antimicrobials, and are required for
aquatic uses of antimicrobials.
For antimicrobial chemicals, the
Agency considers the aquatic use
pattern in part 161 to include the
following uses: Once-through industrial
processes and water systems,
antifoulant paints and coatings, and
aquatic areas. Therefore, the Agency
proposes to continue its current
requirement for two acute aquatic fish
toxicity studies (one warm water and
one cold water species) and one
invertebrate toxicity study for these use
patterns. For wood preservatives these
three studies have been required on a
case-by-case basis; therefore, this
proposal would codify current practices.
For the low environmental exposure
grouping, the Agency is proposing to
require the acute freshwater fish toxicity
study in one species, either a warm
water or a cold water species. Testing on
a second species is required if the active
ingredient or principal transformation
products are stable in the environment
or if the LC50 in the first species tested
is greater than 1 part per million (ppm)
or 1 milligram/liter (mg/L). This would
codify existing practices. Additionally,
the shift from CR to R for the low
environmental exposure grouping
(which contains many of the ‘‘indoor’’
uses) would also codify current
practices.
2. TEP testing. Typical End-Use
Product (TEP) testing is proposed for
both the acute freshwater fish and
invertebrate toxicity studies. This is an
existing requirement according to the
test notes to the table in § 161.490.
F. Avian Dietary Toxicity
Currently in part 161 an avian dietary
LC50 study is conditionally required for
the greenhouse and indoor use patterns
and required for all other use patterns.
Today the Agency is proposing to
continue this existing requirement by
requiring the avian dietary study for
aquatic areas and conditionally
requiring the study for all other
antimicrobial use patterns.
G. Avian Reproduction
The Agency has adapted the current
data requirements in part 161 for avian
E:\FR\FM\08OCP2.SGM
08OCP2
59414
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
reproduction testing to determine the
avian reproduction data requirements
for antimicrobial chemicals. An avian
reproduction study is conditionally
required for aquatic uses in part 161.
The Agency is proposing to require
the avian reproduction study for the
antimicrobial aquatic areas use pattern.
The proposed change from
conditionally required to required is
consistent with the Agency’s current
practices.
For all other antimicrobial use
patterns, the Agency is proposing to
conditionally require the avian
reproduction study. For wood
preservatives this study has always been
considered when EPA made its case-bycase determinations on the data needed
for risk assessment; therefore, this
proposal would codify the current
practices used for wood preservatives.
Since part 161 conditionally requires
this testing for ‘‘aquatic uses,’’ the
Agency’s proposal continues the
existing data requirement for the oncethrough industrial processes and water
systems. Since the testing is also
proposed to be conditionally required
for the low environmental exposure
grouping, this would expand the
number of use patterns for which these
studies are conditionally required.
H. Acute Estuarine and Marine Study
Acute estuarine and marine toxicity
studies are performed on three species:
An estuarine/marine mollusk, an
estuarine/marine invertebrate, and an
estuarine/marine fish. These studies
measure toxicity in representative
estuarine and marine species of the
nontarget species most likely to be
adversely affected.
1. TGAI testing. The Agency is
proposing to require these three acute
estuarine and marine studies for
antifoulant paints and coatings, and
conditionally require these studies for
wood preservatives. This would codify
the Agency’s current practices.
Testing for all other antimicrobial use
patterns would also be conditionally
required. The Agency is proposing in
part 158, subpart W to use the same
conditionalities (as described in the test
notes) for requiring these studies as in
part 161, i.e. the testing is required if
residues from the parent compound
and/or transformation products are
likely to enter the estuarine/marine
environment.
Part 161 conditionally requires this
testing for ‘‘aquatic uses.’’ Therefore, the
Agency’s proposal continues the
existing data requirement for the oncethrough industrial processes and water
systems, and aquatic areas. Since the
testing is also proposed to be
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
conditionally required for the low
environmental exposure grouping, this
would expand the number of use
patterns for which these studies are
conditionally required.
2. TEP testing. For the acute estuarine
and marine studies, TEP testing is
proposed to be conditionally required
for the low environmental exposure
grouping, once-through industrial
processes and water systems, and
aquatic areas. This is an existing
requirement according to the table in
§ 161.490.
I. Fish Early Life Stage and Aquatic
Invertebrate Life-Cycle Study
The Agency proposes in § 158.2240 to
require both a fish early life stage and
an aquatic invertebrate life-cycle study
for once-through industrial processes
and water systems, antifoulant paints
and coatings, and aquatic areas. For
these use patterns this would codify
current practices.
The Agency also proposes to
conditionally require both studies for
the low environmental exposure
grouping. This would expand the
number of use patterns for which the
test is conditionally required.
The Agency proposes to conditionally
require both studies for wood
preservatives. The studies would be
required if pesticide residues from
treated wood would be likely to enter
freshwater or estuarine/marine
environments, as determined by the
Agency.
Currently, in part 161 only one of
these studies is conditionally required.
Part 161 requires the submission of
either the fish early life stage or the
aquatic invertebrate life-cycle study,
based on the more sensitive of the two
species, as determined by the acute
ecotoxicity studies. However, since both
fish and invertebrates may be exposed
when an antimicrobial pesticide enters
natural waters, the Agency now believes
both studies are needed. Neither study
would adequately substitute for the
other. While data from acute
invertebrate and acute fish studies
would be available, EPA does not
believe that these acute studies would
predict chronic sensitivity.
For the low environmental exposure
grouping the requirements are triggered
if antimicrobial pesticide residues from
the parent compound and/or
transformation products are likely to
enter freshwater or estuarine/marine
environments, as determined by the
Agency. For wood preservatives the
requirements are triggered if
antimicrobial pesticide residues from
the parent compound, transformation
products, and/or leachates from
PO 00000
Frm 00034
Fmt 4701
Sfmt 4702
preservative-treated wood are likely to
enter freshwater or estuarine/marine
environments, as determined by the
Agency.
J. Fish Life Cycle
Currently, this existing data
requirement is conditionally required
for all antimicrobials except ‘‘indoor’’
uses in part 161. The Agency is now
proposing to expand this conditional
requirement to all antimicrobial use
patterns.
The fish life cycle study is a two
generation reproductive study in fish
that can characterize a number of
sensitive life stages. Just as with
conventional pesticide chemicals, it is
triggered on the results of the fish earlylife stage or invertebrate life cycle test,
or other information indicating the
reproductive physiology of fish may be
affected. For the low environmental
exposure grouping, the screening-level
fate assessment would also inform the
determination to require this study. If
the antimicrobial is not degraded by the
processes in the WWTP and is in the
effluent released to surface water, then
this study may be required.
K. Aquatic Organisms, Bioavailability,
Biomagnification Toxicity Tests
This data requirement is composed of
three studies: The oyster
bioconcentration factor, the fish
bioconcentration factor, and the aquatic
food chain transfer. All three studies are
not needed for every antimicrobial. The
most commonly submitted study is the
fish bioconcentration factor.
Currently, these studies are
conditionally required for all
antimicrobials except ‘‘indoor’’ uses in
part 161. The Agency is now proposing
to expand this conditional requirement
to all antimicrobial use patterns. For the
low environmental exposure grouping,
the screening-level fate assessment
would also inform the determination to
require this study. If the antimicrobial is
not degraded by the processes in the
WWTP and is in the effluent released to
surface water, then this study may be
required.
For antimicrobials that have the
potential to reach freshwater or
saltwater, these studies are needed to
identify those antimicrobials that could
concentrate in various aquatic taxa. EPA
is proposing to clarify in the test notes
the three specific circumstances under
which the study is not required. These
three circumstances are the same as in
the final rule for conventional pesticide
chemicals.
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
L. Simulated or Actual Field Testing for
Aquatic Organisms
For all antimicrobial use patterns, the
Agency is proposing to conditionally
require simulated or field studies for
aquatic organisms. These studies would
be triggered when under actual use
conditions significant impairment of
nontarget aquatic organisms is likely to
occur in the natural environment. This
proposal would codify current practices.
The Agency currently determines
whether simulated or field studies are
required for antimicrobials on a case-bycase basis, considering information such
as:
• The pesticide’s intended use.
• The pesticide’s use rates.
• The pesticide’s toxicity.
• The pesticide’s physical and
chemical properties.
• The parent compound’s
environmental fate characteristics and
transformation products (such as
metabolites and degradation products).
• Nontarget organisms likely to be
exposed.
• Likelihood of exposure.
As with conventional pesticides, the
Agency is proposing to require
independent laboratory validation of the
environmental chemistry methods used
to generate the data associated with this
study.
sroberts on PROD1PC70 with PROPOSALS
M. Sediment Testing
The Agency is proposing to require
acute invertebrate sediment testing, both
freshwater and marine, for antifoulant
paints and coatings and to conditionally
require these studies for once-through
industrial processes and water systems,
wood preservatives, and aquatic areas.
This would codify current practices.
Additionally, EPA proposes to expand
the conditional requirement to all other
antimicrobial use patterns. This study
would be triggered based on the
antimicrobials presence in the water
column (for example when released
from a WWTP), the potential to sorb to
sediment, and the persistence of the
antimicrobial.
The Agency is proposing to
conditionally require chronic
invertebrate sediment testing, both
freshwater and marine, for all
antimicrobial use patterns. This study is
triggered by the same criteria as the
acute sediment study, but would be of
longer duration as determined by the
persistence of the antimicrobial. This
conditional requirement would codify
current practices for the high
environmental exposure grouping, and
would then expand the requirement to
the low environmental exposure
grouping.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
Testing of aquatic organisms exposed
to treated sediments allows EPA to
assess the effects of sediment-bound
pesticide residues in aquatic
environments. The effects of sedimentbound pesticides (or their degradates)
on aquatic environments cannot be
accurately assessed from bioassays on
compounds suspended in the water
column alone. For example, lipophilic
or hydrophobic chemicals can dissipate
from the water column, but may remain
in the aquatic environment adsorbed to
sediment. As discussed in the proposed
rule for conventional pesticides (70 FR
12275) sediment-bound pesticides may
differ significantly from pesticides in
solution, showing different physical,
chemical, and biological properties,
chemical partitioning, bioavailability,
concentrations in interstitial or pore
water, exposure from sediment
ingestion and possible manifestations of
food chain effects. By serving as a
potential pesticide sink, exposure to
these compounds may lead to
significant environmental risk to a wide
variety of fish and aquatic invertebrates
which live and feed at the bottom of a
lake or stream. Sediment toxicity testing
is needed to assess the bioavailability of
a sediment-bound compound and to
characterize the possible impact to
sediment-dwelling benthic organisms.
Once the Agency determines or
extrapolates that the use pattern has the
likelihood for chemical exposure to an
aquatic system, then the available
information on the adsorption of the
chemical is reviewed. If the Agency
determines that the antimicrobial meets
one or more of the criteria for
adsorption, then the available
information on persistence of the
chemical is reviewed. If one or more of
the criteria for persistence are met, then
a sediment study is required.
Persistence (half-life of the pesticide in
sediment) drives the decision regarding
whether the acute or chronic study is
conducted.
Before designing the protocol,
consultation with the Agency is needed
if the applicant is uncertain as to which
length of study is appropriate. For
certain antimicrobials that are highly
persistent, only the chronic study may
be required. Protocols must be approved
by the Agency prior to the initiation of
the study. Details for developing
protocols are available from the Agency.
N. Honeybee Protection
The current data requirements for
testing pesticide toxicity to honeybees at
§ 161.590 require the honeybee acute
contact LD50 study when honeybees are
likely to be exposed. The Agency
proposes to conditionally require the
PO 00000
Frm 00035
Fmt 4701
Sfmt 4702
59415
acute study for wood preservatives and
the low environmental exposure
grouping. Since the study would be
required only for uses involving
treatment of beehives, empty or
occupied, and since there are few such
uses for antimicrobials, this study
would be infrequently required. This
study may not be required if the use
pattern (as described on the label)
prohibits fumigating or spraying
beehives.
Since beehives can be constructed of
materials that have been treated with
antimicrobials, the Agency proposes to
conditionally require a study to
determine the toxicity of treated wood
and other materials to bees. This study
must be conducted in a manner similar
to that of the Honey Bee Toxicity of
Residues on Foliage. This would codify
current practices. Protocols must be
approved by the Agency prior to the
initiation of the study. Details for
developing protocols are available from
the Agency.
XIV. Plant Protection Data
Requirements
A. Plant Protection Data Requirements
EPA proposes to adapt the basic
nontarget plant protection data types as
listed in 40 CFR part 158, subpart G to
support applications for antimicrobial
products. EPA proposes to modify the
applicability of those requirements to
antimicrobials to reflect differing risks
and levels of exposure. Part 161 is not
explicit in the data that are currently
required because those use patterns are
not delineated for antimicrobial
pesticide chemicals. The proposed table
in § 158.2250 will provide greater
transparency and clarity.
Plants represent the most basic
component of any functioning
ecosystem by providing oxygen and a
food source for aquatic and terrestrial
animals. Therefore, it is important to
determine the toxicity of the
antimicrobial to plants. The data
obtained from these studies will be used
to conduct nontarget plant risk
assessments. For aquatic environments
such an assessment could include an
effluent from a wastewater treatment
plant being released into the
environment. For terrestrial
environments such an assessment could
include wood preservatives in contact
with soil, land-application of biosolids,
or antimicrobials that partition to soil
and sediment.
B. Requirement for Tier II Testing for
Antimicrobials
The Agency’s guidelines for
conducting nontarget plant protection
E:\FR\FM\08OCP2.SGM
08OCP2
59416
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
studies specify two types of tests:
Single-dose studies (referred to in the
guidelines as Tier I tests) and multipledose studies (Tier II). Usually, the
applicant would conduct the singledose studies first, and then, based on
the results of the single-dose studies,
proceed to the multiple-dose studies,
which evaluate the effects of multiple
dosage levels on plant growth and are
used to determine acute toxicity levels
in comparison with environmental
concentrations. Such studies are used to
estimate the risk to nontarget plants and
endangered plant species.
Many antimicrobial pesticides are
used to control plant pests such as algae
in industrial processes (paper making,
cooling towers, wastewater, sewage
water treatment), and residential uses
(swimming pools, ornamental ponds,
moss growing on roofs). Some
antifoulants, ballast water treatments,
and wood preservatives are also
intended to control plant pests.
Therefore, antimicrobial pesticides used
for plant pest control are expected to be
phytotoxic to nontarget plants once
released into terrestrial or aquatic
environments.
Accordingly, for all antimicrobial use
patterns, the Agency is proposing only
to require multiple-dose studies, which
is consistent with the testing of certain
phytotoxic conventional chemicals such
as herbicides which also start at Tier II.
In part 161, for most plant studies, the
Tier II study is conditionally required
and the Tier I study is required. For
antimicrobials, EPA believes that the
nontarget plant studies have been
interpreted in the context of, and
consistent with other phytotoxic
chemicals, and this proposal would
codify the shift from the use of the Tier
I study to a Tier II study.
If the applicant is in possession of
single-dose studies that the applicant
believes provide sufficient information,
then the applicant is encouraged to
consult early in the application process
with EPA. The Agency can evaluate the
information and inform the applicant as
to the sufficiency, or the need for
multiple-dose studies. If the applicant
does not have any studies, then
multiple-dose studies must be
conducted.
C. The Low Environmental Exposure
Grouping
The use patterns within this grouping
are the same as those described in the
Unit XI.B. of this preamble for
environmental fate data requirements.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
D. The High Environmental Exposure
Grouping
The use patterns within this grouping
are the same as those described in the
Unit XI.B. of this preamble for
environmental fate data requirements.
E. Seedling Emergence (Tier II – DoseResponse)
This terrestrial plant toxicity test is
designed to evaluate toxicity to
germinating seedlings and their ability
to survive after chemical uptake from
the surrounding soil. The Agency is
proposing to require this study for the
high environmental exposure grouping.
This proposal would codify the shift
from the use of the Tier I study to a Tier
II study and thereby would codify
current practices.
The Agency is also proposing to
conditionally require the Tier II study
for low environmental exposure
grouping based on the results of the
algal study. This would expand the
number of use patterns for which this
study is conditionally required.
F. Vegetative Vigor (Tier II – DoseResponse)
This terrestrial plant toxicity test is
designed to evaluate toxicity to young
plants. The antimicrobial is applied to
the foliage to evaluate uptake of the
antimicrobial from the exposed green
tissue. The Agency is proposing to
require this study for wood
preservatives and aquatic areas. For
wood preservatives, this would codify
current practices. For aquatic areas, this
would codify the shift from the use of
the Tier I study to a Tier II study and
thereby would codify current practices.
The Agency is also proposing to
conditionally require this study for the
low environmental exposure grouping,
and industrial processes and water
systems (once-through). This would
expand the number of use patterns for
which this study is conditionally
required.
G. Aquatic Plant Growth (Lemna gibba)
(Tier II – Dose-Response)
The Agency is proposing to require
the Aquatic Plant Growth (Lemna gibba)
(Tier II – Dose-Response) study for the
high environmental exposure grouping.
This would codify the shift from the use
of the Tier I study to a Tier II study and
thereby would codify current practices.
The Agency is also proposing to
conditionally require the Tier II study
for low environmental exposures based
on the results of the algal study. This
would expand the number of use
patterns for which this study is
conditionally required.
PO 00000
Frm 00036
Fmt 4701
Sfmt 4702
Lemna gibba or duckweed is an
important wildfowl food source and is
used in wastewater reclamation.
Therefore, it is important to understand
the impact of an antimicrobial on this
food source.
H. Aquatic Plant Growth (Tier II – DoseResponse)
The Agency is proposing to require
one or more of the Aquatic Plant Growth
(Tier II – Dose-Response) studies for all
antimicrobial use patterns. As with the
aquatic plant study discussed in the
previous section, part 161 requires the
Tier I study and conditionally requires
the Tier II study. For the high
environmental exposure grouping, this
would codify the shift from the use of
the Tier I study to a Tier II study and
thereby would codify current practices.
Testing is required for four species
representing green algae, freshwater
cyanobacteria, a freshwater diatom and
a marine diatom. These four species are
used to represent hundreds of different
species.
Testing is required in only one
species (green algae) for the low
environmental exposure grouping. This
would expand the number of use
patterns for which this study is
required.
Green algae produce oxygen, serve as
a food source for aquatic animals, and
provide the basic energy needs of any
aquatic ecosystem. The results of the
green algae study will allow the Agency
to determine if the other three aquatic
plant growth studies are required for the
low environmental exposure grouping.
I. Terrestrial and Aquatic Field Studies
The Agency is proposing to
conditionally require Terrestrial and
Aquatic Field Studies for all
antimicrobial use patterns. Field studies
provide more realistic information on a
pesticide’s impacts than laboratory
studies which focus only on one
parameter, because field studies
consider all potential impacts on plant
growth. The need for these higher tier
studies would be based on the results of
the lower tier plant protection studies,
adverse incident reports, intended use
pattern, and environmental fate
characteristics that indicate potential
exposure.
These two studies are conditionally
required in part 161 for three use
patterns. Due to the use patterns
currently used in part 161, there is not
sufficient delineation for comparison to
the antimicrobial use patterns proposed
today. While EPA routinely considers
the need for these studies in
determining the data needed for its risk
assessments, it has required these
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
studies based on case-by-case
circumstances on a very infrequent basis
for antimicrobials.
Since the testing is proposed to be
conditionally required for all
antimicrobial pesticide use patterns,
this would expand the number of use
patterns for which these studies are
conditionally required. Additionally,
this would harmonize the requirements
for antimicrobials with those of
conventional pesticides.
XV. Peer Review
sroberts on PROD1PC70 with PROPOSALS
A. National Research Council
Recommendations
The National Academy of Sciences
issued a report in 1993 entitled,
‘‘Pesticides in the Diets of Infants and
Children’’ (Ref. 19). The study,
conducted by the National Research
Council (NRC), was initiated to address
the question of whether the current
regulatory system adequately protected
infants and children from pesticide
residues in food. The Council reviewed
EPA’s then-current practices and data
requirements related to dietary risk
assessment as well as testing
modifications planned by the Agency.
The panel of experts concluded that, at
that time, EPA approaches to data
requirements and risk assessments
emphasized the evaluation of the effects
of pesticides in mature animals and, in
general, there was a lack of data on
pesticide toxicity in developing
organisms.
The Council’s recommendations with
respect to regulatory needs for data
development included the following:
• Discussed the need to investigate the
effects of pesticide exposure on
immunotoxic responses in infants and
children.
• Supported the need for acute and
subchronic neurotoxicity testing and
encouraged the Agency to have these
studies as part of the required data for
all food-use pesticides.
• Encouraged further work in the area
of developmental neurotoxicity.
Many of the NRC recommendations
were incorporated into the data
requirements that were promulgated for
conventional pesticides (72 FR 60933),
and for biochemical and microbial
pesticides (72 FR 60988). By
deliberately building on the foundation
of these promulgated rules, and
harmonizing to the extent practicable
considering the differences in use
patterns, many of the NRC
recommendations, such as
immunotoxicity testing, are
incorporated into this proposed rule for
antimicrobial pesticides.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
B. FIFRA Scientific Advisory Panel
(SAP)
1. 1994 meeting. In 1994, EPA held a
2–day meeting of the SAP to review the
Agency’s proposed amendments to the
data requirements for pesticide
registrations contained in 40 CFR part
158, which covered antimicrobials. The
SAP was asked to comment on each
data requirement and identify, in their
scientific opinion, which requirements
were necessary to fully and thoroughly
evaluate the potential hazard of a
chemical compound and which were
not intrinsically useful in providing
practical scientific information. The
revisions presented to the Panel, i.e., the
changes to the data requirements
presented in this document, were
generally endorsed. A very complete
discussion of the 1994 SAP meeting was
presented in the proposed rule for
conventional pesticides (70 FR 12276).
2. June 1997 meeting: A set of
scientific issues being considered by the
Agency to determine antimicrobial
issues. On June 3, 1997, the Agency
presented an early version of the part
158, subpart W proposal in an open
meeting to the SAP. The Agency asked
for specific comments in five areas
covered by proposed 158W data
requirements: Toxicology; residue
chemistry, ecological effects and
environmental fate, human exposure,
and efficacy. The SAP’s full comments
are found in the docket for this action
(Ref. 29) and are summarized here.
i. Toxicology. The Agency asked if its
division of antimicrobial pesticide uses
into high human exposure and low
human exposure groups, with extensive
data requirements for high exposure
uses and tiered data requirements for
low exposure uses, was an acceptable
approach. The SAP agreed that the
Agency’s tiered approach was
reasonable, and made several
suggestions to improve the proposal.
Two of these suggestions were
‘‘unambiguous trigger points indicating
next Tier level of toxicity testing,’’ and
‘‘to continue dialogue with Canadian
counterparts to harmonize, clearly
define trigger points, and improve the
guidelines.’’
The Agency has worked to provide
clear, unambiguous triggers in the test
notes to the toxicology data
requirements tables. EPA is also
committed to dialogue with its
Canadian counterpart. PMRA has
routinely received updates on the status
of the draft antimicrobial data
requirements, and has been actively
engaged throughout the development of
this proposal.
PO 00000
Frm 00037
Fmt 4701
Sfmt 4702
59417
ii. Residue chemistry. The Agency
asked the SAP if the scientific approach
to obtaining dietary residue information
in general, but specifically for indirect
food contact sanitizers, was reasonable.
The SAP agreed that the scientific
approach was reasonable, and remarked
extensively on the residue chemistry
data requirements for indirect food uses
such as sanitizers. They noted that such
products had generally been of low
toxicity or low persistence, and their
belief that a tolerance or tolerance
exemption for such uses was
unnecessary, based on FDA’s practice
with such products. The SAP also
suggested the use of default surface
residue values for estimating sanitizer
residues to obviate the need for
measured data.
Although the SAP believes that a
tolerance or tolerance exemption is
unnecessary, under FFDCA, EPA is
required to establish either a numerical
tolerance, or an exemption from the
requirement of a tolerance for indirect
food uses. To obviate the need for
measured data, EPA uses modeling and
‘‘worst-case’’ estimates, as appropriate.
As discussed in Unit X. of this
preamble, if such estimates when paired
with the toxicity data do not indicate a
concern, then it is unlikely that
measured surface residue data would be
required.
iii. Human exposure. The Agency
asked the SAP if the approaches
presented were reasonable and if the
Agency had adequately accounted for
all antimicrobial use and exposure
scenarios. Additionally, the Agency
asked if multiple exposure scenarios for
one pesticide product would be better
accounted for by data for all applicable
exposure scenarios or a subset of
applicable scenarios.
• The SAP agreed that the Agency’s 12
use categories for antimicrobials were a
reasonable approach to organizing
exposure data requirements, and were,
in fact, similar to the approaches used
by PMRA and the California EPA. EPA
is proposing that these use categories be
codified in § 158.2201 as the
antimicrobial use patterns.
• The SAP also advised that initially,
all applicable exposure scenarios should
be considered for a single antimicrobial
product. The Agency accepted this
recommendation which is now part of
its standard exposure assessment
practices.
• The SAP expressed concern that
post-application exposure might be too
narrowly defined, and noted some
possible exposure scenarios involving
persons not in the 1997 presentation. In
response, the Agency has broadened the
scope of post-application exposure to
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59418
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
include persons who may come in
contact with materials after treatment.
This includes contact with impregnated
materials and children’s exposure to
treated wood. In response, the Agency is
proposing to require the indoor surface
residue dissipation study and the nondietary ingestion exposure study for
residential uses to address this concern.
iv. Ecological effects and
environmental fate. For the 1997
presentation to the SAP, EPA divided
the antimicrobial use sites into two
groupings: high expected environmental
exposure and low expected
environmental exposure. The Agency
asked if a tiered data set to support an
ecological risk assessment for uses with
high expected environmental exposure
was appropriate. The SAP agreed that a
tiered data set to support an ecological
risk assessment would be appropriate.
EPA also asked if ecological risk
assessments were necessary for the low
expected environmental exposure
grouping. In its presentation EPA stated
its intention to require a very reduced
data set suitable for developing
precautionary labeling for
manufacturing and certain end-use
products. At that time EPA considered
that ‘‘indoor’’ uses had minimal
environmental exposures or releases of
pesticide residues to the environment.
The SAP commented that the reduced
data set could be justified only if data
available from other programs within
EPA and elsewhere were adequate to
assess ecological risk. As a result of the
SAP’s concerns, the Pesticide Program
discussed these issues with EPA’s Office
of Solid Waste and Office of Water.
As a result of these discussions in the
late 1990s, the Pesticide Program
continued to believe that
• ‘‘Indoor’’ residential uses of
antimicrobials with the rinses going
down-the-drain had minimal
environmental exposures or releases of
pesticide residues to the environment,
• Industrial effluents that could
possibly contain antimicrobials would
be adequately regulated via the
permitting process under the National
Pollutant Discharge Elimination System
Program of the Clean Water Act and
wastes possibly containing
antimicrobials would be adequately
regulated under the Resource
Conservation and Recovery Act.
Therefore, in 1997, the Agency
determined not to require
biodegradation or microbial data.
More recently, as part of its
development of this proposed rule, EPA
re-evaluated its belief that ‘‘indoor’’
residential uses had minimal
environmental exposures. EPA is now
proposing to require the environmental
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
fate and ecological effects data for
conducting an ecological risk
assessment for down-the-drain
antimicrobials. The rationale for this
decision is discussed in Unit XII.B. of
this preamble.
The SAP expressed its concerns about
‘‘the lack of chemical fate data,’’ and
also stated that biodegradation data
(both aerobic and anaerobic) should be
required.
• In response to the SAP, EPA
reexamined the need for environmental
fate data other than hydrolysis, and as
a result of this 1997 reexamination, the
Agency determined to conditionally
require data on photodegradation in
water for these low expected
environmental exposures. EPA is now
proposing to require the
photodegradation in water study for all
antimicrobial chemicals, including the
low environmental exposure grouping.
• Initially, in 1997, the Agency
determined to not require
biodegradation data. EPA has
reconsidered this 1997 decision and
today is proposing to require an
activated sludge sorption isotherm, a
ready biodegradability test, and a
modified activated sludge, respiration
inhibition study for the low
environmental exposure grouping.
The SAP also questioned why
microbial data to protect publicly
owned treatment works (POTWs) and
other treatment systems which often
rely on microbial treatment processes
were not required. The Agency
investigated this possibility, but could
not in the early 1990s determine a
satisfactory set of data that would then
be useful in protecting the highly
variable conditions of specific POTWs.
EPA is proposing as part of its
environmental fate data requirements, to
require the data that would allow EPA
to assess the impacts of antimicrobials
on wastewater treatment plants.
The SAP questioned the use of
precautionary labeling to protect fish
and wildlife from improper use of
antimicrobials, especially considering
that some use categories would pose
exposure via sewage systems. As a
result, EPA prepared sample labeling to
reduce this source of exposure: ‘‘This
product is toxic to fish and aquatic
invertebrates. Do not discharge effluent
containing this product into lakes,
streams, ponds, estuaries, oceans, or
public water unless this product is
specifically identified and addressed in
a NPDES permit. Do not discharge
effluent containing this product to
sewer systems without previously
notifying the sewage treatment plant
authority.’’ This type of labeling is still
in use today.
PO 00000
Frm 00038
Fmt 4701
Sfmt 4702
The SAP cautioned that although
wildlife exposure to antimicrobials via
water was the most likely source of
exposure, terrestrial exposure is also
possible. The Agency concurred, and is
proposing to require for the aquatic
areas use pattern and to conditionally
require for all other use patterns, the
avian dietary and avian reproductive
studies for performing such an
assessment.
Finally, the SAP expressed concern
that antimicrobial metabolites may be
more toxic than their parent
compounds, and therefore may also
need to be tested. The Agency agrees,
and has revised many of the test notes
in this proposal to clarify the need for
data on metabolites when the available
information demonstrate that the
metabolites are more toxic or otherwise
pose environmental risks.
3. 1998 and 1999 meetings. Data
requirements, as related to the
application of the newly mandated
FFDCA safety factor (required under the
FQPA amendments) were presented to
the SAP in 1998 and 1999. Copies of
documents prepared for the 1998 and
1999 SAP meetings and the final reports
from each of the meetings are in the
docket for this action (Refs. 30, 31, 32,
and 33) and can be found on EPA’s web
site at https://www.epa.gov/scipoly/sap.
A summary of the issues specific to the
proposed antimicrobial data
requirements follows:
i. Toxicology. In December 1998, EPA
presented the SAP an issues paper on
the use of the FQPA safety factor to
address the special sensitivity of infants
and children to pesticides. The
discussion on the developmental
neurotoxicity study was specifically
discussed in the context of the
appropriateness of using an additional
safety factor. At that time, the SAP did
not reach a consensus recommendation
on whether this study should be
routinely or conditionally required. The
issue of what is a complete and reliable
data set was brought before the SAP
again in May 1999. The majority of the
Panel supported the Agency’s approach
to applying data requirements but
advised the Agency to revisit the first
tier of required toxicity studies every
few years to update data requirements
as needed. The Panel also agreed with
the Agency on the need to require the
neurotoxicity battery of studies,
including developmental neurotoxicity
testing, for high exposure pesticides
such as food-use pesticides. The SAP’s
recommendations are reflected in
today’s proposed antimicrobial data
requirements for developmental
neurotoxicity and immunotoxicity. This
also harmonizes the data requirements
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
for conventional pesticides and for
antimicrobials.
ii. Post-application exposure.
Working in collaboration with Health
Canada and the Organization for
Economic Cooperation and
Development (OECD), EPA drafted
guidelines for post-application
exposures studies. They were internally
peer-reviewed and shared with the
California Department of Pesticide
Regulation, representatives from
academia, and the American Crop
Protection Association. The Agency
presented its post-application exposure
guidelines and standard operating
procedures to the SAP in 1998 and
again in 1999. In 1999, the SAP
commended the Agency for making
significant strides toward developing
scenario-based residential and nonoccupational exposure assessments that
are sufficiently conservative as to not
underestimate exposures. The data
requirements proposed for postapplication exposure to antimicrobials
are drawn from this body of work.
4. 2000 meeting. In its response to an
April 2000 presentation on certain
scientific issues concerning
probabilistic ecological risk assessment,
the SAP was asked for
recommendations on sediment toxicity
testing. The SAP stated that the extent
to which a compound partitions from
the aqueous phase to the sediment is a
key consideration in determining the
need for testing benthic organisms.
There was a consensus among SAP
members that compounds with high
Kocs (organic carbon-water partition
coefficient) or Kows (octanol-water
partition coefficient) required sediment
testing for benthic fish or invertebrates.
A copy of the final report is in the
docket for this action (Ref. 34) and can
be found on EPA’s web site at https://
www.epa.gov/scipoly/sap. Based on this
meeting, the guidelines for sediment
testing were developed. For
antimicrobials, acute and chronic
sediment testing are proposed to be
required or conditionally required.
sroberts on PROD1PC70 with PROPOSALS
XVI. International Activities
EPA actively works through
international and regional organizations
and directly with other countries to
develop common or compatible
international approaches to pesticide
registration, including data
requirements. Joint reviews and work
sharing are two of the approaches used
by EPA to increase the harmonization of
pesticide regulatory programs. EPA
believes that making pesticide
regulatory programs more consistent
internationally will:
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
• Maintain high standards for the
protection of human health and the
environment.
• Increase the efficiency of the
registration process by lessening the
resource burden on governments and
the regulatory community.
• Provide more equal access to pest
management tools.
• Strengthen the regulatory process.
• Facilitate the registration of
alternative pest control tools.
• Minimize trade problems.
Harmonization activities are
increasing and evolving as agencies and
applicants build upon their experiences.
A. Joint Data Reviews and Evaluations
EPA is working closely with other
countries toward greater uniformity in
testing, reviewing and evaluating all
pesticides. The benefits of international
regulatory cooperation on
antimicrobials are potentially great:
Improved science through greater
information exchange, and reduced
regulatory and resource burdens on
national governments and regulated
parties through harmonized pesticide
regulatory review. Over the last several
years, substantial progress has been
made toward international cooperation
on pesticide regulatory review. Member
countries of the Organization for
Economic Cooperation and
Development (OECD), including the
United States, have agreed upon
harmonized guidance for the formats of
industry data submissions (dossiers)
and country data review reports
(monographs). Countries now frequently
exchange pesticide reviews or consult
with one another on key technical
aspects of a review.
Under the North American Free Trade
Act (NAFTA), EPA has worked
cooperatively with Canada and/or
Mexico, dividing up detailed evaluation
work on a number of pesticides. The
Agency has also entered into similar
information exchange and comparative
review arrangements with other
countries. There have been multiple
bilateral joint reviews and/or work
sharing with member countries of the
European Union. Trilateral joint reviews
and workshares have been performed
with Canada and Australia. A global
joint review is being conducted among
six countries (the United States,
Australia, New Zealand, Canada,
Ireland, and the United Kingdom.) The
peer reviewers will be four other EU
countries. The primary objective of all
of these arrangements has been to use
resources in the most efficient way
possible.
Concerning antimicrobials, since
2000, Health Canada’s Pest Management
PO 00000
Frm 00039
Fmt 4701
Sfmt 4702
59419
Regulatory Agency (PMRA), the USEPA
and California’s EPA have been
cooperating on a joint review for the reevaluation/reregistration of the
following three heavy-duty wood
preservatives: Pentachlorophenol,
creosote, and chromated copper
arsenate. The review of submitted data,
writing of the risk assessments, and peer
review activities are being shared.
Exposure data used in the preliminary
risk assessment were collected from
both U.S. and Canadian wood-treatment
facilities. Both PMRA and EPA are
contributing to the public comment
process. The cooperative activities
continue as both EPA and PMRA work
toward issuance of their decision
documents in September 2008.
B. Harmonization of Data Requirements
As the international regulatory
community works toward greater
harmonization on pesticide review,
attention has also focused on the data
requirements, how the requirements
compare from one country to another,
and what can or should be done to
establish common requirements. To the
extent that data requirements for
pesticide registration are similar,
sharing reviews and comparing
evaluations is easier and more
meaningful. Requirements that differ
considerably from one country to
another can mean that applicants who
are looking to register a pesticide in
more than one country may have to
conduct many different studies to
satisfy all the various national
requirements. Therefore, from the
perspective of the applicant,
establishing similar requirements also
can reduce the resources that must be
spent to conduct testing.
OECD Member countries have had
discussions about harmonizing
pesticide data requirements within the
OECD community. The pesticide
industry took on the complex task of
looking at data requirement differences
among Member countries to identify
areas that might benefit from
harmonization. Preliminary findings
presented to the OECD Working Group
on Pesticides Meeting in June 2001,
reported, consistent with the positions
of scientific reviewers in OECD Member
countries, that toxicology data
requirements are quite similar across
countries. This does not mean that there
is no room for additional harmonization
work on toxicology data requirements,
but rather that there are other testing
areas where there is much less
consistency on data requirements across
countries.
Ecotoxicological and environmental
fate studies present a particular
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59420
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
challenge for harmonization. Data
requirements in these areas can differ
considerably from one country to
another depending upon how countries’
tiered approaches to data requirements
are applied. National data requirements
must be tied to national use patterns
and environmental and ecological
conditions. A reliable environmental
hazard assessment, for example, must be
based on studies that accurately reflect
the climate, soil types and agricultural
practices of the country doing the
assessment. Because ecological and
environmental studies must be
representative of national conditions to
adequately support national risk
assessments, harmonization of data
requirements for these types of studies
can be difficult. Harmonization can
require extensive dialogue between
scientists to determine which data
requirements can act as common
requirements. Such dialogue can also
include discussions of test
‘‘conditionalities,’’ that are reflected in
the test notes to the tables for the
proposed data requirements.
Since 1995, the United States and
Canada under the NAFTA Technical
Working Group on Pesticides,
Harmonization of the Evaluation of
Antimicrobial Pesticides Project have
worked together to harmonize data
requirements for antimicrobials. These
harmonization activities represent two
efforts. EPA coordinates with Canada’s
PMRA on harmonization activities for
all disciplines except efficacy. For
harmonization activities for efficacy
requirements EPA coordinates with
Health Canada’s Therapeutic Product
Directorate (TPD).
EPA and PMRA approach
antimicrobial data requirements
differently. EPA uses a tiered testing
strategy, while PMRA bases its data
requirements on a defined use pattern
approach. EPA and PMRA’s data
requirements have been carefully
compared. TPD and EPA recently
completed a crosswalk of EPA and TPD
efficacy data requirements, which is
being used for planning purposes to
explore future harmonization activities.
The data requirements proposed in this
document for antimicrobials represent
U.S. national requirements but they
reflect extensive consultation with
Canada. The data requirements are
harmonized to a high degree. The two
countries plan to continue to work
together to keep data requirements for
all disciplines as similar as possible.
OECD has not conducted any activity
specifically aimed at harmonizing data
requirements for biocides. In 1997–
1998, the OECD Pesticide Program
conducted a survey to collect
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
information on the existing
requirements across countries. The
survey served two purposes: (1) To
improve OECD’s understanding of how
Member countries regulate biocides, and
(2) to provide information that could be
used to prepare the way for future
efforts to increase international cooperation in biocide regulation. The
survey shows great variability. At this
time OECD has no plans to work toward
harmonizing these data requirements,
but instead has worked at harmonizing
tools and methodologies in order to
reduce duplication and harmonize
review procedures for possible work
sharing.
C. Protocol/Guideline Harmonization
Harmonization can also involve
protocol/guideline development or
revisions so that the studies produced
can meet common data requirements.
Issues can arise because the study
protocols or guidelines used to generate
the studies to meet the requirements can
be different. In other words, a particular
data requirement might be the same
from one country to the next, but the
study submitted to meet the
requirement can run into acceptance
problems if done according to a protocol
that is acceptable in one country, but
not in another. There is significant
commonality in protocol design for
toxicology studies among various
countries, but less for ecotoxicology and
environmental fate studies. Information
on how to satisfy data requirements is
specified in § 158.70. This section
provides for both the recommended use
of EPA Guidelines and for the
acceptability of OECD protocols with
certain caveats. Section 158.80 allows
for the use of data developed in foreign
countries, again with certain caveats to
ensure that the data will meet EPA’s
needs under FIFRA and FFDCA.
D. Ballast Water Treaty
Both domestically and
internationally, an emerging significant
use of antimicrobials is the treatment of
ballast water. Ballast water provides
needed stability for safe operation of
marine vessels. It is the water that is
pumped in and out of the ship’s ballast
tanks to ensure safe operation, such as
compensating for the ship’s weight
changes due to loading and unloading of
cargo. In recent years there have been
significant concerns about transport of
marine species from one marine
environment to another, via ballast
water. Ballast water treatments are
intended to kill the marine species prior
to discharge. When discharged into a
new environment, a new species may
PO 00000
Frm 00040
Fmt 4701
Sfmt 4702
become invasive and disrupt the native
ecology.
The International Convention for The
Control and Management of Ships’
Ballast Water and Sediments, 2004 (also
referred to as the Ballast Water
Convention) was adopted by consensus
at a diplomatic conference in London on
February 13, 2004. The U. S. delegation
was led by the Coast Guard with
participation by EPA and other Federal
agencies. The treaty opened for
signature on June 1, 2004, and will enter
into force 12 months after ratification by
30 countries representing 35% of the
world’s merchant shipping tonnage.
Once in force, the treaty will require
that ships manage their ballast water to
meet discharge standards according to a
schedule in the treaty. In order to meet
those discharge standards, ships will
need to install equipment to treat their
ballast water, including disinfection. To
date, ten countries representing 3.42%
of the world shipping tonnage have
become Parties to the treaty.
Although the United States has not
signed the treaty, ballast water
discharges in U.S. waters are already
regulated by the Coast Guard under the
Nonindigenous Aquatic Nuisance
Prevention and Control Act, as amended
(16 U.S.C. 4701 et seq.) The existing
Coast Guard ballast water management
regulations can be found at 33 CFR part
151, subparts C and D. At present, the
Coast Guard is engaged in further
rulemaking that would set a
performance standard for the quality of
ballast water discharged in U.S. waters
and which will further foster
development of ballast water treatment
technologies.
The Agency has reviewed few
applications for ballast water
treatments, presumably because such
treatments and technologies are
relatively new. Therefore, for the
purpose of determining data
requirements EPA determined to group
ballast water treatments with antifoulant
paints and coatings since both have the
potential for exposure to marine
organisms. OECD has not developed
data requirements for ballast water.
XVII. Research Involving Human
Subjects
Research with human subjects which
is conducted or supported by the U. S.
government is subject to regulations for
the protection of human subjects
referred to as the Common Rule. EPA
was one of many federal departments
and agencies who jointly promulgated
the Common Rule in 1991. EPA’s
codification of the Common Rule
appears at 40 CFR part 26, subpart A.
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
On February 6, 2006, EPA published
in the Federal Register (71 FR 6138) a
final rule amending 40 CFR part 26 by
adding nine new subparts. These
amendments extend regulatory
protection to human subjects of research
involving intentional exposure and
intended for submission to EPA under
the pesticide laws, when the research is
conducted not by the Federal
government but by private parties with
no support from Federal Common Rule
departments or agencies. As
subsequently amended effective August
22, 2006 (71 FR 36171), this rule (1)
forbids both EPA and third parties who
intend to submit the research to EPA to
conduct new research involving
intentional exposure of pregnant or
nursing women or of children; (2)
extends the substantive provisions of
the Common Rule to third-party human
research involving intentional exposure
of non-pregnant adults that is intended
for submission to EPA under the
pesticide laws; (3) requires submission
to EPA of protocols and related
information about covered human
research before it is initiated; (4)
establishes an independent Human
Studies Review Board to review both
proposals for new research and reports
of covered human research on which
EPA proposes to rely under the
pesticide laws; and (5) forbids EPA to
rely, in its actions under the pesticide
laws, on research involving intentional
exposure of pregnant or nursing women
or of children, or which otherwise fails
to meet criteria for acceptance, except in
narrowly defined circumstances.
The provisions of this amended rule
directly affecting third-party research
intended for submission to EPA are 40
CFR part 26, subparts K, L, and M.
Subpart K extends the substantive
provisions of the Common Rule to thirdparty research involving intentional
exposure of non-pregnant adult subjects
that is intended for submission to EPA
under the pesticide laws. Subpart K also
requires submission to EPA of proposals
for any covered research for review by
EPA staff and the Human Studies
Review Board before it is initiated, and
specifies the range of information
required to support any such proposal.
Subpart L prohibits conduct of any new
third-party research intended for
submission to EPA involving intentional
exposure of pregnant or nursing women
or of children. Subpart M specifies the
range of information required to be
submitted with every report of
completed research with human
subjects to document its ethical
conduct.
Studies required under proposed 40
CFR part 158, subpart W which involve
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
intentional exposure of human subjects
are also subject to subparts K, L, and M
of 40 CFR part 26. The following data
requirements in proposed § 158.2260
and § 158.2270 call for studies likely to
involve intentional exposure of human
subjects:
• Biological monitoring studies.
• Mixer/loader or applicator exposure
studies.
• Post-application exposure studies.
If any studies undertaken to address
these requirements involve intentional
exposure of a human subject (as defined
at 40 CFR §26.1102(i)), then the study
must not be initiated before submission
of protocols and supporting
documentation for review by EPA and
the Human Studies Review Board. The
requirements for protocol submissions
are specified at 40 CFR 26.1125. It may
be possible to design some studies
responsive to the proposed data
requirements for antimicrobials so that
they do not meet the regulatory
definition of research involving
intentional exposure of a human
subject. If there is any question,
however, about whether a proposed
study intended for submission to EPA
falls within or outside this regulatory
definition, consultation with EPA is
recommended before initiating the
study. If EPA did not review the
protocol for a study involving
intentional exposure of a human
subject, the study if subsequently
submitted to the Agency would not be
acceptable under 40 CFR 26.1705.
XVIII. Alternative Testing Paradigms
As with conventional pesticide
chemicals, the Agency is committed to
moving towards a more efficient and
refined testing/risk assessment
paradigm for antimicrobial pesticide
chemicals.
A. Structure Activity Relationship (SAR)
EPA must rely upon information of
appropriate quality and reliability for
each decision made by the Agency. In
the Office of Pesticide Programs (OPP),
the evaluation process for a pesticide
chemical traditionally begins with the
applicant’s submission of a set of
studies conducted with the specific
pesticide chemical of interest. The use
of the results of such testing (measured
data) is a logical, scientifically-rigorous
process that identifies the physical,
chemical, and environmental fate
properties of the pesticide, as well as
the dose and endpoints at which an
adverse effect can occur in various
animal species.
Today, there is significant interest in
determining alternative testing
paradigms that could offer more
PO 00000
Frm 00041
Fmt 4701
Sfmt 4702
59421
flexibility in the design of an integrated
approach in which the selection of the
required studies as well as the design of
the study protocols is influenced by the
existing, reliable information about the
chemical. EPA is committed to moving
towards alternative testing paradigms
that are more efficient, reduce the use of
animal testing, take full advantage of
advances in science, and provide a
sufficient, credible amount of data for
use in a risk assessment that will
support a risk management decision.
EPA is charged with developing a
pesticide regulatory program that is
protective of human health and the
environment. Other factors that also
deserve consideration in the
implementation of such a program are
efficiency and effectiveness. It would be
a poor use of societal resources to
routinely require the submission and
governmental review of a multi-million
dollar database for every active
ingredient if there were alternative
methods of determining which
chemicals could be evaluated in a
scientifically rigorous manner using
means other than measured data. From
the Agency’s perspective an alternative
testing paradigm may also allow for a
stream-lined review process for
chemicals of potential lower toxicity,
thus freeing resources for more indepth, complex reviews of higher
toxicity chemicals.
An integrated approach would focus
on using all relevant, credible
information on the chemical of interest.
Applicants are cautioned that such an
approach will require a different type of
thought process which will incorporate
significantly more planning and ‘‘data
mining’’ types of activities than making
arrangements to conduct the required
studies. However, it could also offer a
flexibility that is not always present
under the currently-used, guidelinedriven (study-by-study) approach.
Both SAR and QSAR techniques play
a critical role in an integrated approach.
In the SAR process, a chemical’s
molecular structure is compared to that
of other chemicals for which data are
available. These structural similarities
are then used to make predictive
judgments about a chemical’s physical,
chemical, and biological properties.
Thus, the chemical’s physical, chemical,
and biological properties are a function
of (or directly related to) the chemical’s
molecular structure. Quantitative SAR is
referred to as QSAR. To develop a
QSAR, a selected set of measured data
on a single physical, chemical, or
biological property are used to derive a
model (an equation) to predict the value
of that property.
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59422
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
EPA’s Office of Pollution Prevention
and Toxics administers two programs,
the Interagency Testing Committee (ITC)
and the New Chemicals Program (NCP)
under the Toxic Substances Control Act,
that have been using various forms of
SAR and QSAR since the late 1970s.
The ITC is an independent advisory
committee that screens chemicals or
classes of chemicals and prioritizes
them for testing. The NCP uses an
expert judgment SAR process to assess
human health and has developed QSAR
models to evaluate physical, chemical
and environmental fate properties and
ecological effects.
Additionally, other agencies (both
U.S. and non-U.S.) are investigating
how to use these alternative techniques.
OECD has devoted a significant amount
of time and effort to coordinating model
development and model validation for
such an integrated approach. EPA has
participated on these workgroups.
During the last 6 years, OPP has made
increasing use of SAR as part of its
regulatory decision-making process.
Documents to establish tolerance
exemptions, documents to support
tolerance reassessment, and
Reregistration Eligibility Decision
Documents have incorporated the use of
SAR, when appropriate. OPP recognizes
the usefulness of incorporating
predictive techniques into its hazard
and risk assessments, and that for
certain chemicals SAR assessments and
QSAR modeling could potentially form
a scientifically-sound basis for hazard
and risk assessments used for regulatory
decisions. Over time, OPP has
progressed from using SAR techniques
to support a dataset of guideline type
studies to, for certain assessments,
relying on SAR techniques as an
acceptable source of information on the
chemical. OPP is now considering when
and how to codify in subpart A of
current part 158 that information
derived from SAR assessments and/or
QSAR modeling could be acceptable for
fulfilling a data requirement. The
submitter of such information would be
expected to supply a rationale
describing the utility of the information
and provide documentation on the
scientific validity of the information.
The determination that the predicted
data fulfills the data requirement would
be at the sole discretion of the Agency.
The Agency seeks comment on the use
of predictive techniques to fulfill the
part 158 subpart W data requirements,
and specifically on when and if the use
of SAR and QSAR should be codified in
part 158, subpart A. Codification in part
158, subpart A means that SAR and
QSAR techniques would be applicable
to conventional, biochemical and
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
microbial, and antimicrobial pesticide
chemicals. The Agency specifically
seeks comment on this issue. Comments
will be used in the further development
of SAR and QSAR approaches for
fulfilling data requirements, but will not
be addressed in the final rule for
antimicrobial data requirements.
Those applicants considering use of
SAR and QSAR as part of a submission
package to OPP should realize SAR and
Quantitative SAR (QSAR) modeling
results can sometimes be used instead of
measured data, but modeled data cannot
be preferentially substituted for wellconducted studies (measured data). If
measured data are available for a
particular endpoint, then the measured
data should carry the greatest weight for
hazard and risk assessment purposes.
Applicants are cautioned that if the
Agency determines that the SAR and/or
QSAR do not fulfill the data
requirement, then the registration may
be delayed while a study (measured
data) is generated according to part 158
requirements.
At this time, the Agency intends to
continue its initial explorations and
begin the process to shift from the
current guideline-driven (study-bystudy) approach to a more integrated
approach in which the use of predicted
data, generated using validated models,
is considered along with information
from open literature and studies
specifically generated under part 158
data requirements. All relevant
information would be considered as part
of a weight-of-evidence evaluation.
The shift to an integrated approach
would occur over some time. OPP has
deliberately chosen to begin this shift
with antimicrobial pesticide chemicals
instead of conventional pesticide
chemicals for two reasons: First, most
conventional pesticide chemicals are
deliberately created for their biological
activity and many require complex risk
assessments. Few conventional
pesticides have non-pesticidal uses.
Second, antimicrobials also have
biological activity, but are more likely to
have non-pesticidal uses and, in fact,
may have been assessed by other
regulatory agencies. The ready
availability of published literature and
publicly-available assessments offer a
unique opportunity for the applicant to
use the available information as a
starting point for fulfilling data
requirements, and offering the possible
option, when appropriate, of SAR and
QSAR for those data requirements that
are not yet fulfilled by measured data.
It should be realized that just as
measured data have uncertainties,
predicted data also have uncertainties.
Use of different models (developed
PO 00000
Frm 00042
Fmt 4701
Sfmt 4702
using different sets of data) would
necessarily have trade-offs. Therefore,
QSAR models must be used with
caution. Expert judgment is required to
determine the appropriate model to use
and if the results of the model strike the
correct balance of accuracy and
precision, with the potential for few
false negatives or false positives.
At this time, EPA believes that for
certain endpoints, especially physical/
chemical and fate properties, that SAR
and QSAR might be effectively utilized
to fulfill these data requirements for
many antimicrobial pesticide chemicals.
When considering biological properties,
EPA believes that SAR and QSAR can
be most effectively utilized in the
evaluation of chemicals that exhibit
lower toxicity for human health and/or
ecotoxicity parameters. This is
appropriate because the risk assessment
for lower toxicity chemicals can be
streamlined, i.e., through use of a
screening-level assessment procedure
rather than multiple tiers of assessments
with progressively more data
requirements.
As appropriate, OPP will consider the
use of SAR and/or QSAR predictive
techniques as part of the hazard
assessment, and eventually the dose and
endpoint selection process for
antimicrobial chemicals. Under a
QSAR-based approach an applicant
could provide the Agency with an
analysis that could frame the actual data
required to register the antimicrobial
pesticide chemical. For some
antimicrobials, applicants may have the
option of characterizing certain of the
active ingredient properties via
predictive techniques. It is the
responsibility of the applicant to
provide sufficient information to
conduct a risk assessment that can be
used to support a risk management
decision. If the applicant believes that a
SAR assessment and/or QSAR model
would provide scientifically credible
information that would be useful to
EPA, then it is the responsibility of the
applicant to provide to the Agency a
rationale on the appropriateness of SAR
or QSAR for that particular endpoint
and sufficient documentation on how
the assessment and/or model is
scientifically valid. Without such
information OPP cannot judge the
validity of the model and therefore the
acceptability of the results of the model
for OPP’s decision-making purposes.
At this time, the use of SAR is not yet
a standardized approach in OPP, and is
being handled on a case-by-case basis.
Therefore, OPP has not yet developed a
standardized format for submission of
such information. Further information
on OPP’s current thinking on how SAR
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
and QSAR modeling can be used as part
of an integrated approach to hazard and
risk assessment to support a regulatory
decision-making process and guidance
on submission formats is contained in
the support document, ‘‘Use of
Structure-Activity Relationship (SAR)
Information and Quantitative SAR
(QSAR) Modeling For Fulfilling Data
Requirements for Antimicrobial
Pesticide Chemicals and Informing
EPA’s Risk Management Process’’ which
is contained in the docket for this
proposed rule (Ref. 43). The Agency
specifically seeks comment on this
support document.
B. International Life Sciences Institute
and Health and Environmental Sciences
Institute Approaches
In both the proposed (70 FR 12276)
and final (72 FR 60934) rules for
conventional pesticide chemicals, EPA
discussed the relevance and importance
of the ILSI/HESI project. There have
been discussions on alternative testing
paradigms with the International Life
Sciences Institute (ILSI) Health and
Environmental Sciences Institute (HESI)
under the Agricultural Chemical Safety
Assessment (ACSA) Technical
Committee, since 2001 (Ref. 14). The
focus of this effort has been toxicity
testing for agricultural chemicals, but
the results would also be applicable to
antimicrobial pesticides.
This project, with the participation of
EPA scientists, represents an evolution
of the current paradigm of animal (in
vivo) toxicity testing toward a more
integrated tiered testing approach for
pesticide chemicals. Under this
integrated approach, both the selection
of studies that would be required, as
well as the design of the tests
themselves, could be influenced by
other substantive and reliable
information about the pesticide.
The goals being pursued by EPA for
this next generation of toxicity testing
are to:
• Incorporate advances in science and
technology in an expeditious manner.
• Identify cost effective and
scientifically sound alternatives to
current animal tests.
• Define a transparent, step wise plan
that leads to an evolution, not
revolution, in testing and assessment.
• Define a clear and credible process,
with external peer-review and
stakeholder participation.
All available information would be
considered: Not only toxicity and doseresponse data from other guideline or
non-guideline studies, but also
structure-activity relationships, data on
the mechanism or mode of action of the
chemical, pharmacokinetic data, studies
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
that examine age-related sensitivity or
susceptibility to chemical exposure, and
information on potential or actual
exposure to humans. These data could
be used to inform a more targeted
testing approach in the design of
studies, or to support a position that the
requirement for specific toxicology tests
should be waived (i.e., the studies are
not needed)or fulfilled via a means
other than data generation, such as SAR.
ACSA represents the first
comprehensive effort to scientifically redesign the toxicology animal-testing
framework for pesticide chemicals. A
series of reports authored by HESI/ILSI
were published in a special edition of
the Journal of Critical Reviews in
Toxicology in January 2006 (Refs. 1, 2,
3, and 6). These four articles
summarized the initial findings and
recommendations.
The ACSA proposal is consistent with
EPA’s direction and goals to develop a
more efficient and reliable testing
paradigm. The ACSA approach departs
significantly from the current
standardized list of hazard studies used
by many national and international
authorities to assess pesticides. Some
studies could be eliminated while
endpoint coverage might be increased in
redesigned studies based on responses
observed in a core set of toxicity tests.
Thus, it will be essential to conduct
retrospective and prospective data
analyses to determine whether this new
testing paradigm will meet EPA’s risk
assessment needs.
The first retrospective analysis has
been completed for the 1–year chronic
dog study. Based on this retrospective
analysis, which was reviewed by the
FIFRA SAP, the 1–year chronic dog
study is no longer required for
conventional pesticide chemicals and is
not proposed as a data requirement for
antimicrobial chemicals. Another
retrospective analysis on the 2generation reproductive toxicity study is
underway. To this end, the Office of
Pesticide Programs is currently working
with EPA’s National Center for
Computational Toxicology to populate a
Toxicological Reference Database
(ToxRef) with data from the rat 2generation reproductive study, prenatal
developmental toxicity and systemic
toxicity studies on hundreds of
pesticides that represent different
classes, modes of action, and toxicity
profiles. EPA will use this relational
database to determine the value of
endpoints currently evaluated in risk
assessment (i.e., the F1 versus F2
responses).
From these analyses the Agency will
gain other information critical for
gaining scientific consensus. Such
PO 00000
Frm 00043
Fmt 4701
Sfmt 4702
59423
information would be the triggers, that
is, the points at which a concern is
indicated and thus a higher level of
testing is needed. The retrospective
analyses will aid the Agency in
confirming the proposed ACSA triggers
or in determining new ones. Once the
analysis is complete, EPA will be able
to complete draft guidance on testing.
EPA plans to request SAP review and
public comment of the analyses and
draft guidance in 2008.
Additionally, there are plans to
conduct several case studies using the
ACSA tiered testing proposal. It is
essential to test how the ACSA scheme
works in practice. From such case
studies, EPA will be able to assess the
feasibility of a testing laboratory’s
ability to perform such a complex study,
and will have the opportunity to
evaluate the ability of the approach and
its parameters to characterize known
toxicants and address risk assessment
needs.
In considering regulatory changes to
reflect the results of EPA’s consideration
of ACSA, the Agency will develop
scientific position papers on the new
approach and recommendations for
internal and external review. Internal
review includes review by the FIFRA
SAP and opportunities for public
comment. External peer review and
acceptability by other national and
international regulatory authorities are
considered before implementation of
any new testing paradigm and data
requirements. Harmonization of data
requirements with our NAFTA and
OECD partners is also an important
factor. International regulations
currently require studies that were
omitted in ACSA. If EPA had
requirements that were significantly
different from those of the international
community, then there could be
significant problems for applicants in
trying to satisfy multiple and different
requirements world-wide.
Thus, as these analyses and the
needed peer reviews are completed,
EPA will have the opportunity to
determine if the new testing paradigm
will meet its risk assessment needs. EPA
will then be able to determine what
revisions to current data requirements
and testing guidelines may be
appropriate.
C. Computational Toxicology
EPA’s Office of Research and
Development (ORD) established the
National Center for Computational
Toxicology (NCCT) in 2005. The NCCT
is developing computational tools for
interpreting data from computational
chemistry, high-throughput screening
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59424
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
(HTS) and genomic technologies as
follows:
• Computational chemistry is the
integration of modern computing and
information technology with
information on molecular biology and
chemistry to predict bioactivity profiles.
• HTS is a system to rapidly and
efficiently test large batches of
chemicals for bioactivity utilizing
robotics and automation applied to
molecular biology and assay methods.
• Genomics is the study of all the
genes of a cell or tissue, and their
function.
EPA’s ToxCastTM Program began in
2006. The underlying hypothesis for
ToxCastTM is that an organism’s
toxicological response is driven by
interactions between chemicals and
biomolecular targets. ToxCastTM also
includes model development to predict
the potential toxicity of environmental
chemicals based on bioactivity profiles.
These models will identify predictive
signatures, derived from the bioassay
data. This means that EPA under
ToxCastTM will develop methods of
prioritizing chemicals for further
screening and testing to assist the
Agency’s programs in the management
and regulation of environmental
contaminants (Ref. 5).
There are three phases to the
development of ToxCastTM:
1. The proof-of-concept phase of
ToxCastTM will examine more than 300
chemicals, with rich toxicological
databases, in over 400 different HTS
bioassays. Predictive signatures will be
created by correlating the HTS bioassay
data to the known toxicity of the 300
chemicals.
2. A signature evaluation and
expansion phase will focus on testing
and extending the ToxCastTM predictive
signatures, through the generation of
HTS data on over 1,000 additional
chemicals.
3. The application phase of ToxCastTM
will be expanded to include a variety of
high-priority chemicals that are either
regulated and/or considered for
regulation by EPA and potentially
thousands of environmental chemicals
requiring prioritization. ToxCastTM is
envisioned as delivering an affordable,
science-based system for categorizing
chemicals.
In 2007 the NCCT awarded nine
contracts for the generation of HTS and
genomics data as part of the ToxCastTM
chemical prioritization research
program, in order to develop the ability
to predict, or forecast toxicity based on
bioactivity profiling. State-of-the-art
HTS and genomic approaches
developed by the pharmaceutical
industry provide information on the
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
impact of chemicals on biological
pathways critical for the function of
systems such as the heart, lungs, brain,
or reproductive organs quickly and in a
cost-efficient manner. Thus, results from
these bioassays will provide a
comprehensive and detailed overview of
the potential impact of environmental
chemicals upon key cellular activities.
As the ToxCastTM database grows so
will confidence in the models
developed from that data, as well as the
resultant predictions of toxicity and
potential mechanisms of action derived
from the models. This could result in
changing and/or reducing the use and
numbers of animals in toxicity testing.
This could also result in fewer in vivo
tests being conducted as scientists and
regulators learn how to interpret and
use ToxCastTM predictions to then
determine the chemicals that must be
tested using traditional toxicity testing.
Results from the first phase of
ToxCastTM are anticipated by the
summer of 2008. However, significant
effort will be needed as ToxCastTM
transitions from proof-of-concept to a
useful prioritization tool.
identification and dose-response
assessment.
• Breadth, providing data on the
broadest possible universe of chemicals,
endpoints, and life stages.
• Animal welfare, causing the least
animal suffering possible and using the
fewest possible animals.
• Conservation, minimizing the
expenditure of money and time on
testing and regulatory review.
The report acknowledged that it was
difficult to simultaneously meet all four
objectives.
In 2007 NAS released its Part II report
entitled ‘‘Toxicity Testing in the 21st
Century: A Vision and a Strategy’’ (Ref.
21). According to NAS, toxicity testing
is approaching a ‘‘scientific pivot
point.’’ Today, there are advances in the
biological sciences that are already
impacting how toxicity testing is
conducted. NAS concluded that a
paradigm shift would be needed to
transform the current testing system but
that ‘‘the result will be a more efficient,
informative and less costly system for
assessing the hazards posed by
industrial chemicals and pesticides.’’
D. National Academy of Sciences (NAS)
Report Concerning Toxicity Testing and
Assessment of Environmental Agents
E. Next Steps
EPA asked NAS to undertake a
comprehensive review of established
and emerging toxicity-testing methods
and strategies. In response to this
request NAS convened the Committee
on Toxicity Testing and Assessment of
Environmental Agents. EPA asked the
Committee to conduct their assessment
in two parts. Part I is a review
document, discussing current and nearterm methods and strategies for
collecting information for human health
risk assessment. Part II is a long-range
vision and strategic plan for changes to
human health risk assessment
paradigms.
In June 2006, NAS released Toxicity
Testing for Assessment of
Environmental Agents: Interim Report
(Ref. 20). This report fulfills EPA’s Part
I request. In conducting its research
NAS considered numerous documents
and resources such as (1) current
toxicity testing protocols and various
testing strategies using these protocols,
(2) impediments to the use of human
data, (3) strategies that rank or screen
chemical substances, and (4) human
health risk assessment guidance
documents. The Part I report identified
four objectives that EPA should strive to
meet as it works to evolve its current
paradigm of toxicity testing:
• Depth, providing the most accurate,
relevant information possible for hazard
PO 00000
Frm 00044
Fmt 4701
Sfmt 4702
EPA will undertake rule-makings on a
timely basis as the science progresses
and changes to the data requirements
are appropriate.
XIX. Animal Welfare Concerns
The Agency understands many
people’s concern about the use of
animals for research and data
development purposes. In both the
proposed rule (70 FR 12276) and in the
final rule (72 FR 60934) for
conventional pesticide chemicals, EPA
discussed its commitment to the
development and use of alternative
approaches to animal testing.
Taking into consideration principles
of sound science and the requirements
of FIFRA to protect humans and the
environment, the Agency is committed
to avoiding unnecessary or duplicative
animal testing. As a result, the Agency
has invested significant resources to
investigate more integrated testing
approaches that include, in silico, in
vitro, and focused in vivo testing. The
Agency’s long-term goal is to create a
testing paradigm so that chemicals are
tested in animals only for those
endpoints most relevant to each
chemical’s exposure or intended use.
The Agency acknowledges that
substantial work remains to achieve this
long-term goal, but the Agency is also
working on the important short-term
goal to make the existing animal testing
paradigm more efficient, reliable, and
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
responsive to its risk assessment and
management needs.
As a result of the Agency’s activities
to move towards a more efficient animal
paradigm, EPA is proposing to eliminate
the existing requirement for the 1–year
chronic dog study for antimicrobial
pesticide chemicals.
XX. Potential Rule-Makings of the
Future for Endangered Species
EPA is charged with protecting
endangered and threatened species from
potential harm from pesticide use.
Under the Endangered Species Act, EPA
must ensure that the registered uses of
pesticides will not jeopardize the
continued existence of endangered or
threatened species, or adversely modify
habitat designated as critical by the U.S.
Fish and Wildlife Service or National
Marine Fisheries Service. Accordingly,
in its proposed and final rules for both
conventional pesticide chemicals, and
biochemical and microbial pesticide
chemicals, the Agency discussed the
possibility of future data and
information needs to develop and/or
refine risk assessments for endangered
and threatened species. As a result of
those proposed rules, EPA received
comments. For the present, EPA will
consider those comments in the context
of its ongoing risk assessments,
including those for antimicrobials. If
EPA finds that it needs to amend
subpart W of part 158 to normalize
endangered species data requirements,
it will consider those comments and any
comments submitted in response to this
proposed rule in the development of a
future proposed rule.
For agricultural pesticides, there is
generally greater specificity relative to
where a pesticide may be used. If
adequate geographic delineation of the
use site is possible, then overlap with
the locations of an endangered or
threatened species may also be possible.
However, antimicrobial pesticides are
different from agricultural pesticides.
The Agency expects that most
antimicrobial uses with potential for
environmental exposure (e.g., wood
preservatives, antifoulant paints,
industrial wastewater discharges, ballast
water discharges) could impact
geographic areas of the United States
that are less well defined. For example,
vessels treated with antifoulant paints
can occur in freshwater, estuarine, or
marine areas within the U.S. (such as
lakes and rivers) and in coastal waters.
Wood preservatives could be used in
locations that may result in an impact
to terrestrial and/or aquatic organisms
depending on the use of the wood,
which could occur throughout the
United States. Antimicrobial use sites
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
will be much more difficult to delineate,
and overlay with endangered or
threatened species locations.
The Agency seeks comment on:
1. The types of data that could be
useful for conducting the assessment
required.
2. Projections of how long it would
take to generate the needed data.
3. Whether antimicrobial use sites can
be adequately correlated with
endangered species locations, and
suggested methods for doing so.
XXI. References
1. Barton, A, Pastoor, TP, Baetcke, K,
Chambers, JE, Diliberto, J, Doerrer, NG,
Driver, JH, Hastings, CE, Iyengar, S,
Krieger, R, Stahl, B, and Timchalk, C.
2006. The acquisition and application of
absorption, distribution, metabolism,
and excretion (ADME) data in
agricultural chemical safety
assessments. Critical Reviews in
Toxicology. 36, 9–35.
2. Carmichael, NG, Barton, HA,
Boobis, AR, Cooper, RL, Dellarco, VL,
Doerrer, NG, Fenner-Crisp, PA, Doe, JE,
Lamb, JC, and Pastoor, TP. 2006.
Agricultural chemical safety assessment:
a multi-sector approach to the
modernization of human safety
requirements. Critical Reviews in
Toxicology. 36, 1–7.
3. Cooper, RL, Lamb, JC, Barlow, SM,
Bentley, K, Brady, AM, Doerrer, NG,
Eisenbrandt, DL, Fenner-Crisp, PA,
Hines, RN, Irvine, L, Kimmel, CA,
Koeter, H, Li, AA, Makris, SL, Sheets, L,
Speijers, GJA, and Whitby, K. 2006. A
tiered approach to life stages testing for
agricultural chemical safety assessment.
Critical Reviews in Toxicology. 36, 69–
98.
4. Dearfield, KL, Auletta, AE, Cimino,
MC, and Moore, MM. 1991.
Consideration in the U. S.
Environmental Protection Agency’s
Testing Approach for Mutagenicity.
Mutation Research. 258, 259–283.
5. Dix, DJ, Houck, KA, Martin, MT,
Richard, AM, Setzer, RW, Kavlock, RJ.
2007. The ToxCast Program for
Prioritizing Toxicity Testing of
Environmental Chemicals; Toxicological
Sciences 95(1), 5–12 (accessed July 2,
2008) https://toxsci.oxfordjournals.org/
cgi/content/abstract/95/1/5.
6. Doe, JE, Boobis, AR, Blacker, A,
Dellarco, VL, Doerrer, NG, Franklin, C,
Goodman, JI, Kronenberg, JM, Lewis, R,
McConnell, EE, Mercier, T, Moretto, A,
Nolan, C, Padilla, S, Phang, W, Solecki,
R, Tilbury, L, van Ravenswaay, B, and
Wolf, DC. 2006. A tiered approach to
systemic toxicity testing for agricultural
chemical safety assessment. Critical
Reviews in Toxicology. 36, 37–68.
PO 00000
Frm 00045
Fmt 4701
Sfmt 4702
59425
7. Food and Drug Administration
(FDA) (January 1993). Sanitizing
Solutions: Chemistry Guidelines for
Food Additive Petitions. (accessed July
2, 2008) https://www.cfsan.fda.gov/
~dms/opa-cg3a.html.
8. FDA (April 2002a). Guidance for
Industry: Preparation of Premarket
Notifications for Food Contact
Substances: Toxicology
Recommendations. (accessed July 2,
2008) https://www.cfsan.fda.gov/~dms/
opa2pmnt.html.
9. FDA (April 2002b). Guidance For
Industry: Preparation of Food Contact
Notifications and Food Additive
Petitions for Food Contact Substances:
Chemistry Recommendations. Final
Guidance. (accessed July 2, 2008) https://
www.cfsan.fda.gov/~dms/
opa2pmnc.html.
10. FDA (August 2006) Estimating
Dietary Intake of Substances in Food
(accessed July 2, 2008) https://
www.cfsan.fda.gov/~dms/opa2cg8.html
11. FDA (December 2007) Guidance
for Industry: Preparation of Premarket
Submissions for Food Contact
Substances: Chemistry
Recommendations. (accessed July 2,
2008) https://www.cfsan.fda.gov/~dms/
opa3pmnc.html
12. Halden, R, and Paull, D. 2005. CoOccurrence of Triclocarban and
Triclosan in U.S. Water Resources.
Environmental Science and Toxicology.
39: 6, 1420–1426.
13. Health Canada, Pesticide
Management Regulatory Agency:
Memorandum from Don Grant, Director
Health Evaluation Division:
Reproductive Toxicity Testing in
Proposed 40 CFR 158, Subdivision W Data Requirements for Antimicrobial
Pesticides. December 1, 1997.
Attachment to Memorandum: The
Assessment of Reproductive Toxicity for
Antimicrobial Pesticides: The Tiered
Approach of USEPA and Proposals for
Change; November 1997 draft.
14. International Life Sciences
Institute, Health and Environmental
Sciences Institute Developing strategies
for agricultural chemical safety
evaluation, a report from an April 22–
23, 2001 workshop. (September 2001)
15. Luster et al. 1992. Risk
Assessment in Immunotoxicology I.
Sensitivity and Predictability of
Immune Tests, Fundamental and
Applied Toxicology. 18: 200–210.
16. Luster et al. 1993. Risk
Assessment in Immunotoxicology II.
Relationships Between Immune and
Host Resistance Tests, Fundamental and
Applied Toxicology. 21: 71–82.
17. McAvoy, D, Schatowitz, B, Jacob,
M, Hauk, A, and Eckhoff, W. 2002.
Measurement of Triclosan in
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
59426
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
Wastewater Treatment Systems.
Environmental Toxicology and
Chemistry, 21: 7, 1323–29.
18. Marzulli, F. and Maibach, H.
Dermatotoxicology (5th ed.). page 284.
19. National Research Council,
‘‘Pesticides in the Diets of Infants and
Children,’’ National Academy Press,
Washington, D.C., 1993.
20. National Research Council 2006.
Executive Summary: Toxicity Testing
for Assessment of Environmental
Agents: Interim Report. (Note: click on
download free executive summary)
(accessed July 1, 2008) https://
www.nap.edu/catalog/11523.html.
21. National Research Council 2007.
Executive Summary: Toxicity Testing in
the 21st Century: A Vision and a
Strategy (Note: click on download free
executive summary) (accessed July 1,
2008) https://www.nap.edu/catalog/
11970.html.
22. Santa Clara Basin Watershed
Management Initiative. 2006. White
Paper: Environmental Emergence of
Triclosan.(accessed July 2, 2008) https://
www.scbwmi.org/PDFs/
WMI_Triclosan_FinalJan06.pdf.
23. Singer, H, Muller, S. Tixiewr, C.,
and Pillonel, L. 2002. Triclosan:
Occurrence and Fate of a Widely Used
Biocide in the Environment: Field
Measurements in Wastewater Treatment
Plants, Surface Waters, and Lake
Sediments. Environmental Science and
Toxicology. 36: 23, 4998–5004.
24. USEPA Federal Register Notice.
Toxicology Data Call-In for
Antimicrobial Pesticides (January 7,
1987) (FRL–3136–3).
25. USEPA (March 9, 1992).
Environmental Fate and Effects Division
Policy Note 1–2: Waiver of the
Photodegradation in Water Data
Requirement Based on the Electronic
Absorption Spectra of the Pesticide
(Henry Jacoby).
26. USEPA (August 5, 1991).
Memorandum: Revised Mutagenicity
Guideline and Requirement –
Explanation, from Kerry L. Dearfield,
Science Analysis and Coordination
Branch.
27. USEPA (September 1993).
Pesticide Reregistration Rejection Rate
Analysis – Environmental Fate (EPA
738–R–93–010).
28. USEPA (February 7, 1996).
Pesticide Registration (PR) Notice 96–1.
Tolerance Enforcement Methods —
Independent Laboratory Validation by
Petitioner. (accessed July 1, 2008) https://
www.epa.gov/opppmsd1/PR_Notices/
pr96–1.html.
29. USEPA Federal Insecticide,
Fungicide and Rodenticide Act (FIFRA)
Scientific Advisory Panel (SAP) Meeting
of June 1997: A Set of Scientific Issues
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
Being Considered by the Agency to
Determine Antimicrobials Issues
(accessed July 1, 2008) https://
www.epa.gov/scipoly/sap/meetings/
1997/june/antimicr.htm.
30. USEPA FIFRA SAP Meeting of
December 1998: A Retrospective
Analysis of Twelve Developmental
Neurotoxicity Studies (Draft 11/12/98)
(accessed July 1, 2008) https://
www.epa.gov/scipoly/sap/meetings/
1998/december/neuro.pdf.
31. USEPA FIFRA SAP Report No.
99–01B: II - A Retrospective Analysis of
Twelve Developmental Neurotoxicity
Studies (January 22, 1999) (accessed
July 1, 2008) https://www.epa.gov/
scipoly/sap/meetings/1998/december/
final2.pdf.
32. USEPA FIFRA SAP Meeting of
December 1998: Toxicology Data
Requirements for Assessing Risks of
Pesticide Exposure to Children’s Health.
(Draft—November 30, 1998). https://
www.epa.gov/scipoly/sap/meetings/
1998/december/10xreq.pdf.
33. USEPA FIFRA SAP Meeting of
May 1999: Toxicology Data
Requirements for Assessing Risks of
Pesticide Exposure to Children’s Health.
(Draft—April 28, 1999). (accessed July 1,
2008) https://www.epa.gov/scipoly/sap/
meetings/1999/may/10xtx428.pdf.
34. USEPA FIFRA SAP Meeting of
April 2000: Implementation Plan for
Probabilistic Ecological Assessment
(August 2, 2000). (accessed July 2, 2008)
https://www.epa.gov/oscpmont/sap/
meetings/2000/april/
freportapril572000.pdf.
35. USEPA (November 28, 2001).
General Principles for Performing
Aggregate Exposure and Risk
Assessments (page 16) (accessed July 2,
2008) https://www.epa.gov/oppfead1/
trac/science/aggregate.pdf.
36. USEPA FIFRA SAP Meeting May
2005: A Comparison of the Results of
Studies on Pesticides from 12– or 24–
Month Dog Studies with Dog Studies of
Shorter Duration (accessed July 2, 2008)
https://www.epa.gov/scipoly/sap/
meetings/2005/may2/
dogstudymay05.pdf.
37. USEPA FIFRA SAP Meeting
Minutes No. 2005–03: A Set of
Scientific Issues Being Considered by
the Environmental Protection Agency
Regarding: A Comparison of the Results
of Studies on Pesticides from 12– or 24–
Month Dog Studies with Dog Studies of
Shorter Duration (accessed June 30,
2008) https://www.epa.gov/scipoly/sap/
meetings/2005/may5/
meetingminutesmay5_6_2005.pdf.
38. USEPA (March 20, 2006). Length
of Dog Toxicity Study(ies) that is
Appropriate for Chronic RfD
Determinations of Pesticide Chemicals.
PO 00000
Frm 00046
Fmt 4701
Sfmt 4702
Health Effects Division/Office of
Pesticide Programs.
39. USEPA (January 2007) FIFRA SAP
Meeting Minutes (accessed June 25,
2008) https://www.epa.gov/scipoly/sap/
meetings/2007/january/
january2007finalmeetingminutes.pdf.
40. USEPA (April 2, 2007) Human
Studies Review Board Meeting Minutes
(EPA-HSRB–07–02) (accessed June 25,
2008) https://www.epa.gov/OSA/hsrb/
files/
April2007HSRBMtgFinalReport.pdf.
41. USEPA (February 5, 2007)
Appendix B – Antimicrobial Product
Use Sites and Categories Index. USEPA,
Antimicrobials Division, Office of
Pesticide Programs.
42. USEPA (December 31, 2007). Four
Case Studies of Antimicrobial Pesticides
in the Down-the-Drain Screening Model,
Using the Proposed Approach for a
Screening-Level Environmental Fate
Assessment. USEPA, Antimicrobials
Division, Office of Pesticide Programs.
43. USEPA (December 17, 2007). Use
of Structure-Activity Relationship (SAR)
Information and Quantitative SAR
(QSAR) Modeling For Fulfilling Data
Requirements for Antimicrobial
Pesticide Chemicals and Informing
EPA’s Risk Management Process.
44. USEPA (2008). Economic Analysis
of the Proposed Data Requirements for
Antimicrobial Pesticides, EAB/BEAD/
OPP.
45. USEPA (August 26, 2008).
Supporting Statement for an
Information Collection Request (ICR),
Data Requirements for Antimicrobial
Pesticides (Proposed Rule), EPA ICR No.
2318.01, OMB Control No. 2070–(new).
XXII. FIFRA Review Requirements
Under FIFRA section 25(a), EPA has
submitted a draft of the proposed rule
to the Secretary of the Department of
Agriculture and the appropriate
Congressional Committees. There were
no comments in response to these
submissions.
Under FIFRA section 21(b) EPA
submitted a draft of the proposed rule
to the Secretary of Health and Human
Services (HHS). Their comments on this
proposed rule included requests for (1)
clarification on the application of these
new testing requirements to current
registrants, (2) information about prions,
(3) the possible effects of antimicrobial
residues present in food on intestinal
flora, and (4) the potential for
antimicrobial resistance.
EPA agrees with HHS that both
current antimicrobial pesticide
registrants and applicants seeking an
antimicrobial registration should
understand the applicability of the
proposed data requirements, once
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
promulgated. Once effective, EPA
would use the promulgated data
requirements as the standard for
reviewing new applications. These same
promulgated data requirements, once
effective, would also be used during
Registration Review, when the Agency’s
scientists prepare the publicly available
documentation on the data needed
during Registration Review to complete
the needed risk assessments.
EPA also agrees that the criteria for
determining the efficacy of proposed
anti-prion agents have not yet been
established.
Concerning HHS’s Center for
Veterinary Medicine’s (CVM) comment
on intestinal flora, EPA believes that the
studies proposed in this rule for use in
a pesticide risk assessment are
protective of human health. EPA has no
specific information on effects on
antimicrobial residues that would not be
captured by the required health effects
studies.
HHS’s CVM is correct that this
proposed rule does not address
potential antimicrobial resistance as a
result of the use of a pesticide product.
While the Pesticide Program is aware of
this issue, we have neither determined
the extent of the problem nor how data
requirements could be developed to
address the issue. The Pesticide
Program will continue to monitor efforts
such as those of the CODEX ad hoc
Intergovernmental Task Force on
Antimicrobial Resistance and the
Interagency Task Force on
Antimicrobial Resistance, on which
EPA is a participant (see https://
www.cdc.gov/drugresistance/
actionplan/). The research being
conducted by the collaborating federal
agencies, which is primarily focused on
antibiotics, may eventually form the
basis for the Pesticide Programs’
approach to potential resistance as a
result of the use of pesticide products.
We have the authority to require studies
on a case-by-case basis and to revise our
data requirements in the future, if
appropriate.
EPA requested that the SAP waive its
review of this proposal based on the
SAP’s 1997 review. The SAP waived its
review of this proposal on February 19,
2008.
sroberts on PROD1PC70 with PROPOSALS
XXIII. Statutory and Executive Order
Reviews
A. Executive Order 12866
Pursuant to Executive Order 12866,
entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993),
the Office of Management and Budget
(OMB) has determined that this
proposed rule is a ‘‘significant
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
regulatory action’’ because this action
might raise novel legal or policy issues
arising out of legal mandates, the
President’s priorities, or the principles
set forth in the Executive Order.
Accordingly, as a result of this OMB
determination, EPA submitted this
proposed rulemaking to OMB for review
under Executive Order 12866. Any
changes made in response to OMB
comments have been documented in the
public docket for this rulemaking as
required by section 6(a)(3)(E) of the
Executive Order.
EPA has prepared an economic
analysis of the potential costs associated
with this proposed action, entitled
‘‘Economic Analysis of the Proposed
Change in Data Requirements for
Antimicrobial Pesticides.’’ It is noted
that this analysis applies only to new
antimicrobial pesticides submitted for
registration, and to new uses of
currently registered antimicrobial
pesticides. For conducting its economic
analysis, EPA considered a registration
action as referring to an application for
registration of a new product that
contains an active ingredient that is not
included in any currently registered
product, an application for a new
product that includes the addition of a
use pattern that is not currently
registered for one or more active
ingredients contained in the product,
and an amendment of a registration of
a product that includes the addition of
a use pattern that is not currently
registered for one or more active
ingredients contained in the product.
A copy of the economic analysis (Ref.
44) can be found in the public docket
for this action, and is briefly
summarized here.
In the proposed rule, EPA is:
• Proposing newly codified data
requirements, which are not currently
established in part 161, but are routinely
considered in current practice.
• Proposing changes to some of the
existing data requirements such as a
change from conditionally-required to
required, a change in the number of test
species, or expanding the number of use
patterns for which the test is required.
• Proposing new data requirements,
which have never been required or have
rarely been required on a case-by-case
basis, and have not been routinely
considered during the Agency’s
evaluation of the data needed for the
purpose of risk assessment.
• Proposing to eliminate the
requirement for the chronic nonrodent
study currently established in part 161.
To calculate the potential costs
associated with this proposal, EPA first
identified the studies that would
generate the data to fulfill the proposed
PO 00000
Frm 00047
Fmt 4701
Sfmt 4702
59427
data requirements, and then gathered
information on the price that
laboratories might charge to conduct
that study. To the extent possible,
several cost estimates were compiled for
each study. The low and high cost
estimates provided by the various
laboratories were averaged to account
for price variations related to differences
in the assumptions about the study
performed (e.g., protocol, species used),
and differences in the price charged by
different laboratories.
EPA assumed that each data
requirement would always be fulfilled
and therefore data would always need to
be generated for each requirement. This
assumption could lead to an
overestimate of the burden of the
proposal, because sometimes the data
are already available because the firm
generated it for their own use. In such
cases, the firm would simply need to
submit those data to EPA, which
involves less burden and cost than
generating it. Some firms may have
surrogate data that could be used, while
others may qualify for a waiver. Some
firms may share the cost of generating
the data. All of these would involve
lower costs than generating the data
anew.
EPA then used historical data on
antimicrobial pesticide registration
actions that occurred from 2000 to 2005
to identify the entities that sought
pesticide registration actions in the past.
The data required for each registration
action depends on several factors,
including the type of registration action
(e.g., registration of a new active
ingredient food-use, registration of a
new active ingredient nonfood-use,
registration and amendments to
registrations involving a major new use);
scientific discipline (e.g., toxicology,
residue chemistry, human exposure),
and use pattern. The percentage of time
a particular test would be required was
estimated from this information. For the
new data requirements, the percentage
of time was estimated by EPA scientists,
based on their past experience in the
program and their understanding of the
need for and the use of the new data
requirements.
The Agency prepared an industry
profile using the same historical data on
pesticide registration actions to identify
the companies involved in those
actions, and based it on public
information gathered about those
companies. EPA also used this industry
profile to analyze the potential impacts
of the proposed rule on small
businesses, the results of which are
summarized in Unit XXIII.B below.
Overall the potential impact of this
proposal on businesses is small, and
E:\FR\FM\08OCP2.SGM
08OCP2
59428
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
therefore the Agency believes that a
negative effect on the availability of
antimicrobial pesticide products to
users is unlikely. On balance, the
Agency believes that the costs of the
proposed rule are justified by the
benefits from enhanced protection of
human health and the environment.
TABLE 2.—TOTAL ANTIMICROBIAL INDUSTRY COST PER YEAR
Total Industry Cost per Year
($1000)
Baseline (BL)
11,080
Current Practices (CP)
11,726
Proposed Rule (PR)
14,961
3,882
Newly Imposed Costs (PR-CP)
sroberts on PROD1PC70 with PROPOSALS
Incremental Costs (PR – BL)
3,236
Thus, the difference between the
baseline (the existing data requirements
that were codified in 1984) and the
Agency’s current practices in requiring
data is $646,000 annually. The
difference between the proposed data
requirements and current practices is
$3.2 million annually. The difference
between the proposed data requirements
and the existing data requirements is
$3.9 million annually. The average cost
per registration action of a new
antimicrobial active ingredient is
approximately $1 million to $4.5
million. It is noted that this analysis
applies only to new antimicrobial
pesticides submitted for registration,
and to new uses of currently registered
antimicrobial pesticides.
For existing chemicals, the proposed
part 158 subpart W data requirements
would be relevant to the registration
review program which began to replace
the reregistration program in 2006 as a
means of systematically reviewing
existing registrations against the
standards of FIFRA. Data needs
identified under registration review for
existing chemicals must be imposed
under the Agency’s Data Call-In (DCI)
program.
EPA has not evaluated the potential
burden of the proposed data
requirements on registrants of existing
chemicals in this proposal. However,
EPA anticipates that there will be
additional costs associated with the
proposed studies under Registration
Review. For each chemical, EPA will
evaluate the specific need for additional
data, including studies proposed today.
Stakeholders and the public have
opportunities for input, consultation
and involvement concerning individual
pesticide cases throughout the
registration review process. Although
EPA has identified the schedule for
which chemicals will be reviewed over
the next few years, the evaluation of
data needs has not been done. Thus, the
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
costs are unknown. EPA will articulate
the specific burden and costs associated
with each DCI pursuant to the
appropriate Information Collection
Request (ICR) approvals under the
Paperwork Reduction Act (PRA).
B. Regulatory Flexibility Act
Pursuant to section 605(b) of the
Regulatory Flexibility Act (RFA), 5 USC
601 et seq., the Agency hereby certifies
that this action will not have a
significant adverse economic impact on
a substantial number of small entities.
The factual basis for the Agency’s
determination is presented in the small
entity impact analysis prepared as part
of the economic analysis for this
proposed rule (Ref. 44), which is
summarized in Unit XXIII.A., and a
copy of which is available in the docket
for this rulemaking. The following is a
brief summary of the factual basis for
this certification.
Under the RFA, small entities include
small businesses, small organizations,
and small governmental jurisdictions.
For purposes of assessing the impacts of
today’s proposed rule on small entities,
small entity is defined in accordance
with the RFA as: (1) a small business as
defined by the Small Business
Administration’s (SBA) regulations at 13
CFR 121.201, which is based on either
the maximum number of employees or
on the sales for small businesses in each
industry sector, as defined by a 6–digit
NAICS code; (2) a small governmental
jurisdiction that is a government of a
city, county, town, school district or
special district with a population of less
than 50,000; and (3) a small
organization that is any not-for-profit
enterprise which is independently
owned and operated and is not
dominant in its field. EPA has
determined that this rulemaking does
not impact any small governmental
jurisdictions or any small not-for-profit
enterprise because these entities are
PO 00000
Frm 00048
Fmt 4701
Sfmt 4702
rarely pesticide applicants or
registrants.
Some of the small entities directly
regulated by this rulemaking are in the
pesticide and other agricultural
chemical manufacturing industry sector
(NAICS code 325320). Firms in this
sector are considered small under the
RFA definition if they employ 500 or
fewer people. The economic analysis for
this proposed rule specifies the NAICS
code used for each of the firms
analyzed.
As detailed in the Economic Analysis,
EPA estimates that 750 unique parent
companies constitute the total universe
of pesticide antimicrobial registrants. Of
these, based on the SBA definition of a
small business and the available sales
data for these firms, EPA estimates that
500, or approximately 67%, qualify as a
small business. The available
antimicrobial pesticide registration data
for 2000–2005 indicates that only a
small portion of the 500 registrants are
likely to be impacted by the proposed
regulation. Specifically, 64 firms with
antimicrobial registrations would have
incurred additional costs under the
proposed rule. Of the 64 firms, EPA
estimates that a total of 25 small
pesticide registrants would have
incurred additional costs under the
proposed rule.
The impacts to small antimicrobial
registrants are measured as the per firm
incremental cost, which is the
difference between the existing data
requirements in part 161 (the baseline)
and those proposed in this rule. The
impact of the regulation is expressed as
the proportion of the average annual per
firm incremental costs to the average
annual firm sales.
The Agency’s analysis of impacts on
small businesses indicates that:
• About 25 (5%) of the 500 small firms
subject to the proposal are likely to
experience some impact (greater than
0%).
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
• About 22 (4.4%) of the 500 small
firms are likely to experience an
economic impact of 1% or more of gross
sales.
• About 14 (2.8%) of the 500 small
firms are likely to experience an
economic impact of 3% or more of gross
sales.
Based on the Agency’s small business
impact analysis, the Agency does not
anticipate that the additional costs to
industry resulting from this proposed
rule will cause a significant adverse
economic impact on a substantial
number of small entities because the
additional costs are a small share of
gross revenues for most firms and less
than 5% of small firms are likely to
experience some impact.
EPA is particularly interested in
receiving comment from small
businesses as to the benefits, costs and
impacts of this rule. Any comments
should be submitted to the Agency in
the manner specified under ADDRESSES.
C. Paperwork Reduction Act
The information collection
requirements contained in this proposed
rule have been submitted for approval to
the Office of Management and Budget
(OMB) under the Paperwork Reduction
Act (PRA), 44 U.S.C. 3501 et seq. EPA
has prepared a new Information
Collection Request (ICR) document
identified by EPA ICR No. 2318.01, a
copy of which has also been placed in
the docket for this proposed rule. (Ref.
45).
Under the PRA, ‘‘burden’’ is defined
at 5 CFR 1320.3(b). In addition, an
agency may not conduct or sponsor, and
a person is not required to respond to
an information collection request unless
it displays a currently valid OMB
control number, or is otherwise required
to submit the specific information by a
statute. The OMB control numbers for
certain EPA regulations in 40 CFR, after
appearing in the preamble of the final
rule, are listed in 40 CFR part 9 and, if
applicable, included with the related
collection instrument (e.g., form or
survey).
The information collection activities
related to the submission of data to EPA
in order to register, amend or retain a
new or existing pesticide product or
obtain a tolerance for that product are
already approved by OMB under the
PRA. As such, this ICR only addresses
the proposed changes to the data
requirements that impact the
information collection activities related
to antimicrobial pesticides. The
procedures for submitting data to EPA
under FIFRA and the FFDCA are not
changed in this proposal, and are
already approved by OMB as follows:
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
1. The data submission activities
associated with the establishment of a
tolerance are currently approved under
OMB Control No. 2070–0024 (EPA ICR
No. 0597);
2. The data submission activities
associated with the application for a
new or amended registration of a
pesticide are currently approved under
OMB Control No. 2070–0060 (EPA ICR
No. 0277);
3. The data submission activities
associated with the generation of data
for reregistration are currently approved
under OMB Control No. 2070–0107
(EPA ICR No. 1504); and
4. The data submission activities
associated with the generation of data
for special review or registration review
are currently approved under OMB
Control No. 2070–0057 (EPA ICR No.
0922).
These program activities are an
integral part of the Agency pesticide
program and the corresponding ICRs are
regularly renewed every three years as
required by the PRA. The total
estimated average annual public
reporting burden currently approved by
OMB for these various activities range
from 8 hours to approximately 3,000
hours per respondent, depending on the
activity and other factors surrounding
the particular pesticide product.
In the new ICR for this proposed rule,
which is based on the Economic
Analysis (Ref. 44), EPA estimates that
the typical current annual paperwork
burden for registrants per antimicrobial
pesticide registration is 194 burden
hours and $12,631. This represents the
baseline antimicrobial pesticide
registration burden and costs. When
considering the potential increase in
this estimated annual burden and cost
resulting from the new data
requirements in this proposed rule, the
Agency estimated the incremental
burden and cost to be 35% of the
baseline burden and costs, i.e., 68
burden hours and $4,421. Assuming an
annual number of 15 antimicrobial
pesticide registrations, the total annual
registrant paperwork burden and costs
for antimicrobial pesticide registrations
are estimated to be approximately 3,929
hours and $255,773.25, of which 1,019
hours and $66,150 represent burden
related to new data requirements, and
$158.25 represents estimated delivery
costs.
Any comments on the Agency’s need
for this information, the accuracy of the
provided burden estimates, and any
suggested methods for minimizing
respondent burden, should be directed
to the docket for this proposed rule,
under Docket ID number EPA–HQ–
OPP–2008–0110. See ADDRESSES
PO 00000
Frm 00049
Fmt 4701
Sfmt 4702
59429
section at the beginning of this
document for where to submit
comments to EPA.
You may also submit a copy of your
comments on the ICR directly to OMB.
Comments to OMB should be sent to the
Office of Information and Regulatory
Affairs, Office of Management and
Budget (OMB), 725 17th Street, NW,
Washington, DC 20503, Attention: Desk
Office for EPA. Since OMB is required
to make a decision concerning the ICR
between 30 and 60 days after October 8,
2008, a comment to OMB is best assured
of having its full effect if OMB receives
it by November 7, 2008.
In the final rule, the Agency will
address any comments received
regarding the information collection
requirements contained in this proposal.
In addition, after the ICR for the final
rule is approved, EPA will incorporate
the increased burden into the existing
ICRs as appropriate.
D. Unfunded Mandates Reform Act
Under Title II of the Unfunded
Mandates Reform Act of 1995 (UMRA)
(Public Law 104– 4), EPA has
determined that this action does not
contain a Federal mandate that may
result in expenditures of $100 million or
more for State, local, and tribal
governments, in the aggregate, or the
private sector in any one year. As
described in this document, the
incremental costs for the proposed part
158 subpart W data requirement
changes for antimicrobial pesticides is
estimated at nearly $3.9 million per year
for the private sector, which is below
the $100 million threshold. Since State,
local, and tribal governments are rarely
pesticide applicants, the proposed rule
is not expected to significantly or
uniquely affect small governments.
Accordingly, this action is not subject to
the requirements of sections 202 and
205 of UMRA.
E. Executive Order 13132
Pursuant to Executive Order 13132,
entitled Federalism (64 FR 43255,
August 10, 1999), EPA has determined
that this proposed rule does not have
‘‘federalism implications,’’ because it
will not have substantial direct effects
on the states, on the relationship
between the national government and
the states, or on the distribution of
power and responsibilities among the
various levels of government, as
specified in the Order. As indicated
above, instances where a state is a
registrant are extremely rare. Therefore,
this proposed rule may seldom affect a
state government. Thus, Executive
Order 13132 does not apply to this
proposed rule. In the spirit of the Order,
E:\FR\FM\08OCP2.SGM
08OCP2
59430
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
and consistent with EPA policy to
promote communications between the
Agency and State and local
governments, EPA specifically solicits
comment on this proposed rule from
State and local officials.
F. Executive Order 13175
As required by Executive Order
13175, entitled Consultation and
Coordination with Indian Tribal
Governments (65 FR 67249, November
6, 2000), EPA has determined that this
proposed rule does not have tribal
implications because it will not have
substantial direct effects on tribal
governments, on the relationship
between the Federal government and
the Indian tribes, or on the distribution
of power and responsibilities between
the Federal government and Indian
tribes, as specified in the Order. As
indicated above, at present, no tribal
governments hold, or have applied for,
a pesticide registration. Thus, Executive
Order 13175 does not apply to this
proposed rule. In the spirit of the Order,
and consistent with EPA policy to
promote communications between the
Agency and State and local
governments, EPA specifically solicits
comment on this proposed rule from
tribal officials.
sroberts on PROD1PC70 with PROPOSALS
G. Executive Order 13045
This section is not subject to
Executive Order 13045, entitled
Protection of Children from
Environmental Health Risks and Safety
Risks (62 FR 19885, April 23, 1997)
because it does not propose an
environmental standard that is intended
to have a negatively disproportionate
effect on children. To the contrary, this
action will provide added protection for
children from pesticide risk. The
proposed data requirements are
intended to address risks that, if not
addressed, could have a
disproportionate negative impact on
children. EPA will use the data and
information obtained by this proposed
rule to carry out its mandate under
FFDCA to give special attention to the
risks of pesticides to sensitive
subpopulations, especially infants and
children.
H. Executive Order 12898
This proposed rule does not have an
adverse impact on the environmental
and health conditions in low-income
and minority communities because this
proposed rule only impacts entities that
intend to register or currently hold a
registration for an antimicrobial
pesticide. Therefore, under Executive
Order 12898, entitled Federal Actions to
Address Environmental Justice in
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
Minority Populations and Low-Income
Populations (59 FR 7629, February 16,
1994), the Agency does not need to
consider environmental justice-related
issues.
I. National Technology Transfer and
Advancement Act
Section 12(d) of the National
Technology Transfer and Advancement
Act of 1995 (NTTAA), 15 U.S.C. 272
note) directs EPA to use voluntary
consensus standards in its regulatory
activities unless to do so would be
inconsistent with applicable law or
impractical. Voluntary consensus
standards are technical standards (e.g.,
materials specifications, test methods,
sampling procedures, etc.) that are
developed or adopted by voluntary
consensus standards bodies. NTTAA
directs EPA to provide Congress,
through OMB, explanations when the
Agency decides not to use available and
applicable voluntary consensus
standards. This regulation proposes the
types of data to be required to support
antimicrobial pesticide registration but
does not propose to require specific
methods or standards to generate those
data.
This proposed regulation does not
impose any technical standards that
would require Agency consideration of
voluntary consensus standards. The
Agency invites comment on its
conclusion regarding the applicability of
voluntary consensus standards to this
rulemaking.
J. Executive Order 12630
EPA has complied with Executive
Order 12630, entitled Governmental
Actions and Interference with
Constitutionally Protected Property
Rights (53 FR 8859, March 15, 1988), by
examining the takings implications of
this rule in accordance with the
‘‘Attorney General’s Supplemental
Guidelines for the Evaluation of Risk
and Avoidance of Unanticipated
Takings’’ issued under the Executive
Order.
K. Executive Order 12988
In issuing this rule, EPA has taken the
necessary steps to eliminate drafting
errors and ambiguity, minimize
potential litigation, and provide a clear
legal standard for affected conduct, as
required by section 3 of Executive Order
12988, entitled Civil Justice Reform (61
FR 4729, February 7, 1996).
L. Executive Order 13211
This rule is not subject to Executive
Order 13211, entitled ‘‘Actions
concerning Regulations that
Significantly Affect Energy Supply,
PO 00000
Frm 00050
Fmt 4701
Sfmt 4702
Distribution, or Use’’ (66 FR 28355, May
22, 2001) because it is not likely to have
any adverse effect on the supply,
distribution, or use of energy.
Lists of Subjects in 40 CFR Part 158
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and record keeping
requirements.
Lists of Subjects in 40 CFR Part 161
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and record keeping
requirements.
Dated: September 24, 2008.
Stephen L. Johnson,
Administrator.
Therefore, it is proposed that 40 CFR
part 158 and part 161 be amended as
follows:
1. The authority citation for part 158
continues to read as follows:
Authority: 7 U.S.C. 136–136y and 21
U.S.C. 346a.
2. Section 158.1(c)(4) is revised to
read as follows:
§ 158.1
Purpose and scope.
*
*
*
*
*
(c) * * *
(4) Antimicrobial pesticides. Subparts
A, B, C, D, and W apply to antimicrobial
pesticides.
3. Section 158.100 is amended by
revising the heading of paragraph (a); by
revising paragraph (b); by redesignating
paragraph (c) as paragraph (e); and by
adding new paragraphs (c) and (d) to
read as follows:
§ 158.100
Pesticide use patterns.
(a). General use patterns for
conventional, biochemical, and
microbial pesticides. * * *
(b) Pesticide use site index for
conventional, biochemical, and
microbial pesticides. The Pesticide Use
Site Index for Conventional,
Biochemical, and Microbial Pesticides is
a comprehensive list of specific
pesticide use sites. The index is
alphabetized separately by site for all
agricultural and all nonagricultural
uses. The Pesticide Use Site Index
associates each pesticide use site with
one or more of the 12 general use
patterns. It may be used in conjunction
with the data tables to determine the
applicability of data requirements to
specific uses. The Pesticide Use Site
Index for Conventional, Biochemical,
and Microbial Pesticides, which will be
updated periodically, is available from
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
the Agency or may be obtained from the
Agency’s website at https://
www.epa.gov/pesticides.
(c) Antimicrobial pesticide use
patterns. The general use patterns for
antimicrobial pesticides are described in
§ 158.2201.
(d) Pesticide use site index for
antimicrobial pesticides. The Pesticide
Use Site Index for Antimicrobial
Pesticides is a comprehensive list of
specific antimicrobial use sites. The
index is alphabetized by antimicrobial
use sites, and associates each
antimicrobial use site with one or more
of the antimicrobial use patterns. It may
be used in conjunction with the data
tables to determine the applicability of
data requirements to specific uses. The
Pesticide Use Site Index for
Antimicrobial Pesticides, which will be
updated periodically, is available from
the Agency or may be obtained from the
Agency’s website at https://
www.epa.gov/pesticides/regulating/
usesite/.
(e) * * *
§ 158.400
[Amended]
4. The table in § 158.400(d) is
amended by removing the category
‘‘Efficacy of antimicrobial agents’’ and
all of the entries under that category.
5. Part 158 is amended by adding
subpart W to read as follows:
Subpart W—Antimicrobial Pesticide
Data Requirements
Sec
§ 158.2200
§ 158.2201
§ 158.2203
§ 158.2210
§ 158.2220
§ 158.2230
§ 158.2240
§ 158.2250
§ 158.2260
§ 158.2270
§ 158.2280
§ 158.2290
Applicability.
Antimicrobial use patterns.
Definitions.
Product chemistry.
Product performance.
Toxicology data.
Nontarget organisms.
Nontarget plant protection.
Applicator exposure.
Post-application exposure.
Environmental fate.
Residue chemistry.
Subpart W—Antimicrobial Pesticide
Data Requirements
sroberts on PROD1PC70 with PROPOSALS
§ 158.2200
Applicability.
Subpart W establishes data
requirements for any pesticide product
that is:
(a) A pesticide that is intended for use
as an ‘‘antimicrobial pesticide’’ within
the meaning of FIFRA section
2(mm)(1)(A), regardless of whether it
also meets the criterion of FIFRA
section 2(mm)(1)(B). That criterion
excludes from the definition any
antimicrobial product that is intended
for a food-use requiring a tolerance or
exemption under FFDCA section 408 or
a food additive regulation under FFDCA
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
section 409. EPA will apply this subpart
to all products intended for an
antimicrobial use, purpose or function;
the exclusion in FIFRA section
2(mm)(1)(B) does not exclude products
from the data requirements of this
subpart.
(b) A product that bears both
antimicrobial and non-antimicrobial
uses or claims is subject to the data
requirements for pesticides in subparts
C – O, and U or V of this part with
respect to its non-antimicrobial uses and
claims, and to the requirements of this
subpart W with respect to its
antimicrobial uses and claims.
(c) A wood preservative, including a
product that is intended to prevent
wood degradation problems due to
fungal rot or decay, sapstain, or molds.
(d) An antifoulant, including a
product that is intended to kill or repel
organisms that can attach to underwater
surfaces, such as boat bottoms.
§ 158.2201
Antimicrobial use patterns.
(a) Antimicrobial use patterns. The 12
general use patterns used in the data
tables in this subpart are:
(1) Agricultural premises and
equipment.
(2) Food-handling/storage
establishments, premises and
equipment.
(3) Commercial, institutional and
industrial premises and equipment.
(4) Residential and public access
premises.
(5) Medical premises and equipment.
(6) Human drinking water systems.
(7) Materials preservatives.
(8) Industrial processes and water
systems.
(9) Antifoulant paints and coatings.
(10) Wood preservatives.
(11) Swimming pools.
(12) Aquatic areas.
(b) Use site index. The Antimicrobial
Use Site Index is a comprehensive list
of specific antimicrobial use sites. The
Index associates antimicrobial use sites
with one or more of the 12 antimicrobial
use patterns. It is to be used in
conjunction with the data tables in this
subpart to determine the applicability of
data requirements to specific uses. The
Antimicrobial Pesticide Use Site Index,
which will be updated periodically, is
available from the Agency or may be
obtained from the Agency’s website at
https://www.epa.gov/pesticides/
regulating/usesite/.
(c) An applicant unsure of the correct
use pattern(s) for his product should
consult the Agency.
§ 158.2203
Definitions.
(a) Definitions. The following terms
are defined for the purposes of this
subpart:
PO 00000
Frm 00051
Fmt 4701
Sfmt 4702
59431
(1) Disinfectant means a substance
that destroys or eliminates a specific
species of infectious or other public
health microorganism, but not
necessarily bacterial spores, in the
inanimate environment.
(2) Fungicide means a substance that
destroys fungi (including yeasts) and
fungal spores pathogenic to man or
other animals in the inanimate
environment.
(3) Microbiological water purifier
means any unit, water treatment
product or system that removes, kills or
inactivates all types of disease-causing
microorganisms from the water,
including bacteria, viruses and
protozoan cysts, so as to render the
treated water safe for drinking.
(4) Sanitizer means a substance that
reduces the bacterial population in the
inanimate environment by significant
numbers, but does not destroy or
eliminate all bacteria or other
microorganisms.
(5) Sterilant means a substance that
destroys or eliminates all forms of
microbial life in the inanimate
environment, including all forms of
vegetative bacteria, bacterial spores,
fungi, fungal spores, and viruses. For
purposes of this subpart, ‘‘sporicide’’
and ‘‘sterilant’’ are synonymous.
(6) Tuberculocide means a substance
that destroys or irreversibly inactivates
tubercle bacilli in the inanimate
environment.
(7) Virucide means a substance that
destroys or inactivates viruses in the
inanimate environment.
(b) Public health claim. An
antimicrobial pesticide is considered to
make a public health claim if the
pesticide product bears a claim to
control pest microorganisms that pose a
threat to human health, and whose
presence cannot readily be observed by
the user, including but not limited to,
microorganisms infectious to man in
any area of the inanimate environment.
A product makes a public health claim
if one or more of the following apply:
(1) A claim is made for control of
specific microorganisms or classes of
microorganisms that are directly or
indirectly infectious or pathogenic to
man (or both man and animals).
Examples of specific microorganisms
include, but are not limited to,
Mycobacterium tuberculosis,
Pseudomonas aeruginosa, Eschericha
coli (E. coli), human immunodeficiency
virus (HIV), Streptococcus, and
Staphylococcus aureus. Claims for
control of microorganisms infectious or
pathogenic only to animals (such as
canine distemper virus or hog cholera
virus) are not considered public health
claims.
E:\FR\FM\08OCP2.SGM
08OCP2
59432
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
(2) A claim is made for the pesticide
product as a sterilant, disinfectant,
virucide, sanitizer, or tuberculocide
regardless of the site of use of the
product, and regardless of whether
specific microorganisms are identified.
(3) A claim is made for the pesticide
product as a fungicide against fungi
infectious or pathogenic to man, or the
product does not clearly state that it is
intended for use only against non-public
health fungi.
(4) A claim is made for the pesticide
product as a microbiological water
purifier or microbial purification
system.
(5) A non-specific claim is made that
the pesticide product will beneficially
impact or affect public health at the site
of use or in the environment in which
applied (such as a ‘sanitary’ claim), and:
(i) The pesticide product contains one
or more ingredients that, under the
criteria in 40 CFR 153.125(a), is an
active ingredient with respect to a
public health microorganism and there
is no other functional purpose for the
ingredient in the product; or
(ii) The pesticide product is similar in
composition to a registered pesticide
product that makes explicit
antimicrobial public health claims.
§ 158.2210
Product chemistry.
The product chemistry data
requirements of subpart D of this part
apply to antimicrobial products covered
by this subpart.
§ 158.2220
Product performance.
(a) General. (1) Product performance
requirement for all antimicrobial
pesticides. Each applicant must ensure
through testing that his product is
efficacious when used in accordance
with label directions and commonly
accepted pest control practices. The
Agency may require, on a case-by-case
basis, submission of product
performance data for any pesticide
product registered or proposed for
registration.
(2) Product performance data for each
product that bears a public health
claim. Each product that bears a public
health claim, as described in
§ 158.2203(b), must be supported by
product performance data, as listed in
the table in this paragraph. Product
performance data must be submitted
with the application for registration or
amended registration.
(3) Determination of data
requirements. Subpart B of this part and
§ 158.2201 describe how to use the table
in paragraph (c) of this section to
determine the product performance data
requirements for antimicrobial pesticide
products.
(b) Key. R = Required; EP = End-use
product;
(c) Table. The following table shows
the data requirements for product
performance.
TABLE — ANTIMICROBIAL PRODUCT PERFORMANCE DATA REQUIREMENTS
Guideline Number
Data Requirement
All Use Patterns
Test Substance
91–2
Products for use on hard surfaces
R
EP
91–3
Products requiring confirmatory
data
R
EP
91–4
Products for use on fabrics and
textiles
R
EP
91–5
Air sanitizers
R
EP
91–7
Products for control of microbial
pests associated with human
and animal wastes
R
EP
91–8
Products for treating water systems
R
EP
sroberts on PROD1PC70 with PROPOSALS
§ 158.2230
Toxicology data.
(a) General. Subpart B of this part and
§ 158.2201 describe how to use the table
in paragraph (d) of this section to
determine the toxicology data
requirements for an antimicrobial
pesticide product. Notes that apply to
an individual test including specific
conditions, qualifications, or exceptions
are listed in paragraph (e) of this
section.
(b) Uses. The applicant for registration
must first determine whether the use is
a high human exposure use or a low
human exposure use. If an applicant is
not sure if a specific use is a high
human exposure or a low human
exposure use, the applicant should
consult the Agency.
(1) High human exposure uses. For
the purpose of determining data
requirements, high human exposure
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
includes those uses which are likely to
result in human exposure over a
considerable portion of the human
lifespan, and which are significant in
terms of frequency, duration, or
magnitude of exposure, i.e., uses for
which there is an expectation of high,
prolonged, or repeated exposure. High
human exposure uses of antimicrobials
include but are not limited to:
(i) Any use which requires a tolerance
or tolerance exemption (except for
indirect food uses requiring a tolerance
or tolerance exemption in which
residues are less than 200 ppb).
(ii) Indirect food uses with residues
equal to or greater than 200 ppb.
(iii) Use in human or animal drinking
water.
(iv) Fruit and vegetable rinses.
(v) Egg washes.
(vi) Swimming pools.
PO 00000
Frm 00052
Fmt 4701
Sfmt 4702
(vii) Outdoor aquatic uses in lakes,
rivers or streams which have the
potential to contaminate potable water.
(viii) Wood preservatives.
(ix) Metalworking fluids.
(2) Low human exposure nonfood and
low human exposure indirect food uses.
Generally, low exposure uses are those
not listed in paragraph (b)(1) of this
section as high exposure uses.
(3) Tiering of data requirements.
Applicants for registration of
antimicrobials may perform tests in a
tiered fashion. After the initially
required tests are conducted, additional
testing may be required if results of the
initial tests trigger the need for
additional data. Conditions that trigger
the need for additional data are given in
the test notes in paragraph (e) of this
section.
E:\FR\FM\08OCP2.SGM
08OCP2
59433
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
(c) Key. R = Required; CR =
Conditionally required; NR = Not
required; MP = Manufacturing-use
product; EP = End-use product; TGAI =
Technical grade of the active ingredient;
TEP = Typical end-use product; PAI =
Pure active ingredient; PAIRA = Pure
active ingredient, radiolabeled; Choice =
choice of several test substances
depending on studies required.
(d) Table. The following table shows
the data requirements for toxicology.
The test notes appear in paragraph (e) of
this section.
TABLE — ANTIMICROBIAL TOXICOLOGY DATA REQUIREMENTS
Use Pattern
Guideline Number
Test Substance to Support
High
Human20Exposure
Uses
Data Requirement
Low
Human
Exposure
Uses
MP
EP
Test Note No.
Acute Testing
870.1100
Acute oral toxicity - rat
R
R
MP and
TGAI
EP and
TGAI
1, 2
870.1200
Acute dermal toxicity
R
R
MP and
TGAI
EP and
TGAI
1, 2, 3
870.1300
Acute inhalation toxicity - rat
R
R
MP and
TGAI
EP and
TGAI
4
870.2400
Primary eye irritation - rabbit
R
R
MP and
TGAI
EP and
TGAI
1, 2, 3
870.2500
Primary dermal irritation
R
R
MP and
TGAI
EP and
TGAI
1, 2, 3
870.2600
Dermal sensitization
R
R
MP and
TGAI
EP and
TGAI
1, 2, 3, 5
870.6200
Acute neurotoxicity - rat
R
CR
TGAI
TGAI
6
870.3100
90–Day oral toxicity - rodent
R
R
TGAI
TGAI
7, 8, 9, 15
870.3150
90–Day oral toxicity - nonrodent
R
CR
TGAI
TGAI
7, 10, 11, 15
870.3250
21/28–Day dermal toxicity
CR
CR
TGAI
EP and
TGAI
12, 13
870.2500
90–Day dermal toxicity
CR
CR
TGAI
EP and
TGAI
7, 13, 14, 15
870.3465
90–Day inhalation - toxicity - rat
CR
CR
TGAI
TGAI
7, 15, 16, 17
870.6200
90–Day neurotoxicity - rat
R
CR
TGAI
TGAI
6, 8
870.4100
Chronic oral toxicity - rodent
R
CR
TGAI
TGAI
18, 19, 20
870.4200
Carcinogenicity - two rodent species
- rat and mouse preferred
R
CR
TGAI
TGAI
19, 21, 22
Subchronic Testing
Chronic Testing
Developmental Toxicity and Reproduction
Prenatal developmental toxicity - rat
and rabbit preferred
R
R
TGAI
TGAI
23, 24, 25, 26
870.3800
Reproduction and fertility effects
R
R
TGAI
TGAI
26, 27, 28, 29
870.6300
sroberts on PROD1PC70 with PROPOSALS
870.3700
Developmental neurotoxicity
CR
CR
TGAI
TGAI
28, 29, 30
870.5100
Reverse mutation assay
R
R
TGAI
TGAI
31, 32
870.5300
870.5375
In vitro mammalian gene mutation
R
R
TGAI
TGAI
31, 33
Mutagenicity
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
PO 00000
Frm 00053
Fmt 4701
Sfmt 4702
E:\FR\FM\08OCP2.SGM
08OCP2
59434
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
TABLE — ANTIMICROBIAL TOXICOLOGY DATA REQUIREMENTS—Continued
Use Pattern
Test Substance to Support
High
Human20Exposure
Uses
Low
Human
Exposure
Uses
MP
EP
In vivo cytogenetics
R
R
TGAI
TGAI
31, 34
870.7485
Metabolism and pharmacokinetics
R
CR
PAI or
PAIRA
PAI or
PAIRA
35
870.7200
Companion animal safety
CR
CR
NR
Choice
36
870.7600
Dermal penetration
CR
CR
Choice
Choice
37
870.7800
Immunotoxicity
R
R
TGAI
TGAI
--
Guideline Number
870.5380
870.5385
870.5395
Data Requirement
Test Note No.
Special Testing
sroberts on PROD1PC70 with PROPOSALS
(e) Test notes. The following test
notes apply to the data requirements in
the table to paragraph (d) of this section:
1. Not required if test material is a gas or
highly volatile liquid.
2. For the six acute toxicity studies
conducted with the end-use product, the test
must be conducted using the product as
formulated for sale and distribution.
However, if the end-use product is labeled
that the product is to be diluted for use, the
applicant may also conduct certain studies
using the highest diluted concentration (i.e.
the least diluted product) permitted by the
labeling. The end-use dilution testing is in
addition to the as- formulated-for-sale testing
and used only for labeling purposes.
Consultation with the Agency is highly
suggested to assure that the appropriate
product and any appropriate dilutions are
tested.
3. Not required if test material is corrosive
to skin or has pH less than 2 or greater than
11.5.
4. Data are required when the product
consists of, or under conditions of use will
result in, a respirable material (e.g., gas,
vapor, aerosol or particulates).
5. Data are required if repeated dermal
exposure is likely to occur under conditions
of use.
6. For low exposure uses, data are required
if the neurotoxicity screen in the 90–day oral
rodent study or other data indicate
neurotoxicity.
7. The 90–day dermal toxicity study or 90–
day inhalation toxicity study may be
substituted for the 90–day oral toxicity study
if the Agency determines that dermal or
inhalation exposure is a major route of
exposure.
8. All 90–day subchronic studies in the
rodent can be designed to simultaneously
fulfill the requirements of the 90–day
neurotoxicity study by adding separate
groups of animals for testing.
9. The 90–day study is required in the
rodent for hazard characterization (possibly
endpoint selection) and dose-setting for the
chronic/carcinogenicity study. It is not
required in the mouse, but the Agency would
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
encourage the applicant to conduct a 90–day
range finding study for the purposes of dose
selection for the mouse carcinogenicity study
to achieve adequate dosing and an acceptable
study. The applicant is also encouraged to
consult with the Agency on the results of the
90–day mouse study prior to conducting the
carcinogenicity study.
10. A 1–year non-rodent study (i.e., 1–year
dog study) may be required if the Agency
finds that a pesticide chemical is highly
bioaccumulating and is eliminated slowly.
Thus it does not achieve steady state or
sufficient tissue concentrations to elicit an
effect during a 90–day study. EPA may
require the appropriate tier II metabolism and
pharmacokinetic studies to evaluate more
precisely bioavailability, half life, and steady
state to determine if a longer duration dog
toxicity study is needed.
11. For low human exposure uses, data are
required if any of the following criteria are
met:
i. The use of the pesticide is likely to result
in repeated human exposure over a limited
portion of the human lifespan, as determined
by the Agency.
ii. The use is an indirect food use (less than
200 ppb).
12. Data are required if the intended use of
the antimicrobial pesticide product is
expected to result in human exposure to the
product, and the three following conditions
are met:
i. Human exposure is via skin contact.
ii. Expected human exposure is not
purposeful, and is over a limited portion of
the human lifespan; however, as determined
by EPA, the exposure is significant in terms
of the frequency of exposure, magnitude of
exposure, or the duration of exposure.
iii. Data from a subchronic 90–day dermal
toxicity study are not available and the 90–
day dermal toxicity study has not been
triggered.
13. EP testing is required if the product or
any component of the product may increase
dermal absorption of the active ingredient(s)
or increase toxic or pharmacologic effects, as
determined by testing the TGAI or based on
PO 00000
Frm 00054
Fmt 4701
Sfmt 4702
available information about the toxic effects
of the product or its components.
14. Data are required if the use pattern is
such that the dermal route would be the
major route of exposure or if the active
ingredient of the product is known or
expected to be metabolized differently by the
dermal route of exposure than by the oral
route, and a metabolite of the active
ingredient is the toxic moiety.
15. A 90–day oral toxicity test is not
required for heating, ventilation, air
conditioning, and refrigeration systems
(collectively referred to as HVAC), and two
90–day toxicity tests, one by the dermal route
and one by the inhalation route are required.
16. Data are required if there is the
likelihood of significant repeated inhalation
exposure to the pesticide as a gas, vapor, or
aerosol.
17. Based on estimates of the magnitude
and duration of human exposure, studies of
shorter duration, e.g., 21– or 28–days, may be
sufficient to satisfy this requirement.
Applicants for registration may consult with
the Agency to determine whether studies of
shorter duration would meet this
requirement.
18. Based on the positive results of the
acute and/or 90–day neurotoxicity studies, or
on other data indicating neurotoxicity, a
chronic/neurotoxicity study (i.e. a chronic
study with additional neurotoxicity
evaluations) may be required to provide
information about potential neurotoxic
effects from long-term exposures.
19. Studies which are designed to
simultaneously fulfill the requirements of
both the chronic oral and carcinogenicity
studies (i.e., a combined study) may be
conducted.
20. For low exposure, data are required if
either of the following criteria are met:
i. The use of the pesticide is likely to result
in repeated human exposure over a limited
portion of the human lifespan, as determined
by the Agency, or
ii. The use requires that a tolerance or a
tolerance exemption be established.
E:\FR\FM\08OCP2.SGM
08OCP2
sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
21. For low exposure, data are required if
any of the following criteria, as determined
by the Agency, are met:
i. The use of the pesticide is likely to result
in significant human exposure over a
considerable portion of the human life span
which is significant in terms of frequency
time, duration, and/or magnitude of
exposure.
ii. The use requires that a tolerance or a
tolerance exemption be established.
iii. The active ingredient, metabolite,
degradate, or impurity
A. is structurally related to a recognized
carcinogen,
B. causes mutagenic effects as
demonstrated by in vitro or in vivo testing, or
C. produces a morphologic effect in any
organ (e.g., hyperplasia, metaplasia) in
subchronic studies that may lead to a
neoplastic change.
22. If the requirement for a carcinogenicity
study in any species is modified or waived
for any reason, then a subchronic 90–day oral
study in the same species may be required.
23. Testing in two species is required for
all uses.
24. The oral route, by oral intubation, is
preferred, unless the chemical or physical
properties of the test substance, or the pattern
of exposure, suggest a more appropriate route
of exposure.
25. Additional testing by other routes of
exposure may be required if the pesticide is
determined to be a prenatal developmental
toxicant after oral dosing.
26. The developmental toxicity study in
rodents may be combined with the twogeneration reproduction study in rodents by
using a second mating of the parental
animals in either generation. Protocols must
be approved by the Agency prior to the
initiation of the study. Details for developing
protocols are available from the Agency.
27. A two-generation reproduction study is
required.
28. An information-based approach to
testing is preferred, which utilizes the best
available knowledge on the chemical (hazard,
pharmacokinetic, or mechanistic data) to
determine whether a standard guideline
study, an enhanced guideline study, or an
alternative study should be conducted to
assess potential hazard to the developing
animal, or in some cases to support a waiver
for such testing. Applicants must submit any
alternative proposed testing protocols and
supporting scientific rationale to the Agency.
Protocols must be approved by the Agency
prior to the initiation of the study. Details for
developing protocols are available from the
Agency.
29. The use of a combined two-generation
reproduction/developmental neurotoxicity
study that utilizes the two-generation
reproduction study in rodents as a basic
protocol for the addition of other endpoints
or functional assessments in the immature
animal is encouraged.
30. A DNT study is required using a
weight-of-evidence approach when:
i. The pesticide causes treatment-related
neurological effects in adult animal studies
(i.e, clinical signs of neurotoxicity,
neuropathology, functional or behavioral
effects).
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
ii. The pesticide causes treatment-related
neurological effects in developing animals,
following pre- or post-natal exposure (i.e.,
nervous system malformations or
neuropathy, brain weight changes in
offspring, functional or behavioral changes in
the offspring).
iii. The pesticide elicits a causative
association between exposures and adverse
neurological effects in human
epidemiological studies.
iv. The pesticide evokes a mechanism that
is associated with adverse effects on the
development of the nervous system (i.e.,
structure-activity-relationship (SAR) to
known neurotoxicants, altered neuroreceptor
or neurotransmitter responses).
31. To enhance the weight-of-evidence
determination for the pesticide’s
mutagenicity, the Agency requires
submission of other mutagenicity test results,
besides those specifically listed in this table,
that may have been performed for other
endpoints that may be predictive of
mutagenicity. A reference list of all studies
and papers known to the applicant
concerning the mutagenicity of the test
chemical must be submitted with the
required studies.
32. Testing in Salmonella and E. coli may
be acceptable, if the testing can be conducted
at high enough levels, as determined by the
Agency. If the testing cannot be conducted at
high enough levels, then the applicant must
consult with the Agency to determine other
needed mutagenicity testing.
33. For the in vitro mammalian gene
mutation study, there is a choice of assays
using either mouse lymphoma L5178Y cell
thymidine kinase (tk) gene locus, maximizing
assay conditions for small colony expression
and detection; Chinese hamster ovary (CHO)
or Chinese hamster lung fibroblast (v79)
cells, hypoxanthine-guanine phosphoribosyl
transferase (hgprt) gene locus, accompanied
by an appropriate in vitro test for
clastogenicity; or CHO cells strains AS52,
xanthine-guanine phosphoribosyl transferase
(xprt) gene locus.
34. There is a choice of assays, but initial
consideration should be given to the rodent
bone marrow assay. The micronucleus rodent
bone marrow assay is preferred; the rodent
bone marrow assays using metaphase
analysis (aberrations) are acceptable.
35. For low exposure, these data are
required when chronic or carcinogenicity
studies are also required. These data may be
required if significant adverse effects are seen
in available toxicology studies and these
effects can be further elucidated by
metabolism studies.
36. These data may be required if the
product’s use will result in exposure to
domestic animals through, but not limited to,
direct application.
37. A risk assessment assuming that dermal
absorption is equal to oral absorption must be
performed to determine if the dermal
penetration study is required, and to identify
the doses and duration of exposure for which
dermal absorption is to be quantified.
§ 158.2240
Nontarget organisms.
(a) General. Subpart B of this part and
§ 158.2201 describe how to use the table
PO 00000
Frm 00055
Fmt 4701
Sfmt 4702
59435
in paragraph (e) of this section to
determine the terrestrial and aquatic
nontarget organisms and nontarget plant
protection data requirements for a
particular antimicrobial pesticide
product. Notes that apply to an
individual test including specific
conditions, qualifications, or exceptions
are listed in paragraph (f) of this section.
(1) Terrestrial and aquatic nontarget
organism data are required to support
the registration of most end-use and
manufacturing-use antimicrobial
products.
(2) Data are generally not required to
support end-use products of a gas,
highly volatile liquid, highly reactive
solid, or a highly corrosive material.
(3) If the Agency determines that the
transformation products of the
parentcompound are more toxic,
persistent, bioaccumulative, or have
been shown to cause adverse effects in
mammalian or aquatic reproductive
studies, then data on those
transformation products are required to
support registration.
(4) For wood preservatives, the
Agency may require data on both the
parent compound, which is
incorporated into wood, and on
transformation/degradation products
which occur in wood post-treatment or
occur as dislodgeable residues (such as
hand contact with treated wood) or
leachate residues (such as from soil or
water contact with treated wood).
(b) Low environmental exposures. For
the purpose of determining data
requirements, the low environmental
exposure grouping of use patterns
includes the following use patterns or
partial use patterns:
(1) Agricultural premises and
equipment.
(2) Food-handling/storage
establishments, premises, and
equipment.
(3) Commercial, institutional and
industrial premises and equipment.
(4) Residential and public access
premises.
(5) Medical premises and equipment.
(6) Human drinking water systems.
(7) Materials preservatives.
(8) Swimming pools.
(9) Recirculating industrial processes
and water systems in which the treated
water is re-used repeatedly within the
system.
(c) High environmental exposures. For
the purposes of determining data
requirements, the high environmental
exposure grouping of use patterns
includes the following use patterns or
partial use patterns:
(1) Once-through industrial processes
and water systems in which the water
is not re-used, and is released after a
single cycle through the system.
E:\FR\FM\08OCP2.SGM
08OCP2
59436
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
(2) Antifoulant paints and coatings.
(3) Wood preservatives.
(4) Aquatic areas.
(d) Key. MP = Manufacturing use
product; EP = End use product; R =
Required; CR = Conditionally required;
NR = Not required; TGAI = Technical
grade of the active ingredient; TEP =
Typical end-use product; PAIRA = Pure
active ingredient radiolabeled; a.i. =
active ingredient.
(e) Table. The following table shows
the data requirements for nontarget
organisms. The test notes appear in
paragraph (f) of this section.
TABLE — ANTIMICROBIAL NONTARGET ORGANISM DATA REQUIREMENTS
Use Pattern
Test Substance to
Support
High Environmental Exposure
Guideline
Number
Data Requirement
Test Note
No.
Low Environmental
Exposure
Industrial
Processes and
Water Systems(OnceThrough)
Antifoulant
Coatings
and Paints
Wood Preservatives
Aquatic
Areas
MP
EP
Tier One Testing
850.2100
Acute avian oral
toxicity
R
R
R
R
R
TGAI
TGAI
1
850.1010
Acute freshwater invertebrates toxicity
R
R
R
R
R
TGAI
TGAI
2
850.1075
Acute freshwater fish toxicity
R
R
R
R
R
TGAI
TGAI
3
Higher Tier Testing
Avian Testing
850.2200
Avian dietary
toxicity
CR
CR
CR
CR
R
TGAI
TGAI
4, 5
850.2300
Avian reproduction
CR
CR
CR
CR
R
TGAI
TGAI
1, 6
Aquatic Organisms Testing
Acute freshwater invertebrates toxicity
CR
R
NR
NR
R
---
TEP
2, 7
850.1075
Acute freshwater fish toxicity
CR
R
NR
NR
R
---
TEP
7
850.1025
850.1035
850.1045
850.1055
850.1075
Acute estuarine
and marine
organisms
toxicity
CR
CR
R
CR
CR
TGAI
TGAI
8, 9
Acute estuarine
and marine
organisms
toxicity
CR
CR
NR
NR
CR
---
TEP
7, 8
850.1400
Fish early-life
stage
CR
R
R
CR
R
TGAI
TGAI
10
850.1300
850.1350
sroberts on PROD1PC70 with PROPOSALS
850.1010
Aquatic invertebrate lifecycle
CR
R
R
CR
R
TGAI
TGAI
10
850.1500
Fish life-cycle
CR
CR
CR
CR
CR
TGAI
TGAI
11, 12
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
PO 00000
Frm 00056
Fmt 4701
Sfmt 4702
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
59437
TABLE — ANTIMICROBIAL NONTARGET ORGANISM DATA REQUIREMENTS—Continued
Use Pattern
Test Substance to
Support
High Environmental Exposure
Guideline
Number
Data Requirement
Test Note
No.
Low Environmental
Exposure
Industrial
Processes and
Water Systems(OnceThrough)
Antifoulant
Coatings
and Paints
Wood Preservatives
Aquatic
Areas
MP
EP
850.1710
850.1730
850.1850
Aquatic organisms, bioavailability,
biomagnification, toxicity
tests
CR
CR
CR
CR
CR
TGAI.PAI,
degradate
TGAI.PAI,
degradate
13
850.1950
Simulated or actual field testing for aquatic
organisms
CR
CR
CR
CR
CR
TEP
TEP
14, 15, 16
Sediment Testing
850.1735
Whole sediment; acute
freshwater invertebrates
CR
CR
R
CR
CR
TGAI
TGAI
15, 17
850.1740
Whole sediment; acute
marine invertebrates
CR
CR
R
CR
CR
TGAI
TGAI
15, 17, 19
None
Whole sediment; chronic
invertebrates
fresh-water
and marine
CR
CR
CR
CR
CR
TGAI
TGAI
15, 18, 19
Insect Pollinator Testing
850.3020
Honeybee acute
contact
CR
NR
NR
CR
NR
TGAI
TGAI
20
850.3030
Toxicity of residues to honeybees
CR
NR
NR
CR
NR
TGAI
TEP or
treated
wood
21
sroberts on PROD1PC70 with PROPOSALS
(f) Test notes. The following test notes
apply to the data requirements in the
table to paragraph (e) of this section:
1. For low environmental exposures, data
are required for one avian species. For
industrial processes and water systems (oncethrough), antifoulant paints and coatings,
wood preservatives, and aquatic areas, data
are required for one waterfowl species and
one upland game bird species.
2. Data are required on one freshwater
aquatic invertebrate species.
3. For low environmental exposures, data
are required on one species of fish, either one
cold water species or a warm water species.
Testing on a second species is required if the
active ingredient or principal transformation
products are stable in the environment and
the LC50 in the first species is greater than 1
ppm or 1mg/L. For all other use patterns,
data are required on two species of fish, one
cold water species and one warm water
species.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
4. For low environmental exposures,
industrial processes and water systems (oncethrough), antifoulant paints and coatings, and
wood preservatives, data are required for one
waterfowl species, if the avian acute oral
LD50 (TGAI testing) is less than or equal to
100 mg a.i./kg and a.i. residues or its
principal transformation products are likely
to occur in avian feed items. Data on one
upland game bird species are required if the
avian dietary LC50 in the first species tested
is less than or equal to 500 ppm a.i. in the
diet.
5. For aquatic areas, data are required on
one waterfowl species and one upland game
bird species.
6. For low environmental exposures,
industrial processes and water systems (oncethrough), antifoulant paints and coatings, and
wood preservatives, data are required if one
or more of the following criteria are met:
i. Birds may be subjected to repeated or
continued exposure to the pesticide or any of
PO 00000
Frm 00057
Fmt 4701
Sfmt 4702
its transformation products, especially
preceding or during the breeding season.
ii. The pesticide or any of its major
metabolites or degradation products are
stable in the environment to the extent that
a potentially toxic amount may persist in
avian feed.
iii. The pesticide or any of its major
metabolites or degradation products are
stored or accumulated in plant or animal
tissues, as indicated by the octanol/water
partition coefficient (Kow is greater than or
equal to 1,000), accumulation studies,
metabolic release and retention studies, or as
indicated by structural similarity to known
bioaccumulative chemicals.
iv. Any other information, such as that
derived from mammalian reproduction
studies that indicate that reproduction in
terrestrial vertebrates may be adversely
affected by the anticipated use of the
pesticide product.
E:\FR\FM\08OCP2.SGM
08OCP2
59438
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
7. TEP testing is required for any product
which meets one or more of the following
conditions:
i. The estimated environmental
concentration (EEC) in the aquatic
environment is equal to or greater than onehalf the LC50/EC50 of the TGAI when the enduse product is used as directed.
ii. An ingredient in the end-use product
other than the active ingredient is expected
to enhance the toxicity of the active
ingredient or to cause toxicity to aquatic
organisms.
8. Data are required on one estuarine/
marine mollusk, one estuarine/marine
invertebrate, and one estuarine/marine fish
species.
9. For low environmental exposures,
industrial processes and water systems (oncethrough), wood preservatives, and aquatic
areas, data are required if the pesticide
residues from the parent compound and/or
transformation products are likely to enter
the estuarine/marine environment.
10. For low environmental exposures, data
are required if pesticide residues from the
parent compound or transformation products
are likely to enter freshwater or estuarine/
marine environments, as determined by the
Agency. For wood preservatives, data are
required if pesticide residues from the parent
compound, transformation products, and/or
leachates from preservative-treated wood are
likely to enter freshwater or estuarine/marine
environments, as determined by the Agency.
Testing should be conducted with the most
sensitive organism (either freshwater or
estuarine/marine vertebrates, or freshwater or
estuarine/marine invertebrates), as
determined from the results of the acute
toxicity tests (acute EC50 freshwater
invertebrates; acute LC50/EC50 estuarine and
marine organisms; acute freshwater fish
LC50.)
11. Data are required on estuarine /marine
species if the product is intended for direct
application to the estuarine or marine
environment, or the product is expected to
enter this environment in significant
concentrations (as determined by the
Agency) because of its expected use or
mobility patterns.
12. Data are required on freshwater species
if the end-use product is intended to be
applied directly to water, or is expected to be
transported to water from the intended use
site, and when one or more of the following
conditions apply:
i. If the Estimated Environmental
Concentration (EEC) in water is equal to or
greater than 0.1 of the no-observed-effect
concentration or no-observed-effect level
(NOEC/NOEL) in the fish early-life stage or
invertebrate life-cycle tests.
ii. If studies of other organisms indicate
that the reproductive physiology of fish may
be affected.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
13. Not required when:
i. The octanol/water partition coefficients
of the pesticide and its major degradates are
less than 1,000; or
ii.There are no potential exposures to fish
and other nontarget aquatic organisms; or
iii. The hydrolytic half-life is less than 5
days at pH 5, 7, and 9.
14. Environmental chemistry methods used
to generate data associated with this study
must include results of a successful
confirmatory method trial by an independent
laboratory. Test standards and procedures for
independent laboratory validation are
available as addenda to the guideline for this
test requirement.
15. Protocols must be approved by the
Agency prior to the initiation of the study.
Details for developing protocols are available
from the Agency.
16. Data are required if the intended use
pattern, and the physical/chemical properties
and environmental fate characteristics of the
antimicrobial indicate significant potential
exposure and based on the results of the
acute and chronic aquatic organism testing
significant impairment of nontarget aquatic
organisms could result.
17. Data are required if the half-life of the
pesticide in the sediment is equal to or less
than 10 days in either the aerobic soil or
aquatic metabolism studies, and if one or
more of the following conditions are met:
i. The soil partition coefficient (Kd) is equal
to or greater than 50.
ii. The log Kow is equal to or greater than
3.
iii. The Koc is equal to or greater than
1,000.
18. Data are required if the EEC in
sediment is > 0.1 of the acute LC50/EC50
values and if one or more of the following
conditions are met:
i. The soil partition coefficient (Kd) is equal
to or greater than 50 L/kg.
ii. The log Kow is equal to or greater than
3.
iii. The Koc is equal to or greater than
1,000.
19. Sediment testing with estuarine/marine
test species is required if the product is
intended for direct application to the
estuarine or marine environment or the
product is expected to enter this environment
in significant concentrations (as determined
by the Agency) either by runoff or erosion,
because of its expected use or mobility
pattern.
20. Data are required only for beehive
applications when the beehive (empty or
occupied) is treated.
21. If beehives are constructed of treated
wood a study similar to ‘‘Honey Bee Toxicity
of Residues on Foliage’’ is required using
treated wood instead of the foliage. Protocols
must be approved by the Agency prior to the
PO 00000
Frm 00058
Fmt 4701
Sfmt 4702
initiation of the study. Details for developing
protocols are available from the Agency.
§ 158.2250
Nontarget plant protection.
(a) General. Subpart B of this part and
§ 158.2201 describe how to use the table
in paragraph (e) of this section to
determine the nontarget plant protection
data requirements for a particular
antimicrobial pesticide product. Notes
that apply to an individual test
including specific conditions,
qualifications, or exceptions are listed
in paragraph (f) of this section.
(b) Low environmental exposures. For
the purpose of determining data
requirements, the low environmental
exposure grouping of use patterns
includes the following use patterns or
partial use patterns:
(1) Agricultural premises and
equipment.
(2) Food-handling/storage
establishments, premises, and
equipment.
(3) Commercial, institutional and
industrial premises and equipment.
(4) Residential and public access
premises.
(5) Medical premises and equipment.
(6) Human drinking water systems.
(7) Materials preservatives.
(8) Swimming pools.
(9) Recirculating industrial processes
and water systems in which the treated
water is re-used repeatedly within the
system.
(c) High environmental exposures. For
the purposes of determining data
requirements, the high environmental
exposure grouping of use patterns
includes the following use patterns or
partial use patterns:
(1) Once-through industrial processes
and water systems in which the water
is not re-used, and is released after a
single cycle through the system.
(2) Antifoulant paints and coatings.
(3) Wood preservatives.
(4) Aquatic areas.
(d) Key. MP = Manufacturing use
product; EP = End use product; R =
Required; CR = Conditionally required;
NR = Not required; TGAI = Technical
grade of the active ingredient; TEP =
Typical end-use product.
(e) Table. The following table shows
the data requirements for nontarget
plant protection. The test notes appear
in paragraph (f) of this section.
E:\FR\FM\08OCP2.SGM
08OCP2
59439
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
TABLE — NONTARGET PLANT PROTECTION DATA REQUIREMENTS
Use Pattern
Test Substance to Support
High Environmental Exposure
Guideline
Number
Data Requirement
Low Environmental Exposure
Industrial
Processes
and Water
Systems(OnceThrough)
Antifoulant
Coatings
and Paints
Wood
Preservatives
EP
Test Note
No.
Aquatic
Areas
MP
850.4225
Seedling
emergence,
Tier II dose response
CR
R
R
R
R
TEP
TEP
1, 2
850.4250
Vegetative
vigor, Tier
II - dose
response
CR
CR
NR
R
R
TEP
TEP
1, 3
850.4400
Aquatic plant
growth
(aquatic
vascular
plant) Tier
II - dose
response
CR
R
R
R
R
TGAI, TEP
TGAI, TEP
2, 4
850.5400
Aquatic plant
growth
(algal) Tier
II (dose
response)
R
R
R
R
R
TGAI, TEP
TGAI, TEP
4, 5, 6
850.4300
Terrestrial
field
CR
CR
CR
CR
CR
TEP
TEP
7, 8, 9
850.4450
Aquatic field
CR
CR
CR
CR
CR
TEP
TEP
7, 8, 9
sroberts on PROD1PC70 with PROPOSALS
(f) Test notes. The following test notes
apply to the data requirements in the
table to paragraph (e) of this section:
1. Data on only one plant species (rice,
Oryza sativa) are required.
2. For low environmental exposures, data
are required if the aquatic (algal) plant
growth Tier II study demonstrates
detrimental effects at less than 1.0 ppm or
mg/L.
3. For low environmental exposures, and
industrial processes and water systems (oncethrough), data are required if one or more of
the following criteria are met:
i. The octanol/water partition coefficient
(Kow) for the active ingredient or principal
transformation products ≥ 1,000 for the active
ingredient or principal transformation
products;
ii. The hydrolysis half-life of the active
ingredient or principal transformation
products in water is > 4 days.
iii. The results of the ready
biodegradability study [§ 158.2280] indicate
that the active ingredient or principal
degradation products are not biodegradable
in 28 days, i.e. the biodegradation curve has
not reached a plateau for at least three
determinations within the 28 days.
4. For TEP testing, data are required for the
applicant’s end-use product if an ingredient
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
in the end-use product, other than the active
ingredient, is expected to enhance the
toxicity of the active ingredient.
5. One Tier II (dose response) study,
conducted with Selenastrum capricornutum,
is required for the low environmental
exposure category grouping. If the results of
this study exhibits detrimental effects (is less
than 1.0 ppm or mg/L), then additional Tier
II (dose response) studies are required on
three species (Anabaena flos-aquae, Navicula
pelliculosa, and Skeletonema costatum.
6. For industrial processes and water
systems (once-through), antifoulant coatings
and paints, wood preservatives, and aquatic
areas, Tier II (dose response) studies are
required on four species (Anabaena flosaquae, Navicula pelliculosa, Skeletonema
costatum, and Selenastrum capricornutum.
7. Environmental chemistry methods used
to generate data must include the results of
a successful confirmatory method trial by an
independent laboratory.
8. Tests are required on a case-by-case
basis based on the results of lower tier plant
protection studies, adverse incident reports,
intended use pattern(s), and environmental
fate characteristics that indicate potential
exposure.
9. Protocols must be approved by the
Agency prior to the initiation of the study.
PO 00000
Frm 00059
Fmt 4701
Sfmt 4702
Details for developing protocols are available
from the Agency.
§ 158.2260
Applicator exposure.
(a) General. Subpart B of this part and
§ 158.2201 describe how to use the table
in paragraph (d) of this section to
determine the applicator exposure data
requirements for antimicrobial pesticide
products. Notes that apply to an
individual test including specific
conditions, qualifications, or exceptions
are listed in paragraph (e) of this
section.
(1) If EPA determines that industrial
standards, such as the workplace
standards set by the Occupational Safety
and Health Administration, provide
adequate protection for a particular
pesticide or a particular use pattern,
applicator exposure data may not be
required for that pesticide or the use
pattern. Applicants should consult with
the Agency on appropriate testing before
the initiation of studies.
(2) The Agency may accept surrogate
exposure data estimations from other
sources to satisfy applicator exposure
data requirements if the data meet the
E:\FR\FM\08OCP2.SGM
08OCP2
59440
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
basic quality assurance, quality control,
good laboratory practice, and other
scientific requirements set by EPA. In
order to be acceptable, the Agency must
find that the surrogate exposure data
estimations have adequate information
to address applicator exposure data
requirements and contain enough
adequate replicates of acceptable quality
to reflect the specific use prescribed on
the label and the applicator activity of
concern, including formulation type,
application methods and rates, type of
activity, and other pertinent
information. The Agency will consider
using such surrogate data for evaluating
human exposure on a case-by-case basis.
(3) Occupational uses include not
only handlers, mixers, loaders, and
applicators, but also commercial
applications to residential sites.
Residential uses are limited to nonoccupational, i.e., non-professional,
antimicrobial applications. Both
occupational and residential applicator
data may be required for the same
product.
(b) Criteria for testing. Applicator
exposure data described in paragraph
(d) of this section are required based on
toxicity and exposure criteria. Data are
required if a product meets, as
determined by the Agency, at least one
of the toxicity criteria in paragraph
(b)(1) of this section, and at least one of
the exposure criteria in paragraph (b)(2)
of this section.
(1) Toxicity criteria. i. Evidence of
potentially significant adverse effects
have been observed in any applicable
toxicity studies.
ii. Scientifically sound
epidemiological or poisoning incident
data indicate that adverse health effects
may have resulted from handling of the
pesticide.
(2) Exposure criteria. i. Dermal
exposure may occur during use.
ii. Respiratory exposure may occur
during use.
(c) Key. R = Required; CR =
Conditionally required; TEP = Typical
end-use product.
(d) Table. The following table shows
the data requirements for applicator
exposure. The test notes appear in
paragraph (e) of this section.
TABLE — ANTIMICROBIAL APPLICATOR EXPOSURE DATA REQUIREMENTS
Guideline Number
Data Requirements
Occupational
Residential
Test Substance
Test Note No
875.1100
Dermal outdoor exposure
R
R
TEP
1, 2, 3
875.1200
Dermal indoor exposure
R
R
TEP
1, 2, 3, 4
875.1300
Inhalation outdoor exposure
R
R
TEP
1, 2, 3
875.1400
Inhalation indoor exposure
R
R
TEP
1, 2, 3, 4
875.1500
Biological monitoring
CR
CR
TEP
1, 2, 3
875.1600
Data reporting and calculations
R
R
TEP
5
875.1700
Product use information
R
R
TEP
—
sroberts on PROD1PC70 with PROPOSALS
(e) Test notes. The following test
notes apply to the data requirements in
the table to paragraph (d) of this section:
1. Protocols must be approved by the
Agency prior to the initiation of the study.
Details for developing protocols are available
from the Agency.
2. Biological monitoring data may be
submitted in addition to, or in lieu of, dermal
and inhalation passive dosimetry exposure
data, provided the human pharmacokinetics
of the pesticide or metabolite/analog
compounds (i.e., whichever method is
selected as an indicator of body burden or
internal dose) allow for the back calculation
to the total internal dose.
3. For products with both indoor and
outdoor uses, and similar conditions of use,
data are generally required for the indoor
applications only. However, data for outdoor
uses are required if the Agency expects
outdoor uses to result in greater exposure
than indoor uses (e.g., higher use rates and
application frequency, or longer exposure
duration, or application methods/equipment
create potential for increased dermal or
inhalation exposure in outdoor versus indoor
use sites). In certain cases, when a pesticide
is used both indoors and outdoors under
dissimilar conditions of use, the Agency may
require submission of applicator exposure
data for both use patterns.
4. For metal working fluids (MWFs), the
Agency can provide written guidance
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
concerning exposure, toxicity, and other data
requirements for ‘‘open’’ and ‘‘closed’’ MWF
systems.
5. Data reporting and calculations are
required when handler exposure data are
required.
§ 158.2270
Post-application exposure.
(a) General. Subpart B of this part and
§ 158.2201 describe how to use the table
in paragraph (d) of this section to
determine the post-application exposure
data requirements for antimicrobial
pesticide products. The data generated
during these studies are used to
determine the quantity of pesticide to
which people may be exposed after
application. Notes that apply to an
individual test, including specific
conditions, qualifications, or exceptions
to the designated test, are listed in
paragraph (e) of this section.
(1) For all end-use products, postapplication exposure data are required
when certain toxicity criteria are met
and the human activities associated
with the pesticide’s use pattern can lead
to potential adverse exposures.
(2) If EPA determines that industrial
standards, such as the workplace
standards set by the Occupational Safety
PO 00000
Frm 00060
Fmt 4701
Sfmt 4702
and Health Administration, provide
adequate protection for a particular
pesticide or a particular use pattern,
post-application exposure data may not
be required for that pesticide or the use
pattern. Applicants should consult with
the Agency on appropriate testing before
the initiation of studies.
(3) The Agency may accept surrogate
exposure data estimations from other
sources to satisfy applicator exposure
data requirements if the data meet the
basic quality assurance, quality control,
good laboratory practice, and other
scientific requirements set by EPA. In
order to be acceptable, the Agency must
find that the surrogate exposure data
estimations have adequate information
to address applicator exposure data
requirements and contain enough
adequate replicates of acceptable quality
to reflect the specific use prescribed on
the label and the applicator activity of
concern, including formulation type,
application methods and rates, type of
activity, and other pertinent
information. The Agency will consider
using such surrogate data for evaluating
human exposure on a case-by-case basis.
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
(b) Criteria for Testing. Postapplication exposure data described in
paragraph (d) of this section are
required based on toxicity and exposure
criteria. Data are required if a product
meets, as determined by the Agency, at
least one of the toxicity criteria in
paragraph (b)(1) of this section, and at
least one of the exposure criteria in
paragraph (b)(2) of this section.
(1) Toxicity criteria. (i) Evidence of
potentially significant adverse effects
have been observed in any applicable
toxicity studies.
(ii) Scientifically sound
epidemiological or poisoning incident
data indicate that adverse health effects
may have resulted from handling of the
pesticide.
(2) Exposure criteria. (i) Outdoor uses.
(A) Occupational human post-
application exposure to residues of
antimicrobial pesticides could occur as
the result of, but is not limited to,
worker re-entry into treatment sites,
clean-up and equipment maintenance
tasks, handling wood preservativetreated wood, or other work-related
activity.
(B) Residential human postapplication exposure to residues of
antimicrobial pesticides could occur
following the application of
antimicrobials pesticides to outdoor
areas and spaces at residential sites,
such as, but not limited to homes,
daycare centers, and other public
buildings.
(ii) Indoor uses. (A) Occupational
human post-application exposure to
pesticide residues could occur following
59441
the application of the antimicrobial
pesticide to indoor spaces or surfaces.
(B) Residential human postapplication exposure to pesticide
residues could occur following the
application of the antimicrobial
pesticide to indoor spaces or surfaces at
residential sites, such as, but not limited
to homes, daycare centers, hospitals,
schools, and other public buildings.
(c) Key. R = Required; CR =
Conditionally required; NR = Not
required; TEP = Typical end-use
product.
(d) Table. The following table shows
the data requirements for postapplication exposure. The test notes
appear in paragraph (e) of this section.
TABLE — ANTIMICROBIAL POST-APPLICATION EXPOSURE DATA REQUIREMENTS
Use Sites
Guideline Number
Test Substance
Data Requirement
Occupational
Test Note
No.
Residential
875.2200
Soil residue dissipation
CR
CR
TEP
1, 2, 3
875.2300
Indoor surface residue dissipation
R
R
TEP
1, 3, 4, 5, 6
875.2400
Dermal exposure
R
R
TEP
1, 3, 7, 8
875.2500
Inhalation exposure
R
R
TEP
1, 8, 9
875.2600
Biological monitoring
CR
CR
TEP
1, 8, 10
875.2700
Product use information
R
R
TEP
---
875.2800
Description of human activity
R
R
TEP
---
875.2900
Data reporting and calculations
R
R
TEP
11
875.3000
Non-dietary ingestion exposure
NR
R
TEP
1, 12
sroberts on PROD1PC70 with PROPOSALS
(e) Test notes. The following test
notes apply to the data requirements in
the table to paragraph (d) of this section:
1. Protocols must be approved by the
Agency prior to the initiation of the study.
Details for developing protocols are available
from the Agency.
2. For residential wood preservative uses,
data are required if there is likely to be soil
in contact with or adjacent to treated wood,
including but not limited to decks, play sets,
and gazebos.
3. The applicant must submit residue
dissipation data in conjunction with dermal
exposure data, to establish chemical transfer
coefficients used to estimate transfer of
residues to human skin.
4. For wood preservatives, data are
required for treated wood surfaces where
post-application contact with treated wood is
anticipated.
5. For occupational uses, data are required
if the pesticide is applied to or around
surfaces, and if the human activity data
indicate that workers are likely to have postapplication dermal contact with treated
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
indoor surfaces while participating in typical
activities.
6. Data are required for residential sites.
This includes but is not limited to the
following use patterns: commercial,
institutional, and industrial premises and
equipment (including residential school and
daycare institutions); residential and public
access premises; material preservatives
(including those used in residential products
including but not limited to paints and
plastic toys) and wood preservatives (when
contact with treated wood is likely to occur).
7. Data are required for occupational and
residential use sites if the human activity
data indicate the potential for postapplication dermal exposures while
participating in typical activities.
8. Biological monitoring data may be
submitted in addition to, or in lieu of, dermal
and inhalation passive dosimetry exposure
data provided the human pharmacokinetics
of the pesticide or metabolite/analog
compounds (i.e., whichever method is
selected as an indicator of body burden or
internal dose) allow for a back-calculation to
the total internal dose.
PO 00000
Frm 00061
Fmt 4701
Sfmt 4702
9. Data are required for occupational sites
if the vapor pressure is greater than 1E–3
mmHg at 25° C and there is the potential for
bystander exposure. Data are also required if
aerosols are generated where bystanders may
be exposed.
10. Biological monitoring data are required
when passive dosimetry techniques are not
applicable for a particular exposure scenario
(such as a swimmer/spa exposure) and
exposure estimates from modeling
techniques used in conjunction with the
toxicity data indicate a risk of concern.
11. Data reporting and calculations are
required when any post-application exposure
monitoring data are required.
12. Data are required for residential sites if
post-application exposures, particularly
those of children, are likely. The selection of
a sampling method will depend on the nondietary pathway(s) of interest. Data must be
generated to consider all potential pathways
of non-dietary ingestion exposure that are
applicable (e.g., soil ingestion, hand-tomouth transfer, and object-to-mouth transfer
of surface residues).
E:\FR\FM\08OCP2.SGM
08OCP2
59442
§ 158.2280
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
Environmental fate.
(a) General. Subpart B of this part and
§ 158.2201 describe how to use the table
in paragraph (e) of this section to
determine the environmental fate data
requirements for antimicrobial pesticide
products. Notes that apply to an
individual test including specific
conditions, qualifications, or exceptions
are listed in paragraph (f) of this section.
(1) Environmental fate data are
required to support the registrations of
all end-use and manufacturing-use
antimicrobial products.
(2) If the Agency believes that the
transformation products of the parent
compound are more toxic, persistent, or
bioaccumulative than the parent
compound, or have been shown to cause
adverse effects in mammalian or aquatic
reproductive studies, then data on those
transformation products are also
required to support registration.
(3) For wood preservatives, the
Agency may require data on both the
parent compound that is incorporated
into the wood, and on transformation/
degradation products that occur in
wood post-treatment or occur as
dislodgeable residues (such as hand
contact with treated wood) or leachate
residues (such as from soil or water
contact with treated wood).
(b) Low environmental exposures. For
the purpose of determining data
requirements, the low environmental
exposure grouping of use patterns
includes the following use patterns or
partial use patterns:
(1) Agricultural premises and
equipment.
(2) Food-handling/storage
establishments, premises, and
equipment.
(3) Commercial, institutional and
industrial premises and equipment.
(4) Residential and public access
premises.
(5) Medical premises and equipment.
(6) Human drinking water systems.
(7) Materials preservatives.
(8) Swimming pools.
(9) Recirculating industrial processes
and water systems in which the treated
water is re-used repeatedly within the
system.
(c) High environmental exposures. For
the purposes of determining data
requirements, the high environmental
exposure grouping of use patterns
includes the following use patterns or
partial use patterns:
(1) Once-through industrial processes
and water systems in which the water
is not re-used, and is released after a
single cycle through the system.
(2) Antifoulant paints and coatings.
(3) Wood preservatives.
(4) Aquatic areas.
(d) Key. MP = Manufacturing use
product; EP = End use product; R =
Required; CR = Conditionally required;
NR = Not required; TGAI = Technical
grade of the active ingredient; TEP =
Typical end-use product; PAIRA = Pure
active ingredient radiolabeled.
(e) Table. The following table shows
the data requirements for environmental
fate. The test notes appear in paragraph
(f) of this section.
TABLE—ANTIMICROBIAL ENVIRONMENTAL FATE DATA REQUIREMENTS
Use Pattern
Test Substance to Support
High Environmental Exposure
Guideline
Number
Data Requirement
Low Environmental
Exposure
Industrial
Pro-cesses
and Water
Systems(OnceThrough)
Antifoulant
Coatings
and Paints
Wood
Preservatives
Aquatic
Areas
MP
EP
Test Note
No.
Degradation Studies - Laboratory
835.2120
Hydrolysis
R
R
R
R
R
TGAI or
PAIRA
TGAI or
PAIRA
1
835.2240
Photodegradation in
water
R
R
R
R
R
TGAI or
PAIRA
TGAI or
PAIRA
2
835.2410
Photodegradation in
soil
NR
NR
NR
R
NR
TGAI or
PAIRA
TGAI or
PAIRA
--
Biodegradation Studies - Laboratory
Activated Sludge
Sorption Isotherm
R
R
NR
NR
NR
TGAI
TGAI
--
835.3110
Ready
Biodegradability
R
R
NR
NR
NR
TGAI
TGAI
3
850.6800
Modified Activated
Sludge, Respiration
Inhibition Test
R
R
NR
NR
NR
TGAI
TGAI
--
835.3220
sroberts on PROD1PC70 with PROPOSALS
835.1110
Porous Pot Study
CR
CR
NR
NR
NR
TGAI
TGAI
4
Leaching and adsorption/desorption
CR
R
R
R
R
TGAI or
PAIRA
TGAI or
PAIRA
5, 7
Mobility Studies
835.1230
835.1240
Metabolism Studies - Laboratory
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
PO 00000
Frm 00062
Fmt 4701
Sfmt 4702
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
59443
TABLE—ANTIMICROBIAL ENVIRONMENTAL FATE DATA REQUIREMENTS—Continued
Use Pattern
Test Substance to Support
High Environmental Exposure
Guideline
Number
Data Requirement
Low Environmental
Exposure
Industrial
Pro-cesses
and Water
Systems(OnceThrough)
Antifoulant
Coatings
and Paints
Wood
Preservatives
Aquatic
Areas
MP
EP
Test Note
No.
835.4100
Aerobic soil metabolism
CR
CR
NR
R
CR
TGAI or
PAIRA
TGAI or
PAIRA
5, 6, 8, 9
835.4200
Anaerobic soil metabolism
CR
NR
NR
CR
NR
TGAI or
PAIRA
TGAI or
PAIRA
5, 8, 10
835.4300
Aerobic aquatic metabolism
CR
R
R
CR
R
TGAI or
PAIRA
TGAI or
PAIRA
5, 8, 10
835.4400
Anaerobic aquatic metabolism
CR
R
R
CR
R
TGAI or
PAIRA
TGAI or
PAIRA
5, 8, 10
CR
CR
CR
CR
R
TEP
TEP
5, 11, 12,
13
Monitoring of representative U.S. waters
CR
CR
CR
CR
CR
residue of
concern
residue of
concern
11, 12,
14
Special leaching
NR
NR
R
R
NR
TGAI
TEP
15, 16
Dissipation Studies -- Field
835.6200
Aquatic (sediment)
Ground and Surface Water Monitoring
None
Special Studies
None
sroberts on PROD1PC70 with PROPOSALS
(f) Test notes. The following test notes
apply to the data requirements in the
table in paragraph (e) of this section:
1. For testing antifoulant paints and
coatings, testing is to be performed with both
sterile buffered distilled water and sterile
synthetic seawater at pH 5, 7, and 9.
2. Not required when the electronic
absorption spectra, measured at pHs 5, 7 and
9, of the chemical and its hydrolytic
products, if any, show no absorption or
tailing between 290 and 800 nm.
3. The selection of the particular
biodegradation study depends on the
physical and chemical properties of the test
substance, and the results of the activated
sludge sorption isotherm and the modified
activated sludge studies.
4. Required if the pass criteria for the ready
biodegradation study are not met. This means
70% or greater removal of dissolved organic
carbon and 60% or greater of theoretical
oxygen demand or theoretical carbon
dioxide. These pass values must be reached
in a 10–day window within the 28–day
period of the test.
5. For low environmental exposure uses,
data are required based on a weight-ofevidence evaluation of the results of the
hydrolysis, photodegradation in water,
activated sludge sorption isotherm, ready
biodegradability, and modified activated
sludge, respiration inhibition tests.
6. For industrial processes and water
systems (once-through), data are required
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
based on a weight-of-evidence evaluation of
the results of the hydrolysis,
photodegradation in water, activated sludge
sorption isotherm, ready biodegradability,
and modified activated sludge, respiration
inhibition tests.
7. Adsorption and desorption using a batch
equilibrium method is preferred. In some
cases, as when the antimicrobial pesticide
degrades rapidly, soil column leaching with
unaged or aged columns may be more
appropriate to fully characterize the potential
mobility of the parent compound and major
transformation products.
8. The environmental media (soil, water,
hydrosoil, and biota) to be utilized in these
studies must be collected from areas
representative of potential use sites.
9. For industrial processes and water
systems (once-through), and aquatic areas,
data are required for use sites that are
intermittently dry.
10. For wood preservatives, data are
required if treated wood is used in aquatic
environments or in soils which may become
flooded or waterlogged.
11. Environmental chemistry methods used
to generate data associated with this study
must include results of a successful
confirmatory method trial by an independent
laboratory.
12. Protocols must be approved by the
Agency prior to the initiation of the study.
Details for developing protocols are available
from the Agency.
PO 00000
Frm 00063
Fmt 4701
Sfmt 4702
13. For industrial processes and water
systems (once-through), antifoulant paints
and coatings, and wood preservatives, data
are required based on the potential for
aquatic exposure and if the weight-ofevidence indicates that the active ingredient
or principal transformation products are
likely to have the potential for persistence,
mobility, nontarget aquatic toxicity, or
bioaccumulation.
14. Data are required if the weight-ofevidence indicates that the active ingredient
or principal transformation products are
likely to occur in nontarget freshwater,
estuarine, or marine waters such that human
or environmental exposures are likely to
occur. The Agency takes into account other
factors such as the toxicity of the chemical(s),
available monitoring data and the
vulnerability of the freshwater, estuarine, or
marine water resources in the antimicrobial
use area.
15. For wood preservatives, an aquatic
leaching study is required. A soil leaching
study is required if human or environmental
exposures are likely to occur from leachates
that contain the active ingredient or principal
transformation products from wood treated
with a preservative product. For these
studies, the Agency accepts the following
methods or their equivalents: American
Wood Preservers’ Association (AWPA)
Method E11–97 (aquatic leaching), and
AWPA Method E20–04 (soil leaching). Prior
approval of studies conducted according to
E11–97 is not required. All other protocols
E:\FR\FM\08OCP2.SGM
08OCP2
59444
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
must be approved by the Agency prior to the
initiation of the study. Details for developing
protocols are available from the Agency.
16. For antifoulant paints and coatings, a
leaching study is required. The Agency
accepts the following method or its
equivalent: American Society for Testing and
Materials (ASTM) Method D5108–90. Prior
approval of studies conducted according to
D5108–90 is not required. All other protocols
must be approved by the Agency prior to the
initiation of the study. Details for developing
protocols are available from the Agency.
§ 158.2290
Residue chemistry.
(a) General. Subpart B of this part and
§ 158.2201 describe how to use the table
in paragraph (f) of this section to
determine the residue chemistry data
requirements for antimicrobial pesticide
products.
(b) Residue chemistry data are
required for products described in this
paragraph.
(1) Each end-use product bearing label
directions for food-uses that require a
tolerance or tolerance exemption,
including, but not limited to the
following:
(i) Direct food uses such as
antimicrobial products used to treat
animal or poultry drinking water, for
egg washing, or fruit and vegetable
rinses.
(ii) Indirect food uses such as
antimicrobial products applied to a
surface or incorporated into a material
that may contact food or feed. Residues
may be expected to transfer to such food
or feed. Data are required regardless of
whether the antimicrobial is applied or
impregnated for the purpose of
imparting antimicrobial protection to
external surfaces of the substance or
article, or for the purpose of protecting
the substance or article itself.
(iii) Aquatic uses that have the
potential to result in residues in potable
water, or in water used for livestock and
poultry drinking water, irrigation of
crops, or water containing fish that may
be used for human food.
(iv) Wood preservative or antifoulant
products intended for treating wood that
may be used for food purposes (e.g.,
lobster pots, fish cages, or fish farms).
(2) Each manufacturing-use product
bearing directions for formulation into
an end-use product bearing food-uses
described in paragraph (b)(1) of this
section.
(c) Except as described in paragraph
(b) of this section, residue chemistry
data are not required to support a
tolerance exemption if dietary exposure
estimates are not needed due to low
toxicity of the active ingredient or
theoretical (modeled) estimates of
exposure are adequate to assess dietary
risk.
(d) Key. R = Required; CR =
Conditionally required; NR = Not
required; TGAI = Technical grade of the
active ingredient; TEP = Typical enduse product; PAI = Pure active
ingredient; PAIRA = Pure active
ingredient radiolabeled; the residue of
concern is determined by the Agency.
(e) Table. The following table shows
the data requirements for residue
chemistry. The test notes appear in
paragraph (f) of this section.
TABLE — ANTIMICROBIAL RESIDUE CHEMISTRY DATA REQUIREMENTS
Use Pattern
Guideline Number
Agricultural
Premises
Data Requirement
Indirect
Food
Uses
Direct
Food
Contact
Uses
Aquatic
Uses
Test substance
Test Note
No.
Supporting Information
860.1100
Chemical identity
R
R
R
R
TGAI
--
860.1200
Directions for use
R
R
R
R
--
--
860.1550
Proposed tolerance
R
R
R
R
--
1
860.1560
Reasonable grounds in support of
petition
R
R
R
R
--
1
860.1650
Submittal of
standards
R
R
R
R
PAI and residue of
concern
2
analytical
reference
Nature of the residue
860.1300
Nature of the residue in plants
CR
NR
R
R
PAIRA
3, 4, 5
860.1300
Nature of the residue in livestock
R
NR
CR
CR
PAIRA or radiolabeled
plant metabolite
6, 7, 8
860.1340
Residue analytical methods for enforcement of tolerances
CR
CR
R
CR
Residue of concern
9
860.1340
Residue analytical methods for data
collection
CR
CR
R
CR
Residue of concern
10
860.1360
Multiresidue method testing
CR
CR
R
CR
Residue of concern
11
R
R
R
R
TEP or residue of
concern
12
sroberts on PROD1PC70 with PROPOSALS
Analytical methods
Magnitude of the residue
860.1380
VerDate Aug<31>2005
Storage stability
21:23 Oct 07, 2008
Jkt 214001
PO 00000
Frm 00064
Fmt 4701
Sfmt 4702
E:\FR\FM\08OCP2.SGM
08OCP2
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
59445
TABLE — ANTIMICROBIAL RESIDUE CHEMISTRY DATA REQUIREMENTS—Continued
Use Pattern
Guideline Number
Agricultural
Premises
Data Requirement
Indirect
Food
Uses
Direct
Food
Contact
Uses
Aquatic
Uses
Test substance
Test Note
No.
860.1500
Crop field trials
CR
CR
R
R
TEP
13, 14
860.1520
Processed food or feed
NR
CR
CR
CR
TEP
15
860.1480
Meat/milk/poultry/eggs
CR
CR
CR
CR
TGAI or plant metabolite
860.1400
Potable water
R
NR
NR
R
TEP
18
860.1400
Fish
NR
NR
NR
R
TEP
19
860.1400
Irrigated crops
NR
NR
NR
CR
TEP
20
860.1460
Food-handling
NR
CR
R
NR
TEP
21
860.1540
Anticipated residues
CR
CR
CR
CR
Residue of concern
22
None
Migration studies
NR
CR
NR
NR
TGAI
23
sroberts on PROD1PC70 with PROPOSALS
(f) Test notes. The following test notes
apply to the data requirements in the
table to paragraph (e) of this section:
1. A petition proposing a numerical
tolerance or a tolerance exemption is
required for any food or feed use subject to
section 408 of the FFDCA if the use is not
covered by an existing tolerance or tolerance
exemption.
2. An analytical reference standard is
required for any food or feed use requiring
a tolerance. Material safety data sheets must
accompany analytical standards as specified
by OSHA in 29 CFR 1910.1200.
3. For agricultural premises, data are
required for postharvest storage of plant
commodities.
4. Data are required for direct food contact
uses, excluding egg washes, to determine the
transformation products in representative
foods.
5. Data are required to support applications
to water if any residues could occur in
irrigated crops, or to crops treated directly in
the field.
6. Data are required when an antimicrobial
pesticide is applied directly to livestock, to
livestock premises, to livestock drinking
water, to livestock feed, or to crops used for
livestock feed.
7. Data are required for aquatic uses if there
is the potential that the treated water could
be used eventually for drinking purposes by
livestock.
8. If results from the plant metabolism
study show differing metabolites in plants
from those found in animals, then additional
livestock metabolism study(ies) involving
dosing with the plant metabolite(s) may be
required.
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
9. A residue analytical method suitable for
enforcement purposes is required whenever
a numeric tolerance is proposed.
Enforcement methods must be supported by
results of an independent laboratory
validation.
10. A residue analytical method suitable
for collecting data to establish tolerances
must quantitate all residues of concern, as
determined by the Agency.
11. Data are required to determine whether
the FDA/USDA multiresidue methodology
would detect and identify the antimicrobial
active ingredient and its metabolites.
12. Data are required for any food or feed
use requiring magnitude of the residue
studies unless analytical samples are stored
frozen for 30 days or less, and the active
ingredient is not known to be volatile or
labile.
13. Residue data are required if
antimicrobial chemicals are to be applied to
mushroom houses, empty or occupied
beehives, wood used to construct beehives,
or any use which could result in residues in
food or feed.
14. If the antimicrobial chemical is applied
to growing crops in the field, then the
requirements of 40 CFR part 158, subpart O
(terrestrial food or feed use pattern) apply.
15. Data on the nature and level of residues
in processed food or feed are required if
residues could potentially concentrate on
processing, thus requiring the establishment
of a separate tolerance higher than that of the
raw agricultural commodity.
16. Data are required when the pesticide
use is a direct application to livestock.
17. Data are required if livestock premises
are treated or if pesticide residues are present
PO 00000
Frm 00065
Fmt 4701
Sfmt 4702
16, 17
in or on livestock feed items or intentionally
added to drinking water. These studies,
however, may not be required in cases where
the livestock metabolism studies indicate
negligible transfer of pesticide residues of
concern to tissues, milk, and eggs at the
maximum expected exposure level for the
animals.
18. Data are required for antimicrobial
pesticides applied directly to water, if there
is the potential that the treated water could
be used for drinking purposes by man or
animals.
19. For aquatic uses, data for fish are
required for antimicrobial pesticides applied
directly to water inhabited, or which will be
inhabited, by fish that may be caught or
harvested for human consumption.
20. Data are required for antimicrobial
pesticides applied directly to water that
could be used for irrigation or to irrigation
facilities such as ditches.
21. Data are required whenever a pesticide
is to be used in a food-handling or feed
handling establishment unless theoretical
calculations, radiolabeled laboratory data, the
nature of the residue study, or other data
show that residues will not occur in food or
feed. Use in a food-handling establishment
also includes fresh fruits and vegetables that
undergo a rinse with either a sanitizing
solution, or with a disinfectant followed by
a potable water rinse.
22. Data are required when estimates of
risk using residues at the tolerance level may
result in a risk of concern. These data may
include washing, cooking, processing or
degradation studies as well as market basket
surveys for a more precise residue
determination.
E:\FR\FM\08OCP2.SGM
08OCP2
59446
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 / Proposed Rules
sroberts on PROD1PC70 with PROPOSALS
23. Migration of residue data are required
for antimicrobial pesticides applied to hard
food surfaces or incorporated into substrates
(wood, plastic, paper, cloth, rubber or similar
products) intended for contact with food or
feed when theoretical (modeled) estimates of
the amount of antimicrobial residue
transferred to the food or feed may result in
VerDate Aug<31>2005
21:23 Oct 07, 2008
Jkt 214001
a risk of concern. Protocols must be approved
by the Agency prior to the initiation of the
study. Details for developing protocols are
available from the Agency.
Part 161
PART 161—[AMENDED]
[FR Doc. E8–23127 Filed 10–7–08; 8:45 am]
6. The authority citation for part 161
continues to read as follows:
BILLING CODE 6560–50–S
PO 00000
Frm 00066
Fmt 4701
Sfmt 4702
Authority: 7 U.S.C. 136 – 136y.
[Removed]
7. Part 161 is removed:
E:\FR\FM\08OCP2.SGM
08OCP2
Agencies
[Federal Register Volume 73, Number 196 (Wednesday, October 8, 2008)]
[Proposed Rules]
[Pages 59382-59446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-23127]
[[Page 59381]]
-----------------------------------------------------------------------
Part III
Environmental Protection Agency
-----------------------------------------------------------------------
40 CFR Parts 158 and 161
Data Requirements for Antimicrobial Pesticides; Proposed Rule
Federal Register / Vol. 73, No. 196 / Wednesday, October 8, 2008 /
Proposed Rules
[[Page 59382]]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Parts 158 and 161
RIN 2070-AD30
Data Requirements for Antimicrobial Pesticides
AGENCY: Environmental Protection Agency (EPA).
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: EPA proposes to revise and update the existing data
requirements for antimicrobial pesticides. The proposed revisions are
needed to reflect current scientific knowledge and current Agency
regulatory practices, and to improve protection of the general
population as well as sensitive subpopulations. The proposed
requirements are intended to further enhance the Agency's ability to
make regulatory decisions about the human health and environmental fate
and effects of antimicrobial pesticide products.
DATES: Comments must be received on or before January 6, 2009.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2008-0110, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA 22202. Deliveries are only
accepted during the Docket's normal hours of operation (8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays). Special
arrangements should be made for deliveries of boxed information. The
Docket Facility telephone number is (703) 305-5805.
Instructions: Direct your comments to docket ID number EPA-HQ-OPP-
2008-0110. EPA's policy is that all comments received will be included
in the docket without change and may be made available on-line at
https://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through regulations.gov or e-
mail. The regulations.gov website is an ``anonymous access'' system,
which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov,
your e-mail address will be automatically captured and included as part
of the comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses.
Docket: All documents in the docket are listed in the docket index
available in regulations.gov. To access the electronic docket, go to
https://www.regulations.gov, select ``Advanced Search,'' then ``Docket
Search.'' Insert the docket ID number where indicated and select the
``Submit'' button. Follow the instructions on the regulations.gov
website to view the docket index or access available documents.
Although listed in the index, some information is not publicly
available, e.g., CBI or other information whose disclosure is
restricted by statute. Certain other material, such as copyrighted
material, is not placed on the Internet and will be publicly available
only in hard copy form. Publicly available docket materials are
available either in the electronic docket at https://
www.regulations.gov, or, if only available in hard copy, at the OPP
Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA 22202. The hours of operation of
this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays. The Docket Facility telephone number
is (703) 305-5805.
FOR FURTHER INFORMATION CONTACT: Kathryn Boyle, Field and External
Affairs Division, Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; mail code 7506P; telephone number: 703-305-6304; fax number: 703-
305-5884; e-mail address: boyle.kathryn@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be affected by this action if you are a producer of
pesticide products (NAICS 32532), antifoulants (NAICS 32551),
antimicrobial pesticides (NAICS 32561) or wood preservatives (NAICS
32519), importers of such products, or any person or company who seeks
to register an antimicrobial, antifoulant coating, ballast water
treatment, or wood preservative pesticide or to obtain a tolerance for
such a pesticide. This listing is not intended to be exhaustive, but
rather provides a guide for readers regarding entities likely to be
affected by this action. Other types of entities not listed above could
also be affected. The North American Industrial Classification System
(NAICS) codes have been provided to assist you and others in
determining whether this action might apply to certain entities. If you
have any questions regarding the applicability of this action to a
particular entity, please contact Norm Cook, Chief of the Risk
Assessment and Science Support Branch in the Antimicrobials Division of
the Office of Pesticide Programs at 703-308-8253 or via email,
cook.norm@epa.gov.
B. What Should I Consider as I Prepare My Comments for EPA?
1. Docket. EPA has established a docket for this action under
docket identification (ID) number EPA-HQ-OPP-2008-0110. Publicly
available docket materials are available either in the electronic
docket at https://www.regulations.gov, or, if only available in hard
copy, at the Office of Pesticide Programs (OPP) Regulatory Public
Docket in Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal
Dr., Arlington, VA 22202. The hours of operation of this Docket
Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding
legal holidays. The Docket Facility telephone number is (703) 305-5805.
2. Tips for preparing your comments. When submitting comments,
remember to:
i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
[[Page 59383]]
iv. Describe any assumptions and provide any technical information
and/or data that you used.
v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
viii. Make sure to submit your comments by the comment period
deadline identified.
II. Background
A. What Action is the Agency Taking?
The Environmental Protection Agency (EPA or the Agency) is
proposing to establish a separate listing of the data requirements for
antimicrobial pesticides in Title 40 of the Code of Federal Regulations
(CFR) in subpart W of part 158. This proposal sets out use patterns
that are designed to make it easier to determine which requirements
apply to antimicrobial products. In addition to retaining most current
data requirements for antimicrobials, this proposal incorporates nine
new data requirements and revises other existing data requirements.
This rule, once final, is intended to further enhance the Agency's
ability to make regulatory decisions about the human health, and
environmental fate and effects of antimicrobial pesticide products.
The Agency has previously issued updated data requirements for
conventional pesticides, and biochemical and microbial pesticides in
part 158. This proposal is part of a larger effort to update and
improve all of the data requirements for pesticide regulatory purposes.
Data requirements for antimicrobial pesticides, currently contained in
part 161, are proposed to be revised and included in part 158 upon
promulgation.
Generally, antimicrobials are considered to be those chemicals that
disinfect and sanitize. However, within this proposal EPA is using the
term antimicrobials to collectively refer to antimicrobial pesticides,
antifoulant coatings and paints, and wood preservatives.
As discussed in Unit XVIII.A., EPA has prepared a white paper
entitled ``Use of Structure-Activity Relationship (SAR) Information and
Quantitative SAR (QSAR) Modeling For Fulfilling Data Requirements for
Antimicrobial Pesticide Chemicals and Informing EPA's Risk Management
Process,'' a copy of which is contained in the docket for this proposed
rule (Ref. 43). The white paper discusses the current level of
information and usage of structure-activity-relationship (SAR)
assessments and Quantitative SAR (QSAR) modeling to fulfill data
requirements in the Pesticide Program. The Agency specifically seeks
comment on this support document.
Since many antimicrobial pesticides are typically rinsed down the
drain, EPA has considered the potential impacts of pesticides that are
discharged into wastewater treatment plants (WWTPs). This proposed rule
addresses the issue of down-the-drain antimicrobials by proposing four
new data requirements for use in a screening-level assessment on the
fate of antimicrobials that reach a WWTP. To assess the impacts of this
screening assessment and utility of the new data requirements for
decision-making, EPA prepared four case studies (Ref. 42). The case
studies, copies of which are contained in the docket for this proposed
rule, are discussed in more detail in Unit XII.D. The Agency
specifically seeks comment on the proposed approach for evaluating the
potential impact of antimicrobial pesticide chemicals on WWTPs and
nontarget organisms in receiving water bodies, and on the case studies,
including the assumptions used in those studies, that were used to
develop the proposed approach. EPA will consider comments specific to
the case studies along with comments on the proposed approach, as the
Agency evaluates the use of the proposed approach for down-the-drain
antimicrobials in the final rule for antimicrobial data requirements.
On October 26, 2007, EPA promulgated final rules establishing data
requirements for conventional pesticides (72 FR 60934), and biochemical
pesticides and microbial pesticides (72 FR 60988). These final rules
were effective on December 24, 2007, and are therefore the current part
158. As part of those actions, on October 24, 2007, (72 FR 60251) EPA
preserved the original part 158 data requirements to provide continued
regulatory coverage for antimicrobial pesticides until the Agency could
promulgate a final regulation. To accomplish this, EPA transferred
intact the original 1984 data requirements of part 158 into a new part
161, entitled ``Data Requirements for Antimicrobial Pesticides.'' Part
161, which applies only to antimicrobial pesticides, contains the
current data requirements for antimicrobial pesticide chemicals.
As explained in the preamble to the conventional pesticide final
rule, EPA intended to preserve the existing data requirements for
antimicrobial pesticides until a new rule tailored specifically to
antimicrobial pesticides could be promulgated. Part 161 is intended to
be transitional. Once subpart W of part 158 is promulgated, there will
be no need for part 161. Accordingly, EPA proposes to revoke part 161
upon the effective date of a final rule arising from today's proposal.
B. Reasons for Today's Action
Since the promulgation of part 158 in 1984, the Agency has
recognized that the tables and test notes promulgated in 1984 failed to
adequately address the unique applications, use patterns, and other
factors germane to antimicrobial pesticides. Part 158 specifies the
types of data and information generally required for making sound
regulatory judgments under the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA). The types of actions for which these data are
needed include experimental use, registration, amended registration,
reregistration, or registration review (collectively referred to in
this proposal as ``registration''). The information required under
FIFRA for registration of food-use pesticides is also information the
Agency needs in order to grant tolerances or exemptions from the
requirement of tolerances under section 408 of the Federal Food, Drug,
and Cosmetic Act (FFDCA).
Required data are intended to provide information about the
potential adverse effects of uses of pesticides, and to define what is
generally expected from applicants for registration in support of their
products. However, it must be emphasized that each applicant has the
continuing obligation under FIFRA to demonstrate that an individual
product meets the standard for registration under section 3 of FIFRA or
section 408 of FFDCA. Accordingly, as indicated in current Sec. 158.75
and Sec. 161.75, additional data may be needed to reflect the
characteristics and use of specific pesticide products under review.
Since the data requirements now set out in part 161 (formerly part
158) were first published in 1984, every disciplinary area and
requirement has been reconsidered and many have been revised in
practice. These changes have been needed because the state of the
science underlying the data requirements has advanced, and because the
Agency has learned in specific registration actions that additional or
different data are necessary to make sound regulatory decisions. These
case-by-case decisions have been made in accordance with Sec. 158.75,
which allows the Agency to impose additional data requirements
[[Page 59384]]
beyond those specified in part 158 and now part 161.
Use patterns specific to antimicrobial pesticides are not specified
in part 161, as they were not set out separately when originally
promulgated in 1984. As a result, applicants have needed to interpret
the data requirements often via extensive consultation with and
interpretation from the Agency to determine the antimicrobial data
requirements for a particular product. Today, EPA is proposing that the
antimicrobial pesticide requirements be codified in a separate subpart
W to part 158 with use patterns (see Unit IV.I. of this preamble) and
groups of use patterns specific to antimicrobials.
Today's proposed rule is part of a series of rules to update all of
the data requirements for pesticide products. On October 26, 2007, EPA
published in the Federal Register two final rules to promulgate the
data requirements for conventional (72 FR 60934), and biochemical and
microbial (72 FR 60988) pesticide chemicals. These rules and their
proposals (conventional (March 11, 2005) (70 FR 12276) and biochemical
and microbial (March 8, 2006) (71 FR12072)) state the rationales for
requiring and/or revising particular data requirements. With few
exceptions, these rationales are also applicable to antimicrobial
pesticide chemicals, and as such have not been repeated in today's
proposed rule. Today's proposal discusses in detail only those
revisions that are singularly applicable to antimicrobial pesticides,
including antifoulants and wood preservatives.
C. Benefits of this Proposal
Greater detail on the benefits of this proposal is provided in the
document entitled ``Economic Analysis of the Proposed Change in Data
Requirements for Antimicrobial Pesticides'' which is available in the
docket for this rulemaking (Ref. 44). The following briefly highlights
the anticipated benefits:
1. More refined assessments mean less uncertainty and clearer
understanding of actual risks. EPA's current applicator/user exposure
data base is not comprehensive, especially regarding exposures to
antimicrobials in industrial and residential settings. The new data
that would be collected once this proposal becomes final would allow
the Agency to conduct improved pre- and post-application exposure
assessments for applicators/users, and the general public. This will
benefit not only workers (including applicators) and consumers by
helping EPA to make better informed regulatory decisions that are
neither too stringent nor too lenient, but also benefit the regulated
industry by reducing the uncertainty in Agency risk assessments. Thus,
today's proposal will reduce, but not eliminate, uncertainty related to
the risks posed by antimicrobial pesticides.
2. Clarity and transparency to regulated community means savings.
The enhanced clarity and transparency of the information presented in
part 158, subpart W should enhance the ability of industry to
efficiently manage their antimicrobial registration submissions.
Applicants may save time and money by understanding when studies are
needed. Having all required studies available to EPA at the time of
application should halt potential delays in the registration process,
thereby enabling registration of antimicrobial pesticides sooner.
Products would enter the market faster.
3. EPA information assists other communities in assessing pesticide
risks. Scientific, environmental, and health communities find
antimicrobial pesticide toxicity information useful to respond to a
variety of needs. For example, medical professionals are concerned
about the health of patients exposed to antimicrobials; poison control
centers use and distribute information on toxicity and treatment
associated with poisoning; and scientists use toxicity information to
characterize the effects of antimicrobial pesticides and to assess
risks of pesticide exposure. Similarly, those responsible for
protection of nontarget wildlife need reliable information about
antimicrobial pesticides and assurance that pesticides do not pose an
unreasonable threat. The proposed changes will help the scientific,
environmental, and health communities by increasing the breadth,
quality, and reliability of Agency regulatory decisions by improving
their scientific underpinnings.
4. Better informed users mean informed risk-reduction choices.
Better regulatory decisions resulting from the proposed changes should
also mean that the label will provide better information on the use of
the antimicrobial pesticide. A pesticide label is the user's direction
for using pesticides safely and effectively. It contains important
information about where to use (or not use) the product, health and
safety information to be read and understood before using a pesticide
product, and how to dispose of that product. This benefits users by
enhancing their ability to obtain antimicrobial pesticide products
appropriate to their needs, and to use and dispose of products in a
manner that is safe and environmentally sound. Applicators/users may
benefit from label information based on the data submitted to the
extent it helps inform their decisions about whether or how to use
particular pesticides to avoid potential exposure.
D. What is the Agency's Authority for Taking this Action?
This action is issued under the authority of sections 3, 4, 5, 10,
12, and 25 of FIFRA as amended and section 408 of FFDCA. The data
required for a registration, reregistration, experimental use permit,
or tolerance are listed in 40 CFR part 158.
III. Statutory and Historical Framework
A. FIFRA
Under FIFRA section 3, every pesticide product must be registered
with EPA or specifically exempted under FIFRA section 25(b) before
being sold or distributed in the United States. Under FIFRA, an
applicant for a new registration or an existing registrant
(collectively referred to as applicant in this proposal) must
demonstrate to the Agency's satisfaction that, among other things, the
pesticide product, when used in accordance with widespread and commonly
recognized practice, will not cause ``unreasonable adverse effects'' to
humans or the environment. This safety determination requires the
Agency to weigh the risks of the use of the pesticide against any
benefits. EPA must determine that the standard for registration
contained in FIFRA is met before granting a registration.
1. Registration. Section 3 of FIFRA contains the requirements for
registration. Specifically, FIFRA section 3(c)(2) provides EPA broad
authority, before and after registration, to require scientific testing
and submission of the resulting data to the Agency by applicants for
registration of pesticide products. An applicant must furnish EPA with
substantial amounts of data on the pesticide, its composition,
toxicity, potential human exposure, environmental properties, and
ecological effects, as well as information on its product performance
(efficacy) in certain cases. Although the data requirements are imposed
primarily as a part of initial registration, EPA is authorized under
FIFRA section 3(c)(2)(B) to require a registrant to develop and submit
additional data to maintain a registration.
2. Reregistration. FIFRA section 4 requires that EPA reregister
each pesticide product first registered before November 1984. This date
was chosen because pesticides registered after 1984 were subject to the
part 158 requirements of the 1984 regulation.
[[Page 59385]]
EPA has completed the reregistration/tolerance reassessment process for
food-use pesticides and expects to complete all reregistration
activities by the statutory deadline of August 2008.
3. Registration review. FIFRA section 3(g) mandates that the
registrations of all pesticides are to be periodically reviewed.
Changes in science, public policy, and pesticide use practices occur
over time. Through the new registration review program implemented via
a regulation promulgated on August 9, 2006 (71 FR 45719) (40 CFR part
155, subpart C), the Agency is periodically reevaluating all registered
pesticides to assure that they continue to meet the statutory standard
of no unreasonable adverse effects. Starting in 2006, registration
review began to replace EPA's reregistration program as the mechanism
for systematic review of existing pesticides. The registration review
process begins by reviewing the available information in the possession
of the Agency and then determining the specific data needed for
assessing a particular pesticide. Thus, the data needed, and the scope
and depth of the Agency's review will be tailored to the specific
circumstances of a particular pesticide. This means that reviews will
be commensurate with the complexity of the issues associated with each
pesticide.
4. Experimental Use Permits (EUPs). Subject to some exceptions,
FIFRA section 5 requires persons seeking permission for experimental
use of a pesticide under controlled condition to obtain an experimental
use permit. A EUP allows limited use of a pesticide for specified
experimental and data collection purposes intended to support future
registration of the pesticide. Because a EUP is for limited use under
controlled conditions, the data needed to support issuance of the
permit are correspondingly less than those required for full
registration. The regulations governing the issuance of EUPs are found
in 40 CFR part 172. In its final rule ``Data Requirements for
Conventional Pesticides'' EPA promulgated subpart C of part 158 to
contain the data requirements for EUPs, which will be applied on a
case-by-case basis to any EUP applications for an antimicrobial
pesticide.
5. Registration requirements for antimicrobials. FIFRA section 3(h)
requires that EPA evaluate its registration process to identify
improvements and reforms that will reduce historical review times for
antimicrobial applications. This includes defining the classes of
antimicrobial use patterns and the types of application review,
conforming reviews to risks and benefits, ensuring efficacy, and
meeting review time goals. EPA believes that this rule assists in
meeting the section 3(h) mandate. By defining the 12 use patterns for
antimicrobials in relation to the data required for a registration
under FIFRA, EPA is providing clearer and more transparent information
to applicants. This should result in submissions to EPA that contain
the required data and therefore can be reviewed and evaluated more
expeditiously.
B. FFDCA
FFDCA requires EPA to determine that the level of pesticide
chemical residues in food and feed will be safe for human consumption.
The safety standard set under FFDCA section 408(b) and (c) defines safe
as ``a reasonable certainty that no harm'' will result from exposures
to pesticide chemical residues. The combination of aggregate and
cumulative exposure assessments required by FFDCA section 408 increases
the nature and scope of EPA's risk assessment, and potentially
increases the types and amounts of data needed to determine that the
FFDCA safety standard is met.
Under FFDCA section 408, EPA is authorized to establish tolerances
for pesticide residues in food and feed, or to exempt a pesticide from
the requirement of a tolerance, if warranted. In this preamble,
references to tolerances include exemptions from tolerance since the
standards and procedures for both are the same. The safety standard
applies to tolerances in a number of regulatory situations, including:
Tolerances that support registration under FIFRA;
Tolerances for imported products which are established to
allow importation of pesticide-treated commodities, but for which no
U.S. registration is sought;
Time-limited tolerances which are established for FIFRA
section 18 emergency exemptions; and
Temporary tolerances established for experimental use
permits under FIFRA section 5.
C. Linking FIFRA and FFDCA Safety Standards
Under FIFRA section 2(bb), a pesticide that is inconsistent with,
or does not meet, the FFDCA section 408 safety standard poses an
unreasonable adverse effect that precludes new or continued
registration. Given this linkage between registration and tolerances,
it makes sense for EPA to define data requirements for both purposes:
The data required to support a determination of ``reasonable certainty
of no harm'' under FFDCA are an integral part of the data needed for an
``unreasonable adverse effects'' determination under FIFRA.
Consequently, when promulgated, these proposed data requirements would
encompass the basic data requirements for both registration and
tolerance-setting determinations. EPA has authority to require
additional data on a case-by-case basis.
D. Scope of Proposed Subpart W
FIFRA contains a number of provisions specific to ``antimicrobial
pesticides'' as defined in FIFRA section 2(mm). The statutory
definition contains a complex construction of functionality, types of
organisms, and intended use to describe what is encompassed by the term
``antimicrobial pesticide.'' EPA believes that the definition was
primarily intended to be used in conjunction with the provisions of
section 3(h), which contains requirements for process improvements,
timeframes for review purposes, and other regulatory matters, but,
significantly, does not include provisions pertaining to data
requirements. The definition in section 2(mm) as it relates to section
3(h) was discussed fully in a proposed rule issued in the Federal
Register of September 17, 1999 (64 FR 50672).
The statutory definition, however, does not mesh with the Agency's
needs in developing this proposed rule concerning data requirements.
Data requirements depend upon the use pattern, taking into account the
pesticide's hazard and exposure profiles. How well the pesticide kills
or repels particular pests are relevant factors in the determination of
product performance data requirements.
Neither FIFRA section 3(c)(2) nor section 3(h) requires the Agency
to develop data requirements for an ``antimicrobial pesticide'' as
defined specifically in section 2(mm). Therefore, the scope of this
proposal has been expanded beyond ``antimicrobial pesticide'' as
defined by FIFRA section 2(mm) to include related pesticides that are
excluded from the 2(mm) definition. The broader applicability of this
40 CFR part 158, subpart W is intended to ensure that all pesticides
currently considered as antimicrobial products for purposes of FIFRA
section 33 fees and review periods are covered.
Accordingly, this proposal applies to:
Antimicrobial pesticides, as defined in FIFRA section
2(mm).
Pesticide products for antimicrobial uses in/on food or
feed.
Antifoulant paints and coatings.
[[Page 59386]]
Wood preservatives.
Pesticide products intended to be manufactured into any of
the above.
IV. Introduction to Subpart W
A. Data Requirements for Registration
First promulgated in 1984, EPA's pesticide data requirements
outline the kinds of data and related information typically needed to
register a pesticide. In this proposal, the data requirements are
organized by scientific discipline (e.g., toxicology), just as the
existing data requirements in part 158 for conventional, and
biochemical and microbial pesticides and those in part 161 for
antimicrobials. A significant change in this proposal from the existing
data requirements in part 161 is the introduction of 12 use patterns
specific to antimicrobials. Since there is much variety in pesticide
chemistry, exposure, and hazard, the requirements are designed to be
flexible. Test notes to the data requirements tables explain the
conditions under which data are typically needed. Essentially, the data
requirements identify the questions that the applicant will need to
answer regarding a pesticide product before the Agency can register it.
Data requirements address both components of a risk assessment, i.e.,
the hazards that the pesticide presents, and the estimated level of
exposure to humans or nontarget species. Having the appropriate
information enables the Agency to understand when those hazards pose
risks. The answer to one question may inform the kind of information
needed to answer other questions. For example, a pesticide that is
persistent and toxicologically potent may require more extensive
exposure data to help establish a safe level of exposure. In addition,
because a number of antimicrobials are used for public health purposes
(for example, disinfectants, sterilants, or sanitizers), there are
product performance data requirements to assure that the antimicrobial
product works as intended.
B. Structure of Part 158
At this time data requirements for conventional, biochemical, and
microbial pesticides are established in 40 CFR part 158. Data
requirements for antimicrobial pesticides are established in 40 CFR
part 161.
Part 158 contains general provisions concerning all pesticide data
(subpart A), instructions on how to use the data tables that follow
(subpart B), and a series of disciplinary data tables that are focused
on conventional pesticides (subparts C - O). Individual subparts are
devoted to biochemical (subpart U) and microbial (subpart V)
pesticides. The revised data requirements for antimicrobial pesticides
would be incorporated into part 158 as subpart W.
C. Subpart W of Part 158
Subpart W is proposed to be a freestanding series of tables and
regulatory text establishing specific data requirements for each
scientific discipline for antimicrobial pesticides. EPA recognizes that
antimicrobial uses are generally different from the uses more typically
associated with conventional pesticides (e.g., agricultural outdoor
uses) and therefore can have different combinations of exposure
considerations. The use patterns and expected exposures typically
determine the data requirements for any pesticide. Antimicrobial
pesticides are no different in this regard from conventional,
biochemical, and microbial pesticides.
The order of proposed subpart W mirrors that of the larger part
158: from product chemistry, to efficacy, to hazard/toxicity
requirements (both human health and ecological toxicity), to exposure
data requirements (application and post-application human exposures,
and exposure to residues in food), and environmental fate requirements,
which overlap human exposure through drinking water. Units V-XIV of
this preamble describe the revisions to the current requirements. The
proposed data requirement tables are comprehensive. Generally, the data
requirements for each discipline are discussed separately, but the
applicator and post-application exposure disciplines are discussed
together in a single unit.
D. Clarifying How to Use the Data Tables
Part 158 subpart B contains a step-wise process to assist the
applicant in determining the data needed to support its particular
product. At this time subpart B is specific to the needs of
conventional, and biochemical and microbial pesticides. The process
needed for antimicrobials is no different. EPA is proposing certain
clarifying changes to subpart B to specify the needs of antimicrobial
pesticides. Specifically, EPA proposes to include antimicrobial use
patterns in Sec. 158.100 and a reference to the antimicrobial use site
index that will be available on the EPA website.
While EPA is attempting to assist the applicant in subpart B, it is
important to emphasize that it is the applicant's obligation under
FIFRA to demonstrate that an individual product meets the standard
under FIFRA and that of FFDCA. Accordingly, applicants are encouraged
to consult with the Agency on the appropriate data requirements, as
proposed here, as related to their specific product prior to and during
the registration process.
EPA is continuing its current system of identifying the
applicability of data requirements in the data tables. In essence, the
data requirements illustrate the questions the registrant will need to
answer about the safety of the pesticide product before the Agency can
register it. Because of the variety of chemicals and use patterns, and
because EPA must retain flexibility to tailor data requirements as
appropriate, only qualitative descriptors are in the tables. Test notes
provide more specific information on the applicability of specific data
requirements.
The table descriptors NR (not required), R (required), and CR
(conditionally required) should be viewed as a general presentation,
indicating the likelihood that the data requirement applies. The use of
R does not necessarily indicate that a study is always required, but
that it is more likely to be required than not. For example, if the
applicant wanted to apply his pesticide to apples, then crop field
trials would be required almost always on apples. However, if the
physical/chemical properties of the chemical did not lend themselves to
the test, such as performing an inhalation test with a chemical that is
a solid and has an extremely low vapor pressure, then a waiver might be
granted. Generally test notes for R studies discuss any particular
circumstances when the testing might not be required.
The use of CR means a study is less likely to be required. Triggers
in the test notes indicate the circumstances under which the Agency has
learned through experience that the information is needed. Although
only an approximation, if percentages were to be assigned to indicate
the need for a particular study, then R could be viewed as representing
the submission of a study 50% to 100% of the time and CR would be up to
50%.
Thus, NR, R, and CR are used for convenience to make the table
format feasible, but serve only as a general indication of the
applicability of a data requirement. In all cases, the test notes
referred to in the table must be consulted to determine the actual need
for the data. Applicants are also encouraged to visit the Agency's
website, entitled ``Data Requirements for Pesticide Registration'' (see
https://www.epa.gov/pesticides/regulating/data_requirements.htm). Since
it is not
[[Page 59387]]
possible to sufficiently delineate all circumstances in test notes,
consultation with EPA is encouraged.
The table format includes a column heading entitled ``Guideline,''
which refers to the OPPTS (Office of Pollution Prevention and Toxic
Substances) Harmonized Test Guidelines. Guideline numbers are provided
as information/guidance to applicants. These Guidelines set forth
recommended instructions and test methods for performing a study to
generate the required data. Since these are guidance documents, the
applicant is not required to use these Guidelines, but may instead seek
to fulfill the data requirement by other appropriate means such as
alternative test methods, submission of an article from open
literature, or use of modeling. The applicant may submit a protocol of
his own devising for the Agency to review. However, the OPPTS
Harmonized Guidelines have been developed through a rigorous scientific
process, including extensive peer review by the FIFRA Scientific
Advisory Panel. Additionally, many of the Guidelines have been
harmonized internationally. As such, they represent the recommended
approach to developing high-quality data that should satisfy EPA's data
needs for risk assessment.
E. The Nature of Changes to Requirements
Proposed subpart W does not differ greatly from the data
requirements for conventional pesticides promulgated in October 2007.
Where this proposal differs is in the explicit adaptation of those data
requirements to antimicrobials. As previously discussed, antimicrobial
uses were covered in the original (1984) part 158. However part 158
(now transitioned for antimicrobials as part 161) was developed
primarily for agricultural pesticides. Since the use patterns which now
appear in tables in part 161 are not specific to antimicrobials, often
it has been difficult to discern directly from such tables the data
requirements for certain antimicrobials. Without extensive consultation
with and interpretation from the Agency, frequently it has been
difficult for applicants to effectively use the tables to determine
which data requirements apply to antimicrobials.
Today's proposal reflects the Agency's current needs for risk
assessment of antimicrobials. Describing the antimicrobial data
requirements in terms of use patterns specific to antimicrobial uses
provides a clarity that should reduce the need for extensive
consultations.
There are nine new data requirements for antimicrobials set out in
this proposal. Two (developmental neurotoxicity and immunotoxicity) are
the same new data requirements as promulgated in the final rule for
conventional chemicals (72 FR 60934) (see Unit VIII). While
photodegradation in soil studies have been routinely required for
conventional chemicals, this study would be a new data requirement for
wood preservatives (see Unit XII). Similarly, two new exposure data
requirements (soil residue dissipation and non-dietary ingestion
exposure) are today proposed for antimicrobials (see Unit IX.D).
Four new data requirements (activated sludge sorption isotherm
study; ready biodegradability study; porous pot study; and modified
activated sludge, respiration inhibition test) are proposed today for
antimicrobials that are not included in the final rule for conventional
pesticides. This is due to the nature of antimicrobial pesticides,
which includes many down-the-drain uses, i.e. those discharged to
public treatment systems, and is discussed in Units XII.B. and C.
Most screening-level environmental fate assessments would be
performed using the hydrolysis, photodegradation in water, activated
sludge sorption isotherm, ready biodegradability, and modified
activated sludge, respiration inhibition tests. For wood preservatives,
the results of the photodegradation in soil study may also be
considered in the screening-level assessment. If the porous pot study
is triggered based on the results of the ready biodegradability study,
then those results would also be considered.
EPA notes that its proposed approach for performing a screening-
level fate assessment could potentially result in the submission of
higher-tiered studies. There are seven higher-tiered environmental fate
studies, that could be triggered based on a weight-of-evidence
evaluation of the results of the screening-level studies. For example,
if the screening-level assessment were to indicate that a down-the-
drain chemical would partition to sludge, soil, or sediment, then
higher-tiered environmental fate studies such as the aerobic and
anaerobic soil metabolism studies may be required. If the chemical
would partition to water then higher-tiered ecotoxicity studies such as
the fish early life stage may be required. Thus, the higher-tiered
studies that could be triggered include both the environmental fate and
ecotoxicity scientific disciplines.
While not a new data requirement, subchronic dermal testing of end-
use products has not been routinely required and therefore would be
considered a new testing requirement. The circumstances for requiring
the testing is the same as for conventional chemicals. (See Unit VIII).
Each data requirement proposed in Units, VIII, IX, X, XII, XIII,
and XIV is described as ``new,'' ``current practices,'' or
``existing.'' ``New'' means that the data requirement has never been
required or has rarely been required on a case-by-case basis, and has
not been routinely considered during the Agency's evaluation of the
data needed for the purpose of risk assessment.
``Current practices'' encompasses the data that is typically
required to register an antimicrobial pesticide product. This would
include existing data requirements that are codified in part 161 as
well as those that are not codified in part 161 and are now being
proposed for codification in part 158, subpart W. It would also include
any study that has been routinely required on a case-by-case basis, or
any study that is routinely considered during the Agency's evaluation
of the data needed for the purpose of risk assessment but is
infrequently required because the triggers for that study are
infrequently met.
``Existing'' requirements are a subset of ``current practices.''
This particular subset means that the data requirement is codified in
part 161 and being transferred to part 158, subpart W either ``as is''
or with specified changes to the test notes, to the Rs, CRs, and NRs,
or to the use patterns for which required. If there are proposed
revisions to an existing data requirement, then clarifications on these
proposed revisions are included in the preamble. Such revisions include
proposing changes such as a change from conditionally-required to
required, a change in the number of test species, or expanding the
number of use patterns for which the test is required.
As previously discussed, there are frequently consultations to
discern data requirements for certain of the antimicrobial use
patterns. These consultations have led to general understandings as to
the data required for a particular use pattern. For certain use
patterns, all of the studies are considered to be the Agency's current
practices. As an example, for the wood preservative use patterns, there
is not a good fit to any of the part 161 use patterns in the tables and
therefore the data needed to register a wood preservative is difficult
to interpret from those tables. Given these circumstances,
[[Page 59388]]
EPA developed a series of requirements developed specifically for wood
preservatives. These requirements are not codified in CFR, but the
applicants understand that these are the data needed for wood
preservatives and they routinely provide these studies to EPA.
F. Tiered Data Requirements
The Agency has organized the proposed requirements for
antimicrobial pesticide products to support a tiered testing approach.
Under such an approach the Agency prescribes a specific subset of
``lower tier'' studies that are conducted first. The results of this
first- or lower-tiered testing are then used in conjunction with
exposure data or other information to determine the need for more
complex ``higher tier'' studies. The risk assessment must provide
sufficient information to make the risk management decisions needed to
register the product or establish a tolerance. This is a significant
factor in the tiering process.
Data requirements have been tiered when EPA believes it can
adequately conduct a risk assessment using a tiered approach. The
conditions for ``triggering'' these higher tiered studies are specified
in the test notes to the tables in proposed subpart W. A tiered data
submission process is intended to allow the Agency to assess a
pesticide's risk without requiring the applicant to conduct and submit
studies that may not be needed for the regulatory decision. For certain
chemicals, data from lower tiered requirements may be sufficient in and
of themselves or in combination with other data to address the Agency's
risk concerns without submission of higher tiered data requirements. In
other cases, data from lower tiered requirements may indicate that
higher tiered data need to be provided. The Agency expects applicants
to consult with the Agency, as needed, to determine when submission of
higher tiered data may be required.
The Agency has tiered the data requirements based on an
understanding of the potential exposure for a specific use pattern. As
an example, for toxicology studies used to support human health risk
assessments, the high human exposure grouping specifies 19 toxicology
studies as required at the lower tier. The low human exposure grouping
specifies 13 toxicology studies as required. The Agency considered the
frequency, duration, and/or magnitude of the exposure to determine the
lower tier of toxicology testing requirements for both the high and low
human exposure groupings.
For ecotoxicity data requirements, the Agency requires a first tier
of required data for all antimicrobials regardless of the use pattern.
The need for higher tiered data depends not only on the frequency,
duration, or magnitude of the exposure, but also on the results of the
first tier of the data.
Such a flexible approach allows EPA to require enough data, but not
more than enough, to make the required safety finding. Such an approach
is the same as that used for other pesticides; however, for
antimicrobials the progression from lower to higher tier requirements
may differ from that of conventional pesticides because the uses and
expected exposures are different.
G. Impact of this Proposal on Future and Existing Registrations
This proposal concerns prospective data requirements for future
registrations of antimicrobial pesticides. That is, these proposed data
requirements, once final, would apply to all new applications for
registration of antimicrobial pesticides submitted after the effective
date of the rule. The new data requirements would also apply to
applications of antimicrobial pesticides that are undergoing Agency
review when the new regulation goes into effect. EPA believes that
there may be a need for some type of a limited transition ``window''
for certain antimicrobial registration applications. EPA anticipates
applicants of applications that were submitted, but not yet approved
when the new regulations go into effect, may need to discuss with EPA
the specifics of their application and whether additional time may be
needed to complete generation of certain studies that may then be
required to fulfill new data requirements. The Agency specifically
requests comment on implementing the effective date of the final rule
for antimicrobials with regards to future registrations of
antimicrobials.
The Agency does not intend to apply these requirements
automatically or routinely to all existing pesticide registrations.
While EPA intends a flexible approach to imposing the new requirements
upon existing products, the Agency may find it necessary to call-in
data on certain existing registrations, for example, as warranted by
emerging risks of concern for particular pesticides or as a result of
possible future programmatic changes and priorities on existing
pesticides, or during registration review.
However, EPA notes that issuance of this proposed rule provides
notice to applicants of potential new data requirements and of
potential expansion of existing data requirements to additional
antimicrobial use patterns. Applicants and potential applicants for new
registrations as well as registrants of existing products may wish to
evaluate their products in light of the proposed requirements. As
always, the Agency encourages applicants to consult with EPA, if they
have any questions regarding data requirements.
H. Weight-of-Evidence Approach
The weight-of-evidence (WOE) approach is referenced in several
subpart W test notes. Such an approach requires a critical analysis of
the entire body of available data for consistency and biological
plausibility. Some considerations in this approach are listed below:
Sufficiency of data. Studies that completely characterize
both the effects and exposure of the agent have more credibility and
support than studies that contain data gaps.
Quality of the data. Potentially relevant studies are
judged for quality and studies of higher quality are given more weight
than those of lower quality.
Evidence of causality. The degree of correlation between
the presence of an agent and some adverse effect is an important
consideration.
Corroborative information. Supplementary information
relevant to the conclusions reached in the assessment is incorporated,
e.g., studies demonstrating agreement between model predictions and
observed effects.
WOE considers the kinds of evidence available, how that evidence
fits together in drawing conclusions, and significant issues/strengths/
limitations of the data and conclusions. WOE is not simply tallying the
number of positive or negative studies.
I. Use Patterns in Subpart W
The general use pattern groups described in subpart B of part 158
are not used as the bases for describing antimicrobial data
requirements. Those general use patterns were developed for and are
appropriate to conventional pesticide chemicals.
Some years ago, 12 use categories were developed specifically for
antimicrobials. At that time the Agency's data requirements for all
pesticide chemicals were specified by use patterns developed for and
appropriate to conventional pesticide chemicals. To fit antimicrobial
uses into this agricultural scheme, the antimicrobial use categories
referred back to the then-existing use patterns. With the Agency's
intention to establish specific data requirements for
[[Page 59389]]
antimicrobials in subpart W, this referral is no longer needed.
Therefore, the Agency is proposing that the use categories employed
in recent years to generalize the range of uses for individual
antimicrobial pesticide chemicals, now constitute the use patterns for
specifying the antimicrobials data requirements in the tables in
proposed subpart W. Additionally, EPA is proposing to codify in Sec.
158.2201 the specific use patterns for antimicrobials.
FIFRA section 3(h)(3)(A)(ii)(I) requires that EPA ``define the
various classes of antimicrobial use patterns.'' For antimicrobial
pesticides, the Agency proposes to structure its requirements by using
a system of 12 use patterns based on similarity of use, purpose,
pesticidal function, the nature of the exposure, and, in some cases,
application methods. Today's proposal meshes with the statutory mandate
to identify classes of antimicrobial use patterns by defining for each
use pattern the data requirements that apply. EPA requests comment not
only on the 12 antimicrobial use patterns described in this Unit, but
also on the usefulness of these use patterns. EPA also requests comment
on whether or not any different/additional use patterns should be
codified by splitting or recombining the existing use patterns to make
separate and distinct use patterns.
Antimicrobial use patterns also reflect environmental concerns for
indoor versus outdoor use, as well as food versus nonfood-use, and high
versus low human exposure. The 12 general use patterns for
antimicrobial pesticides are described below. Examples within each use
pattern are provided:
1. Agricultural premises and equipment. This use pattern includes
many indirect food uses with mostly indoor use sites.
Farm and farm animal premises such as animal houses and
pens (including milk houses), parlors, stalls, and barns.
Transportation vehicles used to transport animals.
Equipment such as forks, shovels, scrapers; halters,
ropes, other restraining equipment; racks, mangers, feeders, waterers,
troughs, and fountains.
Food-handling equipment such as milking equipment.
2. Food-handling/storage establishments, premises, and equipment.
This use pattern also includes many indirect food uses due to the
treatment of food contact surfaces and the resultant human exposures.
All use sites are indoor.
Food or feed processing plants.
Eating establishments such as restaurants and cafeterias.
Food storage or distribution facilities.
Commercial transportation vehicles, shipping, and storage
containers.
Food or feed stores and markets.
Vending machines.
3. Commercial, institutional and industrial premises and equipment.
This use pattern includes nonfood contact areas of commercial sites.
Typically, antimicrobial pesticides would be applied to ceilings,
doors, doorknobs, fixtures, floors, light switches, stairs, walls,
windows, and woodwork as part of routine cleaning practices. Included
within this use pattern are residential school and daycare
institutions.
This use pattern includes both indoor and outdoor uses. Some of the
uses have the potential for significant exposure due to the repetitive
nature of certain exposures and therefore may be considered as high
human exposure.
4. Residential and public access premises. This use pattern
includes mostly nonfood areas, although it includes food-handling areas
in homes. Some of the uses have the potential for significant exposure
due to the repetitive nature of certain exposures and therefore may be
considered as high human exposure. Most uses are indoor.
Premises, contents, and equipment of homes, apartments,
mobile homes and shelters, including home-based daycare.
Public areas, public buildings, and public rooms.
Commercial kennels, or living quarters of pets, zoo
animals, race horses, or laboratory animals.
5. Medical premises and equipment. Medical waste is defined as any
solid waste that is generated in the diagnosis, treatment, or
immunization of human beings or animals, in research pertaining
thereto, or in the production of biologicals including, but not limited
to, culture and stocks, pathological wastes, human blood and blood
products, and sharps. This use pattern is considered to be indoor
nonfood. Some of the uses have the potential for repeated exposure and
therefore may be considered as high human exposure.
Hospital or medical environments such as clinics, dental
offices, nursing homes, sick rooms, morgues, and veterinary clinics.
Non-critical medical equipment such as bedpans, basins,
and furniture.
6. Human drinking water systems. Human drinking water systems
include any methods used to provide potable water from raw water
supplies. This use pattern is considered to be high human exposure due
to the potential for human exposures via drinking water, as well as
dermal exposures to the treated water.
Public water systems.
Individual water systems.
Emergency water systems.
Water purifier units.
Private water systems of individual homes, farms,
institutions, camps, resorts, and industrial plants.
Emergency water systems for the public, campers,
travelers, military, and fishermen.
7. Materials preservatives. Materials preservatives are
antimicrobial chemicals added during industrial processes to prevent
the growth of microorganisms. Examples of such uses include paints,
coatings, adhesives, textiles, and paper. This use pattern includes
food and nonfood, and mostly indoor uses.
8. Industrial processes and water systems. Certain antimicrobial
chemicals, known as microbiocides, are used to control the growth of
bacteria, fungi, and algae in circulating water systems. There are two
types of systems: ``once-through'' and ``recirculating.''
For ``once-through'' systems, the water is not re-used and is
therefore released into the aquatic environment or a wastewater
treatment plant after a single cycle through the system. Once-through
uses have the potential for significant environmental exposure when the
treated water is released to the environment. Large volumes of water
(as much as millions of gallons per minute) may be released directly to
a river, estuary, or marine environment within minutes or hours of
adding the antimicrobial to the system. In addition to the potential
for environmental exposure after release, there is the potential for
high human exposure via drinking water if the intake pipe for a
drinking water treatment plant is downstream. Also, the water could be
used in crop and/or livestock production thus providing for additional
human exposure.
However, for many uses of water in industrial plants the treated
water is re-used repeatedly within the system, ``recirculating'' in the
system multiple times until released into the aquatic environment or a
wastewater treatment plant. EPA has assumed that the releases are
scheduled as the antimicrobial has been ``used-up.'' Given the lower
frequency of release, resulting in lower volumes released to the
environment, recirculating uses are likely to have less environmental
exposure than that of once-through systems.
As will be explained later in Unit XI, for the purposes of
determining data requirements for environmental fate and
[[Page 59390]]
ecological effects, the industrial processes and water systems use
pattern will be subdivided. Because of the distinct differences between
the once-through and recirculating water systems, the once-through
water system will be grouped with those use patterns with potential for
higher environmental exposures and the recirculating water system with
those use patterns with the potential for lower environmental
exposures.
9. Antifoulant paints and coatings. Antifoulants are coatings and
paints applied to boat hulls and bottoms, crab and lobster pots, and
underwater structures or equipment to control the growth of freshwater
or marine fouling organisms. Antifoulant coatings have the potential
for high environmental exposure most particularly for marine (both
freshwater and saltwater) environments.
Also included within this use pattern is ballast water, that is,
the water that is pumped in and out of ballast tanks as a ship's weight
changes due to loading and unloading of cargo. Ballast water provides
needed stability for safe operation of marine vessels. In recent years
there have been significant concerns about transport of marine species
from one marine environment to another in ballast water. When
discharged into a new environment, the new species may become invasive
and disrupt the native ecology. Ballast water treatments (such as
adding an antimicrobial to the ballast water before discharge) are
intended to prevent this. The Agency has reviewed few applications for
ballast water treatments, presumably because treatment of ballast water
to prevent the transfer of microorganisms from one marine environment
to another is relatively new. Since ballast water treatments also have
the potential for high exposure to the aquatic (both freshwater and
seawater) environment, EPA has grouped the ballast water treatment
pesticide chemicals with the antifoulant coating pesticide chemicals.
10. Wood preservatives. Wood preservative products are those which
claim to control wood degradation problems due to fungal rot or decay,
sapstain, molds, or wood-destroying insects. This use pattern has the
potential for high exposure for both humans and the environment with
mostly outdoor use sites. Certain uses can be food-uses. The types of
wood and the products that can be manufactured with this treated wood
are:
Freshly cut logs or lumber.
Seasoned building materials.
Utility poles, fence posts and rails.
Structural members.
Structures and dwellings.
Transportation vehicles (truck beds and support
structures).
Crop containers.
Lawn furniture and decks.
Playground equipment.
Garden/landscape timbers.
Log homes.
11. Swimming pools. Products in this use pattern are used to
prevent/control the growth of bacteria or algae in the water systems of
swimming pools, Jacuzzis, and hot tubs. This use pattern is considered
to be high human exposure. Under routine use little or no environmental
exposure is expected, as the water in swimming pools, Jacuzzis, or hot
tubs is considered to be separated from the natural environment.
However, when draining is needed, depending on the volume of water and
the location of the pool or hot tub, it is most likely that discharge
would be down-the-drain to a wastewater treatment plant, to a storm
drain that discharges to a stream, or directly to soil.
12. Aquatic areas. Products in this use pattern are designed to
control or kill slime-forming bacteria, fungi, or algae in lakes,
ponds, streams, drainage ditches, and other bodies of water. In
addition to the potential for environmental exposure, there is the
potential for high human exposure via drinking water if the intake pipe
for a drinking water treatment plant is in a lake or downstream, or
through recreational activities such as swimming. Also, the water could
be used in crop and/or livestock production thus providing for
additional human exposure.
J. Use Site Index
As part of this action, the Agency is proposing to place on its
website an Antimicrobial Use Site Index similar to the existing
Pesticide Use Site Index at https://www.epa.gov/pesticides/regulating/
usesite/index.htm. Information similar to that which would be included
on the Antimicrobial Use Site Index is included in the docket for this
action (Ref. 41). The existing Pesticide Use Site Index will be re-
titled, the Pesticide Use Si